e </w>
s </w>
t h
i n
d </w>
o n
a n
e r
t </w>
t i
th e</w>
e n
r e
, </w>
y </w>
a l
o r
f </w>
e d</w>
o f</w>
. </w>
on </w>
a r
o </w>
an d</w>
r o
g </w>
a t
in </w>
s t
a </w>
i c
a ti
al </w>
e s</w>
in g</w>
t o</w>
s i
er </w>
e c
c o
e l
a c
or </w>
a s
d i
u r
i t
a s</w>
( </w>
u n
) </w>
i s</w>
u l
en t</w>
i l
m </w>
ati on</w>
e s
m p
th </w>
c h
t s</w>
o l
a t</w>
p ro
c on
re s
l </w>
a p
an </w>
; </w>
w i
v e</w>
o s
s u
t r
e x
ti on</w>
l y</w>
q u
d e
f or</w>
en </w>
u s
a b
l e
o w
wi th</w>
m e
a g
i s
h </w>
t er
o t
l e</w>
c e</w>
o p
v i
i g
er e</w>
m ent</w>
a d
on s</w>
f f
o u
0 </w>
th at</w>
a m
s e
p </w>
s h
at ed</w>
w h
o m
i r
1 </w>
l i
o c
co mp
c l
b y</w>
at e</w>
w as</w>
r i
d u
b e
k </w>
p er
ar e</w>
v er
t ed</w>
: </w>
f or
it y</w>
ti c
2 </w>
ic </w>
w ere</w>
n o
en ts</w>
b e</w>
s p
n e
5 </w>
u d
p l
g en
st r
m a
ar </w>
2 0
h a
e m
co m
p ar
th is</w>
si on</w>
u m
v el
re c
ur e</w>
qu ot
t e
& quot
&quot ;</w>
p h
en t
m o
f ro
3 </w>
fro m</w>
i d
t w
ro u
/ </w>
th er</w>
g n
p res
t a
i t</w>
i </w>
i m
er s</w>
4 </w>
no t</w>
i f
as e</w>
en ce</w>
ig h
o ur
an t</w>
n </w>
du c
p or
o g
p re
b u
c </w>
ti m
ic al</w>
th e
t er</w>
o b
al l</w>
in ter
p o
an y</w>
in e</w>
ati ons</w>
% </w>
a f
c el
si gn
ti ve</w>
ch </w>
l ow
on al</w>
e v
ar y</w>
si s</w>
6 </w>
re d</w>
s c
d s</w>
p ati
for m
s er
in c
ab le</w>
w e</w>
e ar
b o
en ti
es s</w>
an g
& #
d ing</w>
g rou
&# 9
t y</w>
al ly</w>
on e</w>
f i
e t</w>
s o</w>
an ce</w>
con t
i al</w>
e ff
m or
8 </w>
u s</w>
i mp
u t
i z
ag e</w>
ha ve</w>
re g
w </w>
t re
s y
ic h</w>
st ud
l o
ap os
& apos
o d</w>
r a
c or
com m
h e
an c
20 0
re s</w>
s ec
e st
ti ons</w>
7 </w>
wh ich</w>
un d
i es</w>
p a
en d
our </w>
h as</w>
w il
or s</w>
stud y</w>
su b
m in
pati ents</w>
sp ec
f ac
in g
di ff
as s
res p
o ther</w>
&apos ;
ec t</w>
h i
it s</w>
l s</w>
es e</w>
e p
9 </w>
m on
v ed</w>
0 .
re l
tr an
en c
tic </w>
f in
wil l</w>
i d</w>
c an</w>
es t</w>
t ing</w>
al so</w>
grou p</w>
a y</w>
in v
b er</w>
us e</w>
&apos; s</w>
m ar
s e</w>
ou s</w>
s t</w>
d r
th er
i p
g r
as ed</w>
f l
u c
ul d</w>
mor e</w>
ol og
ir </w>
if ic
res ul
p r
u m</w>
o un
diff er
ti es</w>
e ment</w>
ou t</w>
at es</w>
b </w>
es s
d e</w>
w or
un c
th ese</w>
n o</w>
ic e</w>
ati ve</w>
i a</w>
d el
t u
20 1
t o
al y
ti v
tim e</w>
os e</w>
be en</w>
a mp
tre at
p e
as t</w>
on g</w>
th an</w>
w e
ma y</w>
af ter</w>
m an
b i
b l
cl ud
d at
or y</w>
cel ls</w>
bu t</w>
d ec
v al
p ri
g o
a y
t ec
ar g
y p
d ic
b r
us ed</w>
e en</w>
f ir
as es</w>
- </w>
an aly
c ur
be tw
ul ar</w>
m il
betw een</w>
inc re
sh ow
re por
vel op
sign ific
ar i
comp any</w>
treat ment</w>
de velop
st e
0 0</w>
ac h</w>
f ol
an ti
s ur
a u
an d
a in
el y</w>
k e</w>
f e
igh t</w>
co l
om e</w>
cont ro
gen er
ch ang
the ir</w>
su ch</w>
g h</w>
di s
co un
in clud
h y
1 ;</w>
&#9 1;</w>
&#9 3
&#93 ;</w>
p os
pro duc
me th
dat a</w>
pro vi
resp on
su p
ar d</w>
m at
per i
f er
tw o</w>
il ity</w>
x </w>
le vel
ex pres
v er</w>
am e</w>
d ed</w>
us ing</w>
a v
d er
it ed</w>
c r
j ec
d er</w>
o uld</w>
t en
b le</w>
resul ts</w>
f r
re qu
h igh
t e</w>
u p
tran s
op er
h ow
c ar
at ing</w>
u e</w>
g l
v </w>
al s</w>
1 9
pro te
il e</w>
pro c
c a
ap pro
f ig
n um
t ly</w>
di rec
th ere</w>
v ari
m s</w>
ati onal</w>
k ing</w>
re e</w>
al l
p u
cl in
tr i
eff ec
oc i
a d</w>
fol low
m os
s el
k s</w>
t ors</w>
wi th
d ur
form ation</w>
ec ted</w>
in f
ser v
me as
v en
ti onal</w>
in to</w>
sh a
on ly</w>
1 0</w>
fir st</w>
e -
con si
ta in
he al
par tic
il </w>
ac tiv
e ach</w>
t or</w>
h ol
c ri
– </w>
oun d</w>
ul ation</w>
f ul
str uc
c er
n ow
y e
f unc
e t
cel l</w>
ear s</w>
po si
di se
s ti
contro l</w>
e i
p ur
vel y</w>
tr ac
ay s</w>
p ol
el </w>
= </w>
f o
b in
ver y</w>
ic ation</w>
p s</w>
o ff
reg i
c y
n a</w>
m ent
an ts</w>
e g
t ;</w>
ad di
mo del
me di
s ol
mar k
vi r
ha d</w>
en g
ev er</w>
en tr
is su
ou t
dur ing</w>
for e</w>
ap p
l oc
ass oci
m ents</w>
s o
l es</w>
di es</w>
0. 0
num ber</w>
c ap
ne w</w>
ac c
ec tion</w>
on -
b ec
de p
y ears</w>
w el
mos t</w>
t ure</w>
und er</w>
iz ed</w>
bo th</w>
c ases</w>
st u
ing s</w>
r </w>
i f</w>
cl u
ab ility</w>
low </w>
h n
t yp
i ties</w>
n or
c ul
vi e
g ro
di vi
a il
an n
di st
se qu
or t
l a
analy sis</w>
ste m</w>
e d
s en
r is
expres sion</w>
ex p
n ational</w>
meas u
t ur
b ased</w>
und er
id enti
per form
develop ment</w>
in formation</w>
us t</w>
wh en</w>
d es
l in
u p</w>
m ic
ic i
it al</w>
th rou
ou </w>
how ever</w>
li m
r ate</w>
h um
the y</w>
c entr
olog y</w>
tr a
fig ure</w>
differ ent</w>
cur r
st s</w>
clin ical</w>
ol </w>
signific ant</w>
h ig
a red</w>
ma in
si ty</w>
on g
ye ar</w>
eff ect</w>
tec hn
ent ly</w>
ad e</w>
an s</w>
es ti
hig h</w>
ex </w>
comp le
t ot
d ate</w>
e ty</w>
d ay</w>
enc es</w>
s amp
m ul
t ro
f ur
iz ation</w>
dise ase</w>
m al
for m</w>
t able</w>
1 .
heal th</w>
tic al</w>
sy stem</w>
stu dies</w>
m e</w>
r ap
de sign
b ac
p er</w>
k now
rel ated</w>
ther ap
o x
em ber</w>
e qu
si ve</w>
l arg
s m
1 0
al ity</w>
o ds</w>
o ver
g i
includ ing</w>
ch in
a in</w>
a ff
dr u
s es</w>
s ome</w>
u tion</w>
s ed</w>
un i
l y
an tly</w>
throu gh</w>
sup por
ac cor
gener al</w>
sha res</w>
c anc
ac tion</w>
h ed</w>
st at
duc ed</w>
2 0</w>
u </w>
de ter
fi ed</w>
at er</w>
3 0</w>
th ree</w>
imp ort
si ble</w>
partic ip
m un
or g
comp ared</w>
mic ro
si ons</w>
pu bl
fl u
me m
po in
b lo
pri m
f ound</w>
se t</w>
y ou</w>
o ver</w>
m is
c al
$ </w>
tot al</w>
y l
com e</w>
+ </w>
19 9
& l
&l t;</w>
prote in</w>
ch il
li on</w>
pa th
col l
v e
olog ical</w>
level s</w>
i ti
ac t</w>
ch em
imp ro
h el
n on-
con di
g g
ob ser
o us
il l
ti vely</w>
enc y</w>
sh ould</w>
chang e</w>
a re
th s</w>
res ear
rec ei
ag re
d om
sec on
wel l</w>
g u
pl ac
am in
d ers</w>
th en</w>
in al</w>
ic es</w>
v ing</w>
level </w>
s al
wh o</w>
en d</w>
in dic
s a
x im
we e
h an
incre ased</w>
oc k</w>
h os
p op
canc er</w>
spec if
model </w>
hum an</w>
d ro
k e
un ited</w>
grou ps</w>
man ag
esti g
co uld</w>
s ame</w>
inv estig
d o
comp l
n ot
enti al</w>
g re
dep end
di ag
st er
th ose</w>
with in</w>
1 2</w>
w ould</w>
vie w</w>
re pres
at ely</w>
ther e
pre vi
l ine</w>
un d</w>
fi g</w>
ag es</w>
co p
b us
signific antly</w>
h er
high er</w>
ou gh</w>
ab out</w>
5 0</w>
el ec
s af
repor ted</w>
cont in
requ i
si mil
d o</w>
du e</w>
t um
blo od</w>
gro w
fin anc
ti s
b el
su gg
in s</w>
st ing</w>
activ ity</w>
chang es</w>
comm it
im mun
associ ated</w>
er g
func tion</w>
ex per
wor k</w>
ch ar
st ed</w>
m al</w>
re si
l ed</w>
hi st
sy n
des cri
re le
e ther</w>
ati c</w>
sec ur
bus in
pro b
m r
i p</w>
h o
pro g
2 .
m any</w>
com bin
w ay</w>
gen e</w>
ter s</w>
l ess</w>
a use</w>
gen e
ta in</w>
resear ch</w>
ad v
min i
ut e</w>
as s</w>
c c
t ab
d y</w>
at ure</w>
specif ic</w>
prim ary</w>
meth ods</w>
, 0
ph y
t es</w>
clu sion</w>
org an
g h
ris k</w>
wh ile</w>
or der</w>
typ e</w>
incre ase</w>
t om
per s
bec ause</w>
hi b
d es</w>
consi der
p ot
mon ths</w>
ap pl
m a</w>
s in
f -
tain ed</w>
therap y</w>
be fore</w>
a ir
c re
e mp
inv est
te mp
al u
t est</w>
end ed</w>
peri od</w>
sc ri
obser ved</w>
fur ther</w>
follow ing</w>
v es</w>
val ue</w>
ac h
it e</w>
import ant</w>
f il
ev alu
b ro
mil lion</w>
addi tion</w>
reg ul
pe op
repor t</w>
busin ess</w>
a m</w>
or e</w>
at ory</w>
m ut
u ro
comm on</w>
mul ti
v en</w>
b as
d y
ati s
e ting</w>
is m</w>
l is
en e
c u
b re
d ow
r ang
gen es</w>
en ted</w>
d ays</w>
su m
th ough</w>
st ates</w>
g e</w>
g er
ex pl
1 5</w>
show ed</w>
b a
effec ts</w>
tic s</w>
it er
st and
j ect</w>
si z
c d
at eg
bo dy</w>
resp ec
au th
show n</w>
peop le</w>
te e</w>
pati ent</w>
ti on
em ents</w>
w om
depend ent</w>
el l
v al</w>
issu e</w>
saf ety</w>
par t
de tec
k in
in divi
indivi du
p le
dru g</w>
st ate</w>
ac coun
m ot
mark et</w>
u es</w>
h e</w>
respon se</w>
t arg
res ol
is e</w>
d en
es tim
t -
b ed</w>
m ec
n ing</w>
l ast</w>
tri bu
res s</w>
m i
0 0
coun tr
hos p
se e</w>
po st
k ed</w>
inv ol
a st
li f
i i</w>
s ul
se ver
c ent
c le
dec re
perform ed</w>
v ol
low er</w>
accor ding</w>
de f
financ ial</w>
ous ly</w>
ven tion</w>
ex t</w>
y -
inter national</w>
chil dr
pres ent</w>
as si
ro s
p at
u al</w>
n ec
manag ement</w>
am ong</w>
childr en</w>
in iti
ob jec
in te
on ic</w>
me d
st ock</w>
al e</w>
exper im
sh are</w>
grow th</w>
ne t</w>
ac ti
wom en</w>
sh ip</w>
mec han
comp ar
chin a</w>
in du
l ab
l os
tre ated</w>
c are</w>
comm un
commit tee</w>
agre ement</w>
con centr
go ver
wh ere</w>
id e</w>
o f
simil ar</w>
uc le
ex peri
suppor t</w>
am oun
s .</w>
fac tors</w>
li ke</w>
em s</w>
ic ations</w>
nor mal</w>
b ers</w>
ex c
c an
tis su
char ac
ati on
c ase</w>
as se
pro f
sm all</w>
3 .
effec tive</w>
s ure</w>
dist ri
deter min
distri bu
tw or
posi tive</w>
di d</w>
ent al</w>
fer ence</w>
or t</w>
,0 00</w>
uni ver
ne twor
t en</w>
al though</w>
meth od</w>
m b
sh all</w>
ar ly</w>
2 5</w>
ma j
il y</w>
ro le</w>
an t
duc tion</w>
re co
s ch
m ol
ass ess
s ing
b an
ful </w>
str y</w>
y ing</w>
si te</w>
t op
u res</w>
er c
m y
f t</w>
l ing</w>
re t
l ong
co ur
m it
fac e</w>
ad mini
curr ent</w>
publ ic</w>
o m</w>
gover n
provi de</w>
proc ess</w>
lim ited</w>
larg e</w>
s k
mat er
ra di
de fin
with out</w>
produc ts</w>
j o
sy st
bo ard</w>
r ic
rec or
there fore</w>
ac tions</w>
on om
0.0 5</w>
b il
2 4</w>
charac ter
n ess</w>
igh ts</w>
1 1</w>
m ade</w>
an g</w>
p t
gr am
m ice</w>
sa id</w>
me dic
f am
d -
ter m</w>
m l</w>
st ar
cl os
si de</w>
sc i
sc re
no sis</w>
1 8</w>
− </w>
at or</w>
serv ices</w>
sin ce</w>
j u
how </w>
z ed</w>
med ical</w>
av ail
ment al</w>
know n</w>
provi ded</w>
par a
1 00</w>
3 1</w>
en ter
d na</w>
ap </w>
ver age</w>
w ar
° </w>
i ed</w>
ev en</w>
oc y
ac y</w>
condi tions</w>
st ance</w>
m g</w>
sp l
ph one</w>
par t</w>
secon d</w>
h is</w>
sugg est
br an
inf ection</w>
l at
b er
s -
c es</w>
pre dic
e vi
or al</w>
respec tively</w>
differ ence</w>
n s</w>
ab lis
est ablis
dec ember</w>
bi o
ul t</w>
f ication</w>
ta ke</w>
p ow
l l</w>
th us</w>
g e
ac tive</w>
n al</w>
ex amin
comp an
techn ology</w>
n ucle
ear ly</w>
w s</w>
b ility</w>
b ra
1 4</w>
oper ation</w>
ma in</w>
wh ether</w>
a k
sever al</w>
con tribu
samp les</w>
jec ts</w>
recei ved</w>
be ing</w>
imp le
sy mp
measu res</w>
h ar
ic s</w>
ad ing</w>
pop ulation</w>
hy per
prote ins</w>
st atis
objec tive</w>
in sti
1 6</w>
f requ
ic ally</w>
p tion</w>
qu ality</w>
in hib
4 0</w>
proc ess
st an
ot yp
wor l
s ing</w>
4 .
t ter</w>
r and
de mon
descri bed</w>
du ce</w>
demon str
en z
f oc
ol d</w>
appro xim
qu i
me eting</w>
h em
c ir
pot ential</w>
en vir
envir on
mol ec
pro gram
d oc
univer sity</w>
ain ing</w>
1 2
g s</w>
m us
resol ution</w>
b ile</w>
ul es</w>
o d
m ac
hosp ital</w>
c le</w>
tum or</w>
u ary</w>
m u
a ut
pl as
n er
go od</w>
at ors</w>
particip ants</w>
addi tional</w>
rap h
d ings</w>
r ights</w>
d ri
ab o
poin t</w>
h ear
m m</w>
contin u
or ity</w>
6 0</w>
pl at
produc tion</w>
n am
ec onom
? </w>
d in
siz e</w>
me an</w>
wee ks</w>
l -
n ed</w>
direc tors</w>
om a</w>
con clusion</w>
± </w>
ac e</w>
prob le
er al</w>
ne ed</w>
gi ven</w>
de m
si tion</w>
pro per
o s</w>
lif e</w>
ti s</w>
pol y
th ir
networ k</w>
s tim
j un
resul t</w>
in duced</w>
su cc
pos ed</w>
fr ame</w>
emp lo
diag nosis</w>
li k
inter est</w>
amoun t</w>
str ateg
el d</w>
ag ain
tim es</w>
id s</w>
as c
mr .</w>
h u
again st</w>
out come</w>
ac hi
l ac
avail able</w>
in d
hol ders</w>
evi d
a i
pro mot
in fl
5 .
perform ance</w>
cr iter
sec tion</w>
g en</w>
includ ed</w>
n ations</w>
o k</w>
ur al</w>
m in</w>
con tain
pur ch
1 3</w>
s oc
differ ences</w>
hist ory</w>
str ation</w>
f ut
previ ous</w>
ne g
design ated</w>
f our</w>
identi fied</w>
val ues</w>
are a</w>
ta k
pos sible</w>
r ight</w>
p ec
ex i
w ater</w>
mo bile</w>
approxim ately</w>
ex ec
b ene
- 1</w>
z </w>
h al
abo ve</w>
elec tr
og raph
me tr
t le</w>
tran scri
m an</w>
b ri
phy s
repres ent
en h
op h
o -
t al</w>
th y</w>
e u
anti -
sti ll</w>
r it
requi red</w>
spec ies</w>
ch r
bene f
los s</w>
the m</w>
str ic
stand ard</w>
secur ity</w>
our ces</w>
si a</w>
i um</w>
ob tained</w>
inte gr
v enti
car di
p ose</w>
a -
f und</w>
tu res</w>
en ing</w>
a verage</w>
struc ture</w>
os ph
f un
oc cur
countr ies</w>
p i
no v
an im
u re
worl d</w>
fo od</w>
tissu e</w>
sen si
is ed</w>
invest ment</w>
be ha
ment ation</w>
soc ial</w>
con duc
o gen
un g</w>
criter ia</w>
o v
produc t</w>
m ust</w>
i e
ic ial</w>
sing le</w>
ag ing</w>
6 .
am er
v ant</w>
' </w>
serv ice</w>
infl am
ph osph
1 8
ver se</w>
e .</w>
symp tom
in t
stan ding</w>
beha vi
fut ure</w>
ph en
pri or</w>
our s</w>
7 .
rang e</w>
d ose</w>
g t;</w>
& gt;</w>
st er</w>
trans f
or din
ex amp
measu red</w>
1 -
n er</w>
t t
ac qui
a z
in dependent</w>
sup ple
pr inc
f em
do es</w>
bin ding</w>
pa y
o t</w>
ne uro
q </w>
&apos ;</w>
or ig
i or</w>
previ ously</w>
now </w>
u b
ver sion</w>
re main
o th
maj or</w>
200 5</w>
inter est
ain s</w>
pa in</w>
n os
1 7</w>
cel l
bac ter
ra m</w>
id ence</w>
c as
fer red</w>
ph ase</w>
in flu
r ati
cr </w>
ob serv
samp le</w>
con fir
distribu tion</w>
rec ep
a x
in -
w ays</w>
di sc
con struc
regi on</w>
vi ties</w>
l ong</w>
2 1</w>
consider ed</w>
ne e
c ent</w>
ex trac
appl ication</w>
eff ici
cap ital</w>
re as
le ast</w>
sub jects</w>
ma ke</w>
st om
ul e</w>
1 3
ac </w>
m en
s l
eng th</w>
ep t</w>
iz e</w>
l ig
le g
ph ar
in jec
pr ice</w>
m ed</w>
sur vi
in ten
o sis</w>
show </w>
qu ar
bu il
lik ely</w>
v ement</w>
hy po
rand om
l ic
a k</w>
el ine</w>
neg ative</w>
wh at</w>
mis sion</w>
hy dro
s .
exec u
sur ger
1 5
g a
or i
e th
at t
rec ent</w>
ta il
acti vities</w>
su per
is h</w>
c t
cal cul
gl ob
re duced</w>
au di
jun e</w>
sha re
tiv ity</w>
u sion</w>
us es</w>
at ten
m ine</w>
s w
con tr
r en
ful l</w>
pres ence</w>
ser um</w>
re comm
pro tec
up on</w>
impro ve</w>
targ et</w>
p le</w>
e ts</w>
activ ation</w>
defin ed</w>
cl es</w>
indu stry</w>
ab il
di ab
rel ation
del i
fac tor</w>
ac id</w>
ati vely</w>
al ter
par ty</w>
anc es</w>
b ur
ei ther</w>
200 6</w>
2 2</w>
est er
sec ret
re view</w>
ad d
me tab
r u
f ree</w>
vari ous</w>
f y</w>
diag nos
n at
surger y</w>
ch arg
pres sure</w>
we ight</w>
ch ro
d ated</w>
determin ed</w>
con cer
st ent</w>
metab ol
p ul
at s</w>
rele vant</w>
res sion</w>
loc al</w>
b al
i v
evid ence</w>
ab s
symptom s</w>
temp er
sequ ence</w>
be tter</w>
1 4
ke y</w>
sub ject</w>
in tr
s es
ep ti
gene tic</w>
d ge</w>
jo in
rel ation</w>
m ight</w>
ow n</w>
examp le</w>
pat ter
qu e</w>
200 4</w>
is ms</w>
re ments</w>
secur ities</w>
st o
chin ese</w>
us ers</w>
design </w>
v it
f ail
ol e</w>
ter ms</w>
201 3</w>
b or
co unc
ow </w>
expres sed</w>
e p</w>
ar ds</w>
st re
re ad
mem bran
pl an</w>
ex erc
c s</w>
1 9</w>
fam ily</w>
compan ies</w>
invol ved</w>
r ates</w>
l og
201 2</w>
counc il</w>
is ol
b on
2 -
201 4</w>
an e
p -
e ding</w>
ful ly</w>
hear t</w>
mo di
st ri
diff ic
ann ual</w>
gh t</w>
bra in</w>
ter min
compl ex</w>
pow er</w>
comple te</w>
f a
e duc
multi ple</w>
m ir
en s</w>
fi eld</w>
ain ed</w>
oper ative</w>
disc us
w a
cer tain</w>
estim ated</w>
is t</w>
spec ial</w>
reco gn
fi ve</w>
appro ach</w>
govern ment</w>
si tes</w>
exp ected</w>
individu al</w>
so f
high -
tic ally</w>
comp on
r na</w>
ad ju
an other</w>
mo d
con trac
ch o
econom ic</w>
af t</w>
2 8</w>
includ e</w>
201 0</w>
1 6
pol ic
analy zed</w>
develop ed</w>
al low
c -
posi tion</w>
o id</w>
tak en</w>
i an</w>
gl u
model s</w>
s ou
201 1</w>
j ur
pu t</w>
le t</w>
b s</w>
are as</w>
al ized</w>
se pt
over all</w>
8 0</w>
concentr ation</w>
anc ed</w>
ar tic
ag g
re fl
a im
pur pose</w>
character is
bas eline</w>
erg y</w>
ag ed</w>
sal es</w>
be g
h ours</w>
associ ation</w>
cor por
de a
it ation</w>
wee k</w>
thir d</w>
por t
deter mine</w>
mon it
experim ental</w>
sur face</w>
gr ad
para me
qu anti
el s</w>
de v
of ten</w>
hel d</w>
p ap
ac ute</w>
200 3</w>
e m</w>
l ight</w>
ex change</w>
if ied</w>
l ar
ne ur
proc e
y our</w>
as ing</w>
accor d
201 5</w>
re ve
h om
un </w>
sc ale</w>
r e</w>
si mp
fin dings</w>
asc ular</w>
anc y</w>
i ally</w>
chr onic</w>
dec i
mar ch</w>
direc t</w>
e .
stat us</w>
inhib it
fin al</w>
sp e
combin ed</w>
stim ul
ba sis</w>
su ff
c at
mor t
in come</w>
mem bers</w>
respon sible</w>
comm is
not e</w>
inter net</w>
li ed</w>
j an
is hed</w>
al ization</w>
w in
sc ore</w>
1 ,
princ ip
decre ased</w>
func tional</w>
st age</w>
li ver</w>
imp act</w>
sequ ences</w>
cont ent</w>
si tu
ar ter
or ts</w>
res ources</w>
se v
l it
c o</w>
in es</w>
man u
n -
ig i
x ed</w>
car ri
t ob
contro l
la w</w>
pre gn
h ere</w>
exp en
p rec
× </w>
p ac
ros s</w>
cl ass</w>
issu ed</w>
experi ence</w>
glob al</w>
ca use</w>
resp ect</w>
nec ess
b ar
direc tor</w>
ul y</w>
de tail
al ing</w>
ep i
h en
execu tive</w>
200 9</w>
ab ly</w>
cent er</w>
sof tw
il -
know le
spec ific
n on
ic k
se par
2 3</w>
v ot
si d
secon d
bec ome</w>
200 7</w>
l and</w>
differ enti
re duce</w>
ban k</w>
inc idence</w>
pur su
x i
vir us</w>
softw are</w>
at ures</w>
admini stration</w>
1 7
gre ater</w>
cap ac
m id
oc k
f low</w>
direc tly</w>
re duction</w>
cu stom
ap pe
dise ases</w>
200 0</w>
ex t
th ro
le ft</w>
8 .
mu ch</w>
ly mp
the sis</w>
er ing</w>
ab </w>
vol um
p sy
ing ly</w>
bac k</w>
in tro
ad op
syst ems</w>
contain ing</w>
tr aining</w>
temper ature</w>
e ti
detec ted</w>
t og
200 8</w>
ex ten
combin ation</w>
ig n</w>
inter vention</w>
follow ed</w>
op en</w>
g o</w>
sept ember</w>
p p
artic le</w>
5 -
fac t</w>
op </w>
l u
ar di
h ong</w>
si x</w>
ma xim
ex pos
o re
imple mentation</w>
pro posed</w>
typ es</w>
c t</w>
re mo
w ard</w>
jan uary</w>
cop y</w>
l as
her e
tran sp
er e
reg ar
form ed</w>
sev ere</w>
medic ine</w>
a si
ab les</w>
qu es
m ag
curr ently</w>
200 2</w>
ic ity</w>
or ing</w>
o gene
individu als</w>
en ergy</w>
al ed</w>
cor respon
b one</w>
survi val</w>
enz y
compar is
c in
me ta
9 5</w>
i .
p cr</w>
demonstr ated</w>
s co
n ext</w>
appro pri
asse mb
ac cur
dru gs</w>
comple tion</w>
tog ether</w>
s n
ti f
m er
2 6</w>
accoun t</w>
to x
j ust</w>
manu fac
w rit
g .</w>
e y
co st</w>
tr ial</w>
heal thy</w>
bre ast</w>
insti tu
en ds</w>
in jur
3 -
ut es</w>
ir e</w>
to co
regi ons</w>
l an
partic ular</w>
de part
bel ow</w>
re ference</w>
tu al</w>
s mo
prog ram</w>
con c
rati o</w>
d am
fe w</w>
second ary</w>
phys ical</w>
cl assi
dow n</w>
hel p</w>
relation ship</w>
sp on
sign ed</w>
us er</w>
a e</w>
sol ution</w>
ca used</w>
si onal</w>
tur al</w>
on es</w>
fo re
mor ph
e uro
200 1</w>
sel f-
gu id
me ans</w>
- term</w>
il i
acc ep
meas ure</w>
reg ulation</w>
t or
on n
our ce</w>
assemb ly</w>
en s
al -
d ra
pro ject</w>
initi al</w>
t ation</w>
frequ ency</w>
plat form</w>
medi a</w>
k ers</w>
vi a</w>
par ti
e very</w>
hal f</w>
glu co
in e
centr al</w>
commun ity</w>
d a</w>
re ad</w>
min im
fac il
p t</w>
y u
mon th</w>
α </w>
li </w>
o therapy</w>
experim ents</w>
di spl
ser ies</w>
mechan ism</w>
g et</w>
consi stent</w>
p an
rec ently</w>
2 7</w>
plac e</w>
contr ast</w>
divi ded</w>
s on</w>
investig ate</w>
off ice</w>
tra di
c m</w>
equ ip
con n
resi stance</w>
poin ts</w>
chem ical</w>
et es</w>
9 .
syn dro
pre sid
sel ected</w>
necess ary</w>
purch ase</w>
all ed</w>
pre v
h or
ox id
pers on</w>
h er</w>
dea th</w>
s oci
wh ere
- up</w>
calcul ated</w>
molec ular</w>
ster ed</w>
analy ses</w>
7 0</w>
eff ic
ev ents</w>
detec tion</w>
9 0</w>
repor ts</w>
dy nam
membran e</w>
st ress</w>
expos ure</w>
pop ul
str ong</w>
re li
knowle dge</w>
succ ess
ind ex</w>
n it
exerc ise</w>
m es</w>
characteris tics</w>
sub si
er r
re pe
yl ation</w>
inc ub
t el
st a
l l
s s</w>
ses sion</w>
ro ph
r il</w>
volum e</w>
ti l</w>
mater ial</w>
re f
d ou
establis hed</w>
pres ented</w>
gr ap
m y</w>
st ant</w>
elec tro
n a
rel ative</w>
cour se</w>
educ ation</w>
e b
vi su
mat ory</w>
cor rec
k ong</w>
environ ment</w>
share holders</w>
show s</w>
op tim
di g
sub sequ
l ung</w>
amer ic
es pec
gl y
commis sion</w>
cul ture</w>
ograph y</w>
ig n
injec tion</w>
condi tion</w>
espec ially</w>
com es</w>
assess ment</w>
gr an
t as
immun e</w>
diab etes</w>
achi ev
c e
effic acy</w>
au g
appropri ate</w>
co sts</w>
em ia</w>
r an
s a</w>
s or</w>
ar ies</w>
om es</w>
0 1</w>
contin ue</w>
un til</w>
conduc ted</w>
capac ity</w>
cy to
cir c
inflam matory</w>
comp u
por tion</w>
asse ts</w>
lin es</w>
accord ance</w>
el igi
ra y</w>
bo dies</w>
sugg est</w>
pro toco
3 5</w>
3 7</w>
examin ation</w>
acc ess</w>
fig ure
post -
4 -
star t</w>
ap ril</w>
pl ay</w>
b est</w>
b le
j uly</w>
plas ma</w>
an no
techn i
decre ase</w>
psy ch
d ail
t ute</w>
rele ase</w>
otyp e</w>
2 9</w>
l ength</w>
vi si
app le</w>
le ad</w>
mem ber</w>
t ow
oper ating</w>
wor king</w>
de b
su s</w>
pursu ant</w>
coll ected</w>
sur ve
dail y</w>
inf ec
h and</w>
v acc
i tion</w>
oper ations</w>
m r</w>
high ly</w>
r h
r y</w>
gener ation</w>
ab or
oc tob
j </w>
e. g.</w>
ac ross</w>
tur n</w>
4 8</w>
rec ru
octob er</w>
b ir
o res
th el
wi de</w>
lin e
parame ters</w>
af ric
r o</w>
der i
manufac tur
hol d</w>
in c</w>
201 6</w>
ch ann
evalu ation</w>
enc ed</w>
reve aled</w>
inter action</w>
c ateg
am ine</w>
con ver
se g
presid ent</w>
en ding</w>
proble m</w>
li fer
th in
i. e.</w>
t ory</w>
ch ed</w>
ox y
app lied</w>
co -
fe atures</w>
mechan isms</w>
ac ts</w>
ver ed</w>
quar ter</w>
con sum
vie w
pre -
ph ot
m ass</w>
pro lifer
ti ce</w>
main ly</w>
it ing</w>
3 0
le ar
3 6</w>
fail ure</w>
ch all
chall eng
syndro me</w>
pr ac
pro spec
form s</w>
countr y</w>
tradi tional</w>
re ven
c ros
confir med</w>
d os
in sul
recep tor</w>
cle ar</w>
join t</w>
er ed</w>
ad s</w>
z h
di sp
wh ole</w>
cor e</w>
o ti
stat ement</w>
respon ses</w>
e ve</w>
a di
l ation</w>
bac k
p al
cas h</w>
anti body</w>
3 3</w>
injur y</w>
j i
w as
h k</w>
proper ties</w>
se ar
st ro
indic ated</w>
en ess</w>
anno unc
sensi tivity</w>
si bility</w>
lab or
sp ace</w>
im aging</w>
pr acti
sch o
cor relation</w>
identi fi
diffic ult</w>
se en</w>
con sti
provi des</w>
program me</w>
vel </w>
incre asing</w>
subsi di
observ ation</w>
c a</w>
un it</w>
4 5</w>
co operation</w>
coll ection</w>
auth or
con f
syst em
concentr ations</w>
sur g
enc ing</w>
or ies</w>
u ti
par ag
al g
nov ember</w>
aff ected</w>
assess ed</w>
resul ting</w>
op a
where as</w>
follow -up</w>
num bers</w>
organ ization</w>
mus cle</w>
sign al</w>
d en</w>
cre di
ocy tes</w>
sub st
depart ment</w>
emplo y
re ment</w>
m ig
li p
op to
mo use</w>
comp eti
mo der
transf er</w>
amp ;</w>
& amp;</w>
ac hed</w>
x -
ad verse</w>
partic ul
fur ther
nee ds</w>
p ast</w>
sup p
bi ological</w>
y n
h ome</w>
lac k</w>
en ro
eligi ble</w>
identi fy</w>
ex hib
acqui sition</w>
evalu ate</w>
gluco se</w>
medi um</w>
sh ort</w>
mit ted</w>
ec ts</w>
de pres
ici ent</w>
pre val
flu ores
y oun
u su
3 2</w>
path way</w>
on ce</w>
inc or
on ed</w>
wi se</w>
c ity</w>
pa y</w>
ass ay</w>
i on</w>
of f</w>
further more</w>
adv ant
foc us</w>
strateg y</w>
re stric
r ing</w>
r up
hi bi
comparis on</w>
di ed</w>
op tions</w>
i di
ed ure</w>
deri ved</w>
proc edure</w>
mort ality</w>
u ment</w>
t a</w>
ang i
n ame</w>
re duc
l ay
atten tion</w>
ad ult</w>
par ties</w>
pap er</w>
ad ded</w>
gr ade</w>
princip al</w>
comple ted</w>
mp tion</w>
anim als</w>
pri v
ud e</w>
s ent</w>
ar ound</w>
te sted</w>
p h</w>
ap opto
dom ain</w>
gener ally</w>
aff ect</w>
k g</w>
stat ements</w>
l or
recor d</w>
c i</w>
impro ved</w>
per cent
issu es</w>
enter pr
fem ale</w>
p epti
r ules</w>
z e</w>
ch ol
0.0 1</w>
f is
t ext</w>
aug ust</w>
n an
ren al</w>
recei ve</w>
sk in</w>
nor mal
um ents</w>
2 5
in ation</w>
develop ing</w>
rel atively</w>
contro ls</w>
en sure</w>
y l</w>
n u
ment ary</w>
regi onal</w>
fin d</w>
sign aling</w>
ati ves</w>
proble ms</w>
cy cle</w>
requi rements</w>
cl ose</w>
sum m
re action</w>
i de
ol s</w>
emplo ye
af f</w>
di ver
re -
eff orts</w>
m m
c alled</w>
mal e</w>
surg ical</w>
a ir</w>
inter nal</w>
id ated</w>
follow s</w>
me mor
str eng
clin ic
statis tical</w>
exi sting</w>
p en
n i
ne y</w>
7 5</w>
l ater</w>
yu an</w>
h c
th re
func tions</w>
control led</w>
re al</w>
g ree</w>
particul arly</w>
op tion</w>
ri </w>
nucle ar</w>
hi v</w>
hibi tion</w>
nat ural</w>
situ ation</w>
dow n
protec tion</w>
tr ic
me ter</w>
co de</w>
dom in
off icial</w>
promot e</w>
inte st
cal c
st aff</w>
r ats</w>
im medi
qu al
s atis
maxim um</w>
dr aft</w>
alter n
al i
vir al</w>
st able</w>
m en</w>
c ence</w>
cell ular</w>
carri ed</w>
polic y</w>
un its</w>
up dated</w>
off ic
sel f</w>
i ous</w>
con ference</w>
he pati
ev ol
he ad</w>
ha ving</w>
appro ved</w>
k er</w>
so ft</w>
fe br
den sity</w>
3 4</w>
go ing</w>
p .</w>
or ders</w>
pre vention</w>
res t</w>
incor por
cl aim
n m</w>
n ct
for ce</w>
— </w>
l t
al es</w>
19 8
2 ,
n as</w>
β </w>
pay ment</w>
e y</w>
co ordin
per c
organ iz
20 0</w>
lo t</w>
le ading</w>
ac k</w>
identifi er</w>
de gree</w>
y s</w>
tu red</w>
go v</w>
inf ected</w>
correspon ding</w>
is es</w>
pre par
gro und</w>
sco res</w>
pl us</w>
ex clud
gen ome</w>
publ ished</w>
leg al</w>
t ol
s ource</w>
in di
examin ed</w>
mon ary</w>
ad ap
ra ther</w>
ste p</w>
comp re
sh ip
therap eu
t ect</w>
suggest ed</w>
fin ally</w>
si mul
te sts</w>
op port
proper ty</w>
fr ac
re tro
regar ding</w>
opport un
ar ti
construc tion</w>
in str
y i
under standing</w>
orig inal</w>
te sting</w>
ay ed</w>
f ri
inter venti
enc ies</w>
th em
ta x</w>
te am</w>
compre hen
achi eve</w>
mo re
long -term</w>
pa id</w>
bel ie
m ented</w>
protoco l</w>
evalu ated</w>
grap h
sh e</w>
dam age</w>
charg e</w>
tion ally</w>
rec ur
scre en</w>
monit oring</w>
popul ations</w>
sci enti
agg reg
suppor ted</w>
chil d</w>
th y
tri als</w>
auth ority</w>
6 -
j ap
st and</w>
simp le</w>
vi v
vi sion</w>
equip ment</w>
pregn ancy</w>
practi ce</w>
process es</w>
rap h</w>
u g
techn ical</w>
se e
in a</w>
more over</w>
u ally</w>
b p</w>
tri al
ro om</w>
ass ess</w>
deci sion</w>
con sol
febr uary</w>
compon ents</w>
deli very</w>
z ation</w>
n ur
medi ated</w>
t y
loc ated</w>
ell ular</w>
recor ded</w>
phosph or
m ach
ul ated</w>
b m
on line</w>
y et</w>
199 9</w>
in st
t in</w>
str ains</w>
is tic</w>
percent age</w>
trial s.
develop </w>
statis tically</w>
min utes</w>
cer e
clinic al
i ii</w>
vi ol
gener ated</w>
lymp h
gi ve</w>
preval ence</w>
i tive</w>
ul tr
clinical trials.
ag ent</w>
corpor ation</w>
resp ir
clinicaltrials. gov</w>
loc ation</w>
st -
ta x
con sul
v ec
fore ign</w>
he ter
ma king</w>
le sions</w>
acc um
u tions</w>
fi xed</w>
str ong
3 8</w>
bil lion</w>
bal ance</w>
tum ors</w>
v -
p ed</w>
influ ence</w>
b ase</w>
mr na</w>
l iter
sel ection</w>
p ass
abs ence</w>
maj ority</w>
b ul
v ascular</w>
m ation</w>
po or</w>
bu ff
read y</w>
y st
vari ables</w>
5 0
w at
represent ative</w>
ro ad</w>
buil ding</w>
n ers</w>
in hibition</w>
qu esti
out comes</w>
e tic</w>
w ester
anim al</w>
d ol
re public</w>
gre at</w>
i als</w>
ch on
off er</w>
us e
immun o
co h
ane ous</w>
dur ation</w>
subst anti
5 5</w>
scre ening</w>
mig r
repor ting</w>
f ra
ch ing</w>
insti tute</w>
process ing</w>
continu ed</w>
environ mental</w>
labor atory</w>
sci ence</w>
fun ds</w>
produc ed</w>
bas ic</w>
car cin
ti l
consi der</w>
dat ab
me t
hol der</w>
vi de
en e</w>
inv a
l ate</w>
resi du
vit ro</w>
patter n</w>
d g
ch air
dom es
co u
f our
not es</w>
w are</w>
prolifer ation</w>
top </w>
pa ir</w>
mut ations</w>
tr ust</w>
′ </w>
h ing</w>
prof es
ly ing</w>
regul atory</w>
ab dom
design ed</w>
insul in</w>
5 3</w>
micro s
hosp it
neur ons</w>
t on</w>
plac ed</w>
ev ent</w>
d on
proce du
pl ant</w>
ap s</w>
4 2</w>
c ro
re pl
~ </w>
th ing</w>
su mption</w>
wester n</w>
recomm end
sal e</w>
cri tical</w>
u k
ta king</w>
on e
co gn
mit o
therapeu tic</w>
viv o</w>
th an
j ing</w>
d .</w>
tissu es</w>
g f
parag raph</w>
compl ications</w>
aut om
tab le
al low</w>
fol d</w>
6 5</w>
inter actions</w>
sear ch</w>
recur r
comprehen sive</w>
add ress</w>
β -
indic ate</w>
p a</w>
procedu res</w>
suggest ing</w>
w w
h ment</w>
p e</w>
auth ors</w>
fo und
ent ation</w>
s al</w>
b -
r ic</w>
behavi or</w>
long er</w>
import ance</w>
om ic</w>
fi bro
is o
al ong</w>
su st
comp ens
dy s
incre ases</w>
loc ations</w>
ann ing</w>
des p
adv is
anti bodies</w>
5 00</w>
it em</w>
impro vement</w>
phy si
f re
pro v
m el
detail ed</w>
regul ated</w>
ta il</w>
consider ation</w>
bacter ial</w>
im age</w>
comp o
wor ds</w>
fr on
transcri p
oc curr
desp ite</w>
larg er</w>
ch es</w>
s qu
pro x
pul monary</w>
abil ities</w>
vari ety</w>
le -
to o</w>
comm erc
domes tic</w>
coll abor
throu gh
ne w
ar ing</w>
pro portion</w>
ess ential</w>
ag ents</w>
iz ing</w>
mater ials</w>
m .</w>
str ain</w>
a de
li er</w>
sou th</w>
ogene sis</w>
metr ic</w>
hyper ten
know </w>
struc tures</w>
intest inal</w>
m c
high est</w>
pers ons</w>
lit tle</w>
ic k</w>
transcri ption</w>
al one</w>
random ly</w>
vol un
4 4</w>
cardi ac</w>
oc ardi
ac et
est ed</w>
win dow
visu al</w>
at al</w>
prev ent</w>
sec re
interventi ons</w>
pre pa
inter pre
oth ers</w>
sup pres
cor on
se tt
supple mentary</w>
en ed</w>
all el
clos ed</w>
arter y</w>
ic ate</w>
effici ent</w>
me an
hos t</w>
k -
scho ol</w>
stre am</w>
fr ag
nu tri
s d</w>
enti ally</w>
adop ted</w>
c ut
metr y</w>
to day</w>
dev ice</w>
chro mos
val u
appl ications</w>
nee ded</w>
youn g</w>
j ud
la un
3 ,
ob lig
wh ite</w>
ser ved</w>
ast ro
f ar</w>
he ad
di men
cont act</w>
mp </w>
respir atory</w>
suggest s</w>
rap id</w>
no tice</w>
sh ort
spec tr
mo tion</w>
el ev
ch ain</w>
investig ated</w>
me -
s y</w>
low -
c .</w>
0. 5</w>
con tained</w>
patter ns</w>
h r
imp l
at eral</w>
occur </w>
phar mac
credi t</w>
em br
f av
isol ated</w>
ch lor
es the
epi thel
secret ary</w>
al most</w>
d one</w>
not ed</w>
path ways</w>
vot e</w>
memor y</w>
2 8
bacter ia</w>
bo ok</w>
cop e</w>
ext ent</w>
diagnos tic</w>
equ ity</w>
h op
_ </w>
c al</w>
4 0
cl ass
in clusion</w>
accoun ting</w>
stu died</w>
ar ity</w>
g -
f ile</w>
o ste
vide o</w>
prepa red</w>
con vention</w>
suff icient</w>
sel ec
7 2</w>
up per</w>
mut ant</w>
ch ec
ai m</w>
reco very</w>
f s</w>
peri ph
questi onn
st atic</w>
reven ue</w>
e f</w>
d a
ro id</w>
2 9
s ors</w>
tr ade</w>
d n
sh ap
differenti ation</w>
appl ic
b ud
coron ary</w>
diagnos ed</w>
ac e
facil it
s mar
f usion</w>
signific ance</w>
im ages</w>
chem otherapy</w>
assi stance</w>
under stand</w>
t n
prog ress</w>
res sed</w>
exc ept</w>
equ al</w>
usu ally</w>
experi ment</w>
prac tic
er gen
at tribu
tiv es</w>
cont ext</w>
benef it</w>
stud ents</w>
ow ned</w>
tas k</w>
remain s</w>
enti t
oun ds</w>
dis orders</w>
cros s-
enh anced</w>
ori th
alg orith
sm all
ad en
f if
m ing</w>
uti li
enter ed</w>
mal ign
w al
cop ic</w>
ar m</w>
ific ation</w>
in trac
ec h
euro pe
in tra
organiz ations</w>
as signed</w>
ultr as
is ing</w>
inten sity</w>
sen ior</w>
v o
expl ore</w>
con venti
ep tion</w>
se ts</w>
g am
lis t</w>
res er
thin k</w>
arti cles</w>
us a</w>
mon ey</w>
belie ve</w>
ro w</w>
al ready</w>
w ant</w>
li sted</w>
n as
achiev ed</w>
si l
p c</w>
st or
co ding</w>
provi sions</w>
radi ation</w>
activ ated</w>
can not</w>
appro val</w>
sta sis</w>
ar ch
n ature</w>
tu b
st aining</w>
indu stri
ar rang
ner ship</w>
oph ag
s le
s 1</w>
ach es</w>
embr y
dist inc
ap poin
sensi tive</w>
f lo
out standing</w>
k id
metabol ic</w>
gen der</w>
o ts</w>
incub ated</w>
3 9</w>
tol er
ade qu
con sent</w>
qu es</w>
i -
ar ms</w>
includ es</w>
er -
specific ally</w>
p ing</w>
* </w>
olog ies</w>
it able</w>
li ance</w>
ques tion</w>
subsequ ent</w>
b en
μ m</w>
re view
mark ers</w>
pro duce</w>
sh e
si on
go og
ex ter
s h</w>
2 6
m ic</w>
li sting</w>
mut ation</w>
g as</w>
4 ,
europe an</w>
ad ul
equ i
fl ic
pol i
occur red</w>
compon ent</w>
e di
to -
5 6</w>
2 7
br al</w>
‐ </w>
b at
chair man</w>
strateg ies</w>
pos t</w>
con flic
dra w
4 3</w>
mid d
int ell
liter ature</w>
otyp es</w>
fe der
bir th</w>
p ic
chon dri
gen ic</w>
ol ic</w>
tom y</w>
u .
ti tle</w>
199 8</w>
f und
goog le</w>
ol der</w>
line ar</w>
ex tre
measu rements</w>
dynam ic</w>
c ar</w>
o ther
reg ard</w>
indic ating</w>
apopto sis</w>
ver sus</w>
inflam mation</w>
provi ding</w>
tion ing</w>
cer tif
vari ation</w>
identi fication</w>
a o</w>
t al
p y
i v</w>
immedi ately</w>
l er</w>
molec ules</w>
spe ed</w>
ha i</w>
financ ing</w>
under lying</w>
be i
f al
post operative</w>
li es</w>
di um</w>
no vel</w>
ad ver
v eg
mito chondri
ep s</w>
prog ression</w>
acqui red</w>
tran spl
pe ak</w>
s ex
li qu
in ning</w>
ro gen</w>
dist ance</w>
≥ </w>
stand ards</w>
de posi
interest s</w>
amin o</w>
e ted</w>
surve y</w>
resul ted</w>
custom ers</w>
effici ency</w>
s chem
m enti
vie ws</w>
ici ency</w>
em ergen
abdom inal</w>
de ed</w>
pl ants</w>
ca uses</w>
eb o</w>
exp an
m t
it ems</w>
prof it</w>
r ule</w>
as y</w>
prox y</w>
enti re</w>
re turn</w>
gr ant</w>
plac ebo</w>
termin al</w>
can di
i o</w>
requ ire</w>
k es</w>
ob tain</w>
m es
ur ation</w>
ag ain</w>
stim ulation</w>
depres sion</w>
me et</w>
sub str
adv anced</w>
lo o
stric t</w>
in sur
random ized</w>
h yp
bi om
admini str
lab el
commun ication</w>
m erg
succ ess</w>
vari able</w>
buff er</w>
fra me
th res
4 1</w>
k n
s c</w>
s or
c y</w>
5 2</w>
c amer
periph eral</w>
ques tions</w>
g ame</w>
character ized</w>
lear ning</w>
ar s</w>
an e</w>
success ful</w>
ver s</w>
ship s</w>
w ent</w>
b ot
for ward</w>
ordin ary</w>
tr ig
fluores cence</w>
al ways</w>
ag o</w>
i m</w>
et ary</w>
si </w>
5 8</w>
p anc
n om
ogen ic</w>
ur </w>
bei jing</w>
p c
4 9</w>
measu rement</w>
ang u
il l</w>
lin ked</w>
cogn itive</w>
writ ten</w>
oc c
car b
lo an</w>
compl ex
h and
through out</w>
in duction</w>
sch ed
struc tural</w>
el im
pro pos
ser ious</w>
trans actions</w>
l a</w>
datab ase</w>
f ic</w>
ven tric
contribu te</w>
on e-
satis fac
ol y
g er</w>
reg ression</w>
priv ate</w>
cle arly</w>
bl oc
w all</w>
reas on</w>
continu ous</w>
μ g</w>
au </w>
re ferred</w>
remain ing</w>
pers onal</w>
a .</w>
t us</w>
g al
in nov
4 6</w>
pac k
ar t</w>
stro ke</w>
coun ter
ad a</w>
employe es</w>
repres ent</w>
la ws</w>
tr u
tiv eness</w>
oc r
enzy me</w>
spec i
other wise</w>
so me
mat ure</w>
col le
mar g
m am
ob vi
expen ses</w>
predic ted</w>
h ab
al co
m ri</w>
quanti t
to m</w>
on set</w>
f u
detail s</w>
f it
entit led</w>
re v
199 7</w>
pa ir
0. 1</w>
beg inning</w>
commerc ial</w>
scienti fic</w>
comp are</w>
mag ne
cri pt</w>
con sumption</w>
ch ie
sub -
cor related</w>
siz ed</w>
tw o-
o red</w>
col on
lo ad</w>
n ia</w>
in d</w>
as pec
wel l-
d on</w>
alco hol
consol idated</w>
ey e</w>
bro ad
agre ed</w>
r he
pri mar
exter nal</w>
o z
tran si
compu ter</w>
ear lier</w>
americ an</w>
for c
t ting</w>
st ly</w>
re ly</w>
t un
conventi onal</w>
le tter</w>
man us
as p
amoun ts</w>
chann el</w>
conn ection</w>
chang ed</w>
p age</w>
accur acy</w>
5 7</w>
in deed</w>
trac t</w>
afric a</w>
rele ased</w>
c ard</w>
oth el
1 a</w>
trans mission</w>
s ex</w>
t an
equi val
tra ff
enh ance</w>
mi x
2. 5</w>
e e
spec tive</w>
primar ily</w>
requi res</w>
man ner</w>
lo ok</w>
lar s</w>
par ent</w>
u. s.</w>
c in</w>
e ight</w>
medi an</w>
ver ified</w>
a sia</w>
col or</w>
ble eding</w>
tow ards</w>
sub scri
mat ri
el ines</w>
recep tors</w>
ho od</w>
benef its</w>
di a
wor k
du </w>
al og
m as
chie f</w>
s f
an ds</w>
in formed</w>
n on</w>
reg ular</w>
el ements</w>
in duc
s at
reas on
obser ve</w>
o il</w>
re actions</w>
mar k</w>
menti oned</w>
jap an</w>
techni que</w>
abs or
in ser
modi fied</w>
cy cl
hol ding</w>
insur ance</w>
mo de</w>
8 -
main tain</w>
manus cript</w>
st ability</w>
6 2</w>
ov ascular</w>
0.0 01</w>
fil m</w>
a er
in struc
infec tions</w>
ec ting</w>
institu tions</w>
mat ter</w>
appe ar</w>
air e</w>
back ground</w>
le uk
aspec ts</w>
par ts</w>
contain s</w>
anti bio
dol lars</w>
frame work</w>
ne um
carcin oma</w>
compens ation</w>
use ful</w>
uni que</w>
d ar
adul ts</w>
descri ption</w>
h ic
st ers</w>
fam il
f el
integr ation</w>
s r
at ric</w>
sh if
l ob
00 ,000</w>
av en
c n
4 7</w>
particip ation</w>
rou t
hyperten sion</w>
adju sted</w>
5 4</w>
intro duced</w>
oxy gen</w>
e asy</w>
altern ative</w>
pl ay
cr yst
ter r
5 1</w>
centr e</w>
iti s</w>
c iv
comp ris
se ven</w>
bi op
out side</w>
scri min
5 9</w>
samp ling</w>
ant ation</w>
m d</w>
resi d
repres ents</w>
kid ney</w>
k it</w>
sw it
lat eral</w>
ex posed</w>
st ore</w>
nct 0
6 0
regi stration</w>
z e
o tic</w>
classi fication</w>
e ast</w>
n ight</w>
enro ll
em erg
fin ding</w>
reg im
tra um
applic able</w>
phar ma
- based</w>
t end
enroll ment</w>
pharmac eu
mir -
cre ate</w>
recomm ended</w>
an esthe
volun te
c all</w>
c i
igh tly</w>
p neum
coh ort</w>
re ached</w>
multi -
estim ates</w>
end othel
lic en
we b
ro b
ur ine</w>
wh y</w>
mach ine</w>
an ter
10 0
c p
enh anc
phys ici
per cent</w>
y es</w>
dis co
m er</w>
dis order</w>
as th
i st
in ary</w>
matri x</w>
plac ement</w>
guid elines</w>
supp ly</w>
t ely</w>
larg est</w>
enterpr ises</w>
recommend ations</w>
part ners</w>
v is
re main</w>
l angu
as sum
midd le</w>
ro w
a war
adju st
o th</w>
v s</w>
de tect</w>
di scrimin
main ten
visi t</w>
dem ic</w>
str ic</w>
m ap</w>
sequ encing</w>
6 7</w>
fil es</w>
smar t</w>
poli tical</w>
four th</w>
or rh
1. 5</w>
mainten ance</w>
dem and</w>
resear ch
coun t</w>
cor rel
particip ate</w>
en g</w>
2 a</w>
admini stered</w>
k er
investig ation</w>
cl er
estim ate</w>
integr ated</w>
cal i
ur b
st ock
prepar ation</w>
li ving</w>
6 3</w>
le a
pepti de</w>
micro soft</w>
t y-
syn thesis</w>
ne ws</w>
g astro
ent er</w>
comple tely</w>
su sp
g ra
profes sional</w>
ner ve</w>
le ad
to ol</w>
ou ght</w>
panc re
reas ons</w>
r un
ati c
i sts</w>
sec tions</w>
soci ety</w>
w t</w>
bo und</w>
h b
imp air
3 00</w>
fem ales</w>
v ess
heal th
pan el</w>
th or
sum mar
sen se</w>
se ems</w>
announc ed</w>
mo vement</w>
agre ements</w>
l um
regi stered</w>
9 9</w>
doc ument</w>
electr onic</w>
pos es</w>
c amp
occ up
bo x</w>
sh ang
b it</w>
e ver
cho ice</w>
i ev
6 1</w>
ent ing</w>
lay er</w>
con version</w>
vari an</w>
g li
s ources</w>
sh o
ar an
j unc
sec u
b ol
v ic
hypo thesis</w>
olog ic</w>
de grad
moder ate</w>
u tr
minim um</w>
am end
effec tiveness</w>
o id
ve hic
t v</w>
corpor ate</w>
bre a
my ocardi
kin ase</w>
pro jects</w>
m 2</w>
metabol ism</w>
cour t</w>
col um
ocy te</w>
questionn aire</w>
offic er</w>
s am
port fol
resi stant</w>
m -
str ength</w>
inhibit or</w>
mot or</w>
f at</w>
establis h</w>
e asi
ul ate</w>
f ast</w>
l en
consti tu
trans action</w>
sp ati
recogn ition</w>
re pair</w>
respec tive</w>
en cour
r are</w>
phosphor ylation</w>
d l</w>
techni ques</w>
i b</w>
con nec
contrac t</w>
di et</w>
sl ightly</w>
ag on
per si
bel iev
comp ounds</w>
polic ies</w>
transp ort</w>
investig ators</w>
con ven
at om
ach ing</w>
quantit ative</w>
ad her
subsidi ary</w>
app ears</w>
adequ ate</w>
pe ace</w>
ogen ous</w>
so dium</w>
fig ures</w>
l ap
h a</w>
occur s</w>
e f
μ l</w>
allow s</w>
circ um
fis cal</w>
b it
is chem
s li
cardi ovascular</w>
ac ting</w>
vec tor</w>
c c</w>
id ation</w>
bl ock</w>
meth yl
tr end</w>
as e-
than k</w>
invest ors</w>
targ ets</w>
os ed</w>
num er
effec tively</w>
we igh
follow </w>
th ick
lip id</w>
pos sibility</w>
ar ia</w>
expres sing</w>
r ab
allow ed</w>
wi del
r ad
av oid</w>
pl ans</w>
app ing</w>
gu aran
gen omic</w>
man if
atic ally</w>
medic ation</w>
mi xed</w>
displ ay</w>
o be
refl ect</w>
mal es</w>
strong ly</w>
bu y</w>
migr ation</w>
ing u
system ic</w>
direc tion</w>
ex clusion</w>
as ked</w>
om er
ul a</w>
remo ved</w>
p il
am s</w>
tain ing</w>
ab und
def iciency</w>
em o
distinc t</w>
prob ability</w>
ar c
r a</w>
a i</w>
me t</w>
widel y</w>
ther n</w>
cou pl
he at</w>
su sc
it self</w>
si x
ar ray</w>
thres hold</w>
k ore
posi tions</w>
har d
hepati tis</w>
del e
fa ir</w>
bi g</w>
mark eting</w>
o varian</w>
lo ans</w>
ca re
con clud
m d
demonstr ate</w>
z er
it ary</w>
10 -
reduc ing</w>
lim it</w>
appro aches</w>
diffic ul
rec i
b and</w>
6 4</w>
advant age</w>
tr ue</w>
inva sive</w>
nor th</w>
ec tomy</w>
specific ity</w>
8 0
shang hai</w>
camer a</w>
vacc ine</w>
h r</w>
lat est</w>
di ty</w>
physi ological</w>
zh ou</w>
c li
inter face</w>
hem at
chro mat
repres ented</w>
end os
at temp
rand om</w>
m ess
sle ep</w>
simil arly</w>
flu id</w>
p bs</w>
pres cri
br and</w>
hi m</w>
th ings</w>
beg an</w>
h ous
exclud ed</w>
networ ks</w>
indic ates</w>
8 5</w>
po ster
eng ine
ac tual</w>
5 ,
st ages</w>
in spec
tr ading</w>
foc used</w>
algorith m</w>
i b
c k
comp liance</w>
discus sion</w>
p s
volunte ers</w>
ga stric</w>
- 2</w>
r mb
promot er</w>
wh ose</w>
comp ut
residu es</w>
pr in
p d
li ve</w>
3 d</w>
prof ile</w>
aggreg ate</w>
v s.</w>
y .</w>
divi sion</w>
to ols</w>
sever ity</w>
accum ulation</w>
separ ate</w>
susc epti
incorpor ated</w>
dou ble</w>
mu co
am in</w>
recogn ized</w>
199 6</w>
comm only</w>
ventric ular</w>
ad d</w>
wor kers</w>
particip ant</w>
mac roph
summ ary</w>
review ed</w>
substanti al</w>
hol dings</w>
om al</w>
on d</w>
small er</w>
nur sing</w>
res sive</w>
spec im
di </w>
dys function</w>
en ough</w>
fi br
ic ates</w>
w r
v ul
window s</w>
clu ster</w>
j our
d ates</w>
der ly</w>
lan ds</w>
z ing</w>
all ing</w>
occurr ence</w>
th i
subsidi aries</w>
gl ut
hy bri
pur poses</w>
schem e</w>
seg ment</w>
syn the
err or</w>
subsequ ently</w>
indu ce</w>
app ear
lt d</w>
mark ets</w>
dat as
saf e</w>
phen otype</w>
under went</w>
sign als</w>
g ain</w>
discus sed</w>
st eps</w>
epithel ial</w>
cere bral</w>
it es</w>
gre en</w>
administr ative</w>
elev ated</w>
v ements</w>
o k
y ear
ac ids</w>
t ations</w>
pl anning</w>
provi sion</w>
om y
appe ared</w>
i phone</w>
ple ase</w>
ess es</w>
recru it
bro w
expan sion</w>
i sion</w>
wh ol
show ing</w>
expres s</w>
fe ature</w>
em ed</w>
del eg
determin ation</w>
sign s</w>
gran ted</w>
mater nal</w>
7 -
contribu tion</w>
deb t</w>
g ol
form er</w>
op in
dev ices</w>
7 3</w>
l igh
conc ept</w>
treat ments</w>
ar y-
y or
cd 4</w>
ast er</w>
dia meter</w>
dom ains</w>
mus ic</w>
l and
accur ate</w>
facil ities</w>
ograph ic</w>
an xi
h ard</w>
chann els</w>
di strict</w>
diver sity</w>
found ation</w>
si vely</w>
p el
c b
al ia</w>
6 8</w>
! </w>
addi tionally</w>
nucle oti
me et
t os
chol ester
doc uments</w>
dr </w>
custom er</w>
recruit ment</w>
or th
cer v
un known</w>
streng then</w>
er y</w>
an ol</w>
r s</w>
sec tor</w>
v ac
techn ologies</w>
ger many</w>
portfol io</w>
peri ods</w>
feder al</w>
s p</w>
in form
k ar
w o
all oc
f ish</w>
ou th</w>
pre ferred</w>
observ ations</w>
ox ide</w>
h .</w>
r un</w>
fr action</w>
ne arly</w>
h p
meet ings</w>
tox icity</w>
targ eted</w>
intell ig
st ated</w>
main tained</w>
emp ha
il s</w>
r ac
pro state</w>
ro und</w>
le y</w>
dos es</w>
sc s</w>
ri tis</w>
investig ator</w>
s ay</w>
bl ack</w>
equival ent</w>
exhib it</w>
classi fied</w>
afric an</w>
f ying</w>
1 1
w ang</w>
re ach</w>
famil ies</w>
n ine</w>
plas m
ris ks</w>
competi tion</w>
cel er
pot entially</w>
in si
smo king</w>
cerv ical</w>
el derly</w>
d op
establis hment</w>
to ok</w>
se tting</w>
re ver
e ds</w>
in ste
regul ations</w>
dep th</w>
repe ated</w>
hem orrh
o 2</w>
col d</w>
diab etic</w>
6 ,
conflic t</w>
gre at
6 6</w>
regi str
opportun ity</w>
ar th
go al</w>
alcohol </w>
y ang</w>
for th</w>
ph il
yor k</w>
sh or
rel ating</w>
ne ar</w>
mark er</w>
t ment</w>
doc um
tran sition</w>
sub jec
parti al</w>
r ich</w>
ic ated</w>
inhibit ors</w>
anter ior</w>
n ic
ac celer
obe sity</w>
accoun ts</w>
re tur
bi os
in ated</w>
program s</w>
interest ingly</w>
ass ays</w>
p ut
s om
w est</w>
langu age</w>
intr aven
war r
in put</w>
it ations</w>
invol ving</w>
g el</w>
h our</w>
pregn ant</w>
7 0
recei ving</w>
b ab
clos ely</w>
we i</w>
clos ing</w>
l ated</w>
j ob
tr ation</w>
on ing</w>
c av
th al
ol ig
si g
program mes</w>
asth ma</w>
dec line</w>
th ought</w>
end a</w>
s we
h t
compo sition</w>
fun ding</w>
employ ment</w>
rout ine</w>
represent ing</w>
en ric
sust ain
wor d</w>
remain ed</w>
r n
c d</w>
ex cell
ill ed</w>
m it</w>
mil d</w>
uni on</w>
pr ices</w>
f at
mini stry</w>
poster ior</w>
challeng e</w>
bl ue</w>
oblig ations</w>
comp ound</w>
calc ium</w>
h -
ch e
ati on-
in ce</w>
r us
et c</w>
research ers</w>
ep ing</w>
extre m
α -
dec id
car ry</w>
&apos; t</w>
erg ic</w>
ke y
el ds</w>
endothel ial</w>
9 6</w>
dig ital</w>
ab normal
liqu id</w>
8 8</w>
per form</w>
i ent</w>
compar able</w>
kin d</w>
gener ate</w>
hum an
be half</w>
in depend
n g</w>
conn ected</w>
pharmaceu tical</w>
v ar
hum ans</w>
su itable</w>
c en
ab normal</w>
conf idence</w>
tu ally</w>
u ter
s on
7 8</w>
re produc
el et
γ </w>
le ads</w>
expl ained</w>
bi ot
mitochondri al</w>
clos ure</w>
impair ment</w>
syn ap
re fer
myocardi al</w>
grow ing</w>
ex tr
hy dr
ext ended</w>
malign ant</w>
writ ing</w>
hor m
ro p
merg er</w>
ent ure</w>
kin es</w>
ad he
behavi oral</w>
de si
si des</w>
con stant</w>
au str
recor ds</w>
tu be</w>
ang le</w>
obvi ous</w>
optim al</w>
ti ous</w>
am y
inste ad</w>
institu tional</w>
sex ual</w>
categ ories</w>
is ation</w>
secret ary-
p .
americ a</w>
a .
con tain</w>
in ity</w>
terr or
secretary- general</w>
sp ir
cap sul
n ings</w>
ac compan
7 7</w>
fr </w>
an sw
share holder</w>
sol utions</w>
de vi
ho use</w>
practic es</w>
pers onn
n one</w>
coll ec
anti gen</w>
bar ri
ag en</w>
sp inal</w>
enzy mes</w>
prospec tus</w>
e al</w>
di scre
7 ,
yi eld</w>
o di
n or</w>
wil d-
dynam ics</w>
h ence</w>
n ar
frequ ently</w>
ris e</w>
de ep</w>
fi x
se as
c s
di lu
7 1</w>
ag ency</w>
ag enda</w>
my el
ca 2</w>
fl exi
opa th
ex amine</w>
spati al</w>
personn el</w>
fin ance</w>
correc t</w>
trans ferred</w>
analy ze</w>
poly morph
vit amin</w>
le sion</w>
par ents</w>
t ou
ill ary</w>
recurr ence</w>
pl ate</w>
om en
restric ted</w>
inter val</w>
fun g
prov ince</w>
oc </w>
por t</w>
h ot
si m
success fully</w>
ec h</w>
it al
st abil
sel l</w>
han g</w>
es ophag
experi enced</w>
mean ing</w>
y le</w>
extrac ted</w>
cul tured</w>
4 00</w>
st ence</w>
ly s
emergen cy</w>
j ac
gen ital</w>
wild- type</w>
path ological</w>
stor age</w>
u k</w>
concer n</w>
magne tic</w>
r ural</w>
an tic
in take</w>
aly sis</w>
bon ds</w>
r at</w>
r al</w>
ad ol
employ ed</w>
1 0.
audi t</w>
invol vement</w>
sto red</w>
v a</w>
o ids</w>
consum er</w>
si an</w>
concer ning</w>
relation ships</w>
ever y
fe eding</w>
en gl
manufactur ers</w>
3 a</w>
was hed</w>
f res
expl ain</w>
co li</w>
psych ological</w>
p se
intro duction</w>
cul tures</w>
ro ot</w>
til ity</w>
can ada</w>
fr u
meth ylation</w>
s 2</w>
j us
y m
cont acts</w>
carb on</w>
spon sor</w>
industri al</w>
col og
as su
s ac
in fer
h d
2 b</w>
en -
av es</w>
· </w>
g a</w>
substr ate</w>
an a</w>
0.0 0
p m
k a</w>
instr uments</w>
cholester ol</w>
f a</w>
ey es</w>
fac ility</w>
sub sti
199 5</w>
fe ed
s m</w>
cur ve</w>
pro motion</w>
phen omen
t l
prog nosis</w>
br on
pl es</w>
shap e</w>
sub mitted</w>
co verage</w>
over l
h d</w>
d ong</w>
or ation</w>
sc an</w>
f low
distribu ted</w>
degrad ation</w>
ma kes</w>
vari ance</w>
protec tive</w>
f ar
sing le-
govern mental</w>
r ho
re ally</w>
typ ical</w>
b os
pse ud
t ex</w>
wa ve</w>
clu sive</w>
ap p</w>
euro pe</w>
benef icial</w>
m atic</w>
ou d</w>
t in
advant ages</w>
chromos ome</w>
gly co
we b</w>
dr y</w>
laun ched</w>
appear ance</w>
strateg ic</w>
7 6</w>
enro l
l .
reason able</w>
invest ments</w>
star ting</w>
c lim
de -
mo graph
d or
do m</w>
jud g
part nership</w>
inter medi
at in
® </w>
squ are</w>
1 b</w>
statis tics</w>
buil d</w>
ur y</w>
web site</w>
inc .</w>
adver tis
n e</w>
consider ing</w>
re al
pr </w>
fil ed</w>
easi ly</w>
mut ants</w>
is ra
li br
id ly</w>
entr y</w>
v ag
on ia</w>
b y
bi as</w>
hepati c</w>
f ever</w>
pair s</w>
v as
we ak
h i</w>
b ig
ag e-
resol utions</w>
ti t
he av
ser ve</w>
f it</w>
per man
indi a</w>
we ap
meth od
intrac ellular</w>
con served</w>
prob ably</w>
evol ution</w>
no de</w>
con serv
ir on</w>
7 4</w>
categ ory</w>
mort g
st ained</w>
contribu ted</w>
. 1</w>
s per
electr ic</w>
h am
ear nings</w>
spec tro
p i</w>
pe ace
dimen sional</w>
add ressed</w>
tw ent
q i
th ous
a ids</w>
prospec tive</w>
2 4
h app
oph il
confir m</w>
v ice</w>
t g
bm i</w>
s ung</w>
8 ,
los ses</w>
mechan ical</w>
be y
if y</w>
typ ically</w>
ti </w>
enterpr ise</w>
manif est
tt p</w>
po sted</w>
requ est</w>
differ ential</w>
g old</w>
streng th
struc tion</w>
oxid ative</w>
respon sibility</w>
p ig
pe di
ic it</w>
go ods</w>
consi st
h an</w>
a g</w>
ent re
accoun ted</w>
s ely</w>
b ar</w>
ol ar</w>
1 50</w>
cy top
hol ds</w>
co ver</w>
ad ed</w>
ne utr
exp ec
pro mis
inf usion</w>
s ar
mon th
p d</w>
sol id</w>
qu it
adol es
hous e
res ection</w>
ne ver</w>
challeng es</w>
car r
clin ically</w>
sur ro
rec ip
val s</w>
dis claim
ph al
super vision</w>
announc ement</w>
facilit ate</w>
de al</w>
ne on
grad ually</w>
lat ter</w>
interpre tation</w>
manag er</w>
ch ap
ic ing</w>
6 9</w>
ax is</w>
lin k</w>
out put</w>
fe tal</w>
pa d</w>
ur ing</w>
kn ock
a ware</w>
intraven ous</w>
8 6</w>
adjust ment</w>
1 20</w>
bor row
compar ing</w>
9 0
tw ice</w>
sol d</w>
sam sung</w>
impro ving</w>
isol ates</w>
defin ition</w>
ill u
t aneous</w>
man date</w>
sign </w>
re verse</w>
opportun ities</w>
su d
dr .</w>
t elec
vir uses</w>
br ing</w>
as set</w>
ar ily</w>
ke eping</w>
princ i
re combin
re ading</w>
h on
dec lar
rec tal</w>
b c</w>
9 ,
- specific</w>
pay ments</w>
se min
bran ch</w>
w .
9 8</w>
fe el</w>
tu ber
ch os
r in
ma il</w>
b a</w>
am ended</w>
imple mented</w>
de emed</w>
neuro log
bey ond</w>
purch ased</w>
anxi ety</w>
o me
associ ations</w>
mel an
domin ant</w>
cy cles</w>
remo val</w>
ba i
el l</w>
cat aly
coordin ation</w>
no des</w>
opin ion</w>
bud get</w>
ti ble</w>
concer ned</w>
inspec tion</w>
centr if
dist ingu
temp or
sol u
gastro intestinal</w>
incub ation</w>
ch am
part ner</w>
amp </w>
r at
fe es</w>
g ar
ai red</w>
poly mer
h 2
princi ples</w>
specif ied</w>
vari ants</w>
thre e-
year -
g ir
suppor ting</w>
influ enz
com a</w>
dis rup
trans fer
arter ial</w>
a id</w>
og en</w>
qu ick
ne ural</w>
exper ts</w>
ultras ound</w>
ju g
app ly</w>
avail ability</w>
c f
inf arc
g y
exten sion</w>
r s
1 c</w>
ab sol
cor ti
auth or</w>
thick ness</w>
label ed</w>
temp oral</w>
up take</w>
anesthe sia</w>
there by</w>
7 9</w>
fron t</w>
the ory</w>
inc id
offic ers</w>
un less</w>
allel e</w>
coun ty</w>
consum ers</w>
s d
con sen
r am
ec </w>
health care</w>
hydro x
t ex
ag ric
at trac
el i
t b</w>
inf ants</w>
∼ </w>
dr in
star ted</w>
mix ture</w>
is a</w>
ir ing</w>
expl an
sp read</w>
orig in</w>
ul tim
cu t</w>
agric ul
er a</w>
gen otype</w>
r hy
heter ogene
cytop las
las er</w>
- related</w>
cre ated</w>
mat ters</w>
en sion</w>
aut o
path ogen
re h
meta stasis</w>
transcrip tional</w>
ell a</w>
parame ter</w>
phosph ate</w>
t .</w>
flo or</w>
contribu tions</w>
9 4</w>
h ap
z one</w>
cor tex</w>
lim itations</w>
advertis ing</w>
secre tion</w>
og lob
ann ot
ph ones</w>
amp lif
so il</w>
ad es</w>
h ttp</w>
h und
pur ified</w>
pos si
mil k</w>
disclaim er</w>
instr ument</w>
tab ular</w>
s un
t 1</w>
go ti
der iv
thy roid</w>
mil let</w>
exten sive</w>
cul tural</w>
ane ously</w>
ar ab
c l</w>
il ls</w>
re al-
tel e
sh op
extrac t</w>
p m</w>
tre e</w>
repl ication</w>
l ution</w>
deli vered</w>
pro be</w>
ch est</w>
p 1</w>
er y
loo king</w>
go als</w>
innov ation</w>
no ise</w>
ul </w>
pl o
predic tion</w>
fri ends</w>
so on</w>
repor ter</w>
gf p</w>
reli able</w>
allow ing</w>
se a</w>
ne igh
me tal</w>
ic a</w>
plat el
ar tif
ur inary</w>
sn ps</w>
in ate</w>
clu sters</w>
du pl
selec tive</w>
thro m
unc ture</w>
am ide</w>
pl ays</w>
as h</w>
here in</w>
pres entation</w>
a way</w>
th ers</w>
perman ent</w>
kore a</w>
l uc
mo un
t ance</w>
m s.</w>
ro les</w>
imple ment</w>
su peri
ed -
complex es</w>
8 4</w>
r t</w>
sc en
biop sy</w>
def ects</w>
su m</w>
f as
b ly</w>
w an</w>
foc al</w>
inf ra
targ eting</w>
b i</w>
ov a</w>
x ia</w>
ti fication</w>
sustain able</w>
spon sors</w>
ne goti
d m</w>
divi d
cyto kines</w>
ur g
secret ari
i e</w>
b ia</w>
h z</w>
lymp h</w>
ill ing</w>
be d
chr on
ver te
sel ves</w>
us al</w>
off ering</w>
hard ware</w>
ww w.
bas al</w>
ac tin</w>
a a</w>
stimul i</w>
cl oud</w>
pr o</w>
initi ally</w>
conduc t</w>
abnormal ities</w>
bri ef
excell ent</w>
l d
om as</w>
macroph ages</w>
vot ing</w>
divid end</w>
rhy th
instruc tions</w>
mal aria</w>
rap idly</w>
promot ing</w>
an y
re placement</w>
g b</w>
horm one</w>
tuber cul
predic t</w>
k ing
inter im</w>
illu str
ei ved</w>
pl an
st op</w>
2 3
c um
gu ang
ari an</w>
pro files</w>
grow n</w>
interest ed</w>
al ign
spectr um</w>
biom ar
feed back</w>
ann ed</w>
specim ens</w>
manufactur er</w>
s low</w>
pro jec
vari ability</w>
ter rit
sp i
traff ic</w>
urb an</w>
at ri
parti cles</w>
dep le
supple ment</w>
econom y</w>
sen s
amend ment</w>
claim s</w>
stand ardi
w an
1 1.
att ached</w>
trans formation</w>
expl o
discrimin ation</w>
and ed</w>
injec ted</w>
chil d
mo stly</w>
p ip
nec ro
co ag
hypo the
ad mission</w>
imp aired</w>
opa thy</w>
st en
sel ling</w>
ac qu
neur onal</w>
ch ip</w>
bec ame</w>
ob ac
idi ty</w>
c m
chem i
h un
wil d</w>
fail ed</w>
organ isms</w>
los t</w>
pres er
op hy
ca the
circ ular</w>
a vi
hop e</w>
cr uc
≤ </w>
ad der</w>
par all
m ass
tre at</w>
infec tious</w>
f all</w>
1 3.
acc es
pro por
deci sions</w>
princip le</w>
diff er</w>
centrif ug
dep ending</w>
kin e
satisfac tion</w>
co vered</w>
secretari at</w>
nct 00
f ing
,0 00,000</w>
del ay</w>
extrac tion</w>
mo bil
audi ted</w>
sp ring</w>
k ne
ma ster</w>
res ource</w>
loc alization</w>
ac a
con fig
influenz a</w>
viol ence</w>
accord ingly</w>
al b
conver tible</w>
provi ders</w>
9 7</w>
fund am
r ig
regul ate</w>
h k
com ing</w>
hab it
de mograph
air s</w>
decid ed</w>
em is
reh abil
co m</w>
tru ste
z hang</w>
8 2</w>
commun ities</w>
pro tect</w>
ex ist</w>
epi de
propos al</w>
gro ss</w>
transpl antation</w>
declar ation</w>
id en
indic ators</w>
bor n</w>
un able</w>
model ing</w>
pay able</w>
wor ks</w>
bon d</w>
phy lo
aff ili
disp os
tion ary</w>
9 2</w>
org an</w>
he pat
qu ite</w>
unc er
har v
ag encies</w>
gu ide</w>
cho ose</w>
con str
rou ght</w>
co cc
ul c
q i</w>
dou ble
ly -
particip ated</w>
ed ly</w>
8 3</w>
ref er</w>
exhib ited</w>
gen ders</w>
c it
bo o
per spective</w>
on going</w>
id es</w>
carr ying</w>
ter y</w>
con sequ
bil ateral</w>
inhib it</w>
employe e</w>
descri be</w>
ti le</w>
infarc tion</w>
consi sts</w>
commun ications</w>
reven ues</w>
arth ritis</w>
ter ed</w>
b .</w>
i er</w>
appoin ted</w>
collabor ators</w>
antic ip
pl ates</w>
10 00</w>
stre et</w>
meta static</w>
con jug
sur pr
y g
molec ule</w>
k 1</w>
here by</w>
di etary</w>
ch en</w>
ne ut
cir cul
manufactur ing</w>
ac tually</w>
he ight</w>
aim ed</w>
mark ed</w>
shif t</w>
artif icial</w>
vi g
organ ized</w>
pro xim
9 -
ji ang</w>
si lic
e book</w>
n t</w>
interest ing</w>
h s</w>
p on
recombin ant</w>
alter ed</w>
mil itary</w>
bro ad</w>
o g</w>
clin ic</w>
consen sus</w>
path ogenesis</w>
ide a</w>
nucleoti de</w>
pre g
n ium</w>
rev ised</w>
olog ous</w>
con genital</w>
8 1</w>
pr ene
flu or
equip ped</w>
ist an</w>
mo ve</w>
a ther
recurr ent</w>
bi dity</w>
um ab</w>
s ound</w>
sal ine</w>
yl ated</w>
quick ly</w>
l am
sen sor</w>
8 9</w>
cr u
there of</w>
numer ous</w>
pepti des</w>
ti fied</w>
sh ock</w>
al lo
sto od</w>
nec k</w>
tra vel</w>
z en</w>
t t</w>
pi x
parall el</w>
es sive</w>
antibio tics</w>
re d
4 a</w>
hospit als</w>
fac es</w>
en able</w>
chemi stry</w>
dilu ted</w>
st ay</w>
co 2</w>
dri ven</w>
n ation
accep ts</w>
x i</w>
entre prene
iz es</w>
8 7</w>
est s</w>
app reci
double -
0. 2</w>
guid ance</w>
monit or</w>
a ster
h g</w>
we ak</w>
le ar</w>
wee k
com b
civ il</w>
and roid</w>
pers on
micro -
6 00</w>
sched ule</w>
lin ed</w>
ma x</w>
contrac ts</w>
peri od
class es</w>
pre fer
psych i
sha red</w>
suppor ts</w>
pres s</w>
terror ism</w>
oper ate</w>
read s</w>
ne ver
al i</w>
is h
on to</w>
se p
traum a</w>
leg is
subscri ption</w>
sett ings</w>
hist o
rang ing</w>
sh ar
fe e</w>
hemorrh age</w>
rehabil itation</w>
bl adder</w>
t ant</w>
prim ers</w>
organ ic</w>
awar eness</w>
cor tical</w>
enrol led</w>
ti me-
cl ar
v e-
plac ing</w>
control ling</w>
iden tical</w>
absol ute</w>
st ar</w>
identi ty</w>
m ia</w>
mortg age</w>
tow ard</w>
stock holders</w>
a w
co lo
with draw
it one
advis ory</w>
app ed</w>
a qu
chec k</w>
pancre atic</w>
frequ ent</w>
pack age</w>
cali for
exc e
org ans</w>
exc ess</w>
author ities</w>
toler ance</w>
dem ocr
h ind</w>
d ly</w>
p 53</w>
c ents</w>
dis charge</w>
bra z
colle ge</w>
construc ted</w>
ses sions</w>
in s
represent atives</w>
electr on</w>
smo oth</w>
l .</w>
ill ness</w>
believ es</w>
author ized</w>
cap </w>
eth ics</w>
objec tives</w>
m b</w>
g ap</w>
end ogenous</w>
micros copy</w>
comparis ons</w>
9 3</w>
inhibit ory</w>
top ic</w>
pharma co
po is
for ces</w>
substi tu
op tical</w>
h c</w>
fac ial</w>
candi date</w>
m g
larg ely</w>
x- ray</w>
distribu tions</w>
them selves</w>
con sequences</w>
siz es</w>
ve in</w>
e at</w>
stimul us</w>
t ary</w>
bre ak</w>
rati os</w>
eff ort</w>
aff airs</w>
inva sion</w>
be aring</w>
re form</w>
phot o
s an</w>
ner v
system atic</w>
su spec
ess or</w>
ra ised</w>
commit ment</w>
um in
cel l-
thel ess</w>
per f
li ability</w>
- induced</w>
never theless</w>
os cler
chos en</w>
path ology</w>
exp ect</w>
op las
lap ar
r t-
superi or</w>
eth anol</w>
hist or
m ol</w>
and a</w>
gly c
mir nas</w>
tas ks</w>
ho t</w>
b 1</w>
d ents</w>
p f
aff ecting</w>
tak es</w>
a or
califor nia</w>
transf ected</w>
el isa</w>
u preg
w ar</w>
sci ences</w>
b al</w>
ce o</w>
nutri tion</w>
in side</w>
certif icates</w>
m o</w>
g ri
off ici
si ties</w>
nor m
concer ns</w>
extrac ellular</w>
b ing</w>
el ection</w>
cy tos
deleg ation</w>
k y
arrang ements</w>
bre ak
t ac
es tion</w>
li fied</w>
vi </w>
certif icate</w>
vess els</w>
fat ty</w>
equ ation</w>
v an
9 1</w>
tim ely</w>
sk ills</w>
inhib ited</w>
r ice</w>
ne i
ain ts</w>
i ons</w>
wi sh</w>
expen di
1 2.
p it
lim b</w>
w ound</w>
ul l</w>
um -
ye ast</w>
ac ted</w>
on ucle
st ation</w>
cri min
develop mental</w>
ed ge</w>
a sts</w>
separ ated</w>
epide mi
sp le
some times</w>
the ore
pl a
low est</w>
comp ati
phenomen on</w>
transcrip ts</w>
vir tual</w>
per fusion</w>
colum n</w>
charg ed</w>
s s
a x</w>
a ver
or -
olog ically</w>
vehic le</w>
expen se</w>
requ ested</w>
accep ted</w>
wor th</w>
ster ing</w>
canc ers</w>
cor d</w>
frac ture</w>
vacc ination</w>
ver ing</w>
ra w</w>
vul ner
p k
aff inity</w>
hi pp
op o
st ances</w>
sh op</w>
cruc ial</w>
ven ous</w>
ful l-
dep ends</w>
tn f-
engine ering</w>
v ill
nei ther</w>
ex ac
ne ph
pa i
dar k</w>
l in</w>
month ly</w>
tubercul osis</w>
initi ation</w>
worl d
bi ology</w>
compu ted</w>
bur den</w>
ob ic</w>
dele tion</w>
displ ayed</w>
0 00</w>
imp lic
ben ign</w>
direc ted</w>
wi d
trans lation</w>
mat ched</w>
bio chemical</w>
inter view</w>
al ities</w>
12 -
weap ons</w>
pal est
y er</w>
e e</w>
exi stence</w>
en coding</w>
el ement</w>
ten tion</w>
real- time</w>
er ce</w>
o h</w>
t aneously</w>
y el
fres h</w>
tum our</w>
oc ular</w>
µ m</w>
adop tion</w>
1. 0</w>
t am
m ers</w>
li abilities</w>
throm bo
sh aring</w>
ann ex</w>
em ic</w>
kne e</w>
don or</w>
pol ice</w>
continu ing</w>
po ver
tro ph
alog ue</w>
h aps</w>
un ic
no d
fr ance</w>
fi elds</w>
assum ed</w>
e th</w>
im ag
. conclusion</w>
laun ch</w>
prac tical</w>
fal se</w>
pro p
retro spec
inf il
us h</w>
ar ization</w>
fibro bl
bo und
3 b</w>
govern ments</w>
regi ster</w>
si on-
aor tic</w>
form ing</w>
s in</w>
rhe a</w>
engl ish</w>
per haps</w>
f ications</w>
off ered</w>
b ial</w>
com for
a th
pow er
sett le
m i</w>
as tic</w>
inv ent
sp o
f p</w>
cle ar
ta i
clim ate</w>
gl ass</w>
tion ed</w>
pi ec
n s
austr alia</w>
g est
al k
sim ulation</w>
modi fication</w>
radi otherapy</w>
accompan ied</w>
simil arity</w>
cham ber</w>
199 4</w>
fif th</w>
clu sions</w>
z z
pop ular</w>
def a
co efficient</w>
marg in</w>
chlor ide</w>
c am
le ase</w>
asi an</w>
eth n
h n</w>
plasm id</w>
ag ree</w>
under stood</w>
absor ption</w>
pover ty</w>
dri ve</w>
e de
stat in</w>
s an
p as
characteris tic</w>
c .
ber g</w>
mar row</w>
sec </w>
r -
down stream</w>
a 1</w>
visi ts</w>
circum stances</w>
oc ar
adhe sion</w>
do or</w>
bai du</w>
# </w>
great ly</w>
emerg ing</w>
stimul ated</w>
usu al</w>
zer o</w>
up -
fundam ental</w>
refl ected</w>
warr ants</w>
0 -
00 1</w>
oc amp
residu al</w>
c p</w>
l ess
meta -
orig in
elet al</w>
t utes</w>
nas al</w>
car bo
fav or
under going</w>
u bi
predic tive</w>
pathogen s</w>
sel ect</w>
1 4.
anti gen
l ens</w>
id ate</w>
termin ation</w>
re active</w>
substanti ally</w>
b ow
docum ented</w>
pr c</w>
v es
err ors</w>
z -
oc ks</w>
recei v
t g</w>
7. 5</w>
st res
in her
li min
in oc
i x</w>
pre ven
ke ep</w>
lo op</w>
datas et</w>
apopto tic</w>
z o
hipp ocamp
nam ely</w>
asp ir
morph ology</w>
d s
con secu
cd 8</w>
k o</w>
it arian</w>
ban ks</w>
suscepti bility</w>
v r</w>
remo ve</w>
neon atal</w>
s av
weigh ted</w>
j e
immuno histo
ro s</w>
su </w>
attribu table</w>
membran es</w>
mo ther</w>
c is
inter vals</w>
an ese</w>
determin ing</w>
li fe
o f-
incre as
d m
2 50</w>
c x
i os</w>
fil ter</w>
pre mi
it us</w>
v -1</w>
entreprene ur
competi tive</w>
analy sed</w>
parti ally</w>
at a</w>
al ph
ow nership</w>
li po
colle ag
short -term</w>
c ross</w>
g radi
pul se</w>
ev ent
possi bly</w>
del ayed</w>
pre limin
qual it
mul tiv
nam ed</w>
2 d</w>
hi p</w>
treat ing</w>
respon d</w>
in direct</w>
meas uring</w>
rel ap
li u</w>
v enture</w>
y a</w>
sp ac
re construction</w>
g ing</w>
invol ves</w>
f e</w>
proce eds</w>
ho me
l ar</w>
neut roph
scen ari
dy sp
be hind</w>
uter ine</w>
t on
manifest ations</w>
consequ ently</w>
ischem ic</w>
seg ments</w>
ot ted</w>
extrem ely</w>
if ic</w>
g d
cont amin
sto res</w>
new ly</w>
mod ul
tr </w>
bec omes</w>
in stance</w>
m ap
amplif ication</w>
av age</w>
charg es</w>
f ed</w>
m outh</w>
pro long
ul ed</w>
f i</w>
physici ans</w>
oper ators</w>
human itarian</w>
amp lit
emo tional</w>
n r
di verse</w>
re tail</w>
ig g</w>
esophag eal</w>
heav y</w>
prov inc
demograph ic</w>
ir a
atten u
cur ative</w>
at p</w>
produc ing</w>
compl icated</w>
simp ly</w>
gen omes</w>
minim al</w>
qual ified</w>
junc tion</w>
coupl ed</w>
sple en</w>
nucle us</w>
discus s</w>
b ad</w>
purch as
world wide</w>
de ep
ap parent</w>
m ell
for tun
bron ch
construc t</w>
ach e</w>
pro mp
process or</w>
1 st</w>
solu ble</w>
pic ture</w>
em bol
re ti
th in</w>
super nat
k ine</w>
tab let</w>
lim itation</w>
sol v
fo x
ca using</w>
min d</w>
dis closed</w>
δ </w>
abund ance</w>
c k</w>
5 a</w>
prelimin ary</w>
de plo
intermedi ate</w>
arch it
pre operative</w>
n ative</w>
capsul e</w>
comm ents</w>
hear ing</w>
ad jac
ro bo
at e
unc lear</w>
p in
t old</w>
circ ulation</w>
stud ent</w>
ad mitted</w>
un ding</w>
ac tively</w>
vari ant</w>
reproduc tive</w>
le ts</w>
independ ently</w>
s low
n f-
s cope</w>
thro mb
t c</w>
op ening</w>
1. 1</w>
ex act</w>
corti co
f 1</w>
mis sing</w>
d less</w>
over night</w>
e igh
over expression</w>
op e</w>
libr ary</w>
table ts</w>
ne ed
en co
sol ve</w>
ant agon
exper t</w>
strength ening</w>
cd na</w>
j ing
cas p
tr yp
ic king</w>
lin k
dr am
ch y
cryst al</w>
supple mented</w>
neurolog ical</w>
jus tice</w>
1. 2</w>
os a</w>
def icient</w>
ep id
en di
res on
loc i</w>
categ or
shor ter</w>
fibro sis</w>
disco very</w>
en se</w>
tox ic</w>
k ept</w>
atten d</w>
devi ation</w>
respon si
le aves</w>
sul f
h is
if n-
cen ters</w>
compan y
mir na</w>
comp osed</w>
non- executive</w>
κ b</w>
il- 6</w>
- like</w>
increas ingly</w>
a co
ubi quit
king dom</w>
immedi ate</w>
f da</w>
2. 0</w>
l ity</w>
crimin al</w>
l un
arrang ement</w>
st e</w>
regar dless</w>
c g
a sis</w>
p g
pri ority</w>
bin d</w>
inter -
differenti ated</w>
fir e</w>
frequ encies</w>
e a</w>
conc ep
import antly</w>
ga ve</w>
educ ational</w>
contin ues</w>
ede ma</w>
sou thern</w>
ob ject</w>
moder n</w>
consecu tive</w>
t es
an atom
fo ot</w>
exp and</w>
f f</w>
8 00</w>
sy m
embry os</w>
run ning</w>
rel ations</w>
tr y</w>
ac u
busin esses</w>
summar ized</w>
cy tot
d c</w>
an tim
consider able</w>
b order</w>
ep iso
mat ch</w>
coun ts</w>
evol u
symp tom</w>
er ation</w>
ol ed</w>
ather oscler
r ene
pro -
fir m</w>
satisfac tory</w>
ot rop
difficul ties</w>
lapar os
quar ters</w>
r end
aster n</w>
in sec
coun ter</w>
se em</w>
chang ing</w>
pil ot</w>
platel et</w>
key words</w>
kar y
comp et
dist al</w>
qu ad
conclud ed</w>
job </w>
ain t</w>
w ech
calc ulation</w>
transp or
bel ong
adjac ent</w>
displ ac
og ly
ad ding</w>
s wi
er t</w>
mag nit
hydro gen</w>
recru ited</w>
ret inal</w>
int ended</w>
appro ve</w>
govern ance</w>
off ers</w>
an k
config uration</w>
te en</w>
publ ication</w>
fl ag
y ed</w>
larg e-
forc ed</w>
physici an</w>
p et</w>
inten sive</w>
po or
s ays</w>
bot tom</w>
gam es</w>
sten osis</w>
align ment</w>
synap tic</w>
g on
cal ls</w>
oz yg
o mp
fi ber</w>
occurr ing</w>
identi fying</w>
gre es</w>
po ol</w>
sn p</w>
ac id
app endi
d an
intellig ent</w>
inter fer
retrospec tively</w>
veg et
vol t
bl ind</w>
min or</w>
gi ving</w>
subjec ted</w>
fil ing</w>
bat tery</w>
ex ic
m mp
cul tiv
therap ies</w>
µ g</w>
est ate</w>
normal ized</w>
fe el
oc ca
ov o</w>
val id</w>
vari ations</w>
retro spective</w>
initi ative</w>
mor ning</w>
electr icity</w>
year- old</w>
ge al</w>
coll agen</w>
di ar
lab or</w>
appendi x</w>
av oid
al de
part um</w>
a h</w>
1 6.
1 5.
ul ative</w>
d re
s er</w>
coun sel
answ er</w>
fluores cent</w>
cytot ox
over -
b es</w>
trans genic</w>
hem o
wid th</w>
adher ence</w>
colleag ues</w>
tr ip
col on</w>
consi sted</w>
multiv ari
def ect</w>
f aster</w>
vag inal</w>
es tive</w>
attribu ted</w>
ocy to
con g
tnf- α</w>
heal ing</w>
loc us</w>
correl ations</w>
hu a
om ing</w>
cyto kine</w>
protoco ls</w>
behavi our</w>
sch iz
micros cope</w>
do ing</w>
mor bidity</w>
top ics</w>
archit ec
or b
recru iting</w>
cut aneous</w>
k b</w>
suppres sion</w>
frag ments</w>
eng aged</w>
ac up
wat ch</w>
tou ch</w>
cop ies</w>
prog ressive</w>
lig and</w>
lik eli
str a
rt- pcr</w>
defa ult</w>
refl ects</w>
fo under</w>
valu able</w>
xi a
correc tion</w>
enti ties</w>
p 2</w>
lab el</w>
alde hy
it y-
chem o
aff ects</w>
sens ory</w>
p b
invest or</w>
in e-
val idation</w>
an ova</w>
m apping</w>
ther mal</w>
ob ese</w>
for d</w>
oc l
res sing</w>
z er</w>
impro vements</w>
lo ve</w>
k u
yn geal</w>
isra el</w>
un ds</w>
wech at</w>
licen se</w>
mo ti
fl uc
separ ation</w>
spon taneous</w>
bl ock
anti oxid
nit rogen</w>
f ati
monit ored</w>
er b
s un</w>
cap able</w>
brief ly</w>
represent ation</w>
bil ities</w>
vi sible</w>
posi tively</w>
per me
ment ing</w>
h ex
ha z
s ent
su g
c ame</w>
tt on</w>
accep table</w>
mam m
def ine</w>
chromat in</w>
regim en</w>
norm ally</w>
ra ise</w>
tr ends</w>
t enc
con clusions</w>
de tail</w>
cou gh</w>
prim er</w>
prof essor</w>
surro unding</w>
mis sions</w>
decre ases</w>
rob ust</w>
nerv ous</w>
og r
ch e</w>
val idated</w>
g ab
de grees</w>
valu ation</w>
te es</w>
grad u
fix ation</w>
speci al
pl anned</w>
rel ess</w>
par a</w>
r on
necro sis</w>
ic ip
m l
bl ed</w>
fluc tu
en jo
cav ity</w>
tenc ent</w>
n k</w>
for um</w>
v ary</w>
du al</w>
air way</w>
recommend ation</w>
pneum onia</w>
y .
ic als</w>
g ue</w>
nor thern</w>
fund ed</w>
wor thy</w>
n ac
window </w>
é </w>
cri me</w>
immun ity</w>
uncer tain
wh om</w>
ent -
c ast</w>
in hal
persi stent</w>
dispos al</w>
b rought</w>
v ation</w>
var ying</w>
3 5
frag ment</w>
st one</w>
sa ve</w>
ab use</w>
ur y
appoin tment</w>
re placed</w>
stre p
vo ice</w>
w er</w>
mun icip
dis ability</w>
psychi atric</w>
perc eived</w>
c ue</w>
alter ations</w>
cl aim</w>
val ve</w>
tur ing</w>
de al
tempor ary</w>
process ed</w>
is hing</w>
lea f</w>
estim ation</w>
itone al</w>
av </w>
chap ter</w>
pe a
separ ately</w>
c v
wil ling</w>
vari ed</w>
2 c</w>
long -
cor ne
i on
am az
af ter
reser ve</w>
likeli hood</w>
sc ales</w>
under go</w>
medic ations</w>
at tit
r 2</w>
rab bit</w>
flu x</w>
m exic
put ative</w>
sust ained</w>
ves ic
requi rement</w>
magnit ude</w>
respon dents</w>
acup uncture</w>
pac ific</w>
wel ling</w>
r d</w>
oxid ation</w>
enhanc ement</w>
… </w>
consti tute</w>
adju vant</w>
pharma colog
y u</w>
explan ation</w>
invol ve</w>
as k</w>
mell itus</w>
man ip
venti lation</w>
suspec ted</w>
mil li
l on
yel low</w>
e ous</w>
mar ks</w>
ge o
st op
on t
cent ury</w>
electr ical</w>
gen otypes</w>
jap anese</w>
nam es</w>
. 2</w>
palest in
immun os
y cl
µ l</w>
hu ge</w>
hc v</w>
se mi
oper ational</w>
pat ent</w>
kin ds</w>
fir st-
autom atically</w>
power ful</w>
x in</w>
braz il</w>
leuk emia</w>
h s
ha ir</w>
cont ents</w>
enric hed</w>
tra its</w>
la w
consi sting</w>
d end
mo tiv
pow der</w>
in ess</w>
o a</w>
h en</w>
f u</w>
post partum</w>
a ment</w>
10 5</w>
isol ation</w>
particip ating</w>
cy s
ery thro
5 7
pro mo
an ch
h es</w>
tis h</w>
cap ture</w>
hu a</w>
kine tics</w>
cir cu
re tri
st yle</w>
off ices</w>
cr aft</w>
secu red</w>
standardi zed</w>
cri sis</w>
prec ur
jour n
al a</w>
repe at</w>
fru it</w>
asse m
n p</w>
phylo genetic</w>
pai red</w>
sel ler</w>
b d</w>
infra structure</w>
f illed</w>
impl ications</w>
dea ths</w>
adv ance</w>
simul taneously</w>
loc alized</w>
pre domin
resol ved</w>
p v
depend ence</w>
perform ing</w>
al ize</w>
lac t
ane ury
re tention</w>
pos s
examp les</w>
k i</w>
d ay
c ities</w>
democr atic</w>
dis closure</w>
se ed</w>
mat ur
an th
fati gue</w>
pro per</w>
dro p</w>
exten d</w>
ly sis</w>
om y</w>
requ iring</w>
moti f</w>
st ocks</w>
bu re
di sci
fl av
mm ol</w>
fo rest</w>
b t</w>
0. 3</w>
s me
te ach
gir ls</w>
199 3</w>
lt d.</w>
em bed
dg ed</w>
ic ed</w>
p ass</w>
f ine</w>
pro gn
con form
ulc er</w>
ultras on
man ual</w>
ar bit
ati tis</w>
extrac ts</w>
1 ,000</w>
assi st</w>
v end
hua wei</w>
integr ity</w>
ent ures</w>
@ </w>
depart ments</w>
difficul ty</w>
d 1</w>
pri or
adoles cents</w>
compar ative</w>
ill in</w>
ter ing</w>
k y</w>
tele phone</w>
initi ated</w>
r ating</w>
o si
progn os
p ure</w>
ol a</w>
mo vements</w>
sal t</w>
ex tra
main taining</w>
registr ant</w>
tab les</w>
th -
on tal</w>
regul ating</w>
re in
der ed</w>
wi reless</w>
disci pl
func tioning</w>
see k</w>
f c</w>
m t</w>
cop d</w>
meta st
lo ading</w>
en ab
situ ations</w>
micro array</w>
ar ma
v ine</w>
barri er</w>
buil t</w>
exclud ing</w>
t s
att ack</w>
aut ophag
cs f</w>
clin ici
id a</w>
correc ted</w>
ver tical</w>
evolu tionary</w>
nan op
sub set</w>
ha em
univer sal</w>
detec table</w>
reli ability</w>
mo thers</w>
min ute</w>
acqu ire</w>
antibio tic</w>
sc at
clear ance</w>
influ enced</w>
op la
re mot
b is
allel es</w>
under taken</w>
h sp
inv est</w>
path y</w>
vess el</w>
the tic</w>
3 3
ou ter</w>
otyp ic</w>
elim ination</w>
den ds</w>
id al</w>
inter act</w>
pedi atric</w>
ill ance</w>
tai wan</w>
divi dends</w>
ic in</w>
se iz
sol ved</w>
purchas er</w>
aut onom
ing -
fol lic
be au
l ps</w>
mam mal
commit ted</w>
spe ech</w>
thy ro
gene sis</w>
pro gen
h u</w>
adap tation</w>
ocar cin
ing ton</w>
t own</w>
s 3</w>
co ated</w>
long it
log is
enti ty</w>
lo aded</w>
cro w
candi dates</w>
v ital</w>
tain ment</w>
wh it
eg fr</w>
adv ice</w>
hund red</w>
e astern</w>
• </w>
tic ity</w>
oglob in</w>
fe wer</w>
settle ment</w>
traum atic</w>
truste e</w>
manag ed</w>
pl ane</w>
arma ment</w>
g c</w>
oph ren
strong er</w>
she et</w>
tim ing</w>
lymph ocytes</w>
as sign
cr p</w>
resi due</w>
en chy
r nas</w>
a ward</w>
aldehy de</w>
ac ks</w>
micro bial</w>
at e-
prolong ed</w>
modi fications</w>
v .</w>
gro w</w>
n 1</w>
hybri di
surve illance</w>
4 5
pel v
guaran tee</w>
3. 5</w>
ph o
dis armament</w>
schiz ophren
lymph oma</w>
bl og
h p</w>
assess ments</w>
mac ro
prob es</w>
ref ers</w>
f ec
az ole</w>
ar ising</w>
li ber
re ality</w>
trans l
oc ity</w>
psy cho
brow n</w>
enc e
dow n-
comm erce</w>
sub unit</w>
sf o</w>
4 b</w>
pa th</w>
at -
c at</w>
gen ous</w>
traff icking</w>
p ene
agricul tural</w>
fron tal</w>
phen otypes</w>
g i</w>
us p
fung al</w>
tal k</w>
tr ained</w>
fac ebook</w>
g 1</w>
dr af
gen ce</w>
m .
treat y</w>
w ai
re p
cy tes</w>
mammal ian</w>
investig ations</w>
spectr a</w>
amplit ude</w>
hor iz
c au
prec ip
in ner</w>
alph a</w>
ph ere</w>
cle an
up date</w>
gradi ent</w>
fa sting</w>
initi atives</w>
transi ent</w>
profes sion
p 2
c iti
heterogene ity</w>
v a
syn chron
pass ed</w>
c ular</w>
br ation</w>
vi ability</w>
tel evi
expl oration</w>
veg f</w>
amp lified</w>
proxim al</w>
bri dge</w>
c 1</w>
ref u
behavi ors</w>
b un
0 5</w>
war ds</w>
plas tic</w>
c n</w>
log istic</w>
d ental</w>
inc ur
i k
perc eption</w>
dri ving</w>
compar ator</w>
grou p.</w>
acc id
re de
vel ocity</w>
val idity</w>
lo g</w>
min ing</w>
t ants</w>
p g</w>
trans formed</w>
activ ate</w>
bri tish</w>
n ig
cur ves</w>
prognos tic</w>
li t</w>
sen d</w>
w ing</w>
assess ing</w>
ul in</w>
discus sions</w>
indi genous</w>
sp orts</w>
susp ension</w>
reve al</w>
retur ned</w>
fam ili
ra z
high ligh
prof its</w>
up grade</w>
induc es</w>
por te
rhe um
incorpor ation</w>
f ab
t ong
le t
d cs</w>
cum ulative</w>
transcri pt</w>
attemp t</w>
thin king</w>
con sequence</w>
colo rectal</w>
restric tion</w>
ar ri
mut ual</w>
ultim ately</w>
g t
reduc es</w>
hist ological</w>
ocr ine</w>
atri al</w>
utili zed</w>
duc t</w>
el ected</w>
wa it</w>
ap hy
experi ences</w>
simul ations</w>
ori entation</w>
frac tures</w>
poin ted</w>
supple mental</w>
week ly</w>
invent ory</w>
lim its</w>
ar -
ins ic</w>
10 6</w>
m acy</w>
requ ests</w>
pois oning</w>
polymer ase</w>
or ph
acc ept</w>
prev enting</w>
associ ates</w>
exc eption</w>
televi sion</w>
o sition</w>
peace keeping</w>
hi v-
s v
bri ef</w>
accep tance</w>
pro min
n d</w>
endos copic</w>
ep il
exp anded</w>
anc ies</w>
j am
thre at
hi v-1</w>
ud es</w>
complex ity</w>
ic u</w>
ma x
yi el
ot ting</w>
exi sts</w>
transf ection</w>
fro zen</w>
lear n</w>
biomar kers</w>
favor able</w>
ap par
descri p
my co
rap porte
fre ed
z he
theore tical</w>
ar med</w>
every one</w>
inc en
} </w>
in ch</w>
op ened</w>
{ </w>
b ay
b enz
vir </w>
ul tra
qualit ative</w>
aff ir
di lution</w>
ma -
0. 4</w>
fl or
transp ar
j in</w>
angi ography</w>
blo t</w>
me ters</w>
neg atively</w>
p p</w>
exce ed</w>
ide al</w>
is land</w>
longit ud
curr ency</w>
sched uled</w>
it ability</w>
evid ent</w>
trac he
compo site</w>
promis ing</w>
muco sal</w>
ai res</w>
bloc ks</w>
comp ro
ra ys</w>
kin etic</w>
end o
industri es</w>
benef ici
in n
sc anning</w>
t 2</w>
d l
issu er</w>
youn ger</w>
intra -
war ran
compro mis
12 4
diff usion</w>
gi ves</w>
pre ference</w>
morph ological</w>
clu stering</w>
reson ance</w>
c f</w>
autom atic</w>
reli ef</w>
expl ored</w>
og ram</w>
am bi
di alogue</w>
ro t
compl ication</w>
win d</w>
don ors</w>
ban king</w>
am a</w>
mar ri
con sci
conver ted</w>
incen tive</w>
is lands</w>
laparos copic</w>
fac tory</w>
o den
ow ner</w>
se as</w>
phar macy</w>
evalu ating</w>
child hood</w>
architec ture</w>
k en
ser ver</w>
plac es</w>
pu ts</w>
q -
v ity</w>
reco vered</w>
calcul ate</w>
en ch</w>
fi bers</w>
metast ases</w>
issu ance</w>
es cence</w>
impl antation</w>
ar ab</w>
re mun
sp ent</w>
equ ality</w>
ag m</w>
antim ic
ak t</w>
embry onic</w>
y mp
multivari ate</w>
mess age</w>
un treated</w>
s en</w>
swit ch</w>
cl ones</w>
ti g
nf- κb</w>
j i</w>
rene w
be ta</w>
ste ad
ell ite</w>
scho ols</w>
d ex
os c
ira q</w>
fas hi
v om
co st-
recor ding</w>
re views</w>
b m</w>
hu ang</w>
oti d</w>
cle avage</w>
ed .</w>
2 2
lin ks</w>
ot ox
str ati
propos als</w>
rel ax
1. 3</w>
sub stance</w>
rad ical</w>
dec ade</w>
jun </w>
exc essive</w>
e- based</w>
ur ia</w>
fac tor
bure au</w>
wo od</w>
utili zation</w>
p ages</w>
ho using</w>
re mark
199 0</w>
se -
remot e</w>
tg f-
house hold</w>
han ds</w>
retri ev
al ig
p o</w>
g han
le e</w>
neph ro
re tained</w>
emis sion</w>
seas on</w>
in ter</w>
mini ster</w>
arbit r
stom ach</w>
ischem ia</w>
hospit alization</w>
labor at
st on</w>
path ogenic</w>
palestin ian</w>
lea ve</w>
m c</w>
prote in
coun ted</w>
an emia</w>
2. 1</w>
wal king</w>
syst olic</w>
ec tive</w>
consist ently</w>
radi o
w it
el uc
ac k
intellig ence</w>
ach ment</w>
sol e</w>
il ed</w>
cathe ter</w>
199 2</w>
comput ing</w>
bow el</w>
inser tion</w>
si rna</w>
restric tions</w>
synthe tic</w>
dep end</w>
mod ule</w>
e str
deple tion</w>
acc ess
ne ther
forc ement</w>
g ains</w>
legis lation</w>
neigh b
dis h</w>
imple menting</w>
9 9
rang ed</w>
x en
be an</w>
d ang
dra in
fil l</w>
quanti fied</w>
dis semin
gl and</w>
cre ation</w>
m 1</w>
sig ma</w>
k ia</w>
oc e
k r
shop ping</w>
ozyg ous</w>
or d
coag ulation</w>
mid -
blog ging</w>
cre atin
hap l
secon ds</w>
er ic</w>
ac ic</w>
glut am
lab </w>
0 2</w>
p un
er ship</w>
withdraw al</w>
fortun ately</w>
k in</w>
differenti ally</w>
y i</w>
b l</w>
vehic les</w>
pres ents</w>
an k</w>
de man
contribu ting</w>
circul ating</w>
bec oming</w>
suscepti ble</w>
ital y</w>
objec ts</w>
ran k</w>
op posi
form al</w>
- 3</w>
e os
ay ing</w>
ex clusive</w>
ob struction</w>
ret in
form ula</w>
ex emp
3. 3</w>
ten d</w>
symptom atic</w>
g p
m v</w>
h 3
bloc king</w>
epil ep
indic ator</w>
c ure</w>
li st
collabor ation</w>
nether lands</w>
assi sted</w>
gover ning</w>
twent y-
embed ded</w>
sp ot</w>
bu s</w>
fr actions</w>
air craft</w>
adap tive</w>
con temp
ep ig
trac k</w>
achiev ing</w>
micro blogging</w>
as sumption</w>
s cler
r .</w>
path ogen</w>
sh u
g est</w>
un like</w>
li ves</w>
bi en
meta- analysis</w>
te aching</w>
large- scale</w>
implic ated</w>
a h
um in</w>
remun eration</w>
event ually</w>
w ast
b o</w>
wom an</w>
cr y
d og
b cl
e ar</w>
rapporte ur</w>
exc ee
combin ations</w>
matur ity</w>
1. 4</w>
cytoplas mic</w>
substr ates</w>
å </w>
schizophren ia</w>
sug ar</w>
gr af
lac king</w>
summ it</w>
du oden
care fully</w>
ot es</w>
inf ant</w>
k et
g ate</w>
1 7.
mm hg</w>
bloc ked</w>
ec ological</w>
ac r
om ics</w>
antioxid ant</w>
struc tured</w>
pro pose</w>
cer tain
refu ge
histor ical</w>
end -
up stream</w>
par k</w>
fem oral</w>
twent y</w>
posi tioning</w>
at er
see king</w>
creatin ine</w>
diar rhea</w>
si tions</w>
assum ing</w>
mexic o</w>
t an</w>
cys tic</w>
hb v</w>
gh ts</w>
acc o</w>
thous ands</w>
fit ness</w>
datas ets</w>
believ ed</w>
if er
di a</w>
associ ate</w>
sk eletal</w>
dra w</w>
tre as
18 0</w>
consul tations</w>
conserv ation</w>
audi tors</w>
3 6
alloc ation</w>
ent ally</w>
es .
metabol ites</w>
el ect</w>
hc c</w>
anti </w>
maxim al</w>
fibrobl asts</w>
ocarcin oma</w>
yl -
n ull</w>
accur ately</w>
partic le</w>
form at</w>
abor tion</w>
so -
sp her
anti- inflammatory</w>
inter n
assu me</w>
nan o
logis tics</w>
condi tional</w>
abs ent</w>
encour age</w>
qu in
cor p</w>
l 1</w>
ap er
4 g</w>
oblig ation</w>
ent ary</w>
pea ks</w>
int act</w>
overl ap</w>
equ ili
ur ance</w>
ri ver</w>
ph ases</w>
w u</w>
mp s</w>
environ ments</w>
we al
pu </w>
ti vel
il legal</w>
necess arily</w>
2 4-
t m</w>
enhanc ing</w>
thous and</w>
compris ed</w>
f 2</w>
v ance</w>
recogn ize</w>
advis er</w>
b yp
longitud inal</w>
sh enz
4. 5</w>
fe a
d uly</w>
mat ching</w>
acet ate</w>
pot ent</w>
melan oma</w>
need le</w>
re fin
y ment</w>
emergen ce</w>
l d</w>
de struction</w>
func tion
provi der</w>
elim inate</w>
cap it
thir d-
s welling</w>
barri ers</w>
intell ec
l o</w>
mar ine</w>
deposi ts</w>
adi ly</w>
op s</w>
jing dong</w>
transfer ase</w>
op en-
practic able</w>
3. 0</w>
a f</w>
uti lity</w>
0. 8</w>
18 .
st ac
enric hment</w>
ban ds</w>
mitochondri a</w>
ocl onal</w>
ob la
tre es</w>
tob acco</w>
conjug ated</w>
i pad</w>
au re
profession als</w>
mo ving</w>
vom iting</w>
volt age</w>
neutr al</w>
on i
con st
g f</w>
not ably</w>
k en</w>
lay ers</w>
nur ses</w>
inc ision</w>
ori ented</w>
opposi te</w>
ex on</w>
nom inal</w>
und ed</w>
to oth</w>
fr ench</w>
v an</w>
prec ise</w>
p es</w>
n ose</w>
dic tion</w>
lim iting</w>
was h
no ver</w>
lead ership</w>
3 8
ran ial</w>
di ast
thor acic</w>
mus cles</w>
rus sian</w>
sin us</w>
fo ot
home o
m aps</w>
flow s</w>
summ er</w>
co ven
re combination</w>
vec tors</w>
sh el
play ers</w>
ro tation</w>
x 2</w>
at us</w>
n h
2. 2</w>
rob ial</w>
re place</w>
optim ization</w>
algorith ms</w>
quar ter
aim s</w>
perf ect</w>
wi </w>
q ing</w>
3 60</w>
drin king</w>
over seas</w>
knock down</w>
ari ties</w>
vac u
inst all
4 8
all ergic</w>
hot el</w>
sur ge
ip s</w>
wa vel
mod ulation</w>
mon oclonal</w>
ethn ic</w>
equ ally</w>
e 2</w>
bab a</w>
h oc</w>
e ip
abund ant</w>
prec ision</w>
antimic robial</w>
6 a</w>
aca demic</w>
osc ill
&# 124
&#124 ;</w>
antigen s</w>
mo bility</w>
satis fied</w>
sat ur
dis per
d n</w>
e z
situ </w>
atom s</w>
op ia</w>
nucle i</w>
es day</w>
trig ger
injur ies</w>
e u</w>
c yp
par ental</w>
ven ess</w>
pri me</w>
e ating</w>
^ </w>
polymorph ism</w>
op sis</w>
ol ing</w>
ar rest</w>
ind ex
x in
ac in</w>
lif est
es .</w>
sp lit</w>
gener ating</w>
no kia</w>
ultrason ography</w>
appl ying</w>
son y</w>
dos e-
eth ical</w>
se ven
cell ul
para site</w>
yn thesis</w>
deli ver</w>
def ense</w>
0. 6</w>
territ ory</w>
5 b</w>
inter views</w>
ri bos
hp v</w>
ch ick
bo vine</w>
epid er
mem ber
prescri bed</w>
suff ering</w>
inv it
com it
en larg
decre asing</w>
k o
re purchase</w>
thre at</w>
t rou
tro p
conven ient</w>
en ic</w>
transpl ant</w>
at mos
hel p
te eth</w>
bre eding</w>
b ic
t te</w>
dec ades</w>
scienti sts</w>
ence phal
doc tors</w>
pre mature</w>
lab our</w>
ke ts</w>
gl omer
ri f
bl ing</w>
y outh</w>
in directly</w>
intellec tual</w>
p es
an -
ro ots</w>
sou ght</w>
foc using</w>
manag ing</w>
ul um</w>
eg g</w>
coh orts</w>
ha o</w>
gly cer
amend ments</w>
re jec
rele vance</w>
chromos omes</w>
y an</w>
tur nover</w>
ti p</w>
str and</w>
gr ants</w>
fe asi
gran ul
draw n</w>
ow ners</w>
3 7
datab ases</w>
un likely</w>
r in</w>
hybri d</w>
dec omp
prescri ption</w>
pr on
extre me</w>
ha m</w>
hyper pl
or ally</w>
199 1</w>
k m</w>
semi -
pr en
poor ly</w>
incur red</w>
ec os
ep it
thrombo sis</w>
telec om
t ability</w>
ali baba</w>
q ol</w>
q t
5. 0</w>
head quarters</w>
quanti fication</w>
eti ology</w>
hist one</w>
resid ents</w>
electro ph
tr im
vir ul
prote in-
k istan</w>
a 2</w>
pix el</w>
li ers</w>
fe ar</w>
de ferred</w>
thal am
0. 9</w>
telec om</w>
man n</w>
co vering</w>
inter ference</w>
en sur
or i</w>
intro duce</w>
ad or</w>
ic illin</w>
dist urb
a king</w>
pot enti
10 4</w>
vari ate</w>
g all
m s
an al
develop ers</w>
m ad
asp ect</w>
innov ative</w>
od ds</w>
fashi on</w>
nutri tional</w>
muco sa</w>
1 25</w>
cocc us</w>
st a</w>
help ful</w>
g m</w>
comfor t</w>
le u
jo in</w>
promin ent</w>
m im
car otid</w>
tec h</w>
b all</w>
mil len
expec tations</w>
ap h
in ver
oxid ase</w>
rec eip
expen sive</w>
al is</w>
supernat ant</w>
flexi ble</w>
adop t</w>
shap ed</w>
m n
dri ed</w>
b 2</w>
adv ances</w>
execu ted</w>
con den
fel l</w>
tain s</w>
su ic
compati ble</w>
ch er
ti an
exac erb
ch ance</w>
o me-
feasi bility</w>
obac ter
la -
se d
man age</w>
prop ag
publ ications</w>
nat ur
c ed</w>
invit rogen</w>
method ology</w>
cle an</w>
el ess</w>
regul ates</w>
olog ists</w>
we ar</w>
exp ir
view ed</w>
pl ot</w>
ol i
ot omy</w>
pass ing</w>
hem oglobin</w>
hyperpl asia</w>
subst ances</w>
anticip ated</w>
mark edly</w>
end ocrine</w>
end or
0 3</w>
il- 1
temp late</w>
guid ed</w>
pro ved</w>
rel igi
de generation</w>
medi al</w>
sc ene</w>
premi um</w>
ob struc
ex port</w>
speci alized</w>
fl at</w>
pelv ic</w>
link age</w>
ag ement</w>
intr insic</w>
beg in</w>
ograph ical</w>
cap abilities</w>
dor sal</w>
distingu ish</w>
bl ast
sal iv
co effici
carri ers</w>
pap ers</w>
h t</w>
sec tional</w>
boo ks</w>
pot assi
as ymp
sp ar
1 d</w>
l ights</w>
conclud e</w>
x yl
igh t
quarter ly</w>
ti zed</w>
l ec
alb umin</w>
deposi t</w>
connec tivity</w>
sep sis</w>
gr aft</w>
an ine</w>
lig ands</w>
t- test</w>
p 3</w>
y cin</w>
c g</w>
hypothe sized</w>
i o
join tly</w>
laborat ories</w>
tax es</w>
ma y
m uc
ocyto sis</w>
coeffici ents</w>
al ter</w>
ec hn
c ns</w>
h it</w>
hel ped</w>
doc tor</w>
dimen sions</w>
cr an
re vol
aggreg ation</w>
el i</w>
. methods</w>
or g</w>
an alog
res cue</w>
ap e</w>
manag ers</w>
sho ul
ev </w>
1. 8</w>
b ular</w>
ber t</w>
te dly</w>
diast olic</w>
synthe sized</w>
emp ir
predomin antly</w>
consul tation</w>
survi v
hypo xia</w>
cir cle</w>
ati cs</w>
agg ed</w>
gu t</w>
ir an</w>
telecom mun
ti zation</w>
hos ph
oly tic</w>
sp or
w ro
l eng
cir rho
id ine</w>
vi d</w>
sign alling</w>
pres enting</w>
spe ak
shenz hen</w>
lead ers</w>
commit ments</w>
cre ating</w>
dec oc
wel ls</w>
g in
c es
w in</w>
origin ally</w>
3 c</w>
dru g-
cat en
ll c</w>
dos age</w>
en velop
head ache</w>
shar p</w>
3. 1</w>
u d</w>
sac char
carri er</w>
protec ted</w>
ch i</w>
inv ited</w>
uni form</w>
ill um
aer obic</w>
corne al</w>
volum es</w>
publ ic
wi des
bl in
smo kers</w>
eng age</w>
questionn aires</w>
hor mon
verte br
fi st
pre p
hyperten sive</w>
potassi um</w>
be ar</w>
l- c</w>
down load</w>
oper ated</w>
ation .</w>
att or
camp a
th es
re aching</w>
roph y</w>
treat ment
was hing</w>
no tic
bin ds</w>
ste el</w>
six th</w>
on in</w>
sub mit</w>
ti al</w>
ac knowle
contemp lated</w>
ear th</w>
byp ass</w>
millen nium</w>
fif ty</w>
job s</w>
establis hing</w>
enter tainment</w>
- dependent</w>
us age</w>
mo tif
j in
t 3</w>
collec tively</w>
hal f-
ide as</w>
receiv ables</w>
lat in</w>
1 10</w>
gener ative</w>
d b</w>
comple ment</w>
1. 6</w>
cli ent</w>
di alysis</w>
sper m</w>
mp tions</w>
recomm end</w>
g ang
accum ulated</w>
ⅱ </w>
simul ated</w>
ta -
disco vered</w>
h in
big gest</w>
ne gl
join ed</w>
temper atures</w>
pl ayed</w>
el se
10 ,
contr ary</w>
dog s</w>
hyp ogly
as ym
pl c</w>
car til
appreci ation</w>
deriv atives</w>
meth yl</w>
aure us</w>
win ter</w>
regar ded</w>
ic ular</w>
at or
wro te</w>
deb ate</w>
harv ested</w>
sp ain</w>
t our
trac king</w>
jur is
pp ed</w>
3 4
expendi ture</w>
lon don</w>
concentr ated</w>
oper ator</w>
cour ses</w>
i ble</w>
ch air</w>
sc al
prin t</w>
ster e
cataly tic</w>
weal th</w>
. 4</w>
ac t
comple mentary</w>
tom ography</w>
r ated</w>
relap se</w>
b id</w>
character ization</w>
o ked</w>
en erg
sp ots</w>
op hosph
amaz on</w>
wr ite</w>
hist opath
tw el
over come</w>
condi tioning</w>
alloc ated</w>
20 -
n in
d d
con comit
t p</w>
motif s</w>
f os
gu ine
plat in</w>
pre ad</w>
sequ enced</w>
p -1</w>
diver si
bri um</w>
prote ase</w>
s 4</w>
dem enti
re mission</w>
inhib its</w>
ge org
comput ational</w>
k da</w>
ophil a</w>
wides pread</w>
infil tration</w>
mo ment</w>
est er</w>
2. 3</w>
alig ned</w>
m ur
mo vi
so- called</w>
pol l
contribu tes</w>
auto immune</w>
pharmacolog ical</w>
up s</w>
famili ar</w>
epi demic</w>
m scs</w>
ut ing</w>
3 2
electro de</w>
ger man</w>
form ulation</w>
os omes</w>
ag ic</w>
audi tory</w>
coll ect</w>
por e</w>
oun ding</w>
ech ocardi
mat uration</w>
period ic</w>
fea sible</w>
st ressed</w>
phosph at
h if
12 ,
vill age</w>
vic tim
sh ell</w>
om s</w>
pro ven</w>
n el</w>
pres um
r ing
predic tions</w>
so meth
id -
ch a
in sufficient</w>
f ight</w>
bal anced</w>
sign ature</w>
z inc</w>
re di
uncertain ty</w>
ang e</w>
decoc tion</w>
il ian</w>
class ical</w>
per mitted</w>
fel t</w>
habit at</w>
intro duc
li p</w>
v ae</w>
gene tics</w>
negoti ations</w>
someth ing</w>
cere bro
ensur ing</w>
mach in
us -
ob ao</w>
perc ep
institu tion</w>
incid ent</w>
nanop articles</w>
j a
di min
program ming</w>
hybridi zation</w>
e i</w>
electroph ore
e te</w>
cap e</w>
inten tion</w>
stimul ate</w>
adjust ments</w>
ap art</w>
sh i
epithel ium</w>
enco ded</w>
s r</w>
gl au
aden ocarcinoma</w>
™ </w>
cyto metry</w>
al leg
label ing</w>
serv es</w>
jour nal</w>
ar rhyth
deposi ted</w>
consist ency</w>
prep are</w>
retur ns</w>
progen it
har b
wast e</w>
r ace</w>
injec tions</w>
freed om</w>
para si
electr on
demonstr ates</w>
gi ant</w>
ster oids</w>
1. 7</w>
int el</w>
be sides</w>
syn erg
certain ly</w>
registr ar</w>
insi ght</w>
v oc
cr c</w>
ti li
inser ted</w>
ir radiation</w>
obvi ously</w>
sc aff
epidemi ological</w>
cytoplas m</w>
anatom ical</w>
ifn- γ</w>
ro se</w>
15 -
practi tion
hydrox y
vacc ines</w>
samp led</w>
develop ments</w>
z y
lar vae</w>
lear ned</w>
atheroscler osis</w>
provinc ial</w>
en forcement</w>
there after</w>
10 ,000</w>
na use
ly cer
5. 5</w>
termin ated</w>
ta obao</w>
polymorph isms</w>
chem icals</w>
ster one</w>
s tic
ra rely</w>
b b</w>
acqui sitions</w>
n 2</w>
centrifug ed</w>
e k</w>
dementi a</w>
u t</w>
ad just</w>
men str
up pres
rou te</w>
techn ological</w>
cut -
7 00</w>
interpre ted</w>
d f</w>
re frac
municip al</w>
d h
l ou
per itoneal</w>
el ong
on co
w a</w>
en sis</w>
mi x</w>
av ing</w>
repe at
on colog
opa usal</w>
lifest yle</w>
al izing</w>
lip ids</w>
ex clu
angi ogenesis</w>
ar d
volun tary</w>
sub cutaneous</w>
por tal</w>
phosphor ylated</w>
contro ver
rn a-
n y</w>
cer tified</w>
colon ies</w>
trig lycer
nac l</w>
spe aking</w>
ti se</w>
ec g</w>
swe den</w>
po oled</w>
scre ened</w>
a ur
an ia</w>
e q</w>
agg ressive</w>
char ter</w>
no thing</w>
transp ort
eng ine</w>
gr ading</w>
fac ing</w>
peop les</w>
p ep
ra ising</w>
g os
dri ver</w>
gen otyp
nause a</w>
al ine</w>
al ve
drain age</w>
le th
li th
cl ick</w>
proper ly</w>
un fortunately</w>
offici ally</w>
analy tical</w>
tex as</w>
bound ary</w>
induc ing</w>
k i
. 3</w>
line age</w>
great est</w>
pl er</w>
demonstr ating</w>
c 2</w>
sc oring</w>
on ym
7. 4</w>
ros ine</w>
hu i</w>
mul tic
10 9</w>
surve ys</w>
constr aints</w>
vulner able</w>
wor se</w>
β 1</w>
co her
responsi bilities</w>
fac ts</w>
pla que</w>
tr ying</w>
promot es</w>
end er</w>
t b
y a
phen otypic</w>
independ ence</w>
construc ts</w>
tri bun
sp ine</w>
sub units</w>
per for
gal ax
h l
1 α</w>
opo ie
sco red</w>
sub </w>
4 4
c ab
a str
arab id
assi stant</w>
feel ing</w>
vas cul
4. 0</w>
coupl ing</w>
op i
tl r
ca m</w>
g one</w>
hyper troph
well- known</w>
repe ti
ti gh
com ment</w>
z ens</w>
op har
in ib</w>
bran ds</w>
super vis
regul ator</w>
ordin ance</w>
highligh ted</w>
rang es</w>
m urine</w>
c ig
ing ent</w>
ch i
comp ression</w>
ell ing</w>
ot ing</w>
se q</w>
rec all</w>
trans mit
iz ations</w>
st ag
lo be</w>
0 4</w>
wel come</w>
sha m</w>
ar rays</w>
de position</w>
lun gs</w>
supple mentation</w>
predic tor</w>
cli ents</w>
imp os
l es
ro y
7 5
d ine</w>
wat er
sli des</w>
p ear
ag s</w>
neigh bor
reser ves</w>
di an</w>
ta g</w>
ic its</w>
all -
scenari o</w>
out patient</w>
b an</w>
tel l</w>
else where</w>
cl onal</w>
um s</w>
1 1,
prec eding</w>
occup ied</w>
f ast
ol -
sen sors</w>
v inc
er ad
u si
d .
bl u
em a</w>
clinici ans</w>
rou s</w>
ab s</w>
l r
are an</w>
off set</w>
f are</w>
commis sion
jo hn</w>
℃ </w>
br </w>
autophag y</w>
ri tic</w>
p ha
secon d-
vi able</w>
st ep
hi a</w>
inter active</w>
mic r
hen g</w>
activ ating</w>
prepar ations</w>
autom ated</w>
preven tive</w>
regul ators</w>
ste in</w>
ul ations</w>
sh en
ang ina</w>
0. 7</w>
f eng</w>
inform al</w>
2 o</w>
hom ogen
bien nium</w>
re agent</w>
au gh
k a
arabid opsis</w>
for war
fil ms</w>
n t
fig s</w>
adap ted</w>
at omic</w>
ch ains</w>
ph yl
ph ag
pt in</w>
2. 4</w>
n i</w>
hom ogene
f d
cross- sectional</w>
y in</w>
ly- owned</w>
sing ap
transcri pt
pol ar
eu kary
ed ings</w>
fr anc
un audited</w>
l ad
respon sive</w>
ther mo
t oral</w>
ph d</w>
sat ellite</w>
am ing</w>
compris ing</w>
un il
y ester
6. 5</w>
oc clusion</w>
ot ed</w>
tox in</w>
rup ture</w>
adv oc
criter ion</w>
tr al</w>
elev ation</w>
hydro gen
or dered</w>
p ation</w>
pu mp</w>
disrup tion</w>
30 -
at o</w>
whol ly-owned</w>
on as</w>
se di
ster ile</w>
respec tivel
chro me</w>
feder ation</w>
episo des</w>
ji ang
proc ure
invest ed</w>
ab ol
sy mb
effici ently</w>
t 2
infer ior</w>
yester day</w>
grap h</w>
ocy tic</w>
v ast</w>
t ar
sk y</w>
p. m.</w>
r ental</w>
luc ifer
g p</w>
sl ight</w>
ph r
3. 2</w>
exec ution</w>
am or
conserv ative</w>
casp ase-
ve ter
oxy gen
g ated</w>
pow ers</w>
sur faces</w>
sp ut
ty rosine</w>
en ia</w>
dop pler</w>
t ments</w>
n c
cartil age</w>
v c</w>
un stable</w>
assu mptions</w>
st ory</w>
wor ked</w>
0.0 001</w>
f ly</w>
ar ose</w>
te tr
gh ly</w>
refrac tory</w>
cent res</w>
subjec tive</w>
b ip
dis solved</w>
sol ely</w>
intra operative</w>
pur ification</w>
hi er
camp </w>
fu el</w>
consol idation</w>
victim s</w>
enchy mal</w>
h im
diff use</w>
co al</w>
transport ation</w>
prog res
nit ro
procure ment</w>
dis k</w>
be ads</w>
refl ecting</w>
con gr
sa w</w>
ab lation</w>
lo id</w>
bu yer</w>
con current</w>
ra ine</w>
adi an</w>
er o
dis soci
be am</w>
re alized</w>
proce edings</w>
vis co
di pl
v il
om al
ow ing</w>
minim ize</w>
3 g</w>
rheum at
tra it</w>
centrifug ation</w>
co ol</w>
re tain</w>
st .</w>
e able</w>
an a
telecommun ications</w>
3 9
in complete</w>
ol ip
indic ation</w>
substitu tion</w>
pl ots</w>
predic tors</w>
f air
inhibit ing</w>
deci sion-
add ressing</w>
lead er</w>
est rogen</w>
hypogly c
horiz ontal</w>
eng agement</w>
chromat ography</w>
bas ically</w>
infer tility</w>
pro pri
hol e</w>
p ca</w>
ca regi
har mon
tub ation</w>
st aphy
viol ations</w>
lo x
oc cu
n ad
sh an</w>
aneury sm</w>
po sts</w>
consi st</w>
sub group</w>
exper tise</w>
fibr ill
immunos uppres
nom ine
multi pl
0 9</w>
er ous</w>
es -
al ty</w>
att acks</w>
attrac tive</w>
malign ancy</w>
impl ant</w>
1 40</w>
singap ore</w>
. com</w>
individu ally</w>
compu ter
l ot
ac compl
character ize</w>
k .</w>
sec tors</w>
sta ke
c v</w>
ass urance</w>
pa in
mon o
coordin ated</w>
al ian</w>
cirrho sis</w>
natur ally</w>
k et</w>
ev a</w>
care ful</w>
sy l
en or
10 1</w>
r b
p ar</w>
n y
cat tle</w>
n- terminal</w>
ab str
para sites</w>
dem n
op tic</w>
ob taining</w>
dos ing</w>
hier arch
re adily</w>
swit zer
cl oned</w>
rup tion</w>
oly sis</w>
o es</w>
upreg ulated</w>
dro s
and -
ge ographic</w>
embry o</w>
echn ology</w>
men opausal</w>
high- risk</w>
na vig
parag raph
1 30</w>
switzer land</w>
n .</w>
c- terminal</w>
prolifer ative</w>
in ating</w>
par tly</w>
six ty</w>
h id
transl ational</w>
0 6</w>
gram -
paragraph s</w>
sec ure</w>
sud den</w>
cl one</w>
homeo stasis</w>
ap o
receip t</w>
comp ly</w>
re l</w>
see ds</w>
bre ast
solv ent</w>
eg gs</w>
g et
brea thing</w>
fist ula</w>
de dic
p yl
neutroph ils</w>
insti tutes</w>
go od
lum bar</w>
enjo y</w>
galax y</w>
radi o</w>
staphy lo
im er</w>
pic tures</w>
0 7</w>
mobil ization</w>
some what</w>
ch eng</w>
o h
ultim ate</w>
d 2</w>
ant a</w>
ser i
pol yp
att achment</w>
descri bes</w>
robo t</w>
dis c</w>
sp end</w>
random ization</w>
mis sed</w>
ag e
go t</w>
glau coma</w>
chec k
br ight</w>
in form</w>
deplo yment</w>
influ ences</w>
oper atively</w>
vol ati
comb at</w>
high light</w>
dy e</w>
1 .</w>
recomm ends</w>
attemp ts</w>
occu pati
am ous</w>
trig ger</w>
at tract</w>
th ick</w>
al t</w>
stud ying</w>
neur on</w>
20 .
per mit</w>
en counter
4 7
ene sis</w>
high- end</w>
5 5
them e</w>
challeng ing</w>
intrac ranial</w>
fe ed</w>
cl c</w>
reti rement</w>
fe et</w>
desi red</w>
men ing
ar ise</w>
star t-
flexi bility</w>
over weight</w>
fo ods</w>
he par
ass es</w>
m om
exerc ised</w>
ste ine</w>
play er</w>
hydro chloride</w>
cre am</w>
cont ex
ne oplas
dist ances</w>
depres sive</w>
l amin
precur sor</w>
plat forms</w>
cardi omy
dol lar</w>
et al</w>
an o
mo od</w>
att ended</w>
ma them
st ret
combin ing</w>
obac ter</w>
wan ted</w>
tum ours</w>
chromos omal</w>
de ad</w>
quanti ty</w>
indic ations</w>
hom ologous</w>
ap ical</w>
biom ass</w>
com modi
dros ophila</w>
continu ation</w>
trans duction</w>
re im
dist ress</w>
shoul der</w>
ot a</w>
di al</w>
i th</w>
e ties</w>
len ovo</w>
offici als</w>
warr ant</w>
cri tically</w>
ht c</w>
li sts</w>
13 ,
dep ic
correl ate</w>
cere bel
100 ,000</w>
ab err
oste op
inst ability</w>
und p</w>
ber ry</w>
ten sion</w>
empha sis</w>
ze al
du m</w>
se ment</w>
olog ist</w>
dec la
exclud e</w>
dec lined</w>
entrepreneur s</w>
fing er</w>
represent ations</w>
r um
om atic</w>
desi r
brow ser</w>
cop per</w>
piec e</w>
at um</w>
est ing</w>
ent a</w>
trans location</w>
exhib its</w>
transf usion</w>
trans mitted</w>
epig ene
cel </w>
inten se</w>
pr one</w>
ind one
pol lution</w>
con tra
bran ches</w>
bu tton</w>
j .</w>
concomit ant</w>
wash ington</w>
i ence</w>
organ ism</w>
intest ine</w>
s ic
ster oid</w>
lu x
here to</w>
nar row</w>
attor ney</w>
secre ted</w>
li e</w>
su res</w>
il ing</w>
continu ously</w>
occupati onal</w>
reduc tions</w>
w u
eg yp
pren atal</w>
g y</w>
bio -
heterogene ous</w>
imp osed</w>
re fr
os copy</w>
mean ing
tw it
observ ational</w>
acet yl
sub types</w>
bu t
sc ans</w>
le g</w>
fil tered</w>
exclu sively</w>
q ing
competi tors</w>
ne a</w>
agricul ture</w>
fis her</w>
6. 7</w>
l ers</w>
p v</w>
14 ,
d p</w>
thes es</w>
repor ters</w>
medic ines</w>
conflic ts</w>
co don</w>
sil encing</w>
iz umab</w>
third- party</w>
electrophore sis</w>
os omal</w>
me al</w>
hormon es</w>
r na
a res</w>
m da</w>
s b
yiel ded</w>
annot ation</w>
wi re</w>
lipo protein</w>
re sting</w>
per tur
x v</w>
g if
sh es</w>
m apped</w>
exp on
deter i
pat ch</w>
guine a</w>
reim bur
0 8</w>
lucifer ase</w>
as -
gene tically</w>
wh e
ver ify</w>
assign ment</w>
w ear
detec ting</w>
0. 25</w>
correspon ds</w>
l p</w>
otrop ic</w>
10 3</w>
dr ich</w>
cig are
deriv ative</w>
il- 10</w>
dis m</w>
0. 0</w>
on y</w>
hear d</w>
h f</w>
calcul ations</w>
u v</w>
hab its</w>
bur n</w>
h 1</w>
an ten
f .</w>
cl oth
re vision</w>
def icits</w>
dist ant</w>
enzy matic</w>
st y</w>
guang zhou</w>
specim en</w>
g an</w>
obser ver</w>
examin ing</w>
yi elds</w>
li tis</w>
bios ynthesis</w>
ge ographical</w>
enter ing</w>
gen us</w>
dis section</w>
regul arly</w>
slow ly</w>
emerg ed</w>
clos er</w>
ax ial</w>
sup er</w>
al le
re ds</w>
ar thro
ici ous</w>
r ub
overl apping</w>
do x</w>
f us
pro hib
or ous</w>
abdom en</w>
hydro ph
phot os
spectr al</w>
k d</w>
h il
optim ized</w>
g al</w>
fl ight</w>
mal ay
tom atic</w>
obstruc tive</w>
c ad
s ds</w>
hippocamp us</w>
inst alled</w>
cut- off</w>
4 6
execu tives</w>
l c</w>
re generation</w>
iso forms</w>
t m
rel and</w>
there to</w>
ob </w>
produc es</w>
pro sec
te -
p par
struc turing</w>
ac cru
part ner
immun op
1 60</w>
g es</w>
14 -
indic es</w>
bur g</w>
am mon
k os
carbo hydr
indi an</w>
p ine</w>
c asc
re min
dimen sion</w>
alg es
am i</w>
circu it</w>
me m</w>
&apos; re</w>
n es
pr is
immun ization</w>
2. 6</w>
har m</w>
p ir
tur ned</w>
let ters</w>
all ergy</w>
p an</w>
machin ery</w>
pron oun
v in
l dl</w>
can adian</w>
4 50</w>
angi ble</w>
rever sible</w>
charac ter</w>
con go</w>
encounter ed</w>
min eral</w>
s ms</w>
zeal and</w>
promo ters</w>
adi pose</w>
happ y</w>
spl icing</w>
4 9
dem ia</w>
g 2</w>
o virus</w>
tub es</w>
h f
dis count</w>
con fer
. results</w>
accompan ying</w>
de pu
t c
soci o
gest ational</w>
n esses</w>
onym ous</w>
m is</w>
stabil ization</w>
quanti fy</w>
f illing</w>
bul k</w>
thir ty</w>
immunohisto chemistry</w>
lymph ocyte</w>
o d-
kore an</w>
ill us</w>
dg es</w>
fluctu ations</w>
val ley</w>
yl ene</w>
ag ar</w>
imp acts</w>
t one</w>
cu red</w>
fur </w>
effec tor</w>
member ship</w>
2. 8</w>
as p</w>
sta ur
ec tin</w>
in activation</w>
pr icing</w>
bir ds</w>
caten in</w>
qu een</w>
fer tili
n ation</w>
si es</w>
p ace</w>
gy nec
le ban
min ority</w>
t- cell</w>
b und
00 0
ac tors</w>
dig estion</w>
pro ve</w>
vot es</w>
piec es</w>
in o</w>
def icit</w>
x 1</w>
fre e
twel ve</w>
re modeling</w>
co des</w>
fri end
colon y</w>
alve olar</w>
oph thal
ti an</w>
stead y</w>
ous ness</w>
i reland</w>
19 .
k 2</w>
bl ack
suppres sed</w>
h ur
differ ed</w>
in demn
hemat opoie
absor b
n c</w>
we ights</w>
equili brium</w>
expendi tures</w>
sub sets</w>
fol ding</w>
at yp
dend ritic</w>
cer tification</w>
found ed</w>
isra eli</w>
al .
capsul es</w>
sil ver</w>
m ar</w>
squ amous</w>
consul ting</w>
gen t
bl es</w>
ch ose</w>
resid ent</w>
produc tivity</w>
b ang
sat uration</w>
au c</w>
di e</w>
encour aged</w>
g ap
contamin ation</w>
expres sions</w>
here of</w>
gradu ate</w>
an alges
d h</w>
can al</w>
preval ent</w>
aver aged</w>
enti rely</w>
insi ghts</w>
xim ab</w>
ess entially</w>
con ti
arter ies</w>
supp liers</w>
virul ence</w>
asymp tomatic</w>
refuge es</w>
[ </w>
0 s</w>
x u</w>
three- dimensional</w>
cap tured</w>
pas sive</w>
constitu tion</w>
cytotox ic</w>
re staur
t agged</w>
k il
pack aging</w>
b its</w>
ul f
la x
si ght</w>
bronch ial</w>
provi sional</w>
investig ating</w>
g ps</w>
affili ated</w>
d t</w>
ot e</w>
g em
con junction</w>
gen ome-
wa iting</w>
promot ed</w>
play ing</w>
displac ement</w>
phosphat ase</w>
tend ency</w>
simul taneous</w>
poly mer</w>
brea ks</w>
super v
pol arization</w>
loc k</w>
decision- making</w>
p sa</w>
inn ate</w>
sc ar
coag ul
] </w>
co s</w>
stimul ating</w>
201 7</w>
plasm ids</w>
com or
belong ing</w>
fo rec
oste o
shop s</w>
s f</w>
az ine</w>
fut ures</w>
sput um</w>
ast om
s as</w>
den mark</w>
decla red</w>
ex ogenous</w>
h ba
loo ked</w>
contrac tion</w>
15 ,
da vid</w>
regim e</w>
vend or</w>
4. 2</w>
cy st</w>
teach ers</w>
as one</w>
al drich</w>
gr </w>
adv anc
immunop recip
ex cre
h ang
m us</w>
bat ch</w>
p ush</w>
collec tive</w>
6 b</w>
r ation
i ary</w>
fr am
du al-
g el
c ann
propor tional</w>
resid ential</w>
meth anol</w>
i i
ris ing</w>
bor ne</w>
rede mption</w>
differenti ate</w>
up- regulated</w>
exten sively</w>
ab ine</w>
el ic
commit tees</w>
s our
pre mis
read er</w>
connec tions</w>
fl ash</w>
b ic</w>
j er
4. 1</w>
ut aneous</w>
susp ended</w>
gr ate
me at</w>
z es</w>
silic on</w>
urg ent</w>
imp lan
illustr ated</w>
refer ences</w>
2. 7</w>
le ak
mit t
aqu eous</w>
ee g</w>
mess ages</w>
in osa</w>
h b</w>
g ray</w>
tic als</w>
nor way</w>
hippocamp al</w>
cy te</w>
k an
ir s</w>
5 ,000</w>
hem is
compar tment</w>
empir ical</w>
ti on-
l v</w>
mo ved</w>
tribun al</w>
loc ally</w>
atmos phere</w>
hund reds</w>
0.0 2</w>
in clusive</w>
biot echnology</w>
hand ling</w>
eligi bility</w>
er ia</w>
ophy si
hypo x
biomar ker</w>
bacter ium</w>
mod ules</w>
pro s
judg ment</w>
lin king</w>
del aware</w>
adver sely</w>
s lo
nutri ent</w>
8. 5</w>
correc tly</w>
marg ins</w>
i od
dis aster</w>
pig s</w>
sen sing</w>
regi stry</w>
4 c</w>
ces arean</w>
para dig
t 4</w>
isol ate</w>
a uc
awar ds</w>
fif ty-
te a</w>
le aving</w>
u red</w>
d ap
c 3</w>
va statin</w>
s and
re ward</w>
achiev ement</w>
con formation</w>
ran ked</w>
lay out</w>
acces sible</w>
ma kers</w>
ver s
γ -
we a
g ent</w>
desir able</w>
if ying</w>
de aling</w>
gram s</w>
d ent</w>
w et</w>
op es</w>
b y-
comp ete</w>
jo hn
le gi
oly mp
v as</w>
war m</w>
prec ed
es h</w>
exerc is
il-1 β</w>
ver ification</w>
ch ic
hyp ot
u c</w>
som atic</w>
mamm ary</w>
borrow er</w>
re conc
l n
10 7</w>
class ic</w>
1 1-
kin son</w>
micro gli
consider ably</w>
ben ch
compris es</w>
re stor
compet ent</w>
p- value</w>
lin ing</w>
ex por
fav or</w>
l ing
s ap
repe ats</w>
r ational</w>
l u</w>
epilep sy</w>
confir mation</w>
om onas</w>
si t
occup ation</w>
w on</w>
d ox
es cal
16 ,
commission er</w>
immunohisto chemical</w>
f l</w>
tra de
concep ts</w>
amin o
aer ug
­ </w>
ven tral</w>
agon ist</w>
u ed</w>
1. 9</w>
imp er
ol e
is s</w>
sav ings</w>
- to-
af ghan
cis platin</w>
knock out</w>
ra in</w>
altern atively</w>
recogn ised</w>
attenu ated</w>
u ted</w>
e- specific</w>
unil ateral</w>
verte bral</w>
compl aints</w>
trans lated</w>
pi 3
sal ary</w>
op ic</w>
annot ated</w>
a ine</w>
seg reg
mo tility</w>
coll ap
fa ther</w>
n oc
cap ability</w>
analy zing</w>
r rna</w>
discre tion</w>
q pcr</w>
→ </w>
la sting</w>
inhal ation</w>
an astom
respon ded</w>
milli ons</w>
depu ty</w>
las tic</w>
ann ually</w>
fl ap</w>
mon ocytes</w>
kin ases</w>
el eg
form ations</w>
b n</w>
predic ting</w>
fal ls</w>
invest ing</w>
in suff
tra jec
fi er</w>
man di
h l</w>
p ent
ti fy</w>
afghan istan</w>
- mediated</w>
l ose</w>
seiz ures</w>
ga ther
sol ic
cr yp
pix els</w>
is hment</w>
ad sor
n ex
attit ude</w>
ser ial</w>
preven ted</w>
mus cular</w>
bi ased</w>
ak i</w>
198 9</w>
chick en</w>
pi g</w>
work shop</w>
excee ded</w>
exc ep
plas ticity</w>
oti de</w>
amy cin</w>
form in</w>
top ical</w>
cy t
docum entation</w>
sulf ate</w>
epigene tic</w>
unic om</w>
out break</w>
sp an
ome tri
fig .
ob stac
ac knowledge</w>
as e
exc it
deb entures</w>
e mail</w>
cryst all
pa kistan</w>
00 -
gre en
condi tionally</w>
clin ics</w>
p ase</w>
hc l</w>
w ol
cr ude</w>
fri end</w>
integr ate</w>
aerug inosa</w>
wh eat</w>
do g</w>
intr am
off spring</w>
wel fare</w>
and re
inter acting</w>
ap er</w>
h la-
life -
te ams</w>
endos copy</w>
7 a</w>
spir it</w>
phot os</w>
was h</w>
beg un</w>
tox ic
h m
hom olog
ca us
upreg ulation</w>
u -
gi um</w>
j ian</w>
sol ar</w>
high lights</w>
vesic les</w>
5 6
yst ems</w>
fing er
du ties</w>
u a</w>
d ness</w>
whol ly</w>
ac tic</w>
ure a</w>
acr yl
e bo
y stem</w>
spo ke</w>
9 00</w>
pr e</w>
guang dong</w>
res em
9 9.
chon dro
bab y</w>
infil tr
un changed</w>
trac tion</w>
hba 1c</w>
tis m</w>
go es</w>
electron ics</w>
fri day</w>
sequ ential</w>
my c</w>
lo on</w>
in adequate</w>
r r</w>
f b
te tra
medi ate</w>
v aries</w>
c adher
10 2</w>
5 c</w>
i ve</w>
regim ens</w>
k el
thyro i
wal k</w>
en ables</w>
equ ations</w>
re store</w>
plac enta</w>
atten ding</w>
indone sia</w>
conven ience</w>
inter f
bal ances</w>
clar ify</w>
re agents</w>
her bal</w>
cy an
j an</w>
main stream</w>
y ou
scri pt</w>
double- blind</w>
metr ial</w>
sp ss</w>
fa il</w>
acceler ated</w>
th ail
chec ked</w>
perme ability</w>
pro of</w>
vi al</w>
stop ped</w>
la ke</w>
l 2</w>
tu bul
ow ns</w>
charg ing</w>
mo des</w>
co operate</w>
ob ste
h3 k
ca usal</w>
c able</w>
g ing
4. 7</w>
bl ast</w>
ag en
ig a</w>
ar re
map k</w>
cat ar
10 8</w>
tr unc
broad er</w>
ri st
through put</w>
loo ks</w>
fung i</w>
trigger ed</w>
organiz ational</w>
sl ope</w>
dn a-
ali sts</w>
relax ation</w>
at om</w>
log ic</w>
i ents</w>
cl ock</w>
f lies</w>
sp ind
os ome</w>
ac com
su cro
at rophy</w>
embol ization</w>
tiv al</w>
termin us</w>
ul ating</w>
h o</w>
remark able</w>
ab sc
li pi
ep tive</w>
mic ro</w>
seven th</w>
con focal</w>
mas sive</w>
le v
ch im
grou p
he ating</w>
seas onal</w>
sub type</w>
ser a</w>
suff ered</w>
re structuring</w>
m iti
18 -
4. 3</w>
duoden al</w>
17 ,
obste tr
lan e</w>
ver sions</w>
thyroi dism</w>
graph ics</w>
2 ,000</w>
tel omer
∶ </w>
exc itation</w>
sud an</w>
e g</w>
wil li
ec topic</w>
dedic ated</w>
gri d</w>
appe al</w>
re flux</w>
lo s</w>
conver sely</w>
y ers</w>
ban k
ro l
osteop or
guaran te
c ari
r us</w>
not e
m its</w>
de t
ta d</w>
de generative</w>
than ks</w>
conduc ting</w>
macroph age</w>
s ong</w>
tong ue</w>
ad ren
r f</w>
prin ting</w>
met formin</w>
resol ve</w>
sub groups</w>
qu ant
visu alized</w>
p al</w>
r as</w>
ul monary</w>
repl icates</w>
thail and</w>
brea th</w>
s q
bon us</w>
un t</w>
meaning ful</w>
fac ed</w>
practition ers</w>
u i</w>
p ock
bo ys</w>
a. m.</w>
pronoun ced</w>
path ophysi
n am</w>
deman ds</w>
ur a</w>
g ast
ic -
χ 2</w>
hom ology</w>
ab st
surpr ising</w>
mic ha
grad ed</w>
d v
consti tutes</w>
correspon d</w>
poss ess</w>
ze br
olig onucle
i tions</w>
ic h
form aldehyde</w>
le i</w>
glutam ate</w>
oni ae</w>
5. 1</w>
sent ence</w>
all otted</w>
satur ated</w>
mag n
off -
is ot
high- quality</w>
scenari os</w>
sl ice</w>
rat ings</w>
stake holders</w>
on ate</w>
nov o</w>
c cr
cali bration</w>
6 6
sever ely</w>
acu ity</w>
sp ending</w>
smar t
an al</w>
al anine</w>
eng er</w>
spectro s
t ang</w>
n mr</w>
cu es</w>
f g
re activity</w>
fit ting</w>
em b
sh ed</w>
trache al</w>
ret ina</w>
inten ds</w>
big u
serv ing</w>
interf ere</w>
b sa</w>
trac e</w>
get ting</w>
h us
wi der</w>
weak ness</w>
menstr ual</w>
sh ot</w>
ce phal
br u
au stri
3. 6</w>
r pm</w>
f bs</w>
reason ably</w>
alle vi
in puts</w>
nic ot
ca d</w>
envelop e</w>
modi fy</w>
ex ha
is co</w>
under writ
dis continued</w>
nas da
st ations</w>
du ty</w>
3. 8</w>
ol er
purch ases</w>
dise ase-
and er
compati bility</w>
survi ve</w>
author ised</w>
r t
re affir
pat ents</w>
dam aged</w>
libr aries</w>
mut ated</w>
assem bled</w>
wavel ength</w>
in ability</w>
des k
soci o-
hematopoie tic</w>
car bon
bip olar</w>
a th</w>
te m</w>
per ic
ed ta</w>
den at
install ation</w>
micro tub
h2 o2</w>
or ted</w>
partner ships</w>
house holds</w>
toler ability</w>
con cre
mod ulate</w>
p in</w>
sho oting</w>
dram atically</w>
propor tions</w>
line ages</w>
gener alized</w>
inten d</w>
de stro
x u
ex er
p n
oce an</w>
syn th
gf p-
g els</w>
r 1</w>
start- up</w>
par alysis</w>
extr a</w>
acceler ate</w>
integr al</w>
nat al</w>
ir rit
inter sti
al ex
sucro se</w>
o 2o</w>
appar ently</w>
gen eva</w>
mac </w>
wea ther</w>
tri ed</w>
hel ix</w>
fo reg
nation ally</w>
all y-
electro des</w>
f le
p b</w>
n ai
ke ys</w>
lim bs</w>
2. 9</w>
0. 5
unic ef</w>
pho to</w>
suff er</w>
imp ort</w>
g m
numer ical</w>
ang er</w>
18 ,
leak age</w>
c ra
f an</w>
direc tions</w>
te en
respectivel y.</w>
4. 4</w>
roph ic</w>
nucleoti des</w>
su red</w>
ju ven
b ases</w>
coll ateral</w>
seri ously</w>
t ase</w>
de form
methyl ated</w>
flag ship</w>
e- commerce</w>
om ers</w>
6. 0</w>
mes enchymal</w>
c is</w>
fi x</w>
man ia</w>
pharmaceu ticals</w>
end ometri
hydroph obic</w>
fi ve-
sub stan
ang ular</w>
ro che</w>
r p</w>
ol ds</w>
prospec ts</w>
res usp
examin ations</w>
rel ate</w>
ho sts</w>
exac tly</w>
se m</w>
sd s-
li pos
immun oglob
flor ida</w>
d 3</w>
nec es
evol ved</w>
8. 0</w>
b .
substan tive</w>
licen sed</w>
re organization</w>
in qu
red und
ca 1</w>
benefici ally</w>
si al</w>
5. 2</w>
s b</w>
al umin
ili ary</w>
counsel </w>
al li
b and
p bm
meth asone</w>
re perfusion</w>
le ases</w>
dis comfort</w>
cy sts</w>
r ent</w>
mamm als</w>
genome- wide</w>
hemorrh agic</w>
3. 4</w>
py ri
t- in</w>
go at</w>
ace ae</w>
dis appeared</w>
p l</w>
sac rif
en a</w>
min er
tend er</w>
int enti
surpr is
par aff
pati ent
cv d</w>
tra in</w>
nasda q</w>
prior ities</w>
5 8
bel ong</w>
atyp ical</w>
bil l</w>
pene tr
rna i</w>
diver gence</w>
be i</w>
bi di
l ative</w>
four -
n k
correl ates</w>
qu ick</w>
co operative</w>
beau ti
mer ch
am bigu
op tional</w>
agre es</w>
tr is
ker at
accru ed</w>
influ encing</w>
dop amine</w>
consider ations</w>
twit ter</w>
wr ong</w>
austr alian</w>
gam ma</w>
198 8</w>
ap point</w>
cal end
end point</w>
whol e-
z i</w>
mir r
pock et</w>
sin a</w>
g az
aca dem
ns clc</w>
f ans</w>
tur key</w>
nod ules</w>
surpris ingly</w>
2 9.
ch i-
sto ol</w>
my o
strati fied</w>
stu di
bo x
defin itive</w>
easi er</w>
rel ates</w>
inten si
8. 1</w>
stric tly</w>
16 -
avi an</w>
in tim
st om</w>
it ated</w>
an omal
k it
deleg ations</w>
ang les</w>
lact ate</w>
audi o</w>
un published</w>
juris diction</w>
summar ize</w>
no on</w>
i g</w>
zh ong
imp lies</w>
ti m</w>
li ke
br ush</w>
dat ory</w>
random ised</w>
endo metrial</w>
transpar ent</w>
β- catenin</w>
sti ff
f- 1</w>
st at</w>
experim entally</w>
jud icial</w>
ar sen
eos in
mr nas</w>
c ess
ati cal</w>
st al
impos sible</w>
co oling</w>
n ps</w>
i u</w>
dou bt</w>
my cin</w>
dig estive</w>
dis sec
os t</w>
stro mal</w>
ac s</w>
a ke</w>
i .</w>
receiv able</w>
rheumat oid</w>
sal mon
ast y</w>
gro unds</w>
in active</w>
5 d</w>
inter mitt
val ent</w>
low ering</w>
me i
anti viral</w>
50 ,000</w>
tax a</w>
ful ness</w>
cl 2</w>
resusp ended</w>
main land</w>
oncolog y</w>
tra vel
is lam
ver bal</w>
span ish</w>
toler ated</w>
in ju
il lin
c ation</w>
ecos ystem</w>
v ox
person ality</w>
nig eria</w>
viol ation</w>
buil t-in</w>
ro ck
5. 6</w>
suppres s</w>
cytotox icity</w>
physi ology</w>
hypertroph y</w>
life time</w>
rhyth m</w>
w nt</w>
no s</w>
wel l
ap ol
stat e-
ici ently</w>
fil am
un related</w>
th o
spe ak</w>
hospit alized</w>
pre term</w>
ser ine</w>
id o</w>
f as</w>
antagon ist</w>
3. 7</w>
cop y
de m</w>
s anc
cellul ose</w>
re tic
desk top</w>
qt l</w>
adi p
echocardi ography</w>
ple ased</w>
prefer ences</w>
academ y</w>
x y
empha sized</w>
o v</w>
ⅲ </w>
staphylo coccus</w>
y an
pneum oniae</w>
ir regular</w>
inju red</w>
sol </w>
lys ates</w>
blin ded</w>
she ep</w>
l v
le ptin</w>
cu stom</w>
ar gent
neutroph il</w>
bio medical</w>
suic ide</w>
p up
ta ste</w>
land sc
q q</w>
all ot
in- depth</w>
concre te</w>
du s</w>
beauti ful</w>
termin ate</w>
enab ling</w>
territ ories</w>
normal ization</w>
impro ves</w>
am o
vulner ability</w>
malay sia</w>
p k</w>
ag on</w>
borrow ings</w>
c u</w>
leng ths</w>
sh ad
discipl inary</w>
aco us
in ely</w>
super f
e ur
hom es</w>
mod alities</w>
self- reported</w>
den se</w>
percent ages</w>
m erc
confir ming</w>
enab led</w>
shor ten
hid den</w>
car ds</w>
hr s</w>
intr aper
cd c
hel ic
f asc
quot ed</w>
cess ation</w>
dy st
attit udes</w>
ag ue</w>
per in
es cent</w>
buff ered</w>
lat ency</w>
ph er
as d</w>
ti me
sch ol
pyl ori</w>
m hc</w>
p us</w>
di ap
consti pation</w>
ill a</w>
recip ient</w>
fibrill ation</w>
t f</w>
2 nd</w>
myel oid</w>
inher ent</w>
men tion</w>
7. 2</w>
se t
glycer ol</w>
4 3
dg ing</w>
har m
19 ,
ma ker</w>
h all
unc tad</w>
emp ty</w>
4. 6</w>
k al
elim inated</w>
a ort
pre dn
char t</w>
g aps</w>
di l
par li
ne o
os ine</w>
coordin ate</w>
er k</w>
lax is</w>
interventi onal</w>
b if
p cs</w>
be ta-
m n</w>
k l
al liance</w>
mot or
arg in
full- length</w>
eth i
mito tic</w>
co x</w>
cadher in</w>
opath ic</w>
valu ed</w>
am ong
en demic</w>
gener ations</w>
6 7
evalu ations</w>
h ong
bin ary</w>
immuno fluorescence</w>
sm ith</w>
pe tro
w aves</w>
indic ative</w>
b in</w>
ag arose</w>
coun ting</w>
over view</w>
ro ws</w>
fav our</w>
ra is
cap illary</w>
ni h</w>
a β</w>
st in</w>
li ved</w>
campa ign</w>
out lined</w>
co sme
dis charged</w>
re iter
tri pl
run s</w>
chlor o
hel ps</w>
arg o</w>
inoc ulated</w>
pit u
5 3
quant um</w>
guarante ed</w>
de hydrogen
s 5</w>
like wise</w>
dissemin ation</w>
adap t</w>
pp ing</w>
public ly</w>
20 ,
ch u
supp lier</w>
stock holder</w>
qu ery</w>
cytos k
re medi
w on
mas k</w>
ge sia</w>
manip ulation</w>
igh t-
g ram</w>
calend ar</w>
glyco sy
m v
. the</w>
trip le</w>
toco cc
ho o</w>
tax onom
bu b
biop sies</w>
ad hd</w>
see ded</w>
expl or
aspir in</w>
8 7
utr </w>
conn ect</w>
func tionally</w>
pes tic
adju sting</w>
ac etic</w>
&apos; m</w>
absorb ance</w>
visco sity</w>
multi lateral</w>
car s</w>
amoun ted</w>
reve als</w>
lit ax
edi ting</w>
t ap
posi tioned</w>
can on
1 16</w>
forwar d-
subscri be</w>
p ending</w>
auth en
oid al</w>
in tubation</w>
br it
doc king</w>
ti um</w>
divi sions</w>
com ed</w>
d enti
pac litax
un ified</w>
al zhe
c z
citi zens</w>
sig ma-
ultra -
n f
bil ir
broad band</w>
refer ral</w>
navig ation</w>
join ing</w>
in verse</w>
e ase</w>
desi re</w>
swit ching</w>
en si
dec ide</w>
op ulmonary</w>
manu ally</w>
dex a
sk i</w>
al d</w>
7. 0</w>
expan ding</w>
embol ism</w>
err a</w>
hydr ation</w>
l amp
nephro pathy</w>
g ers</w>
wi s
precip itation</w>
e ded</w>
cl ade</w>
defin itions</w>
fit ted</w>
mes h</w>
fac ul
mass es</w>
a a
del eted</w>
medi ators</w>
intersti tial</w>
hand le</w>
pear son</w>
t d</w>
c itation</w>
micros copic</w>
cy steine</w>
coven ant</w>
conf identi
am b
18 3</w>
dupl ication</w>
perc utaneous</w>
shif ts</w>
spectro metry</w>
deple ted</w>
terror ist</w>
ul cer
os ing</w>
affili ates</w>
- 2
min i</w>
c 57
sub mission</w>
198 6</w>
th ur
off er
te sto
6 4
fi b
in um</w>
co up
w anda</w>
bcl -2</w>
ev ening</w>
some one</w>
inter governmental</w>
radi al</w>
an thro
cp g</w>
comp eting</w>
br ac
form a</w>
bel gium</w>
pass age</w>
ig en
extrem ity</w>
activ ates</w>
canon ical</w>
ang el
not ing</w>
alzhe imer</w>
iti </w>
conden sed</w>
si l</w>
pal li
malign ancies</w>
adoles cent</w>
mach ines</w>
or a</w>
edi tion</w>
episo de</w>
alter ation</w>
glu ta
r ul
elet on</w>
di s</w>
la sia</w>
presum ably</w>
trop ical</w>
projec ted</w>
es cape</w>
li tig
audi tor</w>
ch er</w>
hu an</w>
no tion</w>
e 1</w>
0. 9
bl otting</w>
micha el</w>
es sion</w>
- controlled</w>
he ads</w>
att end
ic e-
s 6</w>
zh u</w>
1 p</w>
syndro mes</w>
among st</w>
adequ ately</w>
st em
on a</w>
hypoglyc emia</w>
repeat edly</w>
p uncture</w>
ann u
h plc</w>
pre dominant</w>
ig m</w>
pancre as</w>
para metric</w>
zebr af
buil dings</w>
bot t
es cher
k ir
raz ole</w>
uni variate</w>
os in</w>
ot or</w>
wh at
pi3 k</w>
exercis able</w>
pro po
diagnos es</w>
fin land</w>
movi e</w>
de st
g ained</w>
bil iary</w>
az ol
aspir ation</w>
transf ers</w>
d d</w>
ch d</w>
inten sities</w>
n a-
escher ic
consi ders</w>
hel a</w>
prog ester
ch at</w>
far mers</w>
jud ge</w>
2 6.
gre w</w>
sigma- aldrich</w>
5. 7</w>
exc ision</w>
fil tration</w>
k illed</w>
preser ved</w>
grate ful</w>
wel comed</w>
man datory</w>
war ning</w>
pen sion</w>
cut ting</w>
insuff iciency</w>
- 9</w>
rh iz
supp lies</w>
f ev
escheric hia</w>
deli ber
descrip tive</w>
ta i</w>
arter i
198 7</w>
1 ,0
optim ize</w>
st oma</w>
audi </w>
d air
di am
infl ation</w>
egyp t</w>
genotyp ing</w>
h ou</w>
ji an
w ine</w>
2 5-
zebraf ish</w>
ul us</w>
ib m</w>
r an</w>
a w</w>
in ev
s lower</w>
mod est</w>
not ebook</w>
a head</w>
intermitt ent</w>
f atal</w>
rab bits</w>
tri p</w>
al ised</w>
ta u</w>
simil arities</w>
progenit or</w>
phil ip
plac ebo
model ling</w>
testo sterone</w>
st aging</w>
determin ants</w>
religi ous</w>
6- well</w>
dis location</w>
islam ic</w>
bios ci
med line
rac ial</w>
nar row
int oler
sp p</w>
dexa methasone</w>
tax i</w>
epider mal</w>
t z</w>
d mem</w>
medline plus</w>
there in</w>
7. 1</w>
li qui
mol ar</w>
ir radi
in ed</w>
ti er</w>
sub ordin
ch eng
od on
as m</w>
om er</w>
f en
tot yp
kos ovo</w>
analges ic</w>
fl an
lymp ho
val idate</w>
co x
der mal</w>
l g</w>
pol ar</w>
eg m</w>
gluta thi
mon day</w>
organ isation</w>
second ly</w>
rout inely</w>
u g</w>
lipi demia</w>
o ing</w>
strength ened</w>
pol y</w>
hom ozygous</w>
pseud omonas</w>
cycl in</w>
quad r
d ong
surviv ors</w>
r r
5. 3</w>
om at
l an</w>
w av
tran sc
so red</w>
ing ing</w>
ta ke
4. 8</w>
il- 2</w>
remo ving</w>
dri vers</w>
no tified</w>
si erra</w>
prote as
suff iciently</w>
instr um
col or
nur se</w>
where by</w>
activ ator</w>
eg u
z ones</w>
ran king</w>
synth ase</w>
capac ities</w>
thres holds</w>
intr av
mit ral</w>
is ely</w>
con s
wi fe</w>
des er
w ong</w>
in fr
the ast</w>
cost- effective</w>
liqui dity</w>
a il</w>
c up</w>
hypo theses</w>
k ap
gr and</w>
hepar in</w>
ti a</w>
metabol ite</w>
recip ients</w>
ad journ
mo ist
6 8
franc isco</w>
index es</w>
ann ex
manufac ture</w>
counsel ing</w>
forward- looking</w>
ig u
small -
erad ication</w>
truste es</w>
en comp
econom ies</w>
im mer
si ded</w>
dro ps</w>
for ty</w>
progester one</w>
gen cy</w>
el abor
fir ing</w>
ch ang</w>
tor -
tn f</w>
transcript ome</w>
0.0 3</w>
trans membrane</w>
bound aries</w>
sh i</w>
utili zing</w>
co vari
qu e
pe er</w>
ev oked</w>
ky o</w>
ad o</w>
spir al</w>
se ed
here in
i x
defin ing</w>
ann er</w>
sion ally</w>
moun ted</w>
broad cast</w>
interfer on</w>
13 3</w>
un k</w>
si um</w>
p us
ili ation</w>
ec e</w>
advis or</w>
implan ted</w>
initi ate</w>
superf icial</w>
t ch</w>
thir ty-
ath le
socio economic</w>
alk aline</w>
cor ro
extra ordinary</w>
preser vation</w>
h 2</w>
enlarg ed</w>
accid ent</w>
n l
intra ocular</w>
stra ight</w>
u v
care er</w>
determin es</w>
retro viral</w>
con fin
claim ed</w>
pt sd</w>
psych os
osteopor osis</w>
res um
engl and</w>
short -
visu alization</w>
attemp ted</w>
tr it
d p
pre treatment</w>
curr ents</w>
ple ural</w>
bro ken</w>
log ical</w>
aut ologous</w>
displac ed</w>
fur n
al ism</w>
descri bing</w>
real ize</w>
bio film</w>
y e</w>
tend er
um bil
non eth
ps ori
pene tration</w>
hy ster
noneth eless</w>
- free</w>
migr ants</w>
exerc ises</w>
sav ing</w>
hn ess</w>
j a</w>
dair y</w>
neuro pathy</w>
ger min
et te</w>
ten s</w>
scler osis</w>
sh eng</w>
tre m
co ff
hapl otype</w>
autonom ous</w>
ov ary</w>
superv ised</w>
pip eline</w>
litig ation</w>
a thetic</w>
ge m</w>
emis sions</w>
ti ght</w>
cardi a</w>
paclitax el</w>
conc eived</w>
met als</w>
recor dings</w>
sa g</w>
sl ices</w>
ch ai</w>
al in</w>
ch it
mon etary</w>
o ocytes</w>
cu ba</w>
demonstr ation</w>
h at
down- regulated</w>
ad ic
t ancy</w>
cryst als</w>
ch -
ill icit</w>
fr s</w>
grou ped</w>
ing redi
view ing</w>
pro filing</w>
un expected</w>
es tions</w>
analy sts</w>
y un
ulc ers</w>
persi stence</w>
ro ck</w>
aff or
sds- page</w>
ple as
key board</w>
13 -
wh il
1 h</w>
acous tic</w>
const antly</w>
pec tor
f es
drin k</w>
st ones</w>
acces sion</w>
sy no
ce f
na ï
y ang
v is</w>
immun ob
f ai
7. 8</w>
ph age</w>
ti ter</w>
app rais
pro totyp
o x</w>
r ings</w>
provinc es</w>
sy ri
6 5
dro pped</w>
allot ment</w>
dehydrogen ase</w>
ech o</w>
ail ing</w>
stiff ness</w>
al pha
artic ular</w>
n ip
st ation
zhe jiang</w>
counter parts</w>
d in</w>
lig ation</w>
nit ric</w>
controver sial</w>
prec isely</w>
draf ting</w>
new sp
ex ons</w>
threat ening</w>
prepar ing</w>
id el
cut off</w>
ne t
us et
ann i
t oc
sli de</w>
j ia</w>
aort a</w>
ay er</w>
suppor tive</w>
pl en
mod ulated</w>
nor ms</w>
potenti als</w>
t cm</w>
haz ard</w>
less er</w>
go s</w>
pen icillin</w>
col om
belie f</w>
detec tor</w>
propri etary</w>
r h</w>
networ king</w>
se emed</w>
di mer</w>
2 8.
paradig m</w>
approxim ate</w>
se man
friend ly</w>
naï ve</w>
r c
co litis</w>
beau ty</w>
co d
exce eding</w>
si r
mass ach
eigh th</w>
ent ations</w>
k illing</w>
ograph s</w>
whil st</w>
calcul ating</w>
tour ism</w>
cri tic
dram atic</w>
sp an</w>
ali pay</w>
cr -
hypo thalam
res us
rec alling</w>
discre te</w>
under gone</w>
respon ding</w>
massach uset
fev 1</w>
f ate</w>
divi ding</w>
u ber</w>
hydro lysis</w>
leth al</w>
function ality</w>
blo g</w>
def ence</w>
e es</w>
argent ina</w>
b ou
gra in</w>
facilit ating</w>
contr adic
consci ousness</w>
expos ures</w>
every thing</w>
circum ference</w>
dur al</w>
ac tor</w>
transpor ter</w>
exp ects</w>
her nia</w>
for ty-
bidi ties</w>
foreg oing</w>
rel atives</w>
ad renal</w>
cari b
reser vo
peri operative</w>
grad es</w>
herein after</w>
c57 bl</w>
end ers</w>
fi es</w>
mon ol
produc tive</w>
commerc ially</w>
massachuset ts</w>
cardi opulmonary</w>
sh en</w>
ec m</w>
conf ounding</w>
un usual</w>
λ </w>
ris t</w>
co vers</w>
re stored</w>
suppres sor</w>
real istic</w>
ter ti
ub in</w>
elec tions</w>
g sk
as h
platel ets</w>
an ne
heter ozygous</w>
motiv ation</w>
ken ya</w>
op posed</w>
b li
sc c</w>
thro at</w>
displ ays</w>
inst ances</w>
4 d</w>
system atically</w>
si x-
her 2</w>
pertur b
devi ations</w>
dec ay</w>
fres h
tender ness</w>
categor ized</w>
re member</w>
cas e-
hypot ension</w>
enh ances</w>
tgf- β</w>
immun ological</w>
anc ient</w>
med ul
coordin ates</w>
cor ruption</w>
r mb</w>
man ned</w>
al isation</w>
inoc ulation</w>
phen yl
reco ver</w>
gh z</w>
com m</w>
marri ed</w>
&apos; ve</w>
casc ade</w>
ent an
mean while</w>
ophar yngeal</w>
pro phy
oc ellular</w>
inter acts</w>
en na</w>
8 8
path ologic</w>
5. 4</w>
pen n
e ph
conform ational</w>
l as</w>
sugg estions</w>
constitu ted</w>
legis lative</w>
stres ses</w>
vis cer
ga it</w>
g t</w>
ex pedi
tes la</w>
legi tim
compromis ed</w>
comfor table</w>
l h</w>
spectros copy</w>
7 9
encour aging</w>
audi ence</w>
ip o</w>
ed ges</w>
f m</w>
sh rin
fam ous</w>
intr on</w>
ox idi
te ase</w>
o ic</w>
b c
oper ates</w>
corpor ations</w>
pan els</w>
sett led</w>
xi ao</w>
join ts</w>
dm so</w>
repl icate</w>
foc i</w>
m id</w>
en th
transcri bed</w>
ent um</w>
high- level</w>
georg ia</w>
12 6</w>
f ic
17 -
sta ke</w>
en closed</w>
conf id
12 8</w>
por tu
mathem atical</w>
licen sing</w>
ari o</w>
fi re
gener ic</w>
atin ib</w>
l ender</w>
opla sty</w>
h2 o</w>
de oxy
restor ation</w>
ⅰ </w>
commun icate</w>
v or
0 ,000</w>
consum ed</w>
3. 9</w>
dimin ished</w>
z a</w>
arrang ed</w>
homogene ous</w>
foc uses</w>
retriev al</w>
ex it</w>
smo ke</w>
disp osition</w>
integr in</w>
moun tain</w>
schem es</w>
lat ent</w>
surge on</w>
addi tive</w>
covari ates</w>
civ ilian</w>
g od</w>
ug anda</w>
s day</w>
ventric le</w>
responsi veness</w>
des c
b b
re- elect</w>
n ess
c all
br ad
qi agen</w>
head ed</w>
se mic
rejec tion</w>
t ons</w>
austri a</w>
s ounds</w>
f mri</w>
exten ding</w>
mis s</w>
histopath ological</w>
ch or
wel comes</w>
to kyo</w>
under writing</w>
cl o
su it</w>
cr e</w>
one- way</w>
tal ent</w>
prox ies</w>
t ude</w>
feel ings</w>
depres s
micro organisms</w>
radi us</w>
behavi our
gen tly</w>
teach er</w>
1 15</w>
mark et
dig ested</w>
k le
fibr in
ra d</w>
hop e
se y</w>
insec t</w>
pharmaco kinetics</w>
fol </w>
ro c</w>
vot ed</w>
th 1</w>
cent ro
co ded</w>
electro ly
se m
prin ted</w>
tu esday</w>
visi ted</w>
rever sed</w>
orb ital</w>
de priv
direc tional</w>
sur fac
minim ally</w>
2 1,
di zz
sc ar</w>
cong ress</w>
leban on</w>
1 20
def ective</w>
bra ins</w>
selec tively</w>
em ul
phosph olip
electro cardi
eluc idate</w>
9. 5</w>
cho ices</w>
under -
or ange</w>
o .</w>
appe ti
gran ules</w>
6. 2</w>
hem odi
tr on</w>
ter med</w>
salmon ella</w>
ya hoo</w>
enc e-
pres sures</w>
il e
bal loon</w>
r on</w>
bank rup
cd 3</w>
enco des</w>
ab road</w>
promp tly</w>
rec tomy</w>
vend ors</w>
po d</w>
m ab</w>
res ses</w>
eukary otic</w>
carib bean</w>
sho ot</w>
spi ke</w>
transpar ency</w>
draf ted</w>
s anta</w>
ar a</w>
mat ches</w>
h es
s l</w>
pol </w>
compris e</w>
i a
onucle ar</w>
cerebro vascular</w>
astro cytes</w>
perfor ation</w>
dre am</w>
wa ke</w>
3 50</w>
projec tion</w>
it ly</w>
ear li
con junc
serv ic
w are
del </w>
priv acy</w>
d amp
u res
catar act</w>
as cul
atheroscler otic</w>
se al</w>
su ture</w>
uter us</w>
cri mes</w>
poll en</w>
in deb
gl ands</w>
we dn
thur sday</w>
yl ate</w>
co a</w>
supp lied</w>
2 .</w>
del ays</w>
cle a
vi enna</w>
pl ur
magne sium</w>
p ill</w>
5 9
c ited</w>
g at
induc ible</w>
nucle ic</w>
t ended</w>
consum ing</w>
bro m
bilir ubin</w>
w .</w>
7. 3</w>
fer tility</w>
co ating</w>
ind enture</w>
charac ters</w>
app end
ty ph
car ol
d eng
ation- based</w>
hy gi
h ill</w>
commis sions</w>
utili ze</w>
n .
prof itability</w>
smo oth
hemo dynamic</w>
transpl an
oc t</w>
glyc emic</w>
supernat ants</w>
ph on
clu stered</w>
ub icin</w>
i ans</w>
hel ping</w>
5. 8</w>
sh ut
den sities</w>
refl ection</w>
7. 6</w>
vir tu
tre g</w>
cap ital
special ist</w>
any thing</w>
ann um</w>
3 rd</w>
proxim ity</w>
under take</w>
design s</w>
ad -
max illary</w>
seiz ure</w>
ac in
sud den
fal ci
ank le</w>
e ag
ery them
b ow</w>
repl ic
wedn esday</w>
par kinson</w>
inser t</w>
ut ely</w>
tum orig
cl oning</w>
l ending</w>
s od</w>
in effective</w>
n an</w>
elong ation</w>
bang lad
ab a</w>
micr or
immunoglob ulin</w>
augh ter</w>
ad here</w>
well- being</w>
harm ful</w>
sign ing</w>
bio inform
ge ts</w>
le one</w>
un controlled</w>
pharmac ies</w>
l ings</w>
6. 8</w>
t2 dm</w>
distingu ished</w>
analy st</w>
prob able</w>
strep tom
b mp
ne ys</w>
langu ages</w>
str anded</w>
h .
pseud o
obser vers</w>
renew al</w>
pl ated</w>
respon ders</w>
breast feeding</w>
them es</w>
six ty-
pursu e</w>
in consistent</w>
there under</w>
3 ,000</w>
all erg
two- dimensional</w>
k ill</w>
fel low
h 1
ha ir
res in</w>
prev ents</w>
retriev ed</w>
an i</w>
midd le-
ser ot
umbil ical</w>
propo fol</w>
depriv ation</w>
per mission</w>
condi tioned</w>
aer os
hierarch ical</w>
an o</w>
bio tic</w>
obla sts</w>
w all
ess ence</w>
gluco cortico
m tor</w>
po t</w>
non- governmental</w>
sudden ly</w>
lox acin</w>
ne tease</w>
colon ization</w>
metr ics</w>
h ac
incorpor ate</w>
op en
st y
spind le</w>
strong est</w>
ell ar</w>
h dl</w>
rus sia</w>
can cel
marg inal</w>
pro st
multic enter</w>
z umab</w>
1 11</w>
ig h</w>
dn f</w>
mix ing</w>
rou ghly</w>
nin th</w>
ck d</w>
in ous</w>
ti tis</w>
disturb ance</w>
mat r
colum bia</w>
biot a</w>
perin atal</w>
z hao</w>
confer ences</w>
inc enti
out -
cx cr
k ang</w>
pa ying</w>
gen u
ab and
l p
ld l-c</w>
investig ational</w>
per mits</w>
pro- inflammatory</w>
par i
ti tan
prophy laxis</w>
hepat ocellular</w>
ta m</w>
tend on</w>
inst all</w>
d rought</w>
sar coma</w>
p unc
wai ver</w>
for -
tn f
dissoci ation</w>
osteo arthritis</w>
pitu itary</w>
found ers</w>
adjourn ment</w>
selec ting</w>
bl ank</w>
7 7
falci par
min g
d c
dis close</w>
fo res
arch a
f er</w>
hapl otypes</w>
ific ations</w>
f on
el -
qi ang</w>
c m2</w>
1 r</w>
behaviour al</w>
wor m</w>
li a</w>
in tu
si tting</w>
el astic</w>
speak ers</w>
0. 3
consul tant</w>
d ent
ethi opia</w>
f all
accoun tants</w>
oc ial</w>
o meter</w>
sp h
fav our
surge ons</w>
enc e-based</w>
evid enced</w>
re production</w>
rec ycl
sper mat
6. 1</w>
tr s</w>
label led</w>
neighb our
am d</w>
fin ite</w>
contr al
pla ques</w>
ethn icity</w>
glutathi one</w>
excre tion</w>
th r
frag mentation</w>
198 5</w>
pp i</w>
mus cul
pair wise</w>
wor ry</w>
5 00
post natal</w>
adv ised</w>
bur st</w>
transp os
f alling</w>
app lies</w>
e sian</w>
fra ud</w>
serv icing</w>
mos quit
appar atus</w>
8. 3</w>
epidemi ology</w>
bud g
g d</w>
repres sion</w>
lat er
pl au
pro found</w>
secret ory</w>
x- 2</w>
el a</w>
pol e</w>
pro static</w>
ro gen
scat tered</w>
p ci</w>
6. 3</w>
illum ina</w>
mirr or</w>
mut ag
ty pe
nutri ents</w>
o de</w>
enth usi
r ite</w>
instruc tion</w>
anni vers
compu ters</w>
ip -
v ested</w>
2 2,
facilit ated</w>
r is</w>
anal gesia</w>
expon ential</w>
cit rate</w>
recei ves</w>
f arm</w>
lys ine</w>
enter ic</w>
domin ated</w>
earli est</w>
i a-
whit ney</w>
re alization</w>
compl aint</w>
supple ments</w>
carbohydr ate</w>
s audi</w>
b p
qual comm</w>
wor sen
am l</w>
marri age</w>
rec t
ro bert</w>
dele tions</w>
her pes</w>
re stated</w>
experi encing</w>
tr ain
al ties</w>
lum en</w>
6 9
cyto chrome</w>
maxim ize</w>
cro p</w>
log -
aggreg ates</w>
new born</w>
tu </w>
chic ago</w>
exec ute</w>
m all</w>
en counter</w>
h all</w>
ig e</w>
plac ental</w>
s k</w>
pl otted</w>
t gf
stat 3</w>
p cos</w>
corti sol</w>
d ance</w>
fin ished</w>
gram- negative</w>
poly clonal</w>
im balance</w>
ex ert</w>
b t
diff ers</w>
tion .</w>
der mat
proce ed</w>
princip ally</w>
ba th</w>
hum idity</w>
expir ation</w>
person alized</w>
m w
selec tivity</w>
dep reci
trans form</w>
cogn ition</w>
gam ing</w>
s ation</w>
mo ther
infra red</w>
precur sors</w>
collabor ative</w>
el even</w>
commun ity-
gol den</w>
me ga</w>
eg fp</w>
gl uc
12 3</w>
h 3</w>
table 1</w>
per oxidase</w>
pres ently</w>
14 5</w>
pr an
iso form</w>
it ted</w>
den om
clean ing</w>
pal p
sy ring
pector is</w>
resid ence</w>
un ity</w>
2 40</w>
grad ual</w>
1 12</w>
l il
disp ens
ed ic</w>
she ets</w>
im mature</w>
strep tococc
ca uc
mon gol
anti depress
si ae</w>
peace ful</w>
wa ist</w>
gol d
de duc
coher ence</w>
treas ury</w>
gn ess</w>
falcipar um</w>
au tism</w>
mar i
l te</w>
ext inc
o cocc
f ang</w>
m ate</w>
a es</w>
or um</w>
n p
bay esian</w>
respir ation</w>
no tification</w>
commodi ty</w>
bo ston</w>
hb sag</w>
a 4</w>
specific ations</w>
estim ating</w>
exp i
s le</w>
opin ions</w>
sal v
g au
trans -
guid eline</w>
comm and</w>
o metry</w>
bir d</w>
pharmaco kinetic</w>
comb ine</w>
prepar atory</w>
gest ation</w>
bo dy
adi ol</w>
ar ded</w>
heav ily</w>
projec tions</w>
deteri oration</w>
analy zer</w>
acknowle dged</w>
d ust</w>
ca ud
mor gan</w>
ing .</w>
e po
congr u
g ary</w>
si ster</w>
nomine es</w>
v 1</w>
r y
obacter ia</w>
in ferred</w>
at ro
chol ec
c b</w>
poly sacchar
ro ll</w>
un manned</w>
coff ee</w>
reconc iliation</w>
con duction</w>
introduc ing</w>
empha size</w>
- derived</w>
st an</w>
sep tic</w>
pro pi
tic ated</w>
col y
occa sionally</w>
5 4
facul ty</w>
en code</w>
inter rup
0.0 4</w>
di str
wat ers</w>
cau tion</w>
v entures</w>
l b</w>
ear th
moder ately</w>
50 -
lap se</w>
glyc emia</w>
graph y</w>
dat ing</w>
broad ly</w>
tub ular</w>
immun ore
saliv ary</w>
ti de</w>
banglad esh</w>
6. 4</w>
arrhyth mia</w>
transi t</w>
achiev ements</w>
compar tments</w>
impl ants</w>
reg ards</w>
belie fs</w>
0. 8
no -
dizz iness</w>
fil ters</w>
rend er</w>
dis ab
r p
microgli a</w>
sf as</w>
tre ati
il- 4</w>
ad ic</w>
eleg ans</w>
mandi bular</w>
f used</w>
tum or-
ogr aft</w>
p2 p</w>
vi ri
block ade</w>
mater ially</w>
recru it</w>
nor th
cir ca
s ag
landsc ape</w>
fer mentation</w>
co tton</w>
tr aded</w>
aden oma</w>
17 0</w>
dang erous</w>
l ay</w>
1 2.5</w>
uncer tain</w>
chi- square</w>
percep tions</w>
over sight</w>
co ast
am ni
yn thetic</w>
d un
intram us
gen e-
down regulation</w>
cycl ing</w>
acid ic</w>
le gen
ocy top
gli oma</w>
s aying</w>
angi ogenic</w>
triglycer ide</w>
3 00
par is</w>
ly n
b ay</w>
in k
gif t</w>
ch ong
fir m
sh ore</w>
gir l</w>
acet ylation</w>
on- line</w>
caregi vers</w>
coll ecting</w>
equival ents</w>
psycho tic</w>
n b</w>
gen omics</w>
re st
cy lin
p ines</w>
ger m</w>
fil tering</w>
control ler</w>
categor ical</w>
sa har
manifest ation</w>
stan ds</w>
cre ative</w>
2 4,
u sions</w>
ba g</w>
th 2</w>
consci ous</w>
re y</w>
2 3,
emp ow
reci proc
cat al
ga us
comm enced</w>
ali qu
r c</w>
ac cr
calc ification</w>
pol and</w>
ear ned</w>
emo tion</w>
illustr ates</w>
immunosuppres sive</w>
ass ayed</w>
spl en
quanti ties</w>
dam ages</w>
lu te
guaran tees</w>
il- 8</w>
acceler ation</w>
trans verse</w>
see ks</w>
model ed</w>
flow ers</w>
fir stly</w>
placebo -controlled</w>
vacu um</w>
chol ine</w>
lou is</w>
belong s</w>
oste oc
expl ic
illustr ate</w>
as a</w>
circa dian</w>
elic ited</w>
ch ile</w>
4. 9</w>
l. p.</w>
bre ach</w>
refl ex</w>
g ed</w>
cytos olic</w>
mat ing</w>
contral ateral</w>
ro bu
rever sal</w>
cultiv ation</w>
horm onal</w>
cer evi
omy cin</w>
iz u</w>
su c
refin ed</w>
mic s</w>
annivers ary</w>
si le</w>
z heng</w>
tian jin</w>
thromb in</w>
micro biota</w>
dis clos
co o
teen th</w>
ster il
pro inflammatory</w>
terti ary</w>
μ mol</w>
clu b</w>
co ok</w>
accum ulate</w>
fol ded</w>
lin ear
attribu tes</w>
f 4</w>
streng ths</w>
l up
on it
sr c</w>
ana esthe
13 2</w>
pati ent-
incenti ves</w>
per s</w>
agon ists</w>
au ter
fru its</w>
mis diagnosis</w>
at lan
ation .
glut amine</w>
discre p
good will</w>
flexi on</w>
t cr</w>
down regulated</w>
am bul
sol ving</w>
develop er</w>
app li
cu sto
ar c</w>
tor ies</w>
br ated</w>
symb ol</w>
m w</w>
absc ess</w>
hemodi alysis</w>
withdraw n</w>
d as
go v
ogr ams</w>
jam es</w>
us b</w>
mt dna</w>
b ad
dise as
tan dem</w>
wal ls</w>
sn ap
ap ex</w>
2 20</w>
dose- dependent</w>
b om
cerevi siae</w>
con ve
di lat
re str
op ol
transi tional</w>
og rap
ch el
te dness</w>
person ally</w>
cros s
insec ts</w>
viscer al</w>
hist ology</w>
sc aling</w>
it ance</w>
l s
au x
dis abilities</w>
leg ally</w>
g or
spectro photo
juven ile</w>
prob abilities</w>
co il</w>
plen ary</w>
amb ass
con cor
ro oms</w>
if n
comp act</w>
so y
5 00,000</w>
oc ation</w>
ol og</w>
ti ps</w>
mod ality</w>
ap ar
pursu it</w>
cont ingent</w>
bar s</w>
ship ments</w>
pre clud
stre aming</w>
tr ap</w>
scat tering</w>
pl asty</w>
off s</w>
align ments</w>
ex changes</w>
d al</w>
m as</w>
follic ular</w>
sou th
min es</w>
idi opathic</w>
tryp sin</w>
ic 50</w>
fram es</w>
lo ads</w>
ac c</w>
not ch</w>
hyper sensitivity</w>
psychos ocial</w>
r v
gr ass</w>
allow ance</w>
frac tion
om ide</w>
draw ing</w>
him self</w>
back bone</w>
repeti tive</w>
un ep</w>
anal og</w>
ff s</w>
glomer ular</w>
b am
p- values</w>
et in</w>
argin ine</w>
attrac ted</w>
k im</w>
conven ing</w>
m sc</w>
cle ft</w>
deng ue</w>
e- mail</w>
sanc tions</w>
after noon</w>
diap hr
tox ins</w>
ch an</w>
explo itation</w>
sel lers</w>
ber ed</w>
bench mark</w>
research er</w>
. org</w>
abnormal ity</w>
tail ed</w>
abo ve-
bus tion</w>
sor ting</w>
ni k
25 ,
g as
fec al</w>
ophil ic</w>
fair ly</w>
o side</w>
sign atures</w>
expl oring</w>
or ial</w>
imp ression</w>
wor st</w>
un f
estr adiol</w>
colum ns</w>
famil ial</w>
in ations</w>
arbitr ary</w>
a 3</w>
eff usion</w>
ap ine</w>
ra il
conver t</w>
pu b
cr s</w>
ec ular</w>
r m
copy right</w>
8 a</w>
cl a
up- regulation</w>
sc av
she ar</w>
auter ine</w>
protec ting</w>
fig ures
collap se</w>
collabor ator</w>
ma ur
12 2</w>
et c.</w>
u gg
brit ain</w>
epit ope</w>
co ver
pa inf
i onic</w>
gon ad
ll p</w>
initi s</w>
weap on</w>
mod al</w>
ig nor
saf egu
ti ters</w>
premis es</w>
qui to</w>
su pr
sp ok
avoid ance</w>
tr uly</w>
medic inal</w>
syl van
ar my</w>
colom bia</w>
ev ap
bankrup t
ga ap</w>
concer t</w>
cortico steroids</w>
incor rec
fre ely</w>
the -
ku wait</w>
conc eption</w>
tow er</w>
cy st
n av
mr s</w>
irradi ated</w>
gu o</w>
ir a</w>
p ts</w>
ir respective</w>
depic ted</w>
c on</w>
c entered</w>
om orph
16 s</w>
amy loid</w>
con vinc
par as</w>
pan ic</w>
enzy me-
af ore
specific ation</w>
f lower</w>
ec s</w>
tur ally</w>
r ash</w>
tubul in</w>
merg ed</w>
pu er
cigare tte</w>
pe tr
epti de</w>
bankrupt cy</w>
angi ot
ver ies</w>
8. 2</w>
θ </w>
tru th</w>
alumin um</w>
shif ted</w>
dysp lasia</w>
b erg
hc g</w>
lan ding</w>
v ate</w>
pa ul</w>
le ased</w>
aggreg ated</w>
dis til
review ing</w>
appeti te</w>
ment ally</w>
bacter i
anti bacterial</w>
comm on
depres sed</w>
pun ishment</w>
hd l-c</w>
inver ted</w>
answ ers</w>
inter nationally</w>
u x</w>
ribos omal</w>
t wi
cloth ing</w>
veget ables</w>
flo ating</w>
sear ched</w>
philip pines</w>
l c
transplan ted</w>
6. 6</w>
30 00</w>
immuno deficiency</w>
lig ament</w>
nicot ine</w>
ver e
phenomen a</w>
mosquit oes</w>
inter leu
non- invasive</w>
confir ms</w>
carol ina</w>
ri d</w>
apprais al</w>
j .
ou b
dro ple
ch l
defin ite</w>
tr is</w>
peri o
fe i</w>
l ary</w>
5. 9</w>
pro ton</w>
saliv a</w>
interleu kin
fl ur
re put
thre ats</w>
m on</w>
mal formations</w>
0. 4
penn sylvan
compromis e</w>
29 3</w>
vari eties</w>
conver gence</w>
t ong</w>
sc t</w>
wil lin
integr ating</w>
note worthy</w>
0. 6
anticip ate</w>
multi </w>
e if
di oxide</w>
opi oid</w>
8 9
h ag
b old</w>
y ong
arri val</w>
re a</w>
fun </w>
c cl
intoler ance</w>
ne a
ax ons</w>
distil led</w>
conduc ive</w>
tac hy
m ang
jiang su</w>
13 5</w>
o 1</w>
sear ches</w>
s g
bir ths</w>
ap c</w>
analy z
be vac
afore mentioned</w>
symp athetic</w>
lum in
tu p</w>
intr auterine</w>
reli es</w>
journ als</w>
pel let</w>
cm v</w>
differ ently</w>
7 b</w>
7. 7</w>
appli ances</w>
period ontal</w>
resus citation</w>
rend ered</w>
it -
f igh
remark ably</w>
speak er</w>
anatom y</w>
synerg istic</w>
open- label</w>
form ulated</w>
psori asis</w>
ont ology</w>
w m</w>
c alling</w>
contr ain
by e-
vi i</w>
diag nose</w>
obstac les</w>
sc i</w>
s ick
recogn izing</w>
ne ar
mos quito</w>
p d-
▶ </w>
contrain dic
migr ant</w>
comm encing</w>
ak es</w>
r .
b id
cop ing</w>
con flu
o metric</w>
challeng ed</w>
aberr ant</w>
lor d</w>
here under</w>
und oub
pennsylvan ia</w>
painf ul</w>
form ulations</w>
der ing</w>
in activated</w>
conventi ons</w>
s oph
ba i</w>
j os
is o</w>
flav on
un affected</w>
yu gos
pari etal</w>
compet ence</w>
bat ches</w>
ari th
pl ex
m 3</w>
vil le</w>
bm d</w>
super oxide</w>
cross- border</w>
20 ,000</w>
n est</w>
in k</w>
so vere
0. 7
lu o</w>
mr sa</w>
non- specific</w>
re t</w>
- treated</w>
hor se</w>
s ory</w>
os us</w>
edi tor</w>
method ological</w>
bo ot
pul l</w>
f sh</w>
me izu</w>
26 ,
li v
je jun
it a</w>
e au</w>
ak a</w>
emo tions</w>
hemis phere</w>
geo metric</w>
awar ded</w>
ha mp
willin gness</w>
iv o
sp in</w>
k u</w>
pp m</w>
che ap</w>
univer sities</w>
arg ument</w>
e en-
break through</w>
gli al</w>
seman tic</w>
inform ative</w>
s- 1</w>
roy al</w>
e us</w>
g ating</w>
scaff old</w>
disper sion</w>
3 9.
lar val</w>
an aerobic</w>
curr ic
w ants</w>
americ ans</w>
fes tival</w>
disp ute</w>
in patient</w>
and er</w>
tr unk</w>
rep ly</w>
ar coma</w>
gl asses</w>
p 38</w>
re tail
with standing</w>
t esti
gd p</w>
o on</w>
d yl
fore sts</w>
wan chai</w>
hol es</w>
s ick</w>
wil d
undoub tedly</w>
ration ale</w>
hol id
alg ia</w>
af ts</w>
cx cl
la id</w>
co ck
imp ul
nea rest</w>
th omas</w>
en de
spon sored</w>
di ets</w>
entr ance</w>
hygi ene</w>
5 th</w>
company will</w>
semic on
15 5</w>
matr ices</w>
warran ties</w>
ur able</w>
ch ips</w>
p n</w>
9 6-well</w>
spher es</w>
pass word</w>
epid ural</w>
ar i</w>
pancre atitis</w>
2 1-
shad ow</w>
co x-2</w>
age- related</w>
pr iced</w>
anastom osis</w>
fl ag</w>
not able</w>
he ar</w>
threat ened</w>
ec ho
sm a</w>
ubiquit in</w>
198 4</w>
tan z
la m</w>
h cr</w>
19 80</w>
ol factory</w>
fe tus</w>
in spir
n ac</w>
contamin ated</w>
ut ory</w>
der m
br inging</w>
venti l
l enti
john son</w>
weak er</w>
fr ank
gre ece</w>
transpor ters</w>
nan jing</w>
i bility</w>
prefer entially</w>
cycl ic</w>
iod ine</w>
mer cur
sm ad
ner ves</w>
o is</w>
coup le</w>
add resses</w>
swe dish</w>
m if
altern atives</w>
titan ium</w>
conven ed</w>
abstr act</w>
ar ial</w>
re payment</w>
eg o</w>
em t</w>
disp ose</w>
uncertain ties</w>
ammon ium</w>
ste ve</w>
per u</w>
&apos; ll</w>
l r</w>
o tive</w>
pur ity</w>
t ness</w>
v ap
1 14</w>
deal ers</w>
p fs</w>
fir ms</w>
statis tic</w>
comple ting</w>
bevac izumab</w>
anc er</w>
high- speed</w>
f d</w>
vertebr ate</w>
seg mentation</w>
del ta</w>
s 7</w>
cl on
ker atin
n ci</w>
rum ors</w>
d ul
not withstanding</w>
inter viewed</w>
deform ity</w>
expl icit</w>
tic ular</w>
dr al</w>
sept al</w>
b h
lum inal</w>
lar yngeal</w>
pre clinical</w>
distinc tion</w>
con sor
co p</w>
semicon duc
ar ch</w>
under taking</w>
satis fy</w>
main tains</w>
b dnf</w>
list en</w>
t onic</w>
ter -
6 c</w>
restaur ant</w>
at pase</w>
propag ation</w>
du tch</w>
and ong</w>
201 8</w>
a q
neon ates</w>
imp orted</w>
n ial</w>
f t-
possi bilities</w>
md a-
explic itly</w>
t ative</w>
sp ite</w>
fr anch
sel en
e jec
ou red</w>
d b
filam ents</w>
geo metry</w>
multi p
st aff
allel ic</w>
f 3</w>
survi ving</w>
coast al</w>
ur ic</w>
ogen icity</w>
instruc ted</w>
correspon d
l cd</w>
insul in-
de formation</w>
stri king</w>
fl ex
am ic</w>
asym metric</w>
ambi ent</w>
therapeu tics</w>
mor oc
altern ate</w>
0 ,
administr ator</w>
hypothe size</w>
eff lu
12 1</w>
n hs</w>
reimbur sement</w>
cz ech</w>
orig inated</w>
lar yn
fo x</w>
stabil ized</w>
g b
re ty</w>
recogn izes</w>
s son</w>
half- life</w>
pat ches</w>
s bp</w>
hif -
p dg
hepat ocytes</w>
chol in
gener ates</w>
de ad
gem cit
be at</w>
in appropriate</w>
sto ch
attend ance</w>
bo ost</w>
wi fi</w>
8. 6</w>
av a</w>
er ly</w>
vir tually</w>
n ing
sun ing</w>
encour ages</w>
li a
promp t</w>
uni form
col li
0. 10</w>
s ati
col onic</w>
counter -
coordin ator</w>
su ite</w>
pl ain</w>
break down</w>
reli eve</w>
ari um</w>
discrep ancy</w>
arg ued</w>
off line</w>
coven ants</w>
gol gi</w>
2 h</w>
transi tions</w>
7. 9</w>
micro environment</w>
d t
notic ed</w>
in os</w>
acqu iring</w>
smart phone</w>
fibrobl ast</w>
as ser
re dox</w>
mini ster
mig raine</w>
it ting</w>
there on</w>
vi ii</w>
occup ancy</w>
secre t</w>
accoun tability</w>
ab c</w>
cf u</w>
down- regulation</w>
specif y</w>
bro ker</w>
mobil ized</w>
dupl icate</w>
inv itation</w>
k ill
4 ,000</w>
if e</w>
medi ating</w>
mon onuclear</w>
lo ops</w>
facilit ates</w>
behavi ours</w>
adsor ption</w>
mi um</w>
la g</w>
vacc inated</w>
ve ins</w>
imp ly</w>
π </w>
inhal ed</w>
dec l
organ is
re f</w>
ker nel</w>
borrow ing</w>
adi pon
gal ac
g ul
synap ses</w>
t em
ph eric</w>
simp l
non invasive</w>
elec tive</w>
gran ule</w>
sic huan</w>
5- year</w>
dis continuation</w>
27 ,
1 24</w>
advanc ement</w>
ascul arization</w>
ligh t-
optim um</w>
confin ed</w>
m hz</w>
ont ario</w>
optim istic</w>
depreci ation</w>
omer ic</w>
gall bladder</w>
ic c</w>
gran ting</w>
intraper itoneal</w>
st ain</w>
heter o
an n</w>
or ated</w>
ging i
opla sia</w>
plau sible</w>
substitu tions</w>
subsi dies</w>
sacrif iced</w>
ambass ador</w>
it ely</w>
popul arity</w>
casp ase</w>
lo com
tr ab
mo s</w>
bi an</w>
acryl amide</w>
ro m</w>
hospit al
age ing</w>
1. 00</w>
blu e
perc enti
mt t</w>
. 5</w>
read ers</w>
ret ard
f um
id azole</w>
refr ig
entrepreneur ial</w>
carcin omas</w>
14 4</w>
cerebel lar</w>
if n</w>
sp ray</w>
un hcr</w>
ne mat
ili ans</w>
g il
hypox ic</w>
pan demic</w>
ail s</w>
c ine</w>
bon es</w>
ji e</w>
oti des</w>
hop es</w>
fail s</w>
ip si
epit opes</w>
3 1st</w>
ov ulation</w>
commun ic
ens in</w>
spec ulate</w>
deep er</w>
author ization</w>
phys ically</w>
glob ally</w>
loc ked</w>
eng ers</w>
k az
fis her
s ri</w>
it y
bo ards</w>
gi an</w>
volati le</w>
60 -
be ats</w>
lympho id</w>
ib d</w>
0. 15</w>
mac ular</w>
at g
adher ent</w>
cl amp</w>
o dy</w>
cap s</w>
propor tion
n gos</w>
contex ts</w>
g in</w>
respec ts</w>
t el</w>
purch asing</w>
spac es</w>
explor atory</w>
con stric
syri an</w>
q rt-pcr</w>
ma i</w>
re aches</w>
dr illing</w>
streptom ycin</w>
in i</w>
accom mo
ir o</w>
sen escence</w>
z ol
con e</w>
gaus sian</w>
graph s</w>
arg ue</w>
or ubicin</w>
avoid ed</w>
orth op
sym metry</w>
station ary</w>
is on</w>
col our</w>
metr ical</w>
ω </w>
reser ved</w>
thick ening</w>
4 00
leuk ocyte</w>
decl are</w>
ba x</w>
gr asp</w>
am en</w>
ax onal</w>
sm -
thor ough</w>
stat utory</w>
ob ia</w>
ma ize</w>
indeb tedness</w>
frac tional</w>
f idel
k ins</w>
str ap</w>
h la</w>
polymer ization</w>
cor ner</w>
can cell
gn </w>
siz ing</w>
re d-
le an</w>
8. 8</w>
en sive</w>
s g</w>
50 00</w>
predic table</w>
tic a</w>
1 17</w>
g ation</w>
rejec ted</w>
6. 9</w>
arch i
summar izes</w>
o 3</w>
pe ter</w>
p 4</w>
publ icity</w>
ch rist
atlan tic</w>
wat er-
sub tle</w>
di stric
sp ort</w>
star ch</w>
g sh</w>
sen g</w>
immunoprecip itation</w>
tex ture</w>
f c
mim ic</w>
forec ast</w>
li pop
wh en
phr ine</w>
reproduc ibility</w>
ac tin
3 h</w>
treati es</w>
bur un
pre -</w>
junc tions</w>
mp ing</w>
met all
caspase- 3</w>
mal nutrition</w>
otox in</w>
gy rus</w>
less ons</w>
1- 3</w>
pi one
az one</w>
syn onymous</w>
happ en</w>
7 8
remain der</w>
uk raine</w>
th ral</w>
el em
mor al</w>
4 th</w>
wor ms</w>
t tes</w>
gr ass
1 -</w>
ther mia</w>
figure 1</w>
k at
post menopausal</w>
out breaks</w>
c ing</w>
deep ly</w>
anc estr
in y</w>
ati vity</w>
del ine
i asis</w>
fab ric
forc ing</w>
first- line</w>
consul tants</w>
appropri ately</w>
r b</w>
b at</w>
v ol</w>
democr acy</w>
infr ing
t .
pre y</w>
incorpor ating</w>
aden osine</w>
2 -</w>
dissec ted</w>
vertebr ates</w>
ar is</w>
de br
pa ul
t ap</w>
h its</w>
y- based</w>
s- induced</w>
intern ally</w>
over expressed</w>
ut ation</w>
stor m</w>
haem at
8. 9</w>
phosph o
inher ited</w>
o com
stom y</w>
stic k</w>
tim or</w>
bi -
al lot</w>
c pu</w>
co ch
work shops</w>
amino transferase</w>
exemp t</w>
enc ement</w>
adipon ectin</w>
os mo
special ty</w>
em bar
when ever</w>
s and</w>
enlarg ement</w>
diagnos tics</w>
9 8
marg in
reput ation</w>
0.0 00
endor sed</w>
ital ian</w>
co ca
engine ered</w>
be t</w>
0.00 5</w>
decid es</w>
esophag us</w>
ad diction</w>
c asse
chap er
disp osed</w>
ly sed</w>
per spec
ar omatic</w>
br ings</w>
il eg
mom entum</w>
neighbor ing</w>
sh andong</w>
1 18</w>
r v</w>
py ro
tr na</w>
bi ologically</w>
ful f
predic ts</w>
phil os
meas urable</w>
comm encement</w>
xia o
finger print</w>
nos ocom
tur ning</w>
28 ,
ac ro
r as
c ement</w>
el les</w>
obla stoma</w>
high- throughput</w>
cros sing</w>
attenu ation</w>
di -
tor ture</w>
au to</w>
lymph atic</w>
chong qing</w>
re constructed</w>
r en</w>
a id
ro unds</w>
gemcit abine</w>
fidel ity</w>
prototyp e</w>
mit ting</w>
judg es</w>
enc ap
pl ant
access ories</w>
g ates</w>
morph ine</w>
radi ographic</w>
1. 5
pe g</w>
p en</w>
expres s
vi ro
li ant</w>
tanz ania</w>
in door</w>
l ex
jac k
habit ats</w>
ref used</w>
inqu ir
ox if
mon otherapy</w>
erythro cyte</w>
disrup ted</w>
fr uc
yl and</w>
po ols</w>
philos oph
constitu tive</w>
om ere</w>
anc e
int angible</w>
g .
di mer
diversi fied</w>
harv est</w>
orth olog
hous es</w>
mo us
redund ant</w>
whol es
199 0s</w>
on y
publ ishing</w>
cat ch</w>
comput ation</w>
me ier</w>
dilat ation</w>
organ ize</w>
avoid ing</w>
re x
nosocom ial</w>
el age</w>
box es</w>
co w</w>
met allo
appro vals</w>
phot on</w>
sp ong
ati tude</w>
μ </w>
por tions</w>
co sta</w>
err y</w>
rit u
tris -
eb v</w>
immun otherapy</w>
gather ed</w>
en em
e tax
biosci ences</w>
kid neys</w>
bel l</w>
pil ls</w>
tnf α</w>
int ent</w>
sc rap
emplo ying</w>
ig no
autom otive</w>
priv ileg
uc k</w>
stabil ize</w>
p ra
cr t</w>
modul ating</w>
mercur y</w>
aven ue</w>
som at
w en
aff ective</w>
el and</w>
engine ers</w>
nic he</w>
annot ations</w>
ten ds</w>
si de-
gi b
constr ained</w>
termin als</w>
gener a</w>
re purchased</w>
deri ve</w>
stri es</w>
c ac
ophthal m
success or</w>
as part
uti lis
e 3</w>
clea ved</w>
mil l</w>
ir rig
antagon ists</w>
prefer ential</w>
sensi ti
py ram
form ally</w>
doc etax
l n</w>
reservo ir</w>
excee ds</w>
ra id</w>
por table</w>
tigh tly</w>
perio dic
ejec tion</w>
40 -
conti gs</w>
i q
d aughter</w>
yl ase</w>
on- site</w>
s ke
custom s</w>
8. 4</w>
ec ology</w>
enti rety</w>
w rist</w>
anthro po
r g
ax illary</w>
star ts</w>
disturb ances</w>
1 13</w>
pe g
flu ids</w>
rig id</w>
if f</w>
inv ari
guid ing</w>
qu er
cd c</w>
civ ilians</w>
bos nia</w>
deplo yed</w>
sens ation</w>
carri age</w>
phar yngeal</w>
eth yl</w>
ri de</w>
un ido</w>
e gr
w en</w>
ancestr al</w>
pack ages</w>
diff r
gro und
fl as
fus elage</w>
u plo
adhe sive</w>
tax able</w>
an alogue</w>
trunc ated</w>
trans gene</w>
tal king</w>
ã o</w>
v esti
ex -
b- cell</w>
ec al</w>
1 e</w>
3 .</w>
tripl icate</w>
viol et</w>
interpre t</w>
review ers</w>
trit on</w>
competi tiveness</w>
w ounds</w>
qual ification</w>
bu ying</w>
lup us</w>
t z
or adi
mut ually</w>
n al
s n</w>
x ing</w>
w p</w>
sear ching</w>
cro ps</w>
expl ains</w>
rou tes</w>
p ten</w>
exc ited</w>
cb i</w>
gu an
intramus cular</w>
design ing</w>
recycl ing</w>
dis pers
ch r</w>
glob alization</w>
ati zation</w>
answ ered</w>
mix tures</w>
a 5
n b
v 2</w>
hon our</w>
gene ic</w>
adip ocytes</w>
supervis ors</w>
th ou
lif es
w k</w>
trade mark</w>
promp ted</w>
portu gal</w>
small est</w>
al be
ingredi ents</w>
hyper glycemia</w>
he ated</w>
ocy an
peace building</w>
mongol ia</w>
tic ket</w>
h as
x l</w>
tradi tionally</w>
hiv- infected</w>
12 9</w>
trajec tory</w>
beg ins</w>
ob last</w>
cong estive</w>
x 3</w>
table 11</w>
extinc tion</w>
occ ip
mc f-
micros at
- in</w>
electrocardi ogram</w>
proteas ome</w>
wi shes</w>
super script</w>
distric ts</w>
s ort</w>
0. 2
anne aling</w>
igi ble</w>
thromb ocytop
sp ear
gu il
servic er</w>
per oxide</w>
198 2</w>
&apos; an</w>
hear ts</w>
reli ev
sub section</w>
mag azine</w>
bro ker
form erly</w>
sh a</w>
c il
absor bed</w>
os k
mutag enesis</w>
emerg e</w>
degrad ed</w>
black berry</w>
grap hen
s v</w>
perspec tives</w>
n af
imag ine</w>
medi um-
pair ing</w>
d ic</w>
6 00
sed ation</w>
c us</w>
radi ological</w>
hope well</w>
sa -
immun ized</w>
te trac
d am</w>
inv o
ax on</w>
tho od</w>
non linear</w>
exacerb ation</w>
sub trac
initi ating</w>
r wanda</w>
soph is
amp lic
liqu idation</w>
brom ide</w>
judg ed</w>
x a</w>
compens ate</w>
graf ting</w>
inc eption</w>
i op</w>
imp acted</w>
anti retroviral</w>
oc or
top -
recei ver</w>
cle aring</w>
end points</w>
29 ,
sk ull</w>
rad icals</w>
aw a</w>
acces sibility</w>
af en
palli ative</w>
tu re-
mm 3</w>
in ference</w>
res ec
k w
bur ning</w>
ici ans</w>
air -
dist or
z n</w>
co ast</w>
ic on</w>
in som
tax ation</w>
z i
pal m</w>
para formaldehyde</w>
fo ster</w>
wear ing</w>
over expressing</w>
hang zhou</w>
iz er</w>
prohib ited</w>
enor rhea</w>
cy pr
un ce</w>
polar ized</w>
rs v</w>
xi ang</w>
mmp -9</w>
myel oma</w>
segreg ation</w>
le ish
urg ed</w>
qual ify</w>
mini sters</w>
evid ence-based</w>
fellow ship</w>
spl ice</w>
col ors</w>
me tic</w>
taxonom ic</w>
me ster</w>
un secured</w>
in sured</w>
att enti
id ating</w>
h ou
intr igu
ip ot
ag matic</w>
glyc ine</w>
um b
ic ans</w>
confid ent</w>
yiel ding</w>
haz ards</w>
bo ok
budg etary</w>
comb ating</w>
le gs</w>
sex ually</w>
medi ates</w>
9. 2</w>
min us</w>
hemat oma</w>
ne pal</w>
la stly</w>
one- third</w>
j nk</w>
memor an
deal t</w>
tr il
cour ts</w>
ec lamp
analy se</w>
fis hing</w>
lith ium</w>
trou ble</w>
chair person</w>
uni qu
gi ants</w>
pap ill
r ag
fre e-
consor tium</w>
6 3
pu ber
t d
var ic
le ment</w>
sti r
leuk ocytes</w>
tgf- β1</w>
al tit
sp here</w>
k its</w>
expec tancy</w>
elim inating</w>
simp lif
thor ou
chro m
bu yers</w>
p ill
cd 11
burun di</w>
debr is</w>
c- reactive</w>
fai th</w>
in -1</w>
her ze
bol i
cypr us</w>
band width</w>
m ud
promis e</w>
x x
nit rate</w>
mass age</w>
collec tions</w>
t amine</w>
si s-
antic ancer</w>
tlr 4</w>
minister ial</w>
pen alty</w>
ipsi lateral</w>
sev ent
ghan a</w>
block ers</w>
0 9
oscill ations</w>
t f
sc anner</w>
and rogen</w>
defin itely</w>
paraff in</w>
gov ina</w>
pathophysi ology</w>
el se</w>
oc ked</w>
t 1
phylo gen
w n
refer ring</w>
herze govina</w>
cathe ter
out line</w>
de tox
f entan
ph leg
s f-
dox orubicin</w>
tic ation</w>
li ps</w>
cel e
fel low</w>
enter al</w>
ero sion</w>
ur ge</w>
h be
umin escence</w>
retard ation</w>
virtu e</w>
ivo ire</w>
30 ,
settle ments</w>
poor er</w>
a ic</w>
b ought</w>
arbitr ation</w>
p tions</w>
fertili zation</w>
preser ve</w>
tre s</w>
factor -
bl ind
sy phil
bor ing</w>
ati </w>
docetax el</w>
cran ial</w>
occup y</w>
et ine</w>
man n-
exp ire</w>
pd b</w>
flur ane</w>
rec tification</w>
sp reading</w>
histor ically</w>
dis appearance</w>
anti coagul
1- 2</w>
as ticity</w>
mag ic</w>
construc tive</w>
favour able</w>
t angible</w>
lys ate</w>
ba um
deli vering</w>
3 -</w>
diversi fication</w>
sugg estive</w>
swi mm
cro ati
expres ses</w>
h lor
0. 75</w>
0 1
bon ding</w>
with in-
tur k
me ts</w>
g ma</w>
ok ine</w>
cc c</w>
quantit atively</w>
reli ance</w>
employ er</w>
cr is
tail ored</w>
ass ing</w>
simp lified</w>
12 7</w>
cytosk eleton</w>
dispens able</w>
membran e-
di shes</w>
h1 n1</w>
z hu
gly coly
graph ic</w>
cur v
unf pa</w>
198 3</w>
myocardi um</w>
re vi
o hi
do t</w>
wor ker</w>
standardi zation</w>
orb ent</w>
trig gers</w>
chem ically</w>
- positive</w>
py ru
cen sus</w>
inv al
mi st
ar ized</w>
e 2
legitim ate</w>
dec o
z te</w>
thir ds</w>
si m</w>
f gf
eosin oph
men u</w>
dre w</w>
ic t</w>
si t</w>
str ing</w>
ag glut
ro dents</w>
id one</w>
ro c
8. 7</w>
ju ice</w>
phen ol</w>
moroc co</w>
motor ola</w>
dis solution</w>
2 10</w>
coordin ating</w>
free zing</w>
28 -
re sign
m h
disab led</w>
c age</w>
el uted</w>
an is
proce dural</w>
ne ar-
amy gd
cycl ophosph
arab ia</w>
re mia</w>
insom nia</w>
comor bidities</w>
p end
nai ve</w>
te st
shor tly</w>
broker age</w>
short en</w>
bos s</w>
app liance</w>
di ure
del l</w>
p y</w>
exi sted</w>
am er</w>
intraven ously</w>
blo od-
pot ency</w>
tel omere</w>
b is</w>
aer ial</w>
10 00
σ </w>
ne v
negl igible</w>
out door</w>
c af
i as</w>
ros copic</w>
t ags</w>
encephal opathy</w>
vi et
mechan istic</w>
ven ez
m f</w>
4 s</w>
comp ul
og raph</w>
co incid
e- cadherin</w>
seed lings</w>
circu its</w>
percep tual</w>
aut um
log o</w>
er k1</w>
pr er
succ essive</w>
post- operative</w>
15 7</w>
incub ator</w>
gen bank</w>
prof itable</w>
may be</w>
rna- seq</w>
0. 00</w>
imp ed
post operatively</w>
dr agon</w>
star s</w>
at em
ar ach
neuro degenerative</w>
bon fer
derm atitis</w>
eluc idated</w>
bio diversity</w>
fd g</w>
l um</w>
1 19</w>
anc est
distingu ish
corro bor
ent rop
re signed</w>
pro pen
ey el
develop s</w>
li ang</w>
contin ence</w>
ococc al</w>
ch o</w>
phar yn
cro w</w>
war ming</w>
7 50</w>
pul ses</w>
accompl ished</w>
fluor ide</w>
sc -
eg f</w>
ol es</w>
prote ases</w>
ili ac</w>
alpha -
affili ate</w>
cycl o
t uting</w>
ch ur
canc er
exten ds</w>
socio- economic</w>
medi ast
bioinform atics</w>
re vo
6 ,000</w>
sub regional</w>
in o
bro thers</w>
over s</w>
contrac tual</w>
autonom ic</w>
sou theast</w>
modi fying</w>
sor ted</w>
sul ph
m. d.</w>
stri p</w>
arthro plasty</w>
prim ing</w>
high- resolution</w>
prosec ut
2 r</w>
vi bration</w>
immunos orbent</w>
fix ed-
syphil is</w>
thor aco
con vul
graphen e</w>
canc er-
d av
c ay
bi o</w>
cran i
c 4</w>
lac ks</w>
w ay
bro ther</w>
anti sense</w>
se o
albe it</w>
list ening</w>
si r</w>
warran ted</w>
20 20</w>
g v
survi ved</w>
veget ation</w>
per -
ec a</w>
yl in</w>
ye th
ro lim
p f</w>
pre frontal</w>
chemo kines</w>
un common</w>
venez u
ca st
aut op
pa ste</w>
e ing</w>
on ally</w>
sol di
fil ament</w>
willi am</w>
chem okine</w>
aneury sms</w>
ag il
new bor
9 a</w>
sk ill</w>
contrac eption</w>
mo to</w>
leg ia</w>
amor tization</w>
ma d</w>
ic us</w>
y og
retin opathy</w>
athle tes</w>
oti tis</w>
9. 1</w>
ab i
de trim
cor pus</w>
big ger</w>
child bearing</w>
ev en
gynec ological</w>
sh rna</w>
n d
arre sted</w>
t- based</w>
soy bean</w>
ul atory</w>
scaff olds</w>
ar ises</w>
1 31</w>
dr s</w>
emplo y</w>
oph en
an ic</w>
n il</w>
mo z
prior iti
s ac</w>
h h</w>
silic a</w>
troph ic</w>
fox p3</w>
pro phyl
stoch astic</w>
excit atory</w>
v p</w>
wor ri
j ones</w>
198 1</w>
hydr ated</w>
braz ilian</w>
popul ation-based</w>
cc s</w>
gu ardi
tom ato</w>
it ably</w>
polyp s</w>
s j
p ick</w>
mel ting</w>
up dates</w>
ple dged</w>
produc ers</w>
pregn ancies</w>
commerc i
syno vial</w>
v est</w>
coher ent</w>
ther m
or ption</w>
memoran dum</w>
hem or
gu atem
transpor ted</w>
my an
2 80</w>
gra vity</w>
un necessary</w>
assum es</w>
9. 3</w>
robu st
t bi</w>
bonfer ron
ga e</w>
dysp nea</w>
congr at
ab i</w>
my osin</w>
vesic le</w>
synchron ization</w>
v able</w>
liber ia</w>
poll ut
incre mental</w>
ad missions</w>
ep a</w>
cerebro spinal</w>
substitu ted</w>
w c</w>
rou gh</w>
alcohol ic</w>
am end</w>
y un</w>
wav e
mar yland</w>
8 5
earth qu
y ao</w>
clinici an</w>
100 -
plur ipot
c as</w>
r ight-
immuno assay</w>
plat eau</w>
pe ti
ro dent</w>
expec tation</w>
e z</w>
pro mega</w>
discipl ine</w>
al ger
g an
myan mar</w>
mic hig
i um-
ti les</w>
cyclophosph amide</w>
reduc tase</w>
gap dh</w>
us hing</w>
evol ving</w>
pre dat
me tro
disp utes</w>
brea king</w>
j ak
licen ses</w>
di dn</w>
mal a
13 8</w>
s aint</w>
arri ved</w>
ten th</w>
pi vot
valu e-
bub ble</w>
newbor ns</w>
r ut
som alia</w>
genu ine</w>
rel ying</w>
pap illary</w>
ass ure</w>
w -
top ology</w>
concep tual</w>
da w
n cbi</w>
high- dose</w>
zh eng
ref res
ch un</w>
approxim ation</w>
dele ter
mon opol
dec lining</w>
amin es</w>
lac tic</w>
add .
def ici
deal er</w>
follic le</w>
out look</w>
sub cellular</w>
cur cum
os arcoma</w>
1 s</w>
streptococc us</w>
qu orum</w>
publ ish</w>
domin ance</w>
ta o</w>
ful filled</w>
sli p</w>
1. 0
ord an</w>
2 60</w>
ec u
cd 34</w>
bal b</w>
flan king</w>
bot tle</w>
ex am</w>
0.00 2</w>
trans duc
con v
influ x</w>
poly mers</w>
str ingent</w>
n ick
b ite</w>
prev ailing</w>
swi ss</w>
under signed</w>
re placing</w>
near by</w>
th 17</w>
colon oscopy</w>
michig an</w>
contrac eptive</w>
neces sity</w>
c argo</w>
c e-
connec ting</w>
ti dine</w>
diffr action</w>
mul tin
b w</w>
2 c
id in</w>
ing er</w>
in ches</w>
w age</w>
adul thood</w>
nomine e</w>
cre ates</w>
it ate</w>
hel ical</w>
long est</w>
ti bial</w>
sh allow</w>
con temporary</w>
glyco protein</w>
val ence</w>
detrim ental</w>
wa i</w>
autum n</w>
at trs</w>
group s.</w>
discrimin ate</w>
d g</w>
- 6</w>
- a</w>
re forms</w>
as ic</w>
entrepreneur ship</w>
perform s</w>
medic are</w>
refrig er
re v</w>
them atic</w>
scre w</w>
m u</w>
vir gin
asc ites</w>
conf er</w>
deleter ious</w>
pivot al</w>
lab els</w>
brief ing</w>
gar den</w>
sa m</w>
sti pul
16 8</w>
stead y-
le ste</w>
immuno staining</w>
asym metry</w>
quar tile</w>
gre y</w>
acid osis</w>
semiconduc tor</w>
dr ying</w>
conduc tance</w>
neutr alizing</w>
compens atory</w>
differ ing</w>
urg es</w>
sur plus</w>
spher ical</w>
glomer ul
expl aining</w>
govern ed</w>
mp a</w>
kr yp
crow d</w>
robust ness</w>
na il</w>
rati fied</w>
super -
peric ardi
n pc</w>
nation wide</w>
enzyme- linked</w>
phy to
co st
mil es</w>
pestic ide</w>
3 t</w>
tw in</w>
posi tivity</w>
advis ors</w>
chl amy
we b-
r yp
ra ises</w>
lat tice</w>
ar tan</w>
electroly te</w>
h ir
ca ff
dis on</w>
2 g</w>
oxidi zed</w>
rn ase</w>
desc ending</w>
x- 100</w>
econom ics</w>
an ore
exha us
strati fication</w>
k un
resign ation</w>
un conditionally</w>
decomp osition</w>
ig f-
n el
an onymous</w>
bo y</w>
c ats</w>
wit ness</w>
ohi o</w>
dist ur
vi et</w>
co in</w>
6 s</w>
manif ested</w>
m ates</w>
j ordan</w>
cour ier</w>
subordin ated</w>
l amp</w>
tran s</w>
see ing</w>
expor ts</w>
stimul ates</w>
sophis ticated</w>
low- cost</w>
medi ator</w>
at ure
cu ed</w>
ug gl
le asing</w>
treatment .</w>
diver gent</w>
p 21</w>
2 e</w>
bra in
progres sively</w>
am eli
pres entations</w>
g ang</w>
ou ts</w>
plan ar</w>
ze iss</w>
aspart ate</w>
lin ker</w>
te ar</w>
sw allowing</w>
alb icans</w>
andre ws</w>
me als</w>
poss ess
i hc</w>
sahar an</w>
t onn
cros so
abol ished</w>
cis -
eclamp sia</w>
speci alists</w>
z hong</w>
op ho
pa x
explan ations</w>
adver ti
p c-
g a-
l t</w>
igno red</w>
b g</w>
az a</w>
steady- state</w>
spl enic</w>
descrip tions</w>
ther mo</w>
rec alled</w>
in ic</w>
at in</w>
el icit</w>
zy me</w>
an di
phen yl</w>
spon taneously</w>
camp us</w>
sid ase</w>
de tention</w>
gener al
terr ane
serot onin</w>
dec lines</w>
renew ed</w>
tec </w>
duc tal</w>
cam bo
orig ins</w>
an i
appreci ate</w>
agg ra
classi fier</w>
ld h</w>
thorou ghly</w>
bac ked</w>
mar tin</w>
ine phrine</w>
ain -
os es</w>
is let</w>
or ously</w>
treas ure</w>
- 4</w>
aper ture</w>
pip e</w>
ch ori
ca o</w>
const ants</w>
d ak
af raid</w>
ro d</w>
spor adic</w>
hem ip
sme ar</w>
insec tic
ch f</w>
u sted</w>
aut osomal</w>
ce in</w>
cor n</w>
bund le</w>
fif teen</w>
a side</w>
anesthe tic</w>
follic les</w>
15 3</w>
hif- 1α</w>
lif t</w>
spear man</w>
t fs</w>
j et</w>
re ar</w>
ga g</w>
e ed</w>
anti hypertensive</w>
magn ification</w>
aff ord
vill ages</w>
newsp aper</w>
trigger ing</w>
mda- mb
comp ute</w>
ar b
ir reversible</w>
rolim us</w>
man dates</w>
fl ying</w>
9 6
la kes</w>
5 s</w>
lux ury</w>
rati fication</w>
revol ving</w>
bu ty
angiot ensin</w>
am -
a emia</w>
coca ine</w>
mit osis</w>
escal ation</w>
ho used</w>
bios ystems</w>
pyru vate</w>
st ap
ende av
hk frs</w>
as king</w>
pm i</w>
0 7
nas opharyngeal</w>
fo s</w>
program med</w>
rend ering</w>
am ed</w>
blue tooth</w>
ti ll
disc arded</w>
carbo x
st ain
pur ple</w>
determin ant</w>
ric hard</w>
stabil izing</w>
re per
figh ting</w>
ac char
cho osing</w>
ad ds</w>
9 7
anch or</w>
n ag
. 9</w>
tot ally</w>
two- way</w>
refuge e</w>
cultiv ated</w>
ob i
j uni
bio- rad</w>
psychi at
m f
prophyl actic</w>
cor p.</w>
bac </w>
phosph ati
att ac
continu ity</w>
x r</w>
ja und
as al</w>
car ot
soci eties</w>
methyl -
mo on</w>
exc ised</w>
low- dose</w>
hon ey</w>
m ast</w>
amin ergic</w>
ell er</w>
me i</w>
questi oned</w>
distribu tors</w>
tob ac
guatem ala</w>
acc redi
si -
col oc
kryp ton</w>
c ed
dis ast
ear n</w>
coupl es</w>
cru z</w>
c ep
clos est</w>
nom ination</w>
hk as</w>
eth ylene</w>
i ph
ure ter
anno unce</w>
exhib iting</w>
v t</w>
n ap
b red</w>
take overs</w>
sust ain</w>
19 0</w>
e de</w>
sustain ability</w>
manufac tured</w>
20 1</w>
di ego</w>
situ ated</w>
p ale</w>
an xi</w>
cong estion</w>
at ax
reproduc ible</w>
der m</w>
credi ted</w>
nik on</w>
triglycer ides</w>
campa ig
ro mania</w>
me ant</w>
ha iti</w>
mater n
work place</w>
ship ping</w>
carri es</w>
sk illed</w>
con clusive</w>
eth yl
ox etine</w>
croati a</w>
pol l</w>
self- report</w>
ali ve</w>
mid ine</w>
cham bers</w>
bas in</w>
di i</w>
curv ature</w>
analog ous</w>
cardiomy opathy</w>
z en
g was</w>
crow n</w>
ju mp</w>
18 6</w>
mon d</w>
solic itation</w>
proble matic</w>
trans mit</w>
refl ec
mcf- 7</w>
oligonucle otide</w>
fib rous</w>
portfol ios</w>
neoplas tic</w>
lan es</w>
afen ib</w>
swe et</w>
rc ts</w>
chem il
after -
me 3</w>
appear ing</w>
underwrit ers</w>
le af
acin et
0 8
weigh ed</w>
candi da</w>
es crow</w>
protein uria</w>
pre fer</w>
l en</w>
microtub ule</w>
er n
tor ial</w>
inher itance</w>
f li
liter acy</w>
allo geneic</w>
percenti le</w>
pro to
testi s</w>
immun ogenicity</w>
explan atory</w>
ycl ine</w>
f dr</w>
moist ure</w>
la sts</w>
13 6</w>
simul ate</w>
ritu ximab</w>
cosme tics</w>
diag ram</w>
excep tions</w>
tic es</w>
shar p
posi tives</w>
stand ar
tumorig enesis</w>
cheng du</w>
at ar</w>
the ories</w>
pig ment</w>
zh i</w>
classi fy</w>
capac ity-
ambigu ous</w>
hd ac
ig g
lum ia</w>
tachy cardia</w>
movi es</w>
affor d</w>
hel sin
e ye
f arms</w>
enhanc er</w>
plas modi
rin sed</w>
19 9</w>
le m
ri t</w>
betw een-
meth ot
wu han</w>
acinet obacter</w>
us er-
n is</w>
li able</w>
endothel ium</w>
reli ably</w>
conf usion</w>
bur gh</w>
methot rex
offer or</w>
sil ent</w>
be e</w>
psych ology</w>
cann ab
at cc</w>
non specific</w>
phosph o-
bac illus</w>
ric a</w>
cost- effectiveness</w>
asc ending</w>
incorrec t</w>
hus band</w>
alger ia</w>
ill nesses</w>
2 1
as sign</w>
bonferron i</w>
origin ating</w>
qu asi
f p-
ing e</w>
entr ies</w>
ander son</w>
po s</w>
s wee
virgin ia</w>
ell ul
he k
ap i</w>
one ph
bro th</w>
lo sis</w>
sedi ment</w>
proce eding</w>
reciproc al</w>
cerebel lum</w>
venezu ela</w>
impair ments</w>
memor ial</w>
os por
ten ed</w>
in continence</w>
j e</w>
cryst alli
tempor arily</w>
out puts</w>
tin nit
s ar</w>
weak ly</w>
n r</w>
anti- mouse</w>
enter o
sen sor
constitu tional</w>
ro me</w>
typ ing</w>
d le</w>
at m</w>
bi ases</w>
mis match</w>
aux iliary</w>
air port</w>
imp air</w>
z om
men op
swimm ing</w>
flor a</w>
ba o</w>
or ic</w>
ap lastic</w>
- old</w>
underwrit er</w>
occa sions</w>
im aged</w>
vi br
ecos ystems</w>
se t-
ri dge</w>
palest ine</w>
en sem
caff e
glob ulin</w>
polymorph ic</w>
comp lied</w>
meth an
co c
progenit ors</w>
meth ion
def end
4 e</w>
parasi tic</w>
sh u</w>
disper sed</w>
incid ents</w>
y go
flow ering</w>
eur o</w>
bron chos
merc k</w>
17 5</w>
tun ing</w>
olymp us</w>
anesthe tized</w>
hemo stasis</w>
helsin ki</w>
jaund ice</w>
glycosy lation</w>
pr ud
ul ates</w>
den ied</w>
com .</w>
any one</w>
judg ments</w>
gro o
disclos ures</w>
radio active</w>
oxygen ation</w>
pel lets</w>
identifi es</w>
t our</w>
chem ot
concentr ate</w>
15 00</w>
anti tumor</w>
cros sed</w>
le um</w>
p fi
table 2</w>
share holding</w>
carcin ogenesis</w>
oth or
alleg ed</w>
mar ital</w>
lan ka</w>
credi tors</w>
spar se</w>
inter ior</w>
por cine</w>
equ itable</w>
ri o</w>
l ang
exc iting</w>
necro tic</w>
pran dial</w>
co al
e um</w>
neuro transmit
de par
hem op
19 34</w>
depend ency</w>
illin ois</w>
sched ules</w>
ro i</w>
life- threatening</w>
ab le-
un employment</w>
8- k</w>
micro wave</w>
ac .
moun t</w>
agg ing</w>
el ast
z am
pe t
monol ayer</w>
cytos ol</w>
red ness</w>
sed entary</w>
h g
4 80</w>
zh en</w>
anomal ies</w>
u ation</w>
oz o
d ha</w>
hydro ly
occa sion</w>
worsen ing</w>
vi tis</w>
repl icated</w>
coun ties</w>
reser vation</w>
cigare ttes</w>
en tion</w>
sal aries</w>
ecu ador</w>
a j
methotrex ate</w>
par allel
health -related</w>
e du</w>
conflic ting</w>
occip ital</w>
above- mentioned</w>
acid -
ca -
o to</w>
revol ution</w>
char les</w>
georg e</w>
kn ife</w>
aph ase</w>
ear ly-
pros thesis</w>
lifes pan</w>
trajec tories</w>
3 p</w>
sm c</w>
pbm cs</w>
medi terrane
rig orous</w>
correspon ded</w>
∈ </w>
by way</w>
microtub ules</w>
reg s</w>
w est
7 th</w>
ho dg
min nes
f v</w>
agg ression</w>
ne sted</w>
pass engers</w>
it er</w>
m ds</w>
ren e</w>
post- treatment</w>
accid ents</w>
mer ely</w>
tow n
s ore</w>
l ates</w>
ex hibition</w>
obstetr ic</w>
ep ic
adop ting</w>
capacity- building</w>
il- 17</w>
quin ol
s ong
ab ro
il li</w>
tinnit us</w>
ch an
hum idi
denat uration</w>
amni otic</w>
scre en
c ag
ma z
8 6
connec tive</w>
t- cells</w>
ket amine</w>
sar co
ar us</w>
use fulness</w>
t ose</w>
bur ns</w>
k app
se tup</w>
periph ery</w>
oligonucle otides</w>
destro yed</w>
sch ist
3 1,
wholes ale</w>
z hi
baum ann
si rnas</w>
perme abil
ne ts</w>
hand -
ct c</w>
bron cho
curric ulum</w>
alter ing</w>
stat ute</w>
co .</w>
spo use</w>
expir atory</w>
lo y
highligh ting</w>
m k
arti facts</w>
13 7</w>
inter faces</w>
ten ant</w>
bil li
remedi es</w>
pass enger</w>
amygd ala</w>
inf ar
al gae</w>
spi ro
w g</w>
r ct</w>
web sites</w>
refr active</w>
gram- positive</w>
veter inary</w>
at ine</w>
il- 12</w>
restaur ants</w>
b all
br ca1</w>
br ight
nar co
cons ents</w>
g lo
sh -
fibrin ogen</w>
le ica</w>
firm ly</w>
15 2</w>
ag eous</w>
d al
agil ent</w>
van com
volati lity</w>
defici encies</w>
prote ome</w>
minnes ota</w>
fi ers</w>
un infected</w>
sup ine</w>
n he
casse tte</w>
vas o
1. 25</w>
anore xia</w>
mening itis</w>
adi po
tam oxif
allevi ate</w>
sc anned</w>
u sive</w>
ang el</w>
dispers al</w>
kaz ak
hy al
parli ament</w>
vir gin</w>
str ands</w>
campaig ns</w>
ric hness</w>
mo ves</w>
juni or</w>
poly acrylamide</w>
ware house</w>
0.0 6</w>
low ered</w>
fing ers</w>
pseud o-
sp s</w>
neo adjuvant</w>
vas odi
q s</w>
s inc
su pre
accommo date</w>
ow ed</w>
cay man</w>
ger m
el le</w>
g u</w>
ac il</w>
ph an
liv est
wil cox
13 4</w>
be verage</w>
hun gary</w>
distribu te</w>
de pri
y en</w>
ib id</w>
14 1</w>
de an</w>
diam ond</w>
as per
r uled</w>
al together</w>
baumann ii</w>
14 6</w>
ar ts</w>
hyster ectomy</w>
micro vascular</w>
g bm</w>
pf c</w>
st ems</w>
seo ul</w>
f cs</w>
phleg m</w>
g st</w>
cro hn</w>
rec ap
tan k</w>
wear able</w>
15 6</w>
gab a</w>
per ox
ene m</w>
theore tically</w>
z im
e ae</w>
ca sting</w>
k le</w>
fac s</w>
conduc tivity</w>
re b
prote omic</w>
cyt ology</w>
happ ened</w>
un preced
sen eg
constitu tively</w>
sou th-
e b</w>
ln cr
struc turally</w>
rub ber</w>
arsen ic</w>
effec ted</w>
infar ct</w>
loc ate</w>
t x</w>
pr ism</w>
eng aging</w>
pac k</w>
mar king</w>
14 2</w>
relap sed</w>
reve aling</w>
tom a</w>
ambul atory</w>
shorten ing</w>
it abine</w>
petro leum</w>
14 3</w>
cod ons</w>
down loaded</w>
veg f-
bio availability</w>
y ong</w>
j -
phosphor us</w>
entre z-
16 5</w>
hor n</w>
invent ories</w>
tes ticular</w>
rele asing</w>
anim ation</w>
un if
ser um-
h s-
entrop y</w>
ran k
r al
osmo tic</w>
custom ized</w>
per taining</w>
num bered</w>
7 6
ob lastic</w>
phys ics</w>
sm al</w>
aliqu ots</w>
consul t</w>
qu en
stri atum</w>
ra inf
po ultr
d ot
with draw</w>
st ably</w>
ed a</w>
on itis</w>
bat tle</w>
l- 1</w>
efflu x</w>
sr s</w>
hu ang
s at</w>
retur ning</w>
er ec
hypothe tical</w>
e- induced</w>
hist ologically</w>
mig rate</w>
nit rite</w>
neuro path
aug mented</w>
i us</w>
pl ain
g un
est e
lo ts</w>
1, 2</w>
author ise</w>
l ingu
squ ares</w>
≈ </w>
9. 6</w>
gl ory</w>
dan ish</w>
quadr ant</w>
e k
e- to-
toxic ities</w>
semin ar</w>
pre- treatment</w>
wh el
la sted</w>
- resistant</w>
cr ack</w>
li b
me tri
co at</w>
germin ation</w>
dis advantages</w>
hop ed</w>
sk y
rap amycin</w>
u v-
unpreced ented</w>
ad c</w>
pay ables</w>
ch amp
sugg estion</w>
phil ic</w>
ppar γ</w>
k hz</w>
① </w>
so x
f p
y ue</w>
amin o-
secre tions</w>
sha king</w>
propen sity</w>
method ologies</w>
i i-
3 20</w>
bac ks</w>
shap es</w>
v esting</w>
ator ial</w>
visu alize</w>
state- owned</w>
tri mester</w>
cont acted</w>
vascul ature</w>
mo id</w>
is tically</w>
car ies</w>
su ited</w>
to ol
cal f</w>
observ ing</w>
min or
b 6</w>
rail way</w>
mid line</w>
co ar
pol arity</w>
adhe sions</w>
mo xi
we an
prer equi
surro unded</w>
2- fold</w>
b bb</w>
defin es</w>
l avage</w>
rac ism</w>
9. 4</w>
la z
persi st</w>
is one</w>
swit ched</w>
. there</w>
refin ement</w>
contain er</w>
tr a</w>
i q</w>
susp ici
cer vi
in er
m dr
caus ative</w>
thrombocytop enia</w>
end ocytosis</w>
distribu tor</w>
dilu tions</w>
dang er</w>
es co</w>
ty r
inc ur</w>
per it
1 g</w>
rin t</w>
pac king</w>
in in</w>
pe dic
cl av
cl ou
us d</w>
si fication</w>
progen y</w>
capit alization</w>
cle ared</w>
wis dom</w>
n mol</w>
poultr y</w>
8 ,000</w>
n l</w>
τ </w>
mon keys</w>
al ert</w>
empha sizes</w>
c ml</w>
livest ock</w>
- associated</w>
scav eng
er p</w>
pre dec
color ado</w>
it an</w>
cl ades</w>
shel f</w>
p ing
7 4
anc ing</w>
le i
on a
intu itive</w>
an ian</w>
2 1st</w>
a stric</w>
15 0
le uc
d ressing</w>
r ile</w>
o o</w>
carbon ate</w>
subscri ber</w>
onco genic</w>
ing estion</w>
fluor o
mon omer</w>
he at-
stat ins</w>
7 3
boot strap</w>
reg urg
he ading</w>
camer as</w>
febr ile</w>
advis ers</w>
contin ent</w>
is lets</w>
id er</w>
oc clud
sco t
fail ures</w>
19 -
what ever</w>
co stly</w>
endometri osis</w>
financ ed</w>
con idi
harb or</w>
cataly st</w>
veter ans</w>
dev oted</w>
n ar</w>
for th
jer sey</w>
stra ight
inver sely</w>
pro sper
dr a</w>
immunob l
pfi zer</w>
post ure</w>
vol u
ox ylin</w>
co ws</w>
chec ks</w>
d bp</w>
vit amin
ec ta
cambo dia</w>
hand ed</w>
ou tw
ta e</w>
az er
13 9</w>
surro gate</w>
hyper lipidemia</w>
m ous</w>
imped ance</w>
se at</w>
doc toral</w>
ha -
cd k
tra il</w>
as cer
xi ang
prospec tively</w>
gr and
h ad
visu ally</w>
mediterrane an</w>
substi tute</w>
bro ke</w>
h 5
ar tis</w>
wilcox on</w>
altit ude</w>
trans forming</w>
mar s</w>
dy n
b np</w>
ang ola</w>
value- added</w>
metr ically</w>
e -</w>
f its</w>
r d
mis diagnosed</w>
clar ified</w>
imp ose</w>
amp k</w>
ham il
k ai</w>
bott len
sp anning</w>
u .</w>
in t</w>
cloth es</w>
bor ders</w>
il in</w>
crosso ver</w>
disrup t</w>
tur ns</w>
o des</w>
cauc asian</w>
con su
retro grade</w>
4 88</w>
n pt</w>
fast est</w>
l f</w>
inev itable</w>
bran ching</w>
2 30</w>
constr aint</w>
bronch i
hab it</w>
cancell ation</w>
seg mental</w>
haz ard
micro arrays</w>
clinic opath
predn isol
my ster
b ach</w>
can ine</w>
omy el
g un</w>
a esthe
ation ally</w>
am -1</w>
ty mp
ma h</w>
predn isone</w>
spati ally</w>
avi ation</w>
t d-
carb op
five- year</w>
stan ford</w>
ty sis</w>
f n</w>
reser v
restric t</w>
t ang
pl ug
osk eletal</w>
plasmodi um</w>
sp ic
holid ay</w>
att ach</w>
t ol</w>
sec t</w>
p ka</w>
cam bridge</w>
16 2</w>
robo ts</w>
sequ el
d pi</w>
br un
aver aging</w>
lo dged</w>
un paid</w>
sub cut
il lo
engine er</w>
v ar</w>
step wise</w>
tun nel</w>
ti tr
qu it</w>
stro ma</w>
gi tis</w>
frame works</w>
allo y</w>
sil k</w>
motiv ated</w>
sensi tization</w>
bul g
o ocyte</w>
ε </w>
19 2</w>
5 g</w>
e igen
pris on</w>
pa h</w>
as cri
h at</w>
s now</w>
cd 25</w>
un -
i odi
hr qol</w>
a5 49</w>
extr apol
bus y</w>
encephal itis</w>
inv ite</w>
xia ol
200 ,000</w>
ri m</w>
heter odi
nex us</w>
pen g</w>
milli pore</w>
trans duced</w>
spec ulation</w>
ex ual</w>
t uni
per ine
fi el
at las</w>
medul lary</w>
l ag
r bc</w>
c- ms</w>
rec al
moxi bustion</w>
electro physiological</w>
wat ching</w>
hazard ous</w>
1 10
distinc tive</w>
detox ification</w>
biot in
congru ent</w>
0 3
ne oplasia</w>
spec t</w>
y- related</w>
tic kets</w>
er it
orthop edic</w>
figure 11</w>
or f</w>
rol ling</w>
ubiquit ination</w>
cardiomy ocytes</w>
camer oon</w>
sti gma</w>
o st
wo od
al arm</w>
dar fur</w>
extrem ities</w>
g g</w>
ro unded</w>
kill er</w>
all ergen
no ur
cl ause</w>
religi on</w>
4 k</w>
pro stag
m- csf</w>
pos ing</w>
constitu ents</w>
r m</w>
curcum in</w>
s ap</w>
homolog s</w>
soldi ers</w>
merg ers</w>
\ </w>
yn ap
u av</w>
m ci</w>
disast ers</w>
aqu atic</w>
contrac ting</w>
ultras onic</w>
evol ve</w>
nan ot
tic k</w>
nov artis</w>
a is</w>
6 th</w>
eag le</w>
sc rat
ster ic</w>
divi de</w>
le ague</w>
squ ared</w>
sul fur</w>
reper to
€ </w>
figure 2</w>
prostag land
confidenti ality</w>
commodi ties</w>
surve yed</w>
stre am
conjug ate</w>
enc ryp
propos es</w>
rh o</w>
ap nea</w>
t n</w>
id ae</w>
25 6</w>
angel es</w>
minor ities</w>
mi as</w>
hy dra
der eg
organiz ing</w>
civ il
micro bi
ac tu
pre jud
ev il</w>
14 7</w>
consul tative</w>
mil e</w>
legen d</w>
dic hot
b v</w>
ei ve</w>
prednisol one</w>
om itted</w>
graf ts</w>
gradi ents</w>
solv ency</w>
3 2,
bu </w>
. 001</w>
ma il
ph .
lo ose</w>
sym metric</w>
muscul oskeletal</w>
back ward</w>
el bow</w>
weigh ing</w>
b cg</w>
subcut aneously</w>
sho es</w>
to sis</w>
ti tration</w>
ri p
d an</w>
pal ate</w>
appe als</w>
s sc</w>
tab </w>
solu bility</w>
interfer ing</w>
bu tt
k v</w>
mes o
discre panc
ec k</w>
azer bai
sq .
frag mented</w>
se aled</w>
illum ination</w>
0.0 8</w>
au x</w>
parli am
bol us</w>
author ize</w>
intr ons</w>
por ts</w>
schol ars</w>
hyper thyroidism</w>
l enders</w>
dest ination</w>
4, 5</w>
im t</w>
v on</w>
bor der
amplit udes</w>
inf er</w>
de hydration</w>
ta h</w>
fem ur</w>
multi disciplinary</w>
sw ine</w>
enchy ma</w>
chloro form</w>
ge ar</w>
le verage</w>
supre me</w>
mam mograph
sli ps</w>
par king</w>
el ite</w>
prote omics</w>
b 3</w>
san itation</w>
v l</w>
i bs</w>
n j</w>
discrepanc ies</w>
sex es</w>
9. 0</w>
dysp hag
tradi tion</w>
dap i</w>
conver ting</w>
ed .
s ab
ome ters</w>
seneg al</w>
co variance</w>
la i</w>
w bc</w>
syring e</w>
uc li
iph one
&apos; d</w>
hemop tysis</w>
neighbor hood</w>
happ ens</w>
ec han
phag ocytosis</w>
co chr
over whel
j r</w>
bil ls</w>
sequel ae</w>
ce a</w>
fluores cein</w>
tamoxif en</w>
24- hour</w>
re act</w>
10 th</w>
ti eth</w>
g c
cervi x</w>
case- control</w>
so ils</w>
sum med</w>
metall ic</w>
k on
ex ud
resul tant</w>
0 5
conform ations</w>
pul p</w>
veget able</w>
scre ens</w>
imp lied</w>
ce ase</w>
neurolog ic</w>
co ul
q in</w>
pub med</w>
neut ro
9. 7</w>
absol utely</w>
thy m
promo tional</w>
resi li
re mind</w>
lo op
den oted</w>
bu ck
pro mul
chim eric</w>
po res</w>
blo od
ch s</w>
caregi ver</w>
dupl ex</w>
os om
15 4</w>
ca th
d ge
confidenti al</w>
mini -
dop aminergic</w>
our g</w>
log y</w>
dri ft</w>
silic o</w>
si d</w>
gang lion</w>
1, 2,
cor al</w>
imp lying</w>
iz hou</w>
19 78</w>
ol ab
id osis</w>
inter leuk
al ist</w>
s acc
k ow
30 ,000</w>
in tran
spo res</w>
poss esses</w>
inter ven
immunore activity</w>
log arith
cl op
u gu
attribu te</w>
ligh ting</w>
genotyp ed</w>
arc tic</w>
ir is</w>
transcrip tom
seas ons</w>
se a
t ar</w>
dig it</w>
paul o</w>
vic e-
do ts</w>
lab s</w>
otox icity</w>
f m
g is</w>
det achment</w>
benefici aries</w>
t p
ol i</w>
x box</w>
str ange</w>
14 8</w>
con vic
autom ob
comp iled</w>
dysphag ia</w>
br du</w>
sag it
character ised</w>
thro mycin</w>
- i</w>
13 c</w>
bel arus</w>
ali ana</w>
om od
d sm-
sp a</w>
gen der
os ens
lac tobac
methion ine</w>
c- myc</w>
li by
hun an</w>
homogene ity</w>
full- time</w>
hot els</w>
earthqu ake</w>
rec re
comp ares</w>
dis ulf
perturb ation</w>
mil ler</w>
germ line</w>
aut o-
p w
ol in</w>
analyz ed.</w>
intern alization</w>
health -
per oxidation</w>
ur ban
am orph
chemo therapeutic</w>
in version</w>
im mobilized</w>
star vation</w>
as phy
transi ently</w>
el lip
opo si
o int
mon key</w>
sle ep
stret ch</w>
cardi o
t at</w>
concor dance</w>
nod al</w>
m ts</w>
glucocortico id</w>
meth ane</w>
kin a</w>
sour cing</w>
xi e</w>
id omide</w>
enor mous</w>
t us
here di
dele te</w>
path s</w>
se ize</w>
oh chr</w>
oz ygo
omat ous</w>
thou ghts</w>
dou bled</w>
capit alized</w>
te t</w>
fi able</w>
vic tim</w>
ser o
den otes</w>
phot ography</w>
19 79</w>
li doc
sw ap</w>
amplif y</w>
2- 3</w>
extra -
irrig ation</w>
cholec yst
lipos omes</w>
up coming</w>
rec essive</w>
eukary otes</w>
denom inated</w>
it z</w>
par ad
scar ce</w>
know s</w>
resum ed</w>
5- fu</w>
pro pan
lin ux</w>
decomp ression</w>
qu an</w>
c us
electro static</w>
monopol y</w>
facil itation</w>
pos session</w>
nct0 2
oc king</w>
conclud ing</w>
m ere</w>
dro p
t ut
duc ts</w>
ti dal</w>
assi sting</w>
di lig
crystall ine</w>
war far
menop ause</w>
config ur
high er-
neutro pen
gang lia</w>
ex cel</w>
prote olytic</w>
cancel led</w>
whe el</w>
gastro enter
demograph ics</w>
ch ris
5- fold</w>
ad junc
ti ll</w>
pu rely</w>
post ulated</w>
tum or
me dy</w>
pl ug</w>
cp b</w>
ep h</w>
reserv ations</w>
em g</w>
2 p</w>
catheter ization</w>
mb h</w>
pi vac
annex in</w>
annu ity</w>
og aster</w>
regim es</w>
alk al
slo v
lat e-
an t-
def ec
applic ability</w>
con fron
ve f</w>
out- of-
ct a</w>
slo ven
issu ing</w>
ri ba
dri ves</w>
erythem a</w>
tal ked</w>
drin ks</w>
warran ty</w>
3 3,
p ge
ris k-
l 3</w>
kapp a</w>
. 6</w>
effec tors</w>
straight forward</w>
acc used</w>
al ign</w>
trac es</w>
temp lates</w>
autonom y</w>
kazak h
k cl</w>
in- induced</w>
sub scale</w>
phosph ate-
mes enteric</w>
ste at
qual ifications</w>
ten ing</w>
t x
regurg itation</w>
ad p</w>
pow ered</w>
t ag
sub committee</w>
mel at
viet nam</w>
naf ld</w>
plat inum</w>
anten na</w>
cu ts</w>
be st-
capit a</w>
aff er
ur s</w>
ma iled</w>
odon tic</w>
4 .</w>
d f
r s.</w>
hom olog</w>
issu ers</w>
sion- free</w>
ig f-1</w>
air ways</w>
par enchyma</w>
le p
ro sis</w>
pac e
n in</w>
bio genesis</w>
presum ed</w>
g ot
ar ous
40 00</w>
s. methods</w>
hypo thermia</w>
in stant</w>
saf ely</w>
de af
gal y</w>
10- k</w>
da o</w>
fil ings</w>
gri p</w>
ribos ome</w>
gau ge</w>
bur y</w>
distinguish able</w>
c ies</w>
displ aying</w>
k im
suic idal</w>
e o
mess rs.</w>
fibr on
ia ea</w>
blo ts</w>
k cal</w>
linear ity</w>
subscri bers</w>
grou p.
noc tur
staff ing</w>
30 th</w>
riba vir
al c
re lied</w>
mo i
n is
fol ate</w>
phys ic
polysacchar ide</w>
ex chang
epithel i
n mda</w>
ot rophic</w>
min d
spectro meter</w>
surpr ise</w>
lig ase</w>
bright ness</w>
n m
advoc acy</w>
x ian</w>
char m</w>
rh initis</w>
eb it
c trip</w>
heredi tary</w>
p 5
es c
sou p</w>
ac le</w>
comor bidity</w>
nan o-
dissemin ated</w>
she ath</w>
poly cystic</w>
16 3</w>
ra y
check point</w>
r aft</w>
b ending</w>
ky oto</w>
micro bes</w>
k new</w>
ho ods</w>
ser ological</w>
ec tom
t ate</w>
pa m</w>
cir cles</w>
2 70</w>
mil est
op last</w>
ser bia</w>
me te
14 9</w>
phylogen y</w>
lac tation</w>
el e</w>
6 d</w>
pro tr
15 1</w>
od end
o vi
me ets</w>
tal ks</w>
sh ire</w>
prosec ution</w>
super family</w>
asth matic</w>
od or</w>
tor onto</w>
re bound</w>
lidoc aine</w>
ell ites</w>
prost atitis</w>
molec ul
circul atory</w>
interpre tations</w>
t sh</w>
middle- aged</w>
in organic</w>
advant ageous</w>
negoti ation</w>
fentan yl</w>
im a</w>
pe ers</w>
phen olic</w>
colo red</w>
anti genic</w>
prof .</w>
v o</w>
aim ing</w>
ester ase</w>
trans late</w>
microsat ellite</w>
dipl omatic</w>
j s</w>
co oled</w>
antioxid ants</w>
vit re
jack son</w>
b ph</w>
fa ke</w>
hear t
3 52</w>
cn v</w>
y our
phar ma</w>
m h</w>
18 2</w>
ul ing</w>
parti tion</w>
cal ori
fer rit
il le</w>
dis ordered</w>
post prandial</w>
gast ritis</w>
k p
out flow</w>
menti oning</w>
re integration</w>
up grading</w>
occa sional</w>
express ly</w>
pin k</w>
suspici on</w>
effici encies</w>
azerbai jan</w>
q d</w>
child birth</w>
accep tor</w>
he dge</w>
carbop latin</w>
n if
sv m</w>
ol ateral</w>
se em
muc us</w>
neoplas ms</w>
le w
mous ly</w>
prolifer ating</w>
k i-
supervis ory</w>
cu ff</w>
hodg kin</w>
nev ada</w>
ta u
vancom ycin</w>
x 4</w>
off shore</w>
hu b</w>
vide os</w>
β- actin</w>
dv t</w>
factor ial</w>
s- based</w>
zam bia</w>
cy clos
warfar in</w>
short est</w>
re arrangements</w>
reti red</w>
res cued</w>
fresh ly</w>
melan ogaster</w>
plan es</w>
as certain</w>
p cd
idi an</w>
occup ying</w>
o ke</w>
ribavir in</w>
ynap tic</w>
territ orial</w>
coo king</w>
non- small</w>
th aliana</w>
h it
gingi val</w>
x p</w>
15 8</w>
c sa</w>
ca i</w>
tub al</w>
9. 8</w>
m ou
prescri bing</w>
ebit da</w>
9 5
de grading</w>
n ice</w>
v .
0 6
or ate</w>
oplas mic</w>
se ments</w>
un detectable</w>
ric h
migr atory</w>
prior i</w>
in dispensable</w>
k ol
erythro cytes</w>
acet one</w>
pbm c</w>
onit rile</w>
pivac aine</w>
len ses</w>
s ad</w>
i 2</w>
atmos pheric</w>
disco ver</w>
adequ acy</w>
compens ated</w>
voc al</w>
be es</w>
un acceptable</w>
no .
web- based</w>
ver sa</w>
apo e</w>
melat onin</w>
s gm</w>
municip alities</w>
metri x</w>
protein ase</w>
sen ding</w>
neighbour ing</w>
o 4</w>
8 b</w>
appro ving</w>
t ape</w>
accom mod
hem angi
ch ase</w>
2 2-
immun e-
electr ons</w>
be st
in do
tra stu
ρ </w>
ga o</w>
sal via</w>
lymph aden
l vef</w>
jam a
qu ine</w>
con currently</w>
hemat ological</w>
en ters</w>
kazakh stan</w>
iz a</w>
20 6</w>
sh unt</w>
mann- whitney</w>
he dral</w>
t regs</w>
stri ve</w>
s und
25 0
y r</w>
n es</w>
deb ts</w>
ograph ically</w>
ta x-
f gf</w>
antidepress ant</w>
shorten ed</w>
access ed</w>
hydrox yl</w>
sent ences</w>
homogen ized</w>
und -
elec toral</w>
un conditional</w>
pho en
tril lion</w>
ome p
pre paid</w>
ma st
ch ip-
l m</w>
dys functional</w>
si s
198 0s</w>
sequ entially</w>
rheum atic</w>
gather ing</w>
v d</w>
2 25</w>
infring ement</w>
ar row</w>
excell ency</w>
ke to
j v</w>
20 5</w>
dist ension</w>
dysp ep
bi on
9 4
cali brated</w>
p ter
fe t
produc er</w>
interrup ted</w>
1, 4
hbe ag</w>
s ical</w>
it ching</w>
res ected</w>
oid es</w>
controver sy</w>
fo am</w>
le ak</w>
no vel
scen es</w>
nr f2</w>
aff y
wh ich
transcript ase</w>
3 1
afford able</w>
sp 1</w>
out let</w>
mus eum</w>
man -
cur ved</w>
don ation</w>
r pmi</w>
insul a</w>
16 6</w>
inc i
enti ons</w>
alb umin
ch erry</w>
- fi</w>
energ ies</w>
is omer
le ft-
dis advantage</w>
he pg
carbo xyl
her ni
dys lipidemia</w>
studi o</w>
anticoagul ant</w>
d ex</w>
immunobl otting</w>
ec d</w>
appro ached</w>
u z
fulf il</w>
ro ads</w>
premis e</w>
inser tions</w>
an us</w>
pre treated</w>
amoun ting</w>
em ent
a aa</w>
en os</w>
form alin</w>
bulg aria</w>
auc tion</w>
stimul atory</w>
appreci ated</w>
ar rows</w>
pat ri
hel ices</w>
under ing</w>
ch ung</w>
k e-
3 e</w>
vic inity</w>
ur on
acknowle dges</w>
surg ically</w>
n sa
met agen
scal p</w>
ox in</w>
ox ford</w>
bre vi
every day</w>
ob ama</w>
ra in
fol ds</w>
ac ies</w>
susp icious</w>
shif ting</w>
form ul
dy sm
suppres sing</w>
sli ding</w>
trans form
repeti tion</w>
short age</w>
mp ed</w>
b si
par ity</w>
neuro muscular</w>
5 .</w>
5 50</w>
trans national</w>
hsp 70</w>
consol idate</w>
phen y
ator vastatin</w>
20 th</w>
r pe</w>
et -
enrol ment</w>
pot ato</w>
t ing
fas o</w>
gr as
16 9</w>
stud y.</w>
philosoph y</w>
assem bl
harv ard</w>
inev itably</w>
favor ite</w>
curr encies</w>
synchron ous</w>
hu vec
viol ent</w>
work load</w>
mg 2</w>
yun nan</w>
i or
15 9</w>
ar iz
29 3t</w>
ch ester</w>
precip itated</w>
add .1</w>
spi kes</w>
enc um
in spi
cd 44</w>
be ver
m cs</w>
bur kina</w>
bu d</w>
el is
correspond ence</w>
fisher ies</w>
g mbh</w>
o .
3 4,
pre- existing</w>
oint ment</w>
spok es
f ant
mon ocyte</w>
alex a</w>
differenti ating</w>
nor we
community- based</w>
non- probability</w>
intermedi ates</w>
fa o</w>
pro kary
metro pol
ortholog s</w>
sagit tal</w>
pal sy</w>
long ev
ca g</w>
non -</w>
ish es</w>
w ages</w>
fast -
myel o
ric k</w>
prescri ptions</w>
r f
fol i
pr p</w>
bat ter
- 3
cl arity</w>
credi bility</w>
telomer ase</w>
an ion</w>
pa edi
cholin ergic</w>
sp in-
se men</w>
ment -
con ferred</w>
0 2
5 p</w>
oxy toc
idi um</w>
ad jour
ugg le</w>
ran ks</w>
ul n</w>
f an
ere bral</w>
id og
short ness</w>
inquir y</w>
eu than
bi ologic</w>
cxcr 4</w>
omep razole</w>
pe -
o sity</w>
hypothalam us</w>
oper ation.</w>
in solvency</w>
ammon ia</w>
amy lo
stop ping</w>
phosphor yl
prospec t</w>
on ine</w>
er ment</w>
a thy</w>
high- definition</w>
gaz a</w>
vig orously</w>
i el</w>
0.00 3</w>
fu zz
k ur
instrum ental</w>
fit c</w>
ji a
ep is
psych osis</w>
2 1.
ventil ator</w>
on at
pp v</w>
arrhyth mias</w>
p om
expi red</w>
epider mis</w>
which ever</w>
per mis
access ory</w>
physi ologic</w>
nad ph</w>
spon dy
high- tech</w>
br us
ubiquit ous</w>
bir th
cock tail</w>
j en
s au</w>
perform ances</w>
flag ell
exc itability</w>
he pes</w>
worri ed</w>
re- election</w>
p da</w>
poin ting</w>
bul le
no is
a β
t at
ec to
contrac ted</w>
h h
j ack</w>
vitamin s</w>
corne a</w>
ad am
nor m</w>
el ing</w>
willi ams</w>
radi ographs</w>
nucle ar-
clop idog
spec ulated</w>
b arg
discus sing</w>
diaphr agm</w>
fu jian</w>
e as
energ y-
0.0 7</w>
loc al
de struc
direc tor
st ories</w>
pro hibition</w>
xin jiang</w>
pa o2</w>
lob es</w>
reason ing</w>
ur ugu
tric or</w>
retail ers</w>
depri ved</w>
restric tive</w>
6 4-
sept um</w>
suc tion</w>
en am
d k
non- coding</w>
spir it
stal k</w>
com ings</w>
k pa</w>
periodic ally</w>
repres sed</w>
ar bon
orth og
cry op
configur ations</w>
di ary</w>
protec ts</w>
bro kers</w>
for get</w>
ar men
on ment</w>
tuni sia</w>
tl r</w>
indemn ification</w>
20 2</w>
stag nation</w>
ic ul
brad y
ap -
pyram idal</w>
in equ
comm ented</w>
fung us</w>
ati s</w>
fibr e</w>
ph en</w>
im umab</w>
ham mer</w>
an c</w>
mc g</w>
v p
vesti bular</w>
green house</w>
oph ore</w>
z ip
encap sul
conform ity</w>
caud al</w>
mean ings</w>
eos in</w>
assemb lies</w>
sh eng
re actor</w>
lo os
sc aled</w>
up ward</w>
up graded</w>
period on
chemil uminescence</w>
ch ow</w>
la undering</w>
combin es</w>
ag ger
bo di
md d</w>
pol y-
anti fungal</w>
t l</w>
ad o
longev ity</w>
cultiv ars</w>
ser otype</w>
negoti ated</w>
ud ine</w>
uniform ly</w>
p as</w>
al do
om ial</w>
anti coagulation</w>
sloven ia</w>
rele ases</w>
dynam ically</w>
trem or</w>
for fe
sp ra
f in</w>
lu c</w>
norwe gian</w>
drople ts</w>
pollut ants</w>
os acchar
vir us-
str uggle</w>
obstac le</w>
grou ping</w>
multip lied</w>
benef ited</w>
keratin ocytes</w>
b ag
stan ley</w>
explo ited</w>
susp en
fa ec
cor onal</w>
hypo thyroidism</w>
xiaol ong</w>
inval id</w>
wil son</w>
ulcer ative</w>
myco bacterium</w>
19 33</w>
ophil ia</w>
time- dependent</w>
empow erment</w>
prog ressed</w>
bab ies</w>
b p1</w>
bon ucle
om is
si oned</w>
hop ing</w>
g ate
self- efficacy</w>
ch u</w>
hyper activity</w>
ec hol
en vis
transmit ting</w>
attenti onal</w>
n ude</w>
op ian</w>
g fr</w>
trac er</w>
mo d</w>
tonn es</w>
retic ulum</w>
spac ing</w>
10. 0</w>
fri ed</w>
g l</w>
aband oned</w>
g pu</w>
meta- analyses</w>
consu me</w>
lac ked</w>
hem e</w>
tic us</w>
mal i</w>
eigh ty</w>
short comings</w>
gra ins</w>
li m</w>
lys osomal</w>
medium- sized</w>
affy metrix</w>
busin ess
anti- cd
dram a</w>
sl c
24 h</w>
17 2</w>
pol yeth
lac </w>
ul i
individu alized</w>
al ber
70 s</w>
e h
wis con
end ocardi
neuro genesis</w>
ar ding</w>
clopidog rel</w>
sc ap
ma o</w>
2 3-
coun selling</w>
ascri bed</w>
over load</w>
immun omod
sa ved</w>
comm ence</w>
x y</w>
t cl</w>
sub programme</w>
un paired</w>
u b</w>
isot ope</w>
7 c</w>
scienti st</w>
c raz
al ban
suspec t</w>
interleuk in</w>
border line</w>
200 6-
por ous</w>
2 ,0
mm 2</w>
p- 2</w>
premi ums</w>
ser ous</w>
fr ic
distur bed</w>
gr ab</w>
an atomic</w>
disulf ide</w>
plan et</w>
ob sc
fl u</w>
ur gency</w>
od a</w>
har boring</w>
br ach
w ed</w>
link ages</w>
w to</w>
be ings</w>
inspi red</w>
even ly</w>
mal formation</w>
s lot</w>
on .</w>
ful fill</w>
iz able</w>
her it
a -1</w>
di methyl
moi ety</w>
neuro imaging</w>
erit rea</w>
ex agger
adren ergic</w>
l av
and ro
gr en
os an</w>
adoles cence</w>
toler ant</w>
weak ened</w>
anten atal</w>
den s</w>
oc ul
epilep tic</w>
ad el
c max</w>
gonad otrop
18 5</w>
ira qi</w>
de fer
ten ess</w>
c ds</w>
sub traction</w>
hyp onat
k or
ferrit in</w>
computer share</w>
g mp</w>
p it</w>
dia meters</w>
simpl ex</w>
coch lear</w>
anti body
can on</w>
deman ding</w>
8 th</w>
di aly
n t-
zim bab
stres s-
edi ted</w>
in clin
pro line</w>
kle bsi
ic d</w>
no tify</w>
appoin ting</w>
mg cl2</w>
prerequi site</w>
h on</w>
discrimin atory</w>
ven a</w>
en sures</w>
40 ,000</w>
kan sas</w>
ti e</w>
ny se</w>
termin ology</w>
q t</w>
ot ec
anti- tumor</w>
progres sion-free</w>
al p</w>
block er</w>
ex changed</w>
sub- saharan</w>
visi ting</w>
di mers</w>
co- founder</w>
ma ster
nation ality</w>
ic d-
constric tion</w>
bi ol
dis ed</w>
wat ches</w>
table 22</w>
trastu zumab</w>
esophag itis</w>
m mp</w>
fail ing</w>
ed onia</w>
ay ers</w>
c rest</w>
g ar</w>
urugu ay</w>
el ed</w>
uv ei
neutr alization</w>
trig em
drug- resistant</w>
sp in
w er
ros copy</w>
un favorable</w>
op us</w>
sal inity</w>
prejud ice</w>
dis appear</w>
gl p-1</w>
se es</w>
index ed</w>
16 40</w>
plex us</w>
te ars</w>
synchron ized</w>
volt age-
klebsi ella</w>
groo ve</w>
ll er</w>
infec tive</w>
s 100
da i</w>
qi ao</w>
al ong
mo x
lan -
ar y
cat ering</w>
contin ental</w>
volunte er</w>
di al
convinc ed</w>
sh ir
perf ec
hemat ologic</w>
inf ect</w>
preced ent</w>
j o</w>
19 75</w>
lith u
it inib</w>
fluctu ation</w>
con n</w>
- time</w>
mt x</w>
0 4
iq r</w>
phoen ix</w>
le is
yugos la
accr ual</w>
reperto ire</w>
odend ro
£ </w>
stret ching</w>
te tan
we i
ple dge</w>
hor ses</w>
hu bei</w>
lem ma</w>
rev ascularization</w>
e me
hist ologic</w>
2 3.
d ae</w>
abst in
syn ergy</w>
renew able</w>
as cor
den si
ful l
non- proliferation</w>
w ich</w>
cb t</w>
. 05</w>
wh ee
li eu</w>
promis sory</w>
ro ad
ti ed</w>
2 12</w>
notic es</w>
impro per</w>
his panic</w>
for ce
tak e-
pelv is</w>
iti vely</w>
ste ering</w>
hum oral</w>
fin ds</w>
explo sive</w>
af p</w>
ogr afts</w>
company which</w>
deaf ness</w>
selen ium</w>
hand led</w>
edi t</w>
ol ecular</w>
distor tion</w>
pri ze</w>
rel uc
appoin tments</w>
olig odendro
t in-
40 ,
be ars</w>
ol ate</w>
veg fr
cau ght</w>
fe at
op pon
seem ingly</w>
ensem ble</w>
educ ated</w>
your self</w>
sub populations</w>
sq. m.</w>
myco plasma</w>
concentr ation-
es n</w>
tw o
d v</w>
20 3</w>
flavon oids</w>
3 5,
di gn
arous al</w>
re arrangement</w>
ak ia</w>
ar ate</w>
pro t
pac ked</w>
2 2.
break fast</w>
b low
th ri
rainf all</w>
by laws</w>
fa ult</w>
here after</w>
yugosla via</w>
utili ties</w>
ab brevi
oc cul
ar t
lig ated</w>
hom ocy
co incidence</w>
polyp eptide</w>
sha ke</w>
set tle</w>
pl aza</w>
ograp hy
back grounds</w>
hun ger</w>
fre t</w>
bulle tin</w>
alleg ations</w>
bl ings</w>
g pr
wai ved</w>
h ann
visi tors</w>
scaveng ing</w>
il -1</w>
chec king</w>
los ing</w>
bio active</w>
lapar otomy</w>
con founders</w>
erec tile</w>
de als</w>
y am
cholecyst ectomy</w>
usi tis</w>
edi torial</w>
after wards</w>
memor ies</w>
week end</w>
aden ovirus</w>
ul ent</w>
repres sor</w>
e h</w>
16 1</w>
suppres ses</w>
enjo yment</w>
phot ographs</w>
b es
biotin ylated</w>
g cs</w>
ph. d.</w>
t- tests</w>
asphy xia</w>
purchas ers</w>
univer se</w>
q c</w>
pres sing</w>
res sions</w>
q atar</w>
rel in</w>
den ote</w>
fibron ectin</w>
manif est</w>
0. 45</w>
18 f-
h mg
r ative</w>
rul ing</w>
sk a</w>
- c</w>
un explained</w>
sir t1</w>
dn ase</w>
prosecut or</w>
od ic</w>
frag ile</w>
ht ml</w>
imper ative</w>
in soluble</w>
remedi ation</w>
mod ular</w>
asi ans</w>
1 0.5</w>
othor ax</w>
inter play</w>
ch ir
mediast inal</w>
glyco gen</w>
ac i
ophosph or
k t</w>
dysm enorrhea</w>
hemat oxylin</w>
ur ium</w>
sub scales</w>
si i</w>
mac a
β 2</w>
ta z
jama ica</w>
te st-
mis leading</w>
sti s</w>
h 4</w>
weigh ting</w>
oplas tic</w>
sa i</w>
ar ag
toler ate</w>
5- ht
eth an
assu red</w>
craz y</w>
dichot om
sph ing
form ulate</w>
iter ative</w>
multivari able</w>
foot ball</w>
m uni
lamin a</w>
il o</w>
anti- rabbit</w>
o stomy</w>
citi zen</w>
main streaming</w>
b vi</w>
forth coming</w>
od d</w>
-2 31</w>
ct l</w>
co res</w>
qui et</w>
che ung</w>
electro por
t- 1</w>
pi per
oph obia</w>
form ats</w>
po oling</w>
oth i
check list</w>
classi fications</w>
hepg 2</w>
coll ar</w>
mar t</w>
ce ased</w>
atis m</w>
fab r
t 3
h man</w>
lit ter</w>
t ent
contra sts</w>
le ver
10- fold</w>
re mn
rogen s</w>
pit ch</w>
00 00
influ ential</w>
contrac tors</w>
osens ory</w>
inter personal</w>
ul ous</w>
et a</w>
caffe ine</w>
9. 9</w>
cosme tic</w>
pestic ides</w>
entreprene ur</w>
eyel id</w>
co he
minim izing</w>
gli oblastoma</w>
trac ts</w>
succ eed</w>
cab g</w>
lo ad
op position</w>
well- established</w>
jus tified</w>
viol ated</w>
p oc
dec entr
u ous</w>
put ting</w>
ic illin
mas titis</w>
imp rin
un differentiated</w>
sup posed</w>
q 1</w>
suspen sions</w>
end ovascular</w>
acc lim
two- tailed</w>
dyspep sia</w>
stri atal</w>
tris- hcl</w>
bas ement</w>
air lines</w>
end otoxin</w>
do esn</w>
head set</w>
benz ene</w>
neuropath ic</w>
ater ally</w>
h ung</w>
cochr ane</w>
aeros ol</w>
sharp ly</w>
mei otic</w>
juris dic
gel atin</w>
ram an</w>
. 7</w>
lin early</w>
bac illi</w>
fuzz y</w>
tot aled</w>
recep tor
anesthe si
orig inate</w>
excell ence</w>
ancest or</w>
maur iti
16 7</w>
ar in</w>
r dna</w>
pathogen icity</w>
omy ces</w>
thy mus</w>
ad dic
tu tion</w>
modul ates</w>
gu ard</w>
nip ple</w>
aff in
qu ot</w>
di lated</w>
po d
ph i</w>
cyclos por
rif amp
3 6,
chem oradi
r ams</w>
amp li
pk c</w>
k egg</w>
3 65</w>
resol ving</w>
stand by</w>
res orption</w>
19 77</w>
fol ic</w>
at p-
anth rac
rap </w>
kap lan-
rect um</w>
an z
perox is
bit ter</w>
gin seng</w>
law ful</w>
coh en</w>
pd f</w>
simp lic
rev oc
re produce</w>
turk ish</w>
wi res</w>
7 ,000</w>
cav e
orth o
comple teness</w>
ation- induced</w>
at ric
fun dus</w>
tryp top
tr in
im atinib</w>
k is
end urance</w>
si vity</w>
conjunc tival</w>
vox el</w>
read ings</w>
tra de-
oscler osis</w>
trigem inal</w>
um b</w>
jus tify</w>
boli via</w>
dur able</w>
qual ifying</w>
re posi
mala wi</w>
8 4
lic ence</w>
synap se</w>
wee k-
k line</w>
work force</w>
pro stat
ta vi
re stri
nas a</w>
mon omers</w>
biom echan
st ol
d extr
presid ency</w>
s au
atax ia</w>
per oxid
wiscon sin</w>
premi er</w>
electro magnetic</w>
si te
ar m
inv asi
par oxy
inter view
sign al-
1 f</w>
intrigu ing</w>
v ent
micror nas</w>
salv ador</w>
fabric ated</w>
can cel</w>
k ang
boo king</w>
rat a</w>
off ence</w>
bit coin</w>
ici tis</w>
accep tability</w>
or bit</w>
oxytoc in</w>
pge 2</w>
es el</w>
rec ist</w>
over t</w>
automob ile</w>
guaran tor</w>
dav is</w>
oper on</w>
rein forced</w>
pa -
in equality</w>
sedi mentation</w>
0.0 00</w>
pathophysi ological</w>
know ing</w>
miti gate</w>
histopath ology</w>
ti ger</w>
lux emb
6 50</w>
zimbab we</w>
throm bus</w>
in- house</w>
f b</w>
ed y</w>
chick ens</w>
0. 20</w>
0. 12</w>
prob ed</w>
miner als</w>
inter c
pe g-
con dom</w>
in osi
ov aries</w>
jos eph</w>
centr ic</w>
contrac tor</w>
per pend
stri ke</w>
path ologies</w>
glycosy lated</w>
obstetr ics</w>
bic arbon
ang ry</w>
m sm</w>
α 1</w>
om ic
10 80
resec table</w>
del ir
t k</w>
uvei tis</w>
s ally</w>
f vc</w>
a virus</w>
pris on
brach ial</w>
ax es</w>
acet onitrile</w>
computer ized</w>
orth ologous</w>
exer ts</w>
fin e-
disc s</w>
recur ring</w>
mer ic</w>
an hui</w>
16 4</w>
distingu ishing</w>
play back</w>
sor afenib</w>
s w</w>
under lie</w>
h ind
ic an</w>
freed oms</w>
nom inated</w>
h our
neutropen ia</w>
leis ure</w>
cl l</w>
i ya</w>
st yl
ure thral</w>
vig il
re taining</w>
cortico steroid</w>
mess aging</w>
hon ey
rati fy</w>
mac book</w>
su i</w>
wi shed</w>
dat a-
dis infection</w>
bis sau</w>
back -
ide ally</w>
gu an</w>
chondro cytes</w>
luxemb ourg</w>
de fe
10 a</w>
relax ed</w>
hol m</w>
d est</w>
post ural</w>
1 200</w>
19 5</w>
auto antibodies</w>
surger ies</w>
bio films</w>
12- month</w>
correc tions</w>
at ed
n go</w>
electro chemical</w>
blind ness</w>
yn chron
medi ation</w>
graph ical</w>
hierarch y</w>
ox ali
te d.</w>
thrombo tic</w>
vig orous</w>
simplic ity</w>
yog a</w>
hemip legia</w>
de er</w>
er up
per petr
pepti d
t 0</w>
kit chen</w>
op ter
sovere ign
s 8</w>
t ms</w>
acces sions</w>
sug ars</w>
oc rit</w>
sar com
do i</w>
le ton</w>
b ags</w>
suppres sive</w>
wa ste
it y.
my opia</w>
p 65</w>
construc ting</w>
re war
ser oposi
fortun e</w>
sf- 36</w>
invest s</w>
preser ving</w>
7 d</w>
ri es</w>
adv ise</w>
be ta
kr as</w>
ori ental</w>
b att
mda-mb -231</w>
kaplan- meier</w>
gul f</w>
at tained</w>
ap 1</w>
ph asic</w>
sovereign ty</w>
under stand
pac ing</w>
multi media</w>
t of</w>
ophthal mic</w>
therap ist</w>
k v
u mption</w>
custom ary</w>
hypoglyc emic</w>
restri al</w>
r cc</w>
el led</w>
ag ro
id ase</w>
di lation</w>
ad r</w>
emul sion</w>
3 7,
6- month</w>
g us</w>
ac ious</w>
exer ted</w>
neces sit
bel t</w>
interpre ting</w>
under estimated</w>
over- expression</w>
persi sted</w>
ber lin</w>
k h</w>
dys regulation</w>
pleas ant</w>
iodi de</w>
ignor e</w>
photos ynthetic</w>
neuro psychological</w>
el ution</w>
biot ech</w>
loc alize</w>
ag li
pen alties</w>
y n</w>
sol id
arg uments</w>
bif ur
ex osomes</w>
ste adily</w>
e j</w>
slov akia</w>
h ro
z hen
ec o
biot in</w>
mil ti
p sc</w>
dur ations</w>
ac a</w>
anc e-
cat ast
hamil ton</w>
econom ically</w>
empha sizing</w>
won der
ligh t
con dem
assem ble</w>
φ </w>
w f</w>
13 73</w>
perturb ations</w>
contex tual</w>
gab a
presid ential</w>
pan ama</w>
de duction</w>
hyponat remia</w>
s ular</w>
assign ments</w>
em en</w>
identifi able</w>
ma dison</w>
ch ee
mas king</w>
blast oma</w>
tr ad
preclud e</w>
b 12</w>
ww w</w>
de fl
char ts</w>
acceler ating</w>
fl ask</w>
m abs</w>
radi x</w>
high- frequency</w>
2 s</w>
g st
pois son</w>
milti orrh
rev ise</w>
fr ank</w>
ld cs</w>
car d
g le
ma ze</w>
cav a</w>
pig mentation</w>
high- density</w>
li ver
di hydro
20 8</w>
thy mic</w>
co variate</w>
cap ill
me yer</w>
pro lac
or fs</w>
w nt
clinicopath ological</w>
hemat uria</w>
ling ual</w>
norm ative</w>
ac ne</w>
p cr-
3 36</w>
down ward</w>
phan tom</w>
k ingly</w>
high- grade</w>
implic it</w>
abi otic</w>
bec k</w>
land lord</w>
herit age</w>
hemo dynamics</w>
hard ly</w>
dy ing</w>
nod ular</w>
2, 2</w>
applic ant</w>
re deemed</w>
trade marks</w>
ver b
furn ished</w>
b arium</w>
19 76</w>
e w
psychiat ry</w>
rel la</w>
ab olic</w>
sol itary</w>
sequ enc
one- time</w>
paroxy smal</w>
leban ese</w>
dyst rophy</w>
mammograph y</w>
reiter ated</w>
organ elles</w>
th aw
ance stry</w>
ici an</w>
intra epithelial</w>
autom ation</w>
otec an</w>
fore arm</w>
dou b
gv hd</w>
re generative</w>
enthusi asm</w>
ic hi
ol ol</w>
g st-
sc in
per tin
or dering</w>
allerg en</w>
gl ax
mb l</w>
noctur nal</w>
hen an</w>
trac ks</w>
- core</w>
chlor ophy
- 0.
fi ber
co tt
c t-
hypertroph ic</w>
o ios</w>
polic y
town ship</w>
nu t</w>
1, 5
sm ell</w>
u ge</w>
tiv e-
bu cc
oste oblasts</w>
ub es</w>
anxi ous</w>
4 01</w>
h v
á </w>
thin ks</w>
glycoly sis</w>
four ier</w>
emp hy
par alog
contrac tions</w>
sp r
o em</w>
fluores c
ab l</w>
he bei</w>
ty ro
pup il</w>
tw ins</w>
lithu ania</w>
bicarbon ate</w>
counter- terrorism</w>
qt ls</w>
sc r</w>
ar bo
rein force</w>
si s.
ho st-
mauriti us</w>
emphy se
wit ness
vit ality</w>
x s</w>
b 4</w>
1 δ</w>
fav ored</w>
arach no
cont our</w>
ste am</w>
tryp an
discre tionary</w>
vel i
deposi tary</w>
fal se-
al bu
gu ess</w>
ri bonucle
un a</w>
il es</w>
for aging</w>
resum e</w>
ci prof
promul gated</w>
n ish</w>
ber mud
design ation</w>
contribu tors</w>
pe a</w>
m oc
hr p</w>
nsa ids</w>
iz </w>
s ch</w>
intr ad
gen tam
20 4</w>
explo sion</w>
design er</w>
d tt</w>
post- hoc</w>
multipl ex</w>
at opic</w>
si blings</w>
ri a</w>
per idone</w>
incorpor ates</w>
opportun istic</w>
mon oxide</w>
trem end
sm an</w>
la o</w>
eosinoph ils</w>
17 6</w>
14 a</w>
ot us</w>
myel in</w>
vox els</w>
on ds</w>
so res</w>
admini stering</w>
pan -
appro aching</w>
bye- laws</w>
disp arities</w>
ou tre
figure 3</w>
emerg ent</w>
diagnos ing</w>
law suit</w>
tro ops</w>
orb id</w>
adjour ned</w>
sw ol
mmp -2</w>
c ing
carbohydr ates</w>
matern ity</w>
200 8-
2 5.
af ores
hel per</w>
enam el</w>
monit ors</w>
discipl ines</w>
imp orts</w>
strep tavi
erythem at
su re
day time</w>
cal m</w>
re produced</w>
astro cy
mc p-1</w>
batter ies</w>
p ile</w>
uggl ing</w>
si mon
ow s</w>
ingu inal</w>
lingu istic</w>
en sured</w>
announc es</w>
in habit
addi tives</w>
brain stem</w>
op ac
all- cause</w>
ti mp
lin e-
be ds</w>
re medy</w>
tub ules</w>
ch en
ic eland</w>
val v
m at</w>
exter n
0. 50</w>
sc ram
expedi ent</w>
pc na</w>
nan os
ag al
cl -
hf d</w>
mut ational</w>
s kin
fraction ated</w>
spectrophoto meter</w>
oz one</w>
bronch itis</w>
afores aid</w>
ac o</w>
k man</w>
clos ed-
ha art</w>
neuro protective</w>
c ms</w>
repor tedly</w>
0. 95</w>
imp ris
c- terminus</w>
200 4-
fox conn</w>
tic -
ser otypes</w>
mete or
ga me
β- cell</w>
dna- binding</w>
dam aging</w>
moz ambi
outre ach</w>
fibro tic</w>
p ad
0.00 4</w>
particip ates</w>
v ent</w>
in nerv
expec tedly</w>
conc ei
as tig
p raise</w>
practition er</w>
hsp 90</w>
pul sed</w>
v ort
ⅳ </w>
ta yl
explo it</w>
two- thirds</w>
mozambi que</w>
ban corp</w>
d 4</w>
5 62</w>
iv oc
ti o2</w>
advanc ing</w>
pic ked</w>
sh ou
inter ruption</w>
sel ls</w>
f k
ab -
rock et</w>
scat ter</w>
tw e
tor ia</w>
her bs</w>
cn .4</w>
un mi
chur ch</w>
ti bia</w>
yl- coa</w>
5- ht</w>
sy n</w>
re programming</w>
infiltr ating</w>
sever ance</w>
imp ressive</w>
histor ic</w>
ph ase-
re ac
n ad</w>
c uc
w n</w>
y cle</w>
puber ty</w>
predec essor</w>
co 3</w>
spec ially</w>
ra il</w>
immer sion</w>
to oth
n gs</w>
s. a.</w>
qualit atively</w>
fin der</w>
sph inc
t uc
18 8</w>
col lo
insul in
g m-csf</w>
ex es</w>
low er-
li an</w>
s ars</w>
dipl oid</w>
b are
ri ding</w>
mal icious</w>
pione er</w>
direc tory</w>
ter at
o i</w>
cor n
coll agen
di esel</w>
os mi
op y</w>
pass ages</w>
1, 6
zom ib</w>
n h</w>
18 9</w>
ot y
along side</w>
bermud a</w>
g s
sur ge</w>
tr pv
rit es</w>
e to
le pt
ge f</w>
den ing</w>
ben in</w>
agg res
anti psychotic</w>
mt b</w>
2 6-
l av</w>
ch un
pleas ure</w>
wi star</w>
at oes</w>
palp able</w>
wean ing</w>
bl ade</w>
embar r
reco ver
me fs</w>
fib res</w>
delir ium</w>
ic le</w>
mobil ize</w>
si em
ome galy</w>
neighb ors</w>
enem y</w>
perf used</w>
virul ent</w>
anaesthe sia</w>
well- defined</w>
g ad
negl ected</w>
sulf on
critic ism</w>
2 4.
swol len</w>
n ine
me gal
post p
mat lab</w>
omorph ic</w>
cholester ol
cataly zed</w>
secre te</w>
here with</w>
z uc
18 4</w>
bios ynthetic</w>
h oma</w>
f eng
figure 22</w>
qu erc
t ul
uplo ad</w>
trac ing</w>
th kline</w>
com orbid</w>
as us</w>
1 1.5</w>
intenti ons</w>
12 5
ob li
h m</w>
now ad
vir us
out lets</w>
ser vers</w>
t arily</w>
om otor</w>
pit ts
d as</w>
be ad</w>
v m</w>
alloc ate</w>
fur nit
lab elling</w>
0.0 9</w>
vac ancy</w>
tw een</w>
epti des</w>
depar ture</w>
res ver
stres s
ass ment</w>
anti- cancer</w>
laparos copy</w>
g- csf</w>
mon tre
gam bling</w>
amin ase</w>
st un
sub clinical</w>
resi st</w>
hem olytic</w>
c res
consequ ent</w>
fec es</w>
colli sion</w>
1, 3
out patients</w>
at r
t k
in significant</w>
ri d
ref usal</w>
cour age</w>
merch ants</w>
clim atic</w>
bud gets</w>
sim vastatin</w>
b el</w>
lac z</w>
u ph
non- linear</w>
ir relevant</w>
18 1</w>
m cd
treas ur
ep er</w>
nod ule</w>
em ol
vitre ous</w>
ultra violet</w>
at p
prin ts</w>
quad -core</w>
pres ynaptic</w>
pi -
lip id-
nic arag
wi -fi</w>
nowad ays</w>
x anth
sch e</w>
mas ked</w>
as hi</w>
exemp tion</w>
s now
17 1</w>
intermedi ary</w>
offer ings</w>
end o</w>
peri -
cp ap</w>
thre onine</w>
lymp hom
bec </w>
∆ </w>
otox ic</w>
hor ser
f h</w>
pe d
fabr ication</w>
benefici ary</w>
w d</w>
prec au
ac idi
sub family</w>
wavel eng
furnit ure</w>
iv f</w>
chit osan</w>
r age</w>
affir m
success ors</w>
od c</w>
polyeth ylene</w>
hair pin</w>
orthog onal</w>
resver atro
in patients</w>
sub til
gradu ates</w>
un esco</w>
en um
pop </w>
employ ers</w>
solv ents</w>
vi ment
tetrac ycline</w>
dise ased</w>
gluco se-
tu key</w>
lact ating</w>
ce tu
equ ivoc
voc ational</w>
nex t-
qu est</w>
af gh
tr p</w>
t 1-
gener ator</w>
t ad
chol angi
end oplasmic</w>
y fp</w>
post synaptic</w>
introduc es</w>
t 2d</w>
25 ,000</w>
fos sil</w>
pre payment</w>
back up</w>
constitu ent</w>
hp v
res our
arab ine</w>
p ick
miti gation</w>
ariz ona</w>
t s.</w>
17 4</w>
d- 1</w>
expi res</w>
j p</w>
tit les</w>
mc f
um e</w>
acti le</w>
n -</w>
asc ent</w>
h ox
ciprof loxacin</w>
f- actin</w>
valv ular</w>
aver ages</w>
liby an</w>
sent in
euro s</w>
contribu tor</w>
c er</w>
he at
gre ek</w>
ec z
j as
destro y</w>
harb our</w>
low- end</w>
armen ia</w>
amp he
ch a</w>
f lip</w>
sh ed
perpend icular</w>
amp icillin</w>
every where</w>
with holding</w>
25 1</w>
mb p</w>
g ig
ic am-1</w>
pursu ing</w>
o yang</w>
abstr acts</w>
law yers</w>
or f
ozygo sity</w>
w l</w>
phosphate- buffered</w>
ho sted</w>
12 th</w>
b 2b</w>
k rus
patient s.</w>
mor tem</w>
process ors</w>
90 -
as simil
et t</w>
contrac tile</w>
wi de-
adv ent</w>
im migration</w>
sin k</w>
mari time</w>
pol lin
ogen s</w>
organis ations</w>
dn mt
h op</w>
con form</w>
work flow</w>
chil d-
l us
montre al</w>
war m
ad l</w>
17 7</w>
ar f</w>
low- density</w>
i ia</w>
pa re
fibr ils</w>
gynec ology</w>
tom or
hp v-
des cent</w>
xen ograft</w>
ri bo
bin s</w>
exten sions</w>
1- year</w>
duoden um</w>
ep ri
w af
tis tic</w>
ari ans</w>
17 3</w>
men g</w>
in an</w>
c pr</w>
cat echol
compl ic
gr in
air space</w>
at t</w>
ice- cold</w>
cre atine</w>
revi sions</w>
imag ination</w>
19 73</w>
hur t</w>
requ ency</w>
tre ad
bre ed</w>
a 5</w>
t ca</w>
accoun tant</w>
three- year</w>
thir teen</w>
cry o
1080 p</w>
uniqu ely</w>
ja w</w>
dec </w>
fruc tose</w>
3, 3</w>
br a</w>
un saturated</w>
meth ox
fer ro
s nor
che aper</w>
microgli al</w>
rein forcement</w>
on ide</w>
b our
c 5</w>
hyper -
analog ues</w>
18 7</w>
normal ity</w>
1. 1.</w>
compl ained</w>
pursu ed</w>
glax osmi
billi ons</w>
phen otyp
ass ed</w>
cer em
c ages</w>
siem ens</w>
so y</w>
wall is</w>
as tically</w>
0. 35</w>
tri angular</w>
neuro endocrine</w>
h5 n1</w>
pros thetic</w>
lit ter
tar iff</w>
as yl
bio chemistry</w>
f t
solu bil
pace maker</w>
gen it
cover slips</w>
de ut
abst ain</w>
ex tubation</w>
b ill
jap on
kin dly</w>
epidemi ologic</w>
contain ers</w>
re paired</w>
semin ars</w>
mon t</w>
lyn ch</w>
i k</w>
itone um</w>
slow ing</w>
recep tor-
ple -
si veness</w>
ic e
arachno id</w>
br il
u o</w>
recap it
tryptop han</w>
hydro philic</w>
bra f</w>
res ort</w>
stri kingly</w>
supervis or</w>
tigh tness</w>
un successful</w>
ca ve</w>
menstr uation</w>
dr g</w>
re activation</w>
pre eclampsia</w>
glaxosmi thkline</w>
under graduate</w>
gentam icin</w>
wonder ful</w>
up dating</w>
immunosuppres sion</w>
li veli
nucle osome</w>
pers on-
sec toral</w>
noc ic
iter ations</w>
al ters</w>
bo at</w>
κ </w>
ocy cl
5- inch</w>
impl ication</w>
es r</w>
miltiorrh iza</w>
d sa</w>
ap tam
in et</w>
17 8</w>
respon dent</w>
on azole</w>
i. p.</w>
o y
free ze</w>
gl and
t ss</w>
olymp ic</w>
lactobac illus</w>
spong e</w>
b f</w>
pul led</w>
ad mis
utili zes</w>
refriger ator</w>
robo tic</w>
p cr
out sourcing</w>
pat er
univer si
inf used</w>
h ire</w>
ch al
x ue</w>
1, 1</w>
swe at</w>
prof en</w>
17 th</w>
exacerb ations</w>
3 8,
ver ti
dec ree</w>
cap ec
periodon titis</w>
antidepress ants</w>
conden sation</w>
19 74</w>
land mark</w>
slow ed</w>
thalam us</w>
ta q
fre ez
sh ine</w>
pitts burgh</w>
loc king</w>
mr c</w>
op re
ced aw</w>
15 ,000</w>
pl ex</w>
south west</w>
m ir</w>
of i</w>
⋯ </w>
hospital izations</w>
ter restrial</w>
ultr a</w>
radi of
ca ke</w>
tayl or</w>
remin der</w>
a 9</w>
any where</w>
dead line</w>
os um</w>
re marks</w>
thor ax</w>
chu an</w>
subtil is</w>
a dish</w>
af il</w>
ci tic</w>
comprehen sion</w>
one- year</w>
nom inating</w>
meas les</w>
er lot
ter ol</w>
oxali platin</w>
bl y
ophar yn
la si
authen tication</w>
her bi
omyel itis</w>
our acil</w>
m ated</w>
analy tic</w>
tryp sin
pro long</w>
gold man</w>
in er</w>
integr ative</w>
x ing
l 4</w>
pk c
ot t</w>
bucc al</w>
chr y
centr alized</w>
din ner</w>
cy ber
horser adish</w>
19 8</w>
epri stone</w>
sco tt</w>
u tri
ir revoc
inhabit ants</w>
hb v-
cc a</w>
4 2
te k</w>
prev ent
admini ster</w>
so 4</w>
j aco
establis hes</w>
en nial</w>
mir- 3
mif epristone</w>
k .
bl ur
redund ancy</w>
poin t-
fr an
ven om</w>
p- 3</w>
pi erce</w>
tomor row</w>
rac 1</w>
d ab
ucle ar</w>
excep tional</w>
ri b
commerci alization</w>
neuro blastoma</w>
prim ates</w>
ay a</w>
win ning</w>
g dm</w>
prob abil
c and
metropol itan</w>
sti </w>
custo dian</w>
tru sts</w>
leuc ine</w>
disc ord
cl amp
guardi an</w>
te ther
3 5-
pat ency</w>
gaz e</w>
tl r2</w>
re fund</w>
sti tis</w>
prostagland in</w>
prec eded</w>
chim er
therap ists</w>
n vi
ac yl
o reg
ep o</w>
c et
elong ated</w>
lymph ocytic</w>
1- 4</w>
un limited</w>
asc ar</w>
negoti ating</w>
viment in</w>
lay ing</w>
conve y</w>
kal emia</w>
pu zz
car ls
un expectedly</w>
er ic
condi tion
krus k
fibr in</w>
belong ed</w>
pig lets</w>
at tainment</w>
f ps</w>
evap oration</w>
stres sors</w>
de polarization</w>
for ums</w>
fresh water</w>
ga ther</w>
glyco l</w>
dev ast
n ary</w>
ky r
knock -
s bi</w>
6 2
os per
gt p</w>
60 s</w>
t actile</w>
g aining</w>
leu co
re organisation</w>
le t-
qu ir
guang xi</w>
k age</w>
hr v</w>
bot tom
inequ alities</w>
harv esting</w>
week- old</w>
k as
pre p</w>
usp id</w>
paedi atric</w>
pharmac ists</w>
self- management</w>
ha w
e in</w>
radiof requency</w>
or n</w>
c 6</w>
perfec tly</w>
surfac tant</w>
mo sis</w>
in sensitive</w>
bar ley</w>
pus hed</w>
pip ette</w>
ot opic</w>
s ach
f ounding</w>
mac edonia</w>
method .</w>
c iliary</w>
70 -
imag ery</w>
ir anian</w>
ifn γ</w>
resveratro l</w>
mr s.</w>
class room</w>
ori sts</w>
d ing
disc er
ag -
co- expression</w>
circul ated</w>
l. c.</w>
mus h
v 3</w>
ly so
hist amine</w>
selec tin</w>
bon ded</w>
sur render</w>
aug mentation</w>
tab les
sub acute</w>
sh aft</w>
non- significant</w>
olig omers</w>
dilig ence</w>
revol u
mad ag
n gf</w>
deliber ations</w>
3 d
gran tee</w>
clu es</w>
cu bic</w>
rede em</w>
cetu ximab</w>
for- sale</w>
ob enz
an cho
pneum ococcal</w>
sle eping</w>
cross- linking</w>
sp are</w>
do zens</w>
bye- law</w>
spirit ual</w>
announc ing</w>
micror na</w>
on able</w>
nick el</w>
comm it</w>
ste phen</w>
gener ous</w>
un even</w>
er α</w>
4 54</w>
emp oral</w>
comp ressed</w>
comprehen sively</w>
te ach</w>
bud ding</w>
antigen -
hybri ds</w>
1, 8
comm entary</w>
man dated</w>
irrit ation</w>
quasi -
19 67</w>
ken ne
sevent y-
medi um
resi de</w>
gradu ated</w>
ior ly</w>
cr on
cytosk eletal</w>
stain less</w>
blast ocy
az i
gast rectomy</w>
comp liant</w>
δ ct</w>
13 d</w>
sw ing</w>
dupl icated</w>
2 22</w>
ro ber
sub population</w>
injec ting</w>
dy es</w>
imp ur
bon y</w>
zo om</w>
ic ked</w>
accum ulating</w>
dic hlor
or y
jurisdic tions</w>
sp -
par enteral</w>
opho res</w>
ph ages</w>
sto ichi
pro sti
re it</w>
squ ee
onco gene</w>
cc d</w>
k at</w>
bever ages</w>
1 0.1</w>
lt p</w>
ce iling</w>
rec ession</w>
emphyse ma</w>
medic aid</w>
agli ptin</w>
9 th</w>
flag -
surviv in</w>
age- specific</w>
helic obacter</w>
ous ly
dis mut
al ment</w>
au er</w>
ar g</w>
protein- coding</w>
carot en
t ying</w>
humidi fied</w>
techn ically</w>
3 2-
nig er</w>
a e
phr ase</w>
t 7</w>
2 α</w>
gl u</w>
g w
deb tor</w>
m tor
β 3</w>
be ar
serum- free</w>
la e</w>
was hes</w>
verti go</w>
lin d
fric tion</w>
hypothalam ic</w>
mess enger</w>
c ations</w>
capec itabine</w>
dar k
obli que</w>
soc </w>
g 3</w>
gra ve</w>
e- like</w>
f .
cc t</w>
ti d</w>
sal mon</w>
in fin
n im
g -1</w>
ap oli
bal ancing</w>
b mp</w>
apol is</w>
shi eld</w>
at l
fa x</w>
sick ness</w>
tetan us</w>
hemat ocrit</w>
nicarag ua</w>
ophil us</w>
cylin dr
bri st
is cha
reaffir med</w>
spl iced</w>
p ma</w>
medic ally</w>
be ans</w>
cop ically</w>
2 14</w>
27 -
ho ok</w>
ti zing</w>
ic um</w>
ster oidal</w>
solid arity</w>
bl unt</w>
im migrants</w>
j eff
contra st-
4 -</w>
canc erous</w>
ap ps</w>
clo stri
tr iz
acu point</w>
bor te
au xin</w>
ib ia</w>
do s</w>
pre view</w>
obacter ium</w>
ir b</w>
gal 4</w>
y b
cd11 b</w>
off ences</w>
w ind
visi bility</w>
12 8
h ut
synthe size</w>
erlot inib</w>
anastom otic</w>
house keeping</w>
vi p</w>
mac roscopic</w>
es a</w>
albumin uria</w>
pay s</w>
mid wi
hs- crp</w>
deli veries</w>
f o</w>
haem orrh
bre eds</w>
dign ity</w>
re u
p ap</w>
comp elling</w>
pain less</w>
inv ites</w>
accep ting</w>
p 0.05</w>
viv ax</w>
b are</w>
x per
abstin ence</w>
mmp s</w>
ch in</w>
est onia</w>
e tics</w>
nam ibia</w>
mec </w>
inter ro
inter genic</w>
co valent</w>
19 70</w>
p ag
ha emo
af -
del icate</w>
der ma</w>
not ch
le ung</w>
3, 4</w>
requ esting</w>
d bs</w>
happ iness</w>
out set</w>
ri b</w>
p th</w>
photos ynthesis</w>
st ents</w>
ne ov
spe eds</w>
my self</w>
deci sive</w>
bin omial</w>
e at
gf ap</w>
sion .</w>
conc es
destruc tive</w>
cephal ospor
gh relin</w>
il er</w>
car lo</w>
clar ification</w>
silic one</w>
may o</w>
re ject</w>
0. 99</w>
0. 85</w>
es us</w>
prim ed</w>
x r
you tube</w>
st ack</w>
al em</w>
announc ements</w>
our selves</w>
c .1</w>
migr ating</w>
mark ov</w>
steril ization</w>
ic idal</w>
under took</w>
gl it
oscill ation</w>
19 6</w>
inter neurons</w>
volun tarily</w>
common wealth</w>
nor theast</w>
ó n</w>
2 f</w>
tas k-
sh ri
entr usted</w>
du ke</w>
bra e</w>
py re
assess able</w>
m dr</w>
sentin el</w>
hall mark</w>
si sed</w>
mini stries</w>
su mo
stere ot
prim itive</w>
f n
activ ators</w>
ec o</w>
ch imp
x es</w>
tun el</w>
g ases</w>
el asticity</w>
advoc ate</w>
mechan ics</w>
steat osis</w>
inter cellular</w>
four teen</w>
far ming</w>
avail able-
horiz on</w>
ag itation</w>
ab ul
pro lapse</w>
dual- core</w>
gen tle</w>
bo y
bronchos copy</w>
op po</w>
out liers</w>
his tidine</w>
counter part</w>
tr apped</w>
kine to
neurotransmit ter</w>
oneph ritis</w>
rot ating</w>
rev ising</w>
is hi</w>
tot aling</w>
ten stein</w>
encomp assing</w>
er i</w>
en v</w>
under goes</w>
fg fr
vi bri
extr insic</w>
affirm ative</w>
h sc
volu metric</w>
high- performance</w>
moun tains</w>
e der</w>
apoli po
bott les</w>
integr ins</w>
unc le</w>
conjug ation</w>
pericardi al</w>
saf er</w>
attemp ting</w>
compar atively</w>
ecz ema</w>
cele br
til t</w>
flu or</w>
inn oc
cau tious</w>
rob i</w>
no v</w>
quer ies</w>
moun ting</w>
contin gency</w>
dis si
incid ental</w>
nanop article</w>
anc illary</w>
stir red</w>
d x
ana emia</w>
competi tor</w>
waveleng ths</w>
aesthe tic</w>
ch y</w>
lot tery</w>
n ight
7 20</w>
nvi dia</w>
ancho red</w>
accommod ation</w>
a- induced</w>
60 ,000</w>
anthropo metric</w>
of- function</w>
gl os
f g</w>
indemn ity</w>
st ants</w>
v r
revo ked</w>
di g</w>
3 9,
flu id
19 40</w>
bund les</w>
d oxy
transduc er</w>
po ds</w>
hiv- positive</w>
autop sy</w>
j ava</w>
hom a-
par ap
ch ances</w>
surpr ised</w>
o ils</w>
mos aic</w>
heal ed</w>
201 9</w>
est ers</w>
reliev ed</w>
az ep
the astern</w>
eng ines</w>
tissu e-specific</w>
del eting</w>
pertin ent</w>
li vers</w>
conven e</w>
10- year</w>
madag ascar</w>
i oma</w>
e q-
perc eive</w>
adap tor</w>
un ani
inv ention</w>
sup ra
tremend ous</w>
sn r</w>
k el</w>
k no
sup pur
m ary</w>
ar te
occul t</w>
ag a</w>
la ur
disp en
ten -
be ach</w>
tread mill</w>
ar o
analy sing</w>
my ot
endos omes</w>
resili ence</w>
mp h</w>
s sd</w>
3 00,000</w>
safegu ards</w>
pher om
k ton</w>
nai robi</w>
contradic tory</w>
human ity</w>
ens or</w>
proportion ate</w>
8 00
at rop
am bly
shed ding</w>
trou gh</w>
mir na-
k er-
tri angle</w>
13 0
merch andi
po unds</w>
constr ued</w>
univer sit
gr atitude</w>
galac to
optim izing</w>
- 5</w>
glu con
new er</w>
nar rative</w>
sin usitis</w>
o in</w>
ox i
br t</w>
ab ra
counter fe
intrav ascular</w>
sil enced</w>
oid y</w>
a sting</w>
arab ic</w>
ureter al</w>
3- 5</w>
ki- 67</w>
archi ves</w>
v- 2</w>
audi ting</w>
im itation</w>
3 40</w>
accid ental</w>
ha ier</w>
prosper ity</w>
heter ologous</w>
weigh t-
jo y</w>
bri dges</w>
dr y
mot ors</w>
onucle ase</w>
ograp hed</w>
protein- protein</w>
. 00
absor b</w>
pluripot ent</w>
pharyn gitis</w>
pe i</w>
pl ating</w>
open- ended</w>
pep tic</w>
ship ped</w>
fores ee
a vir</w>
credi tor</w>
az ide</w>
unani mously</w>
sol id-
phospholip id</w>
dec on
arg u
employ s</w>
al er
cd -
dou bling</w>
merchandi se</w>
dor m
p ups</w>
moist ur
cannab is</w>
. 01</w>
bio tics</w>
pen ile</w>
reg ret</w>
assess es</w>
six- month</w>
speci es
environ mentally</w>
catal ase</w>
3- fold</w>
met ap
bor row</w>
bra in-
tro pon
def end</w>
vari ances</w>
sty les</w>
dend rites</w>
p 5</w>
ap ers</w>
str um</w>
mal ta</w>
myel ination</w>
n- terminus</w>
cy clin
under lined</w>
2- 4</w>
conf used</w>
i vi
dis counted</w>
c or</w>
di r
c mr</w>
neph ritis</w>
chaper one</w>
kerat in</w>
aden omas</w>
inter section</w>
t s.
cil ia</w>
muco us</w>
al um
pro ud</w>
pol es</w>
i ens</w>
y early</w>
parag u
locom otor</w>
tgf β</w>
tion .
mer it</w>
mark eted</w>
moder n
orth odontic</w>
k ip
conflu ence</w>
elabor ate</w>
camp s</w>
carls bad</w>
comple mented</w>
weak nesses</w>
in finite</w>
sym metrical</w>
ey e-
ol im
y emen</w>
all ograft</w>
c pc</w>
x x</w>
th a</w>
acet ab
ur gently</w>
intensi fied</w>
vascul itis</w>
disease- free</w>
1, 7
ar ena</w>
negoti ate</w>
trab ec
c 18</w>
th ic</w>
ba h
si ves</w>
en force</w>
flas ks</w>
profes sion</w>
inter course</w>
pres cho
arti fact</w>
id c</w>
s ad
re wards</w>
table 3</w>
coun ters</w>
am ox
encapsul ated</w>
time- consuming</w>
ion ization</w>
bcl -
fi erce</w>
ber n
pd t</w>
ill -
superi ority</w>
under ground</w>
m cl
e ased</w>
resp ected</w>
k c</w>
standar dised</w>
20 7</w>
concer ted</w>
e fs</w>
temper ature
n f</w>
st ating</w>
pre dispos
defa ul
retro peritoneal</w>
lei omy
envelop es</w>
aggra v
figure 1
o chemical</w>
lat via</w>
gon dii</w>
observ able</w>
cathe ters</w>
pr l</w>
endometri um</w>
c enti
sub ver
sovere ign</w>
por no
sub optimal</w>
fore stry</w>
cros ses</w>
man t
om on</w>
0. 22</w>
prohib it</w>
neuro science</w>
ah ir
telomer es</w>
- activated</w>
typh im
p ou
mexic an</w>
si al
en forced</w>
altern ating</w>
po 4</w>
intr at
im f</w>
amin e-
low- grade</w>
grow s</w>
ar range</w>
phil ips</w>
pneum othorax</w>
o e</w>
kin em
od or
franch ise</w>
to il
jour ney</w>
fer ment
i si
a ar
0. 11</w>
extr av
un biased</w>
disp at
jer us
exp ose</w>
af il
lew is</w>
refl ective</w>
salv age</w>
his -
incub ating</w>
ann e</w>
s la
ti red</w>
arter io
tail s</w>
smo ked</w>
but ter
201 0
sco li
immer sed</w>
test es</w>
micro biological</w>
oly sacchar
c sc</w>
pea ked</w>
ulcer ation</w>
nan om
newsp apers</w>
re acted</w>
diver tic
he dging</w>
ren min
requi site</w>
30 6</w>
l h
3 f</w>
damp ness</w>
tex ts</w>
trache a</w>
fre ight</w>
xen opus</w>
impris onment</w>
microbi ome</w>
mim ics</w>
sc rut
1, 500</w>
jam ahir
sand wich</w>
tou ched</w>
s s-
ds b</w>
th igh</w>
ge o</w>
z yg
r ine</w>
symb ols</w>
adi posi
e ia</w>
rap e</w>
enh agen</w>
propag anda</w>
fluor ouracil</w>
jamahir iya</w>
sh ots</w>
si ri</w>
li bit
hybridi zed</w>
tor sion</w>
e a
end ocr
foresee able</w>
t ty</w>
issu able</w>
top ological</w>
shu t</w>
z no</w>
ur an
infec tivity</w>
hy d
b illing</w>
rho a</w>
gran ular</w>
ris ky</w>
schol ar
character izing</w>
effic acious</w>
op a</w>
synerg ies</w>
9 ,000</w>
is s
0. 16</w>
oreg on</w>
mm se</w>
p- 4</w>
dismut ase</w>
arri ve</w>
am ation</w>
50 s</w>
stress ful</w>
li en</w>
jerus alem</w>
fraction ation</w>
t ace</w>
et y-
su itability</w>
mother board</w>
refer enced</w>
cardi ology</w>
whit e-
co sm
com b</w>
2 7.
attrac tion</w>
dom s</w>
conti gu
gib co</w>
arterio venous</w>
si te-
blo om
descri bed
2. 5
s as
tol l</w>
aw ak
men is
shrin kage</w>
or bit
g hness</w>
ow a</w>
a q</w>
resem bles</w>
entit lement</w>
trab ecular</w>
rou p</w>
membran ous</w>
unmi k</w>
h scs</w>
immunoprecip itated</w>
n ak
0. 13</w>
sel s</w>
em ir
morph ogenesis</w>
pedic le</w>
amp utation</w>
leish mania</w>
am ylase</w>
tr aps</w>
afgh an</w>
9 3
crystalli zation</w>
mac au</w>
ar ro
narrow ing</w>
micro plate</w>
mon te</w>
un odc</w>
breast -
se ats</w>
if rs</w>
sl r</w>
n cr
17 9</w>
co bal
allerg ies</w>
or ating</w>
② </w>
bas el</w>
har ris</w>
lip ase</w>
m ü
domin ican</w>
tic ks</w>
oste ogenic</w>
ag ers</w>
centrif uge</w>
19 70s</w>
gu est</w>
do dec
aberr ations</w>
lil ly</w>
im ip
n. a.</w>
en force
cr ises</w>
cli p</w>
mater i
w y
es sively</w>
post- translational</w>
200 2-
ô </w>
libit um</w>
un lock</w>
2 35</w>
pain ting</w>
invari ant</w>
il- 17
sh ing</w>
5 10</w>
sensi tized</w>
s ão</w>
lun ch</w>
19 1</w>
a 1c</w>
rho ea</w>
whe el
na ked</w>
leth ality</w>
bil ayer</w>
consum mation</w>
migr ated</w>
sal ic
resem ble</w>
k -1</w>
fos sa</w>
intrac table</w>
coll ater
of loxacin</w>
pear l</w>
re m</w>
os ensi
tl c</w>
adap tations</w>
inter pol
at able</w>
ret t</w>
iter ation</w>
non- parametric</w>
mp -
val idly</w>
9 b</w>
re constituted</w>
borrow ers</w>
es rd</w>
on er</w>
ti i</w>
ent ous</w>
negl ect</w>
inf ancy</w>
n fc</w>
allergen s</w>
se am
high- fat</w>
addi tions</w>
hi d</w>
co sis</w>
cb f</w>
indi ana</w>
ho me-
sp ines</w>
interfer on-
verte brae</w>
l. l.c.</w>
3 d-
pe king</w>
d ation</w>
f st</w>
pm ol</w>
χ </w>
wild life</w>
13. 5</w>
depend ed</w>
tric uspid</w>
it ating</w>
ion ized</w>
ru b</w>
perit onitis</w>
lif ting</w>
andre w</w>
lig and-
acr ine</w>
iso flurane</w>
5 71</w>
v in</w>
hou ston</w>
40 5</w>
priv atization</w>
p x</w>
concep tu
waste water</w>
r ms</w>
k an</w>
arg ues</w>
ho -1</w>
h ct
fl p</w>
witness ed</w>
imag ej</w>
2 21</w>
as ep
inspir ation</w>
16. 5</w>
palestin ians</w>
2 m</w>
bu g</w>
typhim urium</w>
dextr an</w>
bi og
available- for-sale</w>
fr -
ha e</w>
th en
col ori
high way</w>
cor r</w>
s pro
borte zomib</w>
compo sites</w>
dimer ization</w>
inc ap
assi stants</w>
asper g
amor tized</w>
pl a</w>
este em</w>
l atitude</w>
random isation</w>
attenu ate</w>
rab ies</w>
exacerb ated</w>
pr agmatic</w>
sh in
os copic</w>
ole ic</w>
mes othel
roy alty</w>
anti- apoptotic</w>
pe an
innov ations</w>
solic ited</w>
er g</w>
ozyg otes</w>
j n
minim ized</w>
prison ers</w>
ful fil
cyclospor ine</w>
mus ical</w>
jud ici
de hydrated</w>
tr if
oste osarcoma</w>
pre payments</w>
con azole</w>
model led</w>
cylindr ical</w>
z ole</w>
4 8-
entrez- nucleotide</w>
. in</w>
z ha
veget ative</w>
adiposi ty</w>
next- generation</w>
per su
rou ter</w>
yugos lav</w>
equival ence</w>
op res
para thyroid</w>
renmin bi</w>
in ized</w>
u pr
ot c</w>
ss dna</w>
reti re</w>
op ens</w>
bran ched</w>
1 β</w>
biop hy
sl opes</w>
on au
d ac
penetr ate</w>
chlamy dia</w>
on wards</w>
ol ine</w>
cop enhagen</w>
res ale</w>
continu um</w>
mis sense</w>
on ium</w>
equ als</w>
la in</w>
rh in
gran ulation</w>
miner alization</w>
ab cam</w>
construc tions</w>
probabil istic</w>
exerc ising</w>
inc is
qui e
metr on
si s.</w>
homocy steine</w>
atric s</w>
writ er</w>
5 e</w>
previ a</w>
ca es
li d</w>
ag u
2 16</w>
do ors</w>
atri um</w>
19 7</w>
ocy te-
an aphy
hyper cholesterol
advoc ated</w>
govern or</w>
ds rna</w>
dan iel</w>
ari ally</w>
co- mor
b en</w>
he igh
sp ore</w>
whit e
psych otropic</w>
gn rh</w>
shap ing</w>
mei osis</w>
xin hua</w>
pt c</w>
my ri
paragu ay</w>
bo ot</w>
p ps</w>
` </w>
rat e-
ca ver
staphylo cocc
n 3</w>
sedi ments</w>
credi ts</w>
im ide</w>
ob a</w>
mer its</w>
hist ogram</w>
ta virus</w>
lenti viral</w>
rus h</w>
append icitis</w>
as ka</w>
cy s</w>
3 r</w>
ter ri
op posing</w>
tr ail
inter ne
broad -
clean ed</w>
anth ocyan
mac ro</w>
re mic</w>
standardi ze</w>
homolog ues</w>
analog s</w>
sp asm</w>
accompl ish</w>
double- stranded</w>
anti- human</w>
judg ement</w>
bar rel</w>
neighb or</w>
gaba ergic</w>
er son</w>
trac ked</w>
à </w>
au d</w>
parliam entary</w>
ur in
ref use</w>
nitro cellulose</w>
ne tt</w>
hypox emia</w>
re pay</w>
pro t</w>
neurolog y</w>
ischem ia-
es in</w>
fall en</w>
rhyth ms</w>
wel coming</w>
pm 2.5</w>
her itability</w>
post al</w>
bre ad</w>
cylin der</w>
iv a</w>
bo t</w>
cerem ony</w>
tim er</w>
under tak
privileg es</w>
ger i
tau ght</w>
me g
p si</w>
be et
inf requ
cogn ate</w>
if ier</w>
f 5</w>
dri p</w>
intenti onal</w>
sal ts</w>
incre ment</w>
fac e-to-
fet uses</w>
ic p</w>
resi ding</w>
chlor oplast</w>
st ine</w>
illo facial</w>
part -time</w>
w o</w>
dispos able</w>
k 3</w>
adap ter</w>
hek 293</w>
encryp tion</w>
alleg edly</w>
borrow ed</w>
tr ap
triz ol</w>
freez e-
posi tional</w>
casc ades</w>
ter t</w>
emb olic</w>
u tah</w>
d pp
permeabil ized</w>
par an
19 4</w>
hem i
ic o</w>
ul ic</w>
0. 14</w>
3 30</w>
read iness</w>
ron utri
physi ologically</w>
vesic ular</w>
de but</w>
domin ate</w>
multin ational</w>
graph pad</w>
- sensitive</w>
ores t</w>
north west</w>
cla ud
multi ple-
me de
met ac
aid ed</w>
pur pur
semin al</w>
d na
so m</w>
s 1
tymp anic</w>
quanti fying</w>
oli ve</w>
h eng
design ers</w>
al- based</w>
capill aries</w>
otrop y</w>
consti tuting</w>
stipul ated</w>
flav or</w>
eigh ty-
co li
c ati
so ever</w>
amplic ons</w>
cf tr</w>
attrac ting</w>
intim ate</w>
mo i</w>
pl oidy</w>
ss r</w>
5, 6</w>
face-to- face</w>
gonadotrop in</w>
hydro l
a us
it t</w>
co ol
mi -
as c</w>
merg e</w>
s ant
d ss</w>
k um
manip ulated</w>
en su
j el
mom ents</w>
to id</w>
3. 33</w>
flo o
pl u
intra hepatic</w>
80 ,000</w>
j u</w>
p 450</w>
polysacchar ides</w>
irrit ability</w>
law yer</w>
g bs</w>
1, 9
ful filling</w>
ro is</w>
cas u
vers ati
ac -
opi oids</w>
end- stage</w>
t dcs</w>
cathe ps
hop kins</w>
s og
em an</w>
20 9</w>
taq man</w>
motiv ational</w>
separ ating</w>
an ze
company was</w>
syn ucle
not arially</w>
margin ally</w>
res umption</w>
mon t
entr ic</w>
popul arization</w>
ch ap</w>
pater nal</w>
2 k</w>
3 10</w>
kyr gy
re ef</w>
w ales</w>
advertis ers</w>
p assi
c. 3</w>
id ol</w>
2 15</w>
sub divided</w>
eigh teen</w>
envis aged</w>
schist osom
g um</w>
hist ories</w>
met aphase</w>
hang ing</w>
in semin
edi a</w>
need les</w>
sti ll
bottlen eck</w>
ref ine</w>
evid ences</w>
mon ten
mer cap
dic t
&apos; ivoire</w>
2 31</w>
gly can</w>
mon omeric</w>
n p-
chimp anze
ć </w>
bri dging</w>
bac hel
neoplas m</w>
ven ue</w>
twenty- four</w>
im rt</w>
oblig ated</w>
c ô
id ectomy</w>
o tion</w>
ri val</w>
a o
you ku</w>
smooth ly</w>
conver sation</w>
recal ls</w>
patter ning</w>
cy ste
or o
spac er</w>
where of</w>
th umb</w>
i ac</w>
p ct</w>
energ etic</w>
hon dur
b ine</w>
l m
h 7</w>
s z
b age</w>
m ock</w>
dra g</w>
na oh</w>
r il
whee zing</w>
j d</w>
cad mium</w>
ent als</w>
pc c</w>
simplif y</w>
out growth</w>
restric ting</w>
ud ed</w>
to e</w>
li ech
treatment -
r als</w>
erythro po
hydr ate</w>
di gi
fle et</w>
in ally</w>
lin s</w>
suppur ative</w>
morph ologically</w>
gu ests</w>
angi oplasty</w>
loc k
ir in
somat osensory</w>
par p</w>
den ed</w>
ch em</w>
et opo
dra in</w>
fundam entally</w>
o val</w>
c 1
gal act
un e</w>
sh im
pregn anc
def en
col leg
fer tile</w>
antigen -specific</w>
pro ton
tol u
k ai
bo iling</w>
cali br
n n
ot -
agglut ination</w>
mo ore</w>
scho ol
pa w</w>
fi ji</w>
w b</w>
ly tic</w>
bi olog
monten egr
gl ab
de bri
pe t-
max illofacial</w>
f s
nemat ode</w>
hepat ocyte</w>
scre ws</w>
itone ally</w>
human -
k h
qing dao</w>
radi ography</w>
rein forcing</w>
18 th</w>
no rep
endor sement</w>
seg mented</w>
re tains</w>
low- income</w>
liech tenstein</w>
mal on
tax on</w>
p5 3-
tox oplas
rus sell</w>
di dy
j c</w>
age- matched</w>
chemot axis</w>
di vor
cast le</w>
cn ts</w>
. 0
re vit
in expensive</w>
ir on-
second- hand</w>
undertak ings</w>
interc ept</w>
3 75</w>
lim it
be er</w>
alber ta</w>
precip itate</w>
diaphr agmatic</w>
fl ex</w>
mol d</w>
th ai</w>
steril ized</w>
su se</w>
30 8</w>
tran che</w>
cycl ine</w>
emol uments</w>
aldo sterone</w>
cre b</w>
restr aint</w>
su its</w>
oc ulus</w>
p 16</w>
per pe
pol ish</w>
so x2</w>
soci ally</w>
ri vers</w>
tr id
comple ment
mast ectomy</w>
4- fold</w>
cur ing</w>
2, 4
mat rig
de grade</w>
3 80</w>
u el</w>
drople t</w>
p 300</w>
c ic
gra ves</w>
vel oci
tif f</w>
sb sta</w>
erad icate</w>
hex ane</w>
chlorophy ll</w>
fron t-
in distinguishable</w>
phospholip ids</w>
2 11</w>
ch op</w>
overl apped</w>
en quir
in r</w>
n- 3</w>
emergen cies</w>
- 8</w>
wh is
tor que</w>
tac rolimus</w>
des k</w>
op tion
at tain</w>
win ding</w>
ac r</w>
l c-ms</w>
pan or
cost al</w>
congrat ulate</w>
a the
z ip</w>
cer amic</w>
i pod</w>
0. 18</w>
mandi ble</w>
z ers</w>
0. 80</w>
emp tying</w>
atrop ine</w>
n g
f ccc</w>
ori entations</w>
objec tively</w>
s op
osph ere</w>
me tres</w>
ado be</w>
hun gr
ro oted</w>
neuro degeneration</w>
par simon
ev acu
bur ied</w>
sex -
azol am</w>
phosphati dy
3- 4</w>
transfer ring</w>
a ked</w>
milest one</w>
hol istic</w>
on i</w>
terr orists</w>
cap sular</w>
der mis</w>
biomechan ical</w>
psycho metric</w>
simp ler</w>
emir ates</w>
contrac ep
4 f</w>
19 72</w>
my ocytes</w>
4 5-
sof t
fi red</w>
jug ular</w>
radi ology</w>
par enting</w>
physi otherapy</w>
k es
reu ters</w>
b un</w>
aden ine</w>
catal og</w>
gt p
phy top
i. v.</w>
ip scs</w>
defec ation</w>
subtrac ted</w>
cô te</w>
ad t</w>
af m</w>
parad ox
ass ur
tr apping</w>
c. 2</w>
fair ness</w>
bul b</w>
stri ps</w>
integr ates</w>
t ough</w>
sh un
tec h
dep ths</w>
sk eleton</w>
amp hi
it c</w>
tun ed</w>
im mobilization</w>
tend ered</w>
le ver</w>
mis o
mon ot
v oid</w>
idi tis</w>
y ri
secre ting</w>
asperg illus</w>
lia ison</w>
s ine</w>
ds bs</w>
0. 98</w>
re payable</w>
notic eable</w>
avi er</w>
possess ed</w>
predat ors</w>
ds dna</w>
ho sting</w>
4 20</w>
frank lin</w>
y- induced</w>
spok en</w>
cd ma</w>
thir dly</w>
prote obacteria</w>
quie tly</w>
char tered</w>
swe ating</w>
a hr</w>
0. 93</w>
r n</w>
cor ner
26 4</w>
v te</w>
vic toria</w>
ti r</w>
olig osacchar
α 2</w>
cab inet</w>
hungr y</w>
mix ed-
ster n
financ ially</w>
7, 8</w>
disp arity</w>
q ds</w>
ki 67</w>
od 600</w>
25 5</w>
bril liant</w>
2 13</w>
lik ert</w>
company with</w>
tetr ap
ol dest</w>
insi ders</w>
chron ically</w>
prost ol</w>
rot ational</w>
t p53</w>
conjug ates</w>
ra f</w>
k 3
self- care</w>
dra ws</w>
ch ad</w>
puer to</w>
25 4</w>
- 7</w>
2 42</w>
transpos on</w>
6, 7</w>
phen ols</w>
dru g
stock holm</w>
elem entary</w>
sp ur
expor ted</w>
cd 14</w>
v ic</w>
g c-
ske wed</w>
sen ile</w>
pc b</w>
imp utation</w>
succ ession</w>
et -1</w>
multi- center</w>
fi duc
modul us</w>
deep -
c pa</w>
be t
abst entions</w>
hemor he
an es</w>
eleg ant</w>
sw ana</w>
i h</w>
f y
me k</w>
abund ances</w>
def ensive</w>
fin alized</w>
e hr
scoli osis</w>
28 8</w>
sig moid</w>
b -1</w>
pharmacolog y</w>
design ate</w>
2 23</w>
gli omas</w>
ac l</w>
proce eded</w>
apar tment</w>
¯ </w>
song s</w>
25 8</w>
rn p</w>
expir y</w>
fin ish</w>
sa o</w>
glucocortico ids</w>
hondur as</w>
inf usions</w>
ta ip
t ins</w>
adel ph
claim ing</w>
200 0
bien nial</w>
fl at-
six teen</w>
broad casting</w>
dow ns</w>
compo sitions</w>
identi ties</w>
vap or</w>
reposi tory</w>
multi dimensional</w>
col ate</w>
19 71</w>
instrum entation</w>
ur tic
ne bul
st enting</w>
tropon in</w>
accor d</w>
bus h</w>
s. c.</w>
par enchymal</w>
po ts</w>
parti tioning</w>
montenegr o</w>
str atum</w>
we t
b ent</w>
dy spl
q ian</w>
ris peridone</w>
ophosph ate</w>
str at
dr ill</w>
no 2</w>
stre ams</w>
the ta</w>
dist orted</w>
prob ing</w>
cing ulate</w>
amplic on</w>
c em
if ies</w>
qu ili
β- lac
swee p</w>
succ ee
miso prostol</w>
i bu
j ul
arteri osclerosis</w>
epide mics</w>
sub paragraph</w>
oz oa</w>
1 x</w>
am y</w>
embed ding</w>
cul turing</w>
ph thal
receip ts</w>
deplo y</w>
pack aged</w>
contracep tives</w>
lncr nas</w>
omis sion</w>
hi red</w>
so s</w>
m ou</w>
dig it
tab ly</w>
uni ons</w>
bre ad
ab rup
phot ographed</w>
r ation</w>
or acle</w>
ec og</w>
m end
d 6</w>
up grades</w>
car l</w>
micro circulation</w>
fall opian</w>
bo iled</w>
11. 2</w>
shu ang
epi didy
bud s</w>
vibri o</w>
liber ation</w>
ap -1</w>
cb 1</w>
dise quili
thel ial</w>
spokes man</w>
cron bach</w>
poli tics</w>
v l
car t</w>
vic tory</w>
de mobilization</w>
slow down</w>
s 6
intraper itoneally</w>
ucle otide</w>
alban ia</w>
y c
fum ig
fis sion</w>
cl ath
prolong ation</w>
res et</w>
30 2</w>
ap o</w>
im idazole</w>
k am
kw ok</w>
super market</w>
thoraco tomy</w>
sh h</w>
norep inephrine</w>
str ata</w>
. com.</w>
d are</w>
fo vir</w>
telomer ic</w>
dilu tive</w>
tol l-
contigu ous</w>
diure tic</w>
journ alists</w>
quar tered</w>
penetr ating</w>
apolipo protein</w>
lig nin</w>
contraindic ations</w>
le a</w>
c 3
pot atoes</w>
f cc</w>
mist akes</w>
ox al
my d
bot swana</w>
dec ol
contra sting</w>
r af
sub arachnoid</w>
di lemma</w>
we in
im id
do va</w>
t 2-
asyl um</w>
conflu ent</w>
e 4</w>
l is</w>
moistur izing</w>
endo tracheal</w>
wash out</w>
transfer ases</w>
dy ne
r igi
c ili
gate way</w>
inst ant
u e-
0. 17</w>
ha inan</w>
amin ogly
sn ail</w>
compul sory</w>
market place</w>
18. 5</w>
gu y
day -to-
cn .9</w>
de duced</w>
ren ov
doxy cycline</w>
pack et</w>
in- like</w>
mo tions</w>
- containing</w>
vag ina</w>
self- renewal</w>
retrospec tivel
narco tic</w>
ma iling</w>
eigh t-
at ings</w>
occurr ences</w>
hist ones</w>
gh t
ig fb
biosci ence</w>
19 3</w>
voc abul
. 8</w>
nam ing</w>
bl un
gen otypic</w>
d fs</w>
discus ses</w>
d c-
gra vit
en al</w>
ol us</w>
nat ri
11. 1</w>
evalu ates</w>
end ang
entr e</w>
pa ste
num b
astr agal
day-to- day</w>
wor th
consul ted</w>
mt d</w>
h sc</w>
rou ting</w>
head quartered</w>
cr ac
ru i</w>
conf ers</w>
sup pl
12 ,000</w>
analges ics</w>
our ing</w>
26 th</w>
cat abol
correc ting</w>
car ing</w>
atri o
econom ical</w>
be ef</w>
etopo side</w>
all en</w>
s 9</w>
amox icillin</w>
galact ose</w>
14. 5</w>
anti psycho
deposi tor</w>
a un
pu mps</w>
b ats</w>
ep i</w>
haem oglobin</w>
thalam ic</w>
h off
audi ts</w>
autophag ic</w>
cre ativity</w>
pu fa</w>
figure 4</w>
re traction</w>
ig g1</w>
butt ons</w>
benz o
rest oring</w>
50 ,
los s-
rene w</w>
pel le
4- 6</w>
prim ate</w>
s anger</w>
hel min
h gf</w>
dyspl astic</w>
wal ker</w>
p 6</w>
shen mai</w>
deser tification</w>
l or</w>
mp o</w>
intrav it
y ol
leish man
it ri
acetyl choline</w>
affer ent</w>
gland ular</w>
par at
deliber ately</w>
posi tron</w>
td- lte</w>
cati onic</w>
hom ogenous</w>
zer o-
sinc ere</w>
sc d</w>
kary otype</w>
se at
c scs</w>
pro biotic</w>
cap sid</w>
zuc ker
overwhel ming</w>
o ecd</w>
ster nal</w>
en acted</w>
prostat ectomy</w>
cat ch
gl as
ha ven</w>
c ps</w>
affin ities</w>
a wake</w>
ger d</w>
sm cs</w>
- binding</w>
tissu e-
judici ary</w>
ec raft</w>
opath ology</w>
nf κb</w>
xia ob
over looked</w>
poli tic
doc </w>
dak o</w>
micro spheres</w>
dsm- iv</w>
ex ia</w>
a- 2</w>
oc ide</w>
sh un</w>
ff a</w>
lys osomes</w>
co oper
he ur
re classified</w>
cr f</w>
control l
secur ing</w>
q l</w>
sc d
sn ake</w>
di az
harmon ic</w>
epis odic</w>
bo om</w>
p bc</w>
figure 33</w>
atrio ventricular</w>
bon uses</w>
credi ble</w>
st aged</w>
qi u</w>
eric sson</w>
anticip ates</w>
pen is</w>
conc e
helic ase</w>
w and
sil ence</w>
erythemat osus</w>
cris pr</w>
ro man
y os
oxid ant</w>
t ari
repl en
insi der</w>
spl itting</w>
roy alties</w>
where in</w>
for ens
β 2-
plac ements</w>
figure 2
over head</w>
hc v-
an op
cr ash</w>
ome ga-
inser ts</w>
kil ometers</w>
americ as</w>
disequili brium</w>
1 ,000,000</w>
s ers</w>
n up
veloci ties</w>
deep en</w>
homa- ir</w>
dupl ications</w>
my cel
25 00</w>
nemat odes</w>
26 1</w>
thi asis</w>
enhanc ers</w>
ging er</w>
2 90</w>
ish ments</w>
med line</w>
in compatible</w>
bas ket</w>
f ill
in accurate</w>
t all</w>
un willing</w>
val ves</w>
wol f</w>
sc id</w>
numb ness</w>
gt pase</w>
mm c</w>
den g</w>
pain t</w>
grou p-
il i</w>
aden o
quad ru
so hu</w>
single- stranded</w>
it or</w>
opath ies</w>
fo od
if i
v f</w>
socio- demographic</w>
no d</w>
exagger ated</w>
hall uc
pre operatively</w>
wh er
anti le</w>
astr onom
worl d-
flu xes</w>
nct0 14
id ing</w>
8, 9</w>
uz be
ap es</w>
diseas e.
. 10</w>
phot ons</w>
micro biology</w>
factor ies</w>
anomal y</w>
ast -
scri pts</w>
interest -
proc ure</w>
ici ally</w>
su gar
mon uc</w>
kne es</w>
ater ials</w>
dis missed</w>
n ascent</w>
cyto kin
ligh ter</w>
incre ments</w>
he im</w>
b cs</w>
sund ay</w>
p ins</w>
allow ances</w>
pre tty</w>
fl y
computer -
pill ar</w>
glut ar
99 mt
thromb olysis</w>
log- rank</w>
bachel or</w>
v ou
accoun table</w>
tur n
1 i</w>
mechan ically</w>
at resi
brac hy
el usive</w>
sh er
14 th</w>
tel es
conidi a</w>
lasi k</w>
i res</w>
gl en
scot land</w>
do zen</w>
carb ons</w>
lymphom as</w>
p 7</w>
berg er</w>
i si</w>
mo de
hs v</w>
ec ules</w>
xen ografts</w>
en cl
echocardi ographic</w>
prosti tution</w>
trac ed</w>
kin dle</w>
tu re
os a
schem atic</w>
2 26</w>
sw ab</w>
nad h</w>
cott age</w>
15 th</w>
se eding</w>
den v</w>
wat son</w>
swit ches</w>
mede tom
plas min
2 18</w>
t 3-
k p</w>
hac kers</w>
ati de</w>
sha anxi</w>
nois y</w>
r nas
patient s.
nephro tic</w>
un available</w>
dissoci ated</w>
w ings</w>
hin der</w>
chro mo
p ic</w>
cyp 2
o val
log in</w>
deut sche</w>
q 2</w>
y ing
sa h</w>
hyp op
30 5</w>
man nit
r ts</w>
c dr
t bs</w>
fit c-
b d
al ab
carbon yl</w>
monol ayers</w>
9, 10</w>
b anc
stre ets</w>
syn cy
is er</w>
al an</w>
cross- validation</w>
shel ter</w>
luc ky</w>
hmg b1</w>
chromat ographic</w>
retic ul
lipop olysacchar
transp osition</w>
per mutation</w>
fasc ia</w>
mol ars</w>
adelph ia</w>
hc y</w>
daw ley</w>
residu als</w>
th under</w>
pass es</w>
tr uck</w>
th at
se tae</w>
‰ </w>
gly ca
10. 1
cis co</w>
e uc
ingredi ent</w>
wild type</w>
dr astically</w>
isomer ase</w>
xen ophobia</w>
ne e</w>
prolac tin</w>
access ing</w>
0. 30</w>
tw enti
k 562</w>
h 4
devast ating</w>
cyto genetic</w>
cd nas</w>
pai red-
smo ker</w>
querc etin</w>
homolog ue</w>
sach s</w>
d alian</w>
typh oid</w>
oper ation
s mile</w>
gluc agon</w>
n ab
le ase
hun ting</w>
brow sing</w>
is op
inspec ted</w>
t ext
sp r</w>
h sct</w>
9 50</w>
diag onal</w>
spi king</w>
un covered</w>
ca e</w>
calc ium-
h pa</w>
b cl</w>
bo o</w>
jiang xi</w>
bah rain</w>
in takes</w>
in ates</w>
defend ant</w>
later ally</w>
paraff in-
in del
my x
papill oma</w>
bu c
buty rate</w>
synucle in</w>
edi ble</w>
mis sour
regul arity</w>
sa e</w>
long- range</w>
two fold</w>
decid ing</w>
conv ex</w>
ach i</w>
cal cin
neur ite</w>
ati ve-
cytos ine</w>
sim on</w>
f pg</w>
aur ora</w>
advant aged</w>
0. 33</w>
ship ment</w>
nct0 16
year s.</w>
lact ose</w>
80 -
so oner</w>
lay ered</w>
is en</w>
pro active</w>
mo ham
soci o</w>
in tox
opa que</w>
co t</w>
irin otecan</w>
post- effective</w>
invol un
sp aring</w>
re investment</w>
ver tex</w>
3 s</w>
b ail
un it
10. 2</w>
mid azolam</w>
ori ous</w>
e 6</w>
dis counts</w>
cn t</w>
ab bot
in efficient</w>
c ans</w>
mol dova</w>
endocr in
ge fit
201 0-
el li</w>
c fs</w>
venti lated</w>
pc p</w>
impair s</w>
hemat ology</w>
erc p</w>
a z</w>
o ven</w>
photo receptor</w>
par am
br ic
cr y</w>
b cr</w>
den sely</w>
di amin
c. 5</w>
ple i
zo on
att aching</w>
induc er</w>
3 7.5</w>
install ments</w>
erythro mycin</w>
en graf
subsi dy</w>
1- 5</w>
p ud
recep tive</w>
le hman</w>
intensi fy</w>
metron idazole</w>
adip ocyte</w>
re test</w>
b 2c</w>
ne o</w>
lap top</w>
we ed</w>
popul arized</w>
d dr
stem i</w>
0. 96</w>
certain ty</w>
1 -1</w>
gu i</w>
eosin ophilic</w>
exclud es</w>
man eu
pro thrombin</w>
gover n</w>
nct0 17
vie we
sea water</w>
ch ip
gang li
j ar
ing .
tan a</w>
bar ic</w>
e ter
inf est
6 g</w>
60 00</w>
y 1</w>
objec tion</w>
co existence</w>
j ilin</w>
methyl ene</w>
syn ten
practic ing</w>
0. 97</w>
sw abs</w>
cc 1</w>
yp al</w>
alloc ations</w>
manag es</w>
insemin ation</w>
hr -
cn vs</w>
por phy
ic ol</w>
prote olysis</w>
dro w
member ed</w>
no 3</w>
a 2
r ud
hr an</w>
g ill</w>
ob liter
sevent y</w>
10, 11</w>
t pa</w>
dent in</w>
thro w</w>
galacto sidase</w>
ep inephrine</w>
if a</w>
cap turing</w>
custo dy</w>
pro l
treasur er</w>
bi variate</w>
ge ological</w>
assur ances</w>
electropor ation</w>
acet ylated</w>
v b</w>
l ic</w>
oxygen ase</w>
b im
0. 65</w>
chor oidal</w>
ul sion</w>
it ative</w>
euthan ized</w>
val pro
acu points</w>
pro biotics</w>
inser ting</w>
a ks</w>
odi a</w>
archa e
11 th</w>
mc c</w>
yl ic</w>
ris en</w>
12 9
atresi a</w>
flo od</w>
pep per</w>
ro si
sci atic</w>
t sa</w>
radio activity</w>
ifn- α</w>
c bs</w>
jo hann
ant on
sy br</w>
amo y</w>
l end</w>
hemangi oma</w>
om ni
em itted</w>
- 20</w>
empir ically</w>
as signs</w>
sf c</w>
hydrox ide</w>
h us</w>
tempor ally</w>
debri de
transfer rin</w>
month -old</w>
ac ade
emp ire</w>
pri on</w>
pre- dose</w>
nor mo
un predictable</w>
l er
l bp</w>
h3k 4
liber ty</w>
el eph
c ups</w>
non- employee</w>
six tieth</w>
os se
ap ati
far -
vulner abilities</w>
29 9</w>
natri ure
g ut
tim or-
mit ogen
sust aining</w>
impul se</w>
mb a</w>
200 0-
gif ts</w>
palp itations</w>
ch ess</w>
8 3
tog o</w>
0. 90</w>
ben ch</w>
homeo static</w>
dec eased</w>
spermat ozoa</w>
amaz ing</w>
lyn x</w>
sched uling</w>
un identified</w>
3- year</w>
sal ient</w>
n id
bot ul
immunomod ulatory</w>
le ap</w>
ot roph
pre am
shri mp</w>
am ers</w>
cent red</w>
di version</w>
bare ly</w>
igen es</w>
at or-
2 75</w>
m j</w>
medetom idine</w>
classi fiers</w>
amphe tamine</w>
cc tv</w>
s q</w>
tr ate</w>
nct0 18
carbo xy
ch b</w>
0 1-
timor- leste</w>
d- dimer</w>
gl ac
quin one</w>
ag r
pro- apoptotic</w>
mannit ol</w>
tac kle</w>
transc ranial</w>
rad ar</w>
z ine</w>
symp osi
experim entation</w>
tro op</w>
immun ology</w>
lo d</w>
ne asy</w>
chip- seq</w>
densi to
inspir atory</w>
adju stable</w>
cer amide</w>
susp end</w>
h2 ax</w>
mis cell
ur i</w>
consul tancy</w>
glyc ans</w>
sub cortical</w>
in coming</w>
k r</w>
recre ational</w>
l oud</w>
pc 3</w>
k ok</w>
f ab</w>
x .</w>
mis carriage</w>
to s</w>
p de
g 6
5 -</w>
un qualified</w>
immunob lot</w>
ed .results</w>
cc -
vinc ent</w>
cas ual</w>
harmon y</w>
el uting</w>
pr s</w>
le ep</w>
al k</w>
municip ality</w>
hp f</w>
ac res</w>
ascer tained</w>
ta mp
si p</w>
manip ulations</w>
ne u
evolu tion
m el</w>
do ha</w>
b ap
reiter ate</w>
il- 13</w>
3 6-
disrup ting</w>
0. 40</w>
sup pose</w>
c tr
p im
as ynchron
d ress</w>
un equal</w>
sensiti vities</w>
es cs</w>
s enti
un wanted</w>
zucker berg</w>
bifur cation</w>
claim ant</w>
wal let</w>
fire fox</w>
dg -
ba ker</w>
p am
matrig el</w>
prin ter</w>
fo od-
rifamp icin</w>
5 20</w>
top ography</w>
har der</w>
micro- blog</w>
abbot t</w>
sh ig
19 th</w>
su zhou</w>
co om
k een</w>
hen ry</w>
pre defined</w>
coal ition</w>
john s</w>
ten nes
2. 0
99. 1</w>
exha ust</w>
communic ating</w>
e 7</w>
archa ea</w>
ax i
parti te</w>
pat rick</w>
ambly opia</w>
di pine</w>
chro matic</w>
ric kets</w>
com bustion</w>
neuro trophic</w>
pd- 1</w>
nor th-
heter ozygosity</w>
in f</w>
viri ons</w>
se p</w>
ati zed</w>
subtrac ting</w>
ster ol</w>
sat ellites</w>
paraffin- embedded</w>
nc i-
b pa</w>
2 o3</w>
v h</w>
11, 12</w>
din -
d tc</w>
2- year</w>
br ig
0.00 6</w>
cd 133</w>
vul gar
u ality</w>
t ances</w>
erc ept</w>
1. 2
or ch
neuro psychiatric</w>
0. 70</w>
splen ocytes</w>
exp iring</w>
rel oc
thin ner</w>
d w</w>
0. 32</w>
y- level</w>
10 mg</w>
pre disposition</w>
hydrox y-
nom encl
hu ay
ne pad</w>
bur sts</w>
aliqu ot</w>
b ari
circum ci
reiter ates</w>
mit es</w>
0. 24</w>
long- lived</w>
30 4</w>
exhaus tive</w>
wa x</w>
fi ref
colleg es</w>
nucle oside</w>
un bound</w>
ta ji
sy s</w>
th ec
antipsycho tics</w>
well come</w>
fl atten
et us</w>
x ml</w>
inher ently</w>
g 4</w>
tri vial</w>
pro of
i owa</w>
tyro sin
my algia</w>
accredi tation</w>
j ie
sacchar omyces</w>
co- culture</w>
concei vable</w>
cave ol
un fair</w>
co um
compar t
in ase</w>
ure th
dose- response</w>
acet yl</w>
plug -in</w>
3 1.
tennes see</w>
parasi t
sp aw
pro tons</w>
psycho therapy</w>
neur algia</w>
ri bs</w>
ac company</w>
ch ik
man ship</w>
art emis
nct0 13
harb in</w>
re construct</w>
p 3
safegu ard</w>
amer sham</w>
miscell aneous</w>
tou ch
respon ds</w>
expl ants</w>
ke e</w>
for k</w>
orth opa
py r
enro ll</w>
fl oral</w>
ac anth
phil adelphia</w>
lit er</w>
gli a</w>
lan kton</w>
ab original</w>
coar se</w>
diffic ile</w>
pa uc
adop ts</w>
el ap
oc in</w>
h 7
glit azone</w>
sphinc ter</w>
post- dose</w>
dynam ical</w>
18 s</w>
on- year</w>
priv ately</w>
xper ia</w>
wr ong
bas e-
sc o</w>
dis agreement</w>
pr ur
schistosom iasis</w>
connec tic
stac king</w>
phag ocytic</w>
summar ised</w>
d ji
dul bec
wave form</w>
re mif
1 7.5</w>
es q</w>
infer tile</w>
car nit
cell- cell</w>
outw ard</w>
in security</w>
hamp ered</w>
collap sed</w>
sp rint</w>
vas opres
f ak</w>
fa thers</w>
oc ene</w>
da vi
m s-
s 10</w>
co factor</w>
or derly</w>
p 4
contrast- enhanced</w>
ab e</w>
b k</w>
gl cn
0. 21</w>
species -specific</w>
scrat ch</w>
hypo xi
be have</w>
inter- agency</w>
est -
prokary otic</w>
9 00
perman ently</w>
cl otting</w>
reaffir ms</w>
25 0,000</w>
adsor bed</w>
paradig ms</w>
quanti tation</w>
syn cope</w>
lib or</w>
fu sions</w>
back log</w>
manip ulate</w>
det ached</w>
us her</w>
recru its</w>
tw </w>
el iness</w>
vo 2</w>
d cm</w>
le .</w>
accredi ted</w>
al o</w>
pl ag
therap y.</w>
cholec y
vol can
o genetic</w>
electron ically</w>
fun g</w>
8 20</w>
ob sol
16 gb</w>
don ated</w>
flu ency</w>
c w</w>
op ing</w>
pe ter
mon ter
convul sions</w>
inflam ed</w>
bul l</w>
bro mo
24- well</w>
hs v-1</w>
contamin ants</w>
mal e
plasmin ogen</w>
po x</w>
pus hing</w>
neov ascularization</w>
gu y</w>
d all
connectic ut</w>
li -
29 -
r l</w>
lec tin</w>
rede em
spac ed</w>
un adjusted</w>
cohe sion</w>
r u</w>
al istic</w>
thym ocytes</w>
f 6</w>
to- date</w>
pe er-
wo ods</w>
table 33</w>
ham as</w>
3 70</w>
purpur a</w>
dec oration</w>
re modelling</w>
en th</w>
r l
allo steric</w>
- 10</w>
ζ </w>
10- q</w>
yp e</w>
event ual</w>
cha os</w>
promis ed</w>
sin us
as hes</w>
fibro ids</w>
ly ophil
debride ment</w>
z huang</w>
chloro quine</w>
r ater</w>
nh l</w>
po real</w>
des ensi
intravit real</w>
fon t</w>
self- esteem</w>
tis ation</w>
r igh
oste otomy</w>
de gs</w>
an dr
5 40</w>
am id</w>
l op
am enable</w>
laryn gos
pre dation</w>
brac el
gen ocide</w>
chris tian</w>
found ations</w>
blu e-
at tri
hi ps</w>
2 gb</w>
in ward</w>
a av
hard ness</w>
rup tured</w>
dulbec co</w>
previ ously
d az
direc tive</w>
fab ric</w>
un resolved</w>
bif id
uzbe kistan</w>
ch ong</w>
hydro gel</w>
orph an</w>
imp uted</w>
low- level</w>
wor n</w>
techn olog
immunore active</w>
prolifer ate</w>
retri eve</w>
filam entous</w>
ji ao</w>
anti platelet</w>
ga str
co upon</w>
bar cel
catheps in</w>
fix ing</w>
kyrgy z
as best
fertili zer</w>
locom otion</w>
con spic
u mp
anc ial</w>
p ss</w>
ct d</w>
acet amin
i atro
recep tion</w>
te hran</w>
predat or</w>
wa h</w>
j k</w>
deco ding</w>
astragal us</w>
less ness</w>
rb cs</w>
19 69</w>
un es</w>
5 mg</w>
bu pivacaine</w>
vulgar is</w>
dimen sion
particul ars</w>
13. 3</w>
reg ret
con es</w>
str </w>
dex tro
gi -
id ad</w>
ro sen
ile um</w>
stol en</w>
dow </w>
ampli fier</w>
urban ization</w>
comp il
auto immunity</w>
gam ma-
flo x
oce ans</w>
boo ster</w>
ten sile</w>
seat tle</w>
sub mucosal</w>
rigi dity</w>
prepa redness</w>
in ium</w>
satur day</w>
- raising</w>
ox ib</w>
deter gent</w>
nas h</w>
ro tary</w>
metr ies</w>
un healthy</w>
diab et
il a</w>
nan o</w>
hd ac</w>
detec ts</w>
mad rid</w>
sub- health</w>
oc t4</w>
predispos ing</w>
forec asts</w>
ip a</w>
sh anxi</w>
cap tures</w>
mus k</w>
anop hel
qui escent</w>
muc inous</w>
im mort
cac l2</w>
mathem atics</w>
kyrgyz stan</w>
substi tuting</w>
temp le</w>
gastro esophageal</w>
25 th</w>
sog ou</w>
metallo protein
li ximab</w>
ing en</w>
confer ring</w>
dimin ish</w>
- type</w>
acetamin oph
cyp 3
n lr
th read</w>
fen ac</w>
antagon istic</w>
fant astic</w>
investig ative</w>
cas 9</w>
descrip tors</w>
coun t
m sc
trabec ul
c q</w>
b as</w>
nct0 15
under way</w>
homogen ate</w>
resi st
az en
alph ab
indel s</w>
elabor ation</w>
sch mid
r ac</w>
vi ti
thermo dynamic</w>
cit rus</w>
sub division</w>
k ev
fin nish</w>
η </w>
2, 500</w>
k ra
perine al</w>
de acetyl
t su
petr i</w>
bl asts</w>
circu it
sp o2</w>
ris es</w>
1 m</w>
fl at
dex medetomidine</w>
deci du
determin ations</w>
ma th</w>
convinc ing</w>
speci ation</w>
12, 13</w>
glyco proteins</w>
approxim ated</w>
denat uring</w>
- 80</w>
respon der</w>
proto zo
f red</w>
cin ema</w>
m st
synchron y</w>
disp osi
sequ e
su ms</w>
pir acy</w>
exc av
cyto megal
sc or
indu str
gefit inib</w>
c ia</w>
y- specific</w>
stir ring</w>
14- 3-
infec ting</w>
k re
edi tors</w>
year- on-year</w>
c ec
tr uc
attri tion</w>
perc us
inoc ulum</w>
a -</w>
bub bles</w>
ro t</w>
is n</w>
pa st
conces sions</w>
rel ated
ess ors</w>
ter pen
orth olog</w>
imp unity</w>
non- controlling</w>
acetab ular</w>
continu ally</w>
ke eper</w>
administr ators</w>
at ology</w>
cal ves</w>
trac ted</w>
b low</w>
immun ocyto
reluc tant</w>
li f</w>
iatro genic</w>
col a</w>
cru zi</w>
s ns</w>
0.0 25</w>
li u
sub mitting</w>
calori e</w>
defend ants</w>
ear ning</w>
blood stream</w>
duc k</w>
mortg ages</w>
tri -
amp hen
3 2.
stake holder</w>
pas m</w>
drug- induced</w>
adher ed</w>
sme ars</w>
ap ache</w>
rank l</w>
war s</w>
n ach
two- step</w>
registr ars</w>
c -1</w>
pri mor
trip le-
temper ate</w>
4 4,
p est</w>
al lied</w>
man kind</w>
radi olab
h3k 27
transcrip tionally</w>
om an</w>
quadr atic</w>
bil aterally</w>
ati d</w>
vigil ance</w>
os mol
wit nesses</w>
sr nas</w>
2 32</w>
ge ographically</w>
cho colate</w>
dji bou
eb a</w>
un equivoc
r 0</w>
i ority</w>
ent .</w>
under mine</w>
tin y</w>
e q
figure 1a</w>
di electric</w>
ne st
bay er</w>
ribos omes</w>
p el</w>
concor d
6 .</w>
o edema</w>
lo x</w>
institu tion
single- cell</w>
quen ching</w>
8 c</w>
p is
h tt
g ob
appropri ation</w>
conti g</w>
ed ward</w>
pa i</w>
win ner</w>
forc eps</w>
16. 7</w>
ent e</w>
meteor ological</w>
re constitution</w>
astr azen
tran sure
under estimate</w>
j m</w>
propi dium</w>
sub missions</w>
30- day</w>
10. 3</w>
bud es
dupl icates</w>
inv ade</w>
v ps
el ong</w>
yl on</w>
n av</w>
br ut
s ant</w>
clostri dium</w>
len al
tow ns</w>
chori onic</w>
it y.</w>
gg ing</w>
inter quartile</w>
25 3</w>
missour i</w>
with held</w>
hypo kalemia</w>
bo died</w>
lea ther</w>
laun ching</w>
hy ph
0. 23</w>
cd 45</w>
u pr</w>
we d
re patri
forens ic</w>
or der
circumci sion</w>
m cherry</w>
fol k</w>
b ps</w>
f di</w>
us hed</w>
hydro chlor
i κ
infiltr ate</w>
y in
& </w>
oscill atory</w>
seque stration</w>
b n
v ap</w>
v 5</w>
3 ,0
kap lan</w>
in- hospital</w>
dro p-
twi st</w>
wor k-
md m2</w>
health- care</w>
astrazen eca</w>
sun itinib</w>
her o</w>
h ob
metr o</w>
lymph oblastic</w>
nct0 10
0. 86</w>
di methyl</w>
capital isation</w>
di r</w>
in izing</w>
3 1-
eti ological</w>
cg mp</w>
struc ture-
me g</w>
ation s.
mor ris</w>
s cl
par amount</w>
elev enth</w>
ace ous</w>
ro of</w>
commis sioned</w>
there for</w>
0. 19</w>
shi el
sev o
bread th</w>
permis sive</w>
rel ocation</w>
prescho ol</w>
bm -
wal d</w>
olig omer
en rich</w>
pat ented</w>
e jac
natriure tic</w>
c 2
stat 1</w>
b- 2</w>
spac ecraft</w>
m x</w>
2, 3</w>
diar rhoea</w>
cad res</w>
succee ded</w>
ric o</w>
un familiar</w>
13, 14</w>
fru it
re paid</w>
trans formations</w>
resear ches</w>
comput ationally</w>
h ct</w>
encomp asses</w>
3 01</w>
bi ae</w>
b og
transf ec
sec tioned</w>
bis phosph
4 18</w>
sel </w>
c ne
ibu profen</w>
her d</w>
ro tavirus</w>
intern alized</w>
ev ans</w>
glomerul onephritis</w>
2, 5
14, 15</w>
activ ations</w>
bar bad
socio demographic</w>
ch aired</w>
gol f</w>
djibou ti</w>
3 3.3</w>
a 6</w>
affor ded</w>
err one
stro kes</w>
multi modal</w>
su tures</w>
caus ality</w>
tl rs</w>
prec ious</w>
kow loon</w>
z- score</w>
shen yang</w>
plant ar</w>
mul tim
poly p</w>
critic ized</w>
rot ated</w>
barcel ona</w>
soci etal</w>
26 6</w>
arbo xyl
se phar
b v
embry ogenesis</w>
merch ant</w>
6 j</w>
u ts</w>
intr a</w>
mon o-
poly nom
an ov
barbad os</w>
z ard</w>
ag ne
si bly</w>
jejun um</w>
wn v</w>
40 2</w>
transure thral</w>
he il
cru el</w>
e o</w>
figure 3
depic ts</w>
refer rals</w>
4 h</w>
md gs</w>
eb ola</w>
alcohol ism</w>
ar um</w>
ef f</w>
ace a</w>
st ayed</w>
ever olim
2, 6
pc 1</w>
prac tically</w>
ag er</w>
aband on</w>
c ip
gr en</w>
c itations</w>
moder ate-
fro g</w>
taxonom y</w>
prop ylene</w>
blur red</w>
i u
sp otted</w>
2 17</w>
coloc alization</w>
shu i</w>
mail box</w>
un resectable</w>
z a
inf o</w>
ny ha</w>
tun e</w>
contraindic ation</w>
enc ia</w>
macro economic</w>
elev ations</w>
2 24</w>
remif entan
- through</w>
f im
vocabul ary</w>
hol low</w>
i ol</w>
ha y
r ill</w>
3 6.
ad mit</w>
pro st</w>
inc ar
grate fully</w>
ec lip
d ney</w>
kine sis</w>
logis tical</w>
litter mates</w>
m é
vacu oles</w>
ul nar</w>
r g</w>
related ness</w>
alg al</w>
2. 2.</w>
oc d</w>
nu ts</w>
cont est</w>
oc at
plain tiff</w>
∗ </w>
des ert</w>
ph e</w>
corner stone</w>
identifi ers</w>
ivi g</w>
budes onide</w>
unif em</w>
mon ocyto
re g</w>
eth idium</w>
ar one</w>
categor ization</w>
decomp ens
h y</w>
per tus
ec l</w>
at 1</w>
dev oid</w>
low- risk</w>
i ib</w>
t ac</w>
ischemia- reperfusion</w>
qual ities</w>
end ocytic</w>
huvec s</w>
prin ce</w>
pa ypal</w>
se ated</w>
at g</w>
scal e-
wai ve</w>
fac tion</w>
compl ain
li um</w>
0. 28</w>
share -based</w>
tr af
ca a</w>
ass a
par ac
pertur bed</w>
en counters</w>
mi suse</w>
ut an</w>
ban kers</w>
ev s</w>
any way</w>
acetaminoph en</w>
sick le</w>
non- hodgkin</w>
anis otropy</w>
2 28</w>
particul ate</w>
overl aps</w>
9 99</w>
ha i
nation als</w>
colon ial</w>
al ar
un r
bay es</w>
chol era</w>
uti </w>
ann ers</w>
pr -
sp ous
t cs</w>
del hi</w>
ccr 5</w>
un issued</w>
of t</w>
sc and
guy ana</w>
remin is
w ak
acro mi
imip enem</w>
gu izhou</w>
intran asal</w>
les see</w>
f uk
ca vities</w>
b x
fai th
e os</w>
colori metric</w>
ni h.
immuno compromised</w>
r 3</w>
og lit
vi e</w>
mis matches</w>
che wing</w>
ap ent
real ised</w>
post- transcriptional</w>
f low-
aeros pace</w>
c fa</w>
se ized</w>
no ble</w>
m ite</w>
enforce able</w>
m um
26 8</w>
ish ers</w>
particip atory</w>
surfac e-
spec ulative</w>
es cap
in adver
annu alized</w>
convic tion</w>
rec </w>
15, 16</w>
writ e-
lec tures</w>
i to</w>
s vr</w>
to genic</w>
th r</w>
el mer</w>
dil ute</w>
e dr
t nm</w>
ster oid
m k-
taji kistan</w>
shut tle</w>
ce ase
op -
har sh</w>
low- frequency</w>
sch war
anticip ation</w>
2 39</w>
su v
g lobe</w>
n ick</w>
post- infection</w>
logarith mic</w>
3 β</w>
ab an</w>
medium -term</w>
methyl transferase</w>
bri an</w>
er ies</w>
clar k</w>
evolution arily</w>
inadver t
a 8</w>
4 5,
200 5-
d ase</w>
seroposi tive</w>
pcd na
t man</w>
l tr</w>
i uc
pair -
ip f</w>
f ts</w>
z .</w>
un ve
oste oblast</w>
am ate</w>
youn gest</w>
authen tic</w>
diure tics</w>
long- lasting</w>
4 00,000</w>
homogen ates</w>
sli t</w>
twenti eth</w>
intr ag
25 2</w>
contrac tility</w>
denat ured</w>
valu ations</w>
fo ve
ir i</w>
collo idal</w>
acet am
acc u
gl ur
bloom berg</w>
ac th</w>
cin nam
osteoc lasts</w>
second- line</w>
head phones</w>
pe p</w>
symposi um</w>
5 12</w>
trans loc
0.00 8</w>
obacter i
rob in</w>
inter connected</w>
ment .</w>
t ones</w>
propi onate</w>
illu stration</w>
x- rays</w>
4 90</w>
uniform ity</w>
di ur
lamin in</w>
upr ight</w>
0. 91</w>
top o
radi on
lenal idomide</w>
lo fenac</w>
her 2-
cal oric</w>
par aly
post- conflict</w>
r ps
my c-
hemor rho
insectic ide</w>
cor tis
simpl est</w>
dis continue</w>
po orest</w>
sp ider</w>
specific ities</w>
pharmacolog ic</w>
two- sided</w>
il- 18</w>
ul in
ch t</w>
rel ax</w>
irrevoc able</w>
2 65</w>
analy zes</w>
dissemin ate</w>
q rs</w>
immun o-
year- end</w>
thin ning</w>
2, 7
involun tary</w>
ex ed</w>
pip et
gener alization</w>
in bred</w>
is otype</w>
hon est</w>
crow ded</w>
matur ities</w>
ste war
stock -based</w>
qu o</w>
clim bing</w>
sto id</w>
star ter</w>
arb ital</w>
log 10</w>
chlor amphen
er in</w>
univer sally</w>
ag ram</w>
hom odi
wr apped</w>
amorph ous</w>
∞ </w>
cytomegal ovirus</w>
segreg ated</w>
month s.</w>
applic ants</w>
brow se</w>
dis advantaged</w>
z ot
par acrine</w>
n v
reservo irs</w>
v wf</w>
0. 55</w>
g reg
50 6</w>
ten ancy</w>
30 3</w>
il and</w>
um oral</w>
pill ars</w>
pe f</w>
possess ing</w>
ch ers</w>
comp res
ascor bic</w>
neuro genic</w>
n rs</w>
- d</w>
hem olysis</w>
0. 26</w>
j ose</w>
28 6</w>
dyn asty</w>
h ss</w>
deform ities</w>
asi </w>
me to
br ass
pay roll</w>
ac ia</w>
apati te</w>
cl ay</w>
2 38</w>
nih. gov</w>
com bat
progres ses</w>
l au
0. 83</w>
stat utes</w>
down turn</w>
1 l</w>
3 5.
ch as
grin ding</w>
cas ino</w>
elabor ated</w>
eb ay</w>
pi oglit
c aly
instant aneous</w>
sacrif ice</w>
physic ochemical</w>
advis ing</w>
is -
ne y-
at ur
par kin
y o
vi sta</w>
regi stries</w>
inter disciplinary</w>
inf antile</w>
c- jun</w>
cat alysis</w>
nec </w>
d res
biophy sical</w>
olig o
scholar ship</w>
0. 88</w>
nal ox
bari atric</w>
og an</w>
hyp oc
wast es</w>
blo ody</w>
ob arbital</w>
den afil</w>
unc it
cease fire</w>
frag r
prob np</w>
seed ling</w>
intra -</w>
r ar
remin ded</w>
cl a</w>
excit ement</w>
nomencl ature</w>
christ mas</w>
em sa</w>
pur ulent</w>
exhaus tion</w>
combin atorial</w>
co i</w>
0. 67</w>
dou bt
4, 4</w>
reliev ing</w>
di p</w>
phenyl alanine</w>
utilis ed</w>
dig est</w>
day -old</w>
stres s-induced</w>
micro- bo</w>
thal asse
eq- 5d</w>
modul ators</w>
lipopolysacchar ide</w>
cat ching</w>
thy midine</w>
hydra ulic</w>
d ti</w>
ud ge</w>
10. 4</w>
sn ap</w>
gu anine</w>
bid ding</w>
ti mo
multi factorial</w>
benz odi
t ps</w>
he ights</w>
fluctu ate</w>
br igh
pai -1</w>
s low-
cl s</w>
n ul
pul sion</w>
dent ate</w>
corro sion</w>
1- mediated</w>
0. 89</w>
his ti
se is
j or
infer ences</w>
sevo flurane</w>
or poreal</w>
urtic aria</w>
ch ao</w>
li sten
zh ang
rm sd</w>
muni tion</w>
par cel</w>
bed side</w>
diseas e.</w>
endos omal</w>
centr ally</w>
user- friendly</w>
rect angular</w>
normal ize</w>
citi zen
26 3</w>
predomin ance</w>
granul oma</w>
chemoradi otherapy</w>
heigh tened</w>
ch l</w>
co erc
elem ental</w>
loc alities</w>
xi amen</w>
transcriptom ic</w>
extrac ting</w>
hyal ur
mp 1</w>
wr ink
on ization</w>
pl um
coordin ators</w>
sent enced</w>
resem bling</w>
log 2</w>
st ell
co d</w>
acti on-
ac e-
opharyn x</w>
compul sive</w>
si bling</w>
un igenes</w>
neuro cognitive</w>
35 s</w>
whole- genome</w>
s sa</w>
sephar ose</w>
pa co2</w>
ad mir
dis satisfaction</w>
yol k</w>
p 27</w>
z o</w>
thin k
fol der</w>
fl our</w>
mil dly</w>
subordin ate</w>
north western</w>
pertus sis</w>
hydro cephal
am lo
by- laws</w>
1 17
ad al
pri de</w>
m mr</w>
mel on</w>
fri ed
8 50</w>
ind ol
re classification</w>
3 4.
nin ety</w>
j it
geri atric</w>
conver gent</w>
29 8</w>
lev ofloxacin</w>
r k
cm 3</w>
j h</w>
manag er
un employed</w>
st ear
multipl ying</w>
col -
popul ated</w>
20. 0</w>
viol ate</w>
har assment</w>
sc an
the at
r pl
ac ycl
t ali
he al</w>
inclin ed</w>
famili arity</w>
- 4
co- ordin
n 9</w>
fin ishing</w>
l g
ac utely</w>
an tr
z 1</w>
c- fos</w>
hap lo
stand -
r 01
h ide</w>
on ality</w>
28 5</w>
g out</w>
step -
6- 8</w>
cyto meter</w>
deb enture</w>
multi drug</w>
consen ted</w>
micro phone</w>
emb argo</w>
3, 4,
brus sels</w>
peti tion</w>
asi a-
ot emporal</w>
nov a</w>
p ac</w>
li ens</w>
to ys</w>
p 0</w>
cl ari
inci sional</w>
archa eal</w>
perme able</w>
portu gu
expon entially</w>
targ et
emp athy</w>
cho i</w>
monocyto genes</w>
par ks</w>
ie u</w>
dyne in</w>
c ts</w>
x 5</w>
es- 10</w>
rt- qpcr</w>
ap ha
cortis one</w>
what soever</w>
phot ograph
remifentan il</w>
fac eted</w>
bi phasic</w>
star ved</w>
carb ap
n cs</w>
sch w
a usp
conduc tive</w>
follow -
cyto metric</w>
an um</w>
determin istic</w>
str ated</w>
ro ds</w>
ot ta
bec kman</w>
b pd</w>
mac eu
uncit ral</w>
ophy l
accum ulates</w>
ambi tious</w>
nct0 27
cg i</w>
0. 36</w>
y ale</w>
lex ical</w>
f ear
c up
k l</w>
aug ment</w>
be z
real- world</w>
h mm</w>
intra- abdominal</w>
low s</w>
2 27</w>
lay offs</w>
ht l
í </w>
coll ag
mang anese</w>
lipo proteins</w>
lec ture</w>
d son</w>
est rogens</w>
un folded</w>
mush room</w>
26 2</w>
caes arean</w>
persi sts</w>
expos ing</w>
β- cells</w>
dis agree</w>
arth roscopic</w>
00 2</w>
gest ure</w>
c st</w>
how ard</w>
hemo static</w>
two- year</w>
ure ter</w>
1. 15</w>
o vari
clou ds</w>
di thi
d ang</w>
go -
cl ot</w>
if eng</w>
radion ucli
atl anta</w>
y o</w>
200 7-
non- gaap</w>
olig o</w>
un reasonable</w>
sarco idosis</w>
as on</w>
2 48</w>
precau tions</w>
ed in</w>
m k</w>
poly vin
le pro
omy c
oc cl
pioglit azone</w>
16, 17</w>
got ten</w>
tt a</w>
tes bury</w>
en .</w>
of- the-
inf low</w>
lept os
prop yl</w>
n n</w>
review er</w>
fa sted</w>
land locked</w>
ro aming</w>
guil ty</w>
fe els</w>
pean ut</w>
rhyth mic</w>
gf a</w>
0. 82</w>
neighb ours</w>
protr usion</w>
chil ls</w>
co oked</w>
fis hes</w>
ro se
hetero chromatin</w>
so d1</w>
habit ual</w>
f ears</w>
transform ants</w>
ver de</w>
sulph ate</w>
fl ame</w>
nct0 26
op ers</w>
system -
14 a.
al- level</w>
equ atorial</w>
chon dral</w>
entit ling</w>
n aph
alab ama</w>
dv d</w>
hib a</w>
dic lofenac</w>
c k-
an eu
hypercholesterol emia</w>
ri ver
ens en</w>
discrimin ating</w>
micro fluid
pen insula</w>
2 19</w>
crow ding</w>
dermat ology</w>
metabol ized</w>
ac ul
sp reads</w>
l ati
das hed</w>
draf ts</w>
ten ants</w>
14 0
om i
z in</w>
fu els</w>
br anded</w>
abro gated</w>
cor r
chloramphen icol</w>
re constructions</w>
pec uli
al .</w>
dos ages</w>
bal f</w>
top- down</w>
friend ship</w>
cros stalk</w>
thyro iditis</w>
0. 27</w>
mer idian</w>
se af
lp s-
anti- h
l au</w>
ca 125</w>
ro str
clu ster
kn ock</w>
0. 92</w>
lia oning</w>
perpetr ators</w>
deposi tory</w>
emp tive</w>
ori an</w>
n ous</w>
seven -
deb tors</w>
re stenosis</w>
l af
0. 78</w>
in i
prefer able</w>
myco bacterial</w>
un complicated</w>
c it</w>
,0 00
rev .1</w>
doub ts</w>
inst alment</w>
my oblasts</w>
th omp
head aches</w>
adverti sement</w>
unr wa</w>
discrimin ant</w>
won der</w>
0.00 7</w>
nucle osomes</w>
m sp
maur it
toil et</w>
inf liximab</w>
re ared</w>
nct0 28
dis bur
cann ula</w>
pap ua</w>
co- workers</w>
herni ation</w>
luc k</w>
happ ening</w>
collagen ase</w>
rin se</w>
de polar
ac yl</w>
meth ad
veter an</w>
ro bi
bur ned</w>
as parag
f h
alumin ium</w>
3 7.
pois on</w>
ground water</w>
sin ensis</w>
occup ies</w>
flox acin</w>
amlo dipine</w>
27 6</w>
the ater</w>
not ation</w>
custom ization</w>
igf- i</w>
bam boo</w>
in- mediated</w>
er o</w>
im e</w>
elim inates</w>
cancer- related</w>
n els</w>
reti ring</w>
gl ance</w>
car c
immun ogenic</w>
over- the-
un aware</w>
ly with</w>
succ inate</w>
cr m</w>
ess ness</w>
carnit ine</w>
trac ker</w>
myster ious</w>
ma f</w>
non parametric</w>
th in-
excre ted</w>
e f-
pluripot ency</w>
land marks</w>
ta q</w>
cdc 42</w>
stereot actic</w>
dic kinson</w>
umb ent</w>
ro l</w>
or r</w>
recover able</w>
r flp</w>
sym bion
novel ty</w>
a ws</w>
adverti sements</w>
re ts</w>
met al-
rend ers</w>
cell- free</w>
scri p</w>
asep tic</w>
pv df</w>
gr p</w>
18, 19</w>
e pers</w>
si rolimus</w>
en dum</w>
ip tg</w>
0. 94</w>
f a-
17, 18</w>
cyan osis</w>
parame ter
m si</w>
benzodi azep
bacter emia</w>
d q
e on</w>
tubercul ous</w>
d wi</w>
d k</w>
ca 3</w>
sc ars</w>
br ca2</w>
g 0</w>
detec tors</w>
k sh
fulfil ment</w>
0. 60</w>
ol anz
over coming</w>
be ating</w>
9 6.
inflam mas
pedi atrics</w>
invasi veness</w>
so ul</w>
mir- 21</w>
otta wa</w>
b h</w>
re d.</w>
counterfe it</w>
2 37</w>
col d-
am i
leg acy</w>
te am
ban g</w>
19 68</w>
polymer ic</w>
stat a</w>
2, 8
6 20</w>
4 6,
ud a</w>
um a</w>
wa sting</w>
enum er
h um</w>
arg on</w>
sa ke</w>
or che
blin ding</w>
n- acetyl
0. 84</w>
3 25</w>
equili brated</w>
redeem able</w>
g ong</w>
war ned</w>
in alis</w>
vac ancies</w>
os oma</w>
c ac</w>
cor ning</w>
organ ophosphor
15 n</w>
pen al</w>
me gap
super imposed</w>
gr ace</w>
ase an</w>
ern st</w>
assign ing</w>
stra w</w>
sho ots</w>
bar rett</w>
sensor im
univer sid
200 -
modul ator</w>
lin osi
eg fp-
qu et</w>
ly .</w>
ln cap</w>
termin i</w>
colo strum</w>
2 29</w>
compil ation</w>
analog y</w>
nucle ation</w>
3 8.
lin -
r ong</w>
hom o
organophosphor us</w>
bench marks</w>
ad h</w>
dro pping</w>
inv alu
y- to-
leuk o
ann an</w>
ro ma</w>
t v
lig am
od al</w>
over dose</w>
bcl- xl</w>
leuk emic</w>
counter measures</w>
har a</w>
pher es</w>
he avier</w>
co val
fac et</w>
repe ating</w>
bro ker-
pr un
duc tus</w>
re distribution</w>
intr onic</w>
omega- 3</w>
pharmac ist</w>
sh r</w>
da g</w>
p 8</w>
en es</w>
5 mm</w>
invalu able</w>
organ ised</w>
enjo yed</w>
th om
o statin</w>
low -</w>
er v
papill om
schmid t</w>
0. 38</w>
diab etics</w>
repeat ability</w>
h co3</w>
at rophic</w>
th ecal</w>
16 th</w>
ambigu ity</w>
di hedral</w>
t sing
dom a</w>
lymphaden opathy</w>
chair s</w>
tan ks</w>
phot oper
ó </w>
op n</w>
m t-
sa a</w>
mer rill</w>
bi ke</w>
k cn
streptavi din</w>
cross- linked</w>
mar shall</w>
brady cardia</w>
non sense</w>
nucle ase</w>
gab on</w>
d ab</w>
sensorim otor</w>
un folding</w>
si de
hyp hae</w>
invo ice</w>
co ck</w>
tel ls</w>
mp fc</w>
dop ed</w>
chol est
secur iti
dic tionary</w>
arti sts</w>
bur n
radi ograph</w>
av icular</w>
ac illin</w>
pre- operative</w>
trpv 1</w>
chaper ones</w>
mr a</w>
man tle</w>
r umin
ten sions</w>
es burg</w>
n ut
tum our
ke qiang</w>
g α
reaffir m</w>
train ees</w>
sy dney</w>
aer o
yu an
ec 50</w>
1. 4
start- ups</w>
m ur</w>
t max</w>
s ate</w>
cancel ed</w>
sh am-
mim icking</w>
c un
inter molecular</w>
incid ences</w>
mel t</w>
pt b</w>
smart phones</w>
h2 s</w>
in- based</w>
re ls</w>
co workers</w>
sun light</w>
re aring</w>
figure 2a</w>
deep ening</w>
1 a1</w>
on ics</w>
2 36</w>
initi ates</w>
sero conversion</w>
k ids</w>
hyper insulin
s -</w>
pres sed</w>
a sted</w>
0. 87</w>
di ves</w>
inspec tors</w>
inv ading</w>
co- expressed</w>
prefer ably</w>
3 33</w>
n il
ex foli
ses sional</w>
mis sile</w>
c ache</w>
40 4</w>
astr onau
k od
bracel et</w>
everolim us</w>
un desirable</w>
l 5</w>
inosi tol</w>
conver ge</w>
no bel</w>
conjunc ti
id le</w>
bin ocular</w>
cataly zes</w>
hi p
bound ed</w>
si der
den y</w>
si tis</w>
ho g</w>
v em
bro ok</w>
al y</w>
pelle ted</w>
´ </w>
en se
pb s-
ie ties</w>
0. 48</w>
n ts</w>
lad y</w>
occl usal</w>
krusk al-
per ennial</w>
14. 3</w>
inter s</w>
deriv ation</w>
leng th
neuro toxicity</w>
kan amycin</w>
examin es</w>
after- sales</w>
v 6</w>
concomit antly</w>
sol omon</w>
utr s</w>
co v</w>
si ls</w>
it te</w>
e zh
ext ant</w>
lam iv
to in</w>
rh esus</w>
n ic</w>
lease hold</w>
rt ms</w>
co ach</w>
pherom one</w>
satis fying</w>
tos hiba</w>
10. 6</w>
cor tices</w>
ophthalm ology</w>
controll able</w>
op tics</w>
con dyl
ogly can</w>
la- 4</w>
15. 5</w>
cent .</w>
al is
helic op
nalox one</w>
fun nel</w>
2 33</w>
artif icially</w>
maxim izing</w>
azi thromycin</w>
reminis cent</w>
co- operation</w>
the ft</w>
co l</w>
ocor tical</w>
table 1.1.</w>
ble aching</w>
thaw ed</w>
an na</w>
inter vertebral</w>
nct0 25
si rna-
tac k
si l-
en ema</w>
hin dered</w>
ic ally-
d ar</w>
fore front</w>
heter os
reimbur sed</w>
nct0 24
la wr
quad rup
dre ams</w>
ten ure</w>
h ass
bacter icidal</w>
for amen</w>
fil ari
carcin ogenic</w>
remin ders</w>
ros cope</w>
crystall ographic</w>
casp ases</w>
ozo ites</w>
emp er
al op
ph c</w>
del inqu
proportion ately</w>
diur nal</w>
con doms</w>
corrobor ated</w>
3 3.
h 5</w>
presid ents</w>
un corrected</w>
thomp son</w>
lipo fec
p. i.</w>
compet encies</w>
25 7</w>
amp le</w>
di go
bo s</w>
ation- related</w>
xyl ose</w>
citizen ship</w>
chol er
intrac erebral</w>
jur kat</w>
estim ator</w>
k ii</w>
encomp ass</w>
botul inum</w>
take- away</w>
trin idad</w>
sing er</w>
intrigu ingly</w>
prol ol</w>
al fa</w>
di et
it ates</w>
ed o
grap e</w>
m ab
pf u</w>
myocardi tis</w>
31 ,</w>
reaffir ming</w>
albu m</w>
quar tz</w>
hot spots</w>
encour agement</w>
analy te</w>
practic ed</w>
tr ains</w>
see kers</w>
postp oned</w>
to y
att aches</w>
f dg-
conjuncti vitis</w>
c mos</w>
taip ei</w>
am munition</w>
yn e</w>
b ing
ig an</w>
stric ture</w>
glob in</w>
el in</w>
site -specific</w>
minim ization</w>
osteoc last</w>
gu o
mar t
ali en</w>
g sk</w>
cap sa
f ect</w>
dyst roph
alex ander</w>
draw backs</w>
accr ue</w>
manager ial</w>
tr nas</w>
plan ting</w>
go ats</w>
rou ghness</w>
aggrav ated</w>
form ic</w>
spiro metry</w>
semi- quantitative</w>
radio immunoassay</w>
cen p-
bo ul
advis able</w>
compan ion</w>
shut ter</w>
ne ti
endocardi tis</w>
on ella</w>
sul fur
k 4</w>
figure 4
1 13
hi -
hyper baric</w>
- independent</w>
comple mentation</w>
cl ock
athe ter</w>
arith metic</w>
0. 34</w>
assimil ation</w>
theore m</w>
de phosphorylation</w>
hct 116</w>
liter atures</w>
op enia</w>
sq l</w>
d ock</w>
12. 0</w>
accompl ishments</w>
cop es</w>
mercap to
ing ested</w>
discord ant</w>
lute inizing</w>
har t</w>
bar k</w>
specif ying</w>
ut ter</w>
co g</w>
v- infected</w>
chit in</w>
can e</w>
hyp og
take over</w>
amp s</w>
un ops</w>
ut most</w>
correspond ingly</w>
au stin</w>
phosphatidy linosi
recurr ences</w>
tn bc</w>
it unes</w>
hydrocephal us</w>
loss- of-function</w>
u ber
mi stake</w>
scin ti
le m</w>
barg aining</w>
t elling</w>
pauc ity</w>
kruskal- wallis</w>
hr c</w>
obe si
pyro sequencing</w>
distinc tly</w>
u an</w>
no tif
rosi glitazone</w>
hour ly</w>
fu co
ph ased</w>
vo y</w>
repres s</w>
acceler ometer</w>
ent ang
3 15</w>
it ors</w>
insulin- like</w>
hist ograms</w>
commun icated</w>
can opy</w>
multipl icity</w>
par otid</w>
h sp</w>
d j
col ic</w>
6 e</w>
pt v</w>
ori ent
figure 1b</w>
tribun als</w>
gtp ases</w>
two- fold</w>
nct0 23
olanz apine</w>
6 00,000</w>
techn icians</w>
ch ial</w>
maca ques</w>
★ </w>
ex ome</w>
otyp ing</w>
extrac orporeal</w>
son ication</w>
18 f</w>
op er</w>
og tt</w>
shu ff
ik k
f th</w>
ψ </w>
n ylon</w>
her oin</w>
tiv a</w>
m ca</w>
onom ic</w>
st even</w>
5 30</w>
a ic
entero coccus</w>
pro top
4 3,
pig mented</w>
harmon ization</w>
thi op
res ur
an aphase</w>
im s</w>
n ancial</w>
ok a</w>
re start</w>
smooth ing</w>
vis a</w>
1 15
lip id
26 7</w>
hu ox
figure 44</w>
inter cal
2 45</w>
f x</w>
l- glutamine</w>
dr astic</w>
br uc
del o
less on</w>
bacteri oph
chro mium</w>
prog ressing</w>
pe ep</w>
comm end</w>
cultiv ar</w>
z n
peroxid ase-
mon ophy
my ogenic</w>
sil ver
methad one</w>
l ir
endor f</w>
1. 01</w>
sin -
0. 77</w>
granul ocyte</w>
nct0 29
questi onable</w>
w right</w>
ocl avicular</w>
ess ed</w>
po sting</w>
doubt ful</w>
27 8</w>
an ase</w>
concord ant</w>
i etin</w>
d war
san ofi</w>
adap ting</w>
ji u</w>
confir matory</w>
broad en</w>
un cover</w>
ϕ </w>
s sr
liveli hood</w>
e pam</w>
consol e</w>
batt le
worsen ed</w>
fro st</w>
n ol
we dge</w>
ogen ously</w>
d welling</w>
adjunc t</w>
bi directional</w>
mh c-
shel ves</w>
eb p
civil ization</w>
m 4</w>
inter acted</w>
trans aminase</w>
long er
insul t</w>
mon aco</w>
exha usted</w>
iz ers</w>
cyan obacteria</w>
myster y</w>
enz </w>
f en</w>
w al-
pa rel</w>
ro bin
mtor c1</w>
refin ing</w>
for t</w>
it in</w>
pup ils</w>
dec or
medi tation</w>
3- month</w>
de ionized</w>
p fa</w>
hol ly
m- 2</w>
cycl ical</w>
t ing-
bene ath</w>
gu ang</w>
fc γ
ex p</w>
in sp
k ou</w>
pu mping</w>
pyri dine</w>
ec -
plat elet
homogen ization</w>
fas b</w>
rep lies</w>
10. 8</w>
sty rene</w>
k m2</w>
wein berg</w>
counter act</w>
tub ule</w>
non- current</w>
fl aps</w>
toll- like</w>
formul as</w>
le aching</w>
y y</w>
en te
29 2</w>
cv p</w>
un lawful</w>
fortun ate</w>
es c</w>
oz ol
end less</w>
scram bled</w>
pac kets</w>
en ol
direc ting</w>
swi m</w>
r or
27 3</w>
l ut
maurit ania</w>
0. 81</w>
hon or</w>
revolu tionary</w>
agglut inin</w>
in set</w>
x l
4 7,
cryp tic</w>
ph a</w>
ecta sis</w>
h ul
0. 31</w>
4 8,
br ack
loy alty</w>
circuit ry</w>
cc p</w>
gl ass
electroly tes</w>
z ur
60 ,
poly phenols</w>
di aldehyde</w>
a 7</w>
tr ag
cryop reserved</w>
self- administered</w>
erb b2</w>
johann esburg</w>
flu oxetine</w>
sha w</w>
c ite</w>
e- 1</w>
long- standing</w>
li poly
f- 2</w>
4 10</w>
19, 20</w>
thick er</w>
herbi v
pa k</w>
p id</w>
glutam at
hu gh
inst ar</w>
hom ing</w>
exec uting</w>
stret ched</w>
glycoly tic</w>
c ass
b fgf</w>
lumin escence</w>
pul ling</w>
ti -
0. 76</w>
whole- cell</w>
bur g
kin ase-
ong jiang</w>
cd 28</w>
pi e
her b</w>
g sm</w>
2 43</w>
m ip</w>
c enter
0. 56</w>
vi als</w>
os ce</w>
ste in
t cp</w>
organ elle</w>
gu a</w>
6 40</w>
che ese</w>
mb c</w>
repor table</w>
nic hol
8 10</w>
in clusions</w>
lat encies</w>
fer mented</w>
cor rid
l c3</w>
mist ak
se wage</w>
pd- l1</w>
per mitting</w>
di m</w>
embr ace</w>
w ag
80 00</w>
1 16
plan t-
electr on-
us able</w>
do si
pepti de-
immun ologic</w>
t cr
hormon e-
meta zo
titr ated</w>
co inc
lawr ence</w>
predic tability</w>
transc atheter</w>
ant ine</w>
c di</w>
me ta</w>
9 5.
un ra
str ang
ma ke
cum ber
ty r</w>
dipl om
de tained</w>
dereg ulation</w>
vehic le-
inst agram</w>
i j</w>
her pes
par ous</w>
cell- mediated</w>
fl ushing</w>
am enorrhea</w>
- b</w>
luc ent</w>
post- intervention</w>
2 34</w>
ct cae</w>
pp t</w>
lyso zyme</w>
at ed.</w>
nan og</w>
fa ul
z u
c bp</w>
h3k 9
0. 29</w>
7 20
v 4</w>
di e
anomal ous</w>
denom in
az ines</w>
irrit able</w>
mat the
st ains</w>
cent ur
cel iac</w>
fiel d-
hyper methylation</w>
y. methods</w>
indo meth
ix el</w>
fulf ill
stic ky</w>
plan ted</w>
③ </w>
coval ently</w>
epithel ia</w>
gg t</w>
imp arti
mo tile</w>
ate k</w>
s- related</w>
small- scale</w>
iz on</w>
er go
immunoglob ul
coinc ide</w>
inter nation
7 00
p ine
3- d</w>
v y</w>
w at</w>
lob ular</w>
re places</w>
pl s</w>
27 7</w>
zo ster</w>
glutamat ergic</w>
ad rs</w>
ap cs</w>
fic tion</w>
b ca</w>
bi or
- end</w>
sh 2</w>
bm scs</w>
pa 1</w>
kp mg</w>
end onuclease</w>
5 f</w>
tric ho
oblig ed</w>
con caten
austri an</w>
privileg e</w>
15 0,000</w>
tali ban</w>
clear er</w>
cb d</w>
puber tal</w>
sli m</w>
k ent
m ati
th on</w>
ni -
0. 42</w>
onco genes</w>
comm ands</w>
ep ine</w>
d ad</w>
t ann
ag e.</w>
utilis ation</w>
infiltr ated</w>
0. 63</w>
amer ic</w>
cell s.
thalasse mia</w>
sing ular</w>
sp read
12. 1</w>
ex hal
cyt ological</w>
engraf tment</w>
un labeled</w>
if er</w>
p at</w>
ion izing</w>
rheumat ology</w>
4 30</w>
di l</w>
wal- mart</w>
fulfill ment</w>
bit es</w>
retin oic</w>
merg ing</w>
holid ays</w>
dang ers</w>
liqu or</w>
pt a</w>
tem ozol
vacc in
consci ously</w>
replic ating</w>
inform atics</w>
path way
orthopa edic</w>
arth ur</w>
rel ational</w>
manufac tures</w>
se aling</w>
w t-
bodi ly</w>
pharmaco dynamic</w>
wavel et</w>
j ol
cl oth</w>
inste in</w>
10. 7</w>
heil ongjiang</w>
over-the- counter</w>
. edu</w>
e w</w>
oc t
arab in
ku wa
le ments</w>
0. 74</w>
catabol ism</w>
mic elles</w>
▸ </w>
s ons</w>
sc a</w>
adjunc tive</w>
him a</w>
bi of
ad ri
ju an</w>
fb g</w>
cen sored</w>
c ss</w>
ser opre
n tr</w>
exchang eable</w>
reco ur
20, 21</w>
c 7</w>
4 60</w>
interven e</w>
capac itance</w>
stri pping</w>
meth oxy
e- value</w>
cent roid</w>
don ald</w>
ben j
ip v</w>
publ ishers</w>
mes ang
ph le
revo ke</w>
0. 79</w>
arch ive</w>
t- related</w>
gonad al</w>
glutar aldehyde</w>
extr usion</w>
sch olar</w>
shel ls</w>
plat in
28 1</w>
ep p
11. 3</w>
disco veries</w>
chang sha</w>
path ologists</w>
promis es</w>
19 60s</w>
oc s</w>
x rd</w>
a- like</w>
0. 72</w>
wo unded</w>
thoraco s
ed- release</w>
10 80</w>
potenti ation</w>
imp ede</w>
sinc er
ud ing</w>
b ate</w>
k ay</w>
and rogen
k s
false- positive</w>
achiev able</w>
mou th
anc a</w>
tari ffs</w>
p q</w>
transf usions</w>
inspec tions</w>
wor r
gon or
t um</w>
inform ants</w>
colon y-
cuc um
nct0 20
4 gb</w>
non- cash</w>
t 1d</w>
op t</w>
200 9-
conc ession</w>
k ab
sulf ide</w>
arre ars</w>
vi an</w>
de em</w>
bar r</w>
ec ia</w>
nour ishing</w>
mc l</w>
re p</w>
26 9</w>
n md
pr ice
or ship</w>
portugu ese</w>
0. 37</w>
mag net</w>
flavon oid</w>
v at</w>
bl ame</w>
m sa</w>
equ ities</w>
termin ally</w>
lit ers</w>
ro tor</w>
v sd</w>
sc ut
3 m</w>
suspec ts</w>
photo receptors</w>
legitim acy</w>
intim a</w>
cer am
ger y</w>
lic or
s ob
3 42</w>
su z
nct0 19
enhanc ements</w>
eosinoph il</w>
seam less</w>
s oma</w>
q l
2, 9
long- distance</w>
bi .
er us</w>
ep cs</w>
accur acies</w>
thrombo embolism</w>
repeti tions</w>
lamiv udine</w>
0. 52</w>
b cr-
gen s</w>
to y</w>
hum id</w>
g ow</w>
xi an
eclip se</w>
drain ing</w>
cephalospor ins</w>
facilit ators</w>
local izes</w>
pre conditioning</w>
conver ts</w>
18f- fdg</w>
dec ent</w>
cultiv ate</w>
min ed</w>
simul ator</w>
furn ish</w>
recip e</w>
2 n</w>
sing ing</w>
str uggling</w>
calc ified</w>
sing leton</w>
all op
0. 43</w>
air flow</w>
c cl2</w>
mur mur</w>
non- diabetic</w>
6 6.7</w>
transpl ants</w>
2 46</w>
ill usion</w>
moder ator</w>
monter rey</w>
granul osa</w>
communic able</w>
rev ocation</w>
colon ized</w>
6 h</w>
it ol</w>
trans activation</w>
ide ation</w>
si v</w>
s z</w>
13. 0</w>
tsing hua</w>
0. 66</w>
tetra zol
gen i
q a</w>
ppar α</w>
2 44</w>
link edin</w>
con cur
in amide</w>
sa as</w>
an il
c s-
n ir</w>
fac simil
r x
3 4-
neuro -
granul omatous</w>
allevi ation</w>
resour ce-
intenti onally</w>
o il-
dichotom ous</w>
c- 3</w>
propag ated</w>
oppon ent</w>
pa e</w>
ste ep</w>
ho i</w>
fe -
me ga
5 70</w>
le tic</w>
a- 3</w>
intim al</w>
28 3</w>
h iring</w>
in visible</w>
so viet</w>
ic al-
aden ocarcin
aut ocor
lun ar</w>
neg atives</w>
ab l
dur ban</w>
f uro
obsol ete</w>
mcf 7</w>
tri ad</w>
o protein</w>
eag er</w>
longer -term</w>
path ologist</w>
wh ites</w>
inflam m
intr ins
32 gb</w>
y er
ming ham</w>
hs bc</w>
sub region</w>
ti be
un restricted</w>
hel pl
az d
dl bcl</w>
β- galactosidase</w>
p our</w>
j m
medul la</w>
melan in</w>
y. results</w>
agne tic</w>
forfe it
sam oa</w>
au tistic</w>
dig its</w>
delo itte</w>
c im
pancre ati
consist encies</w>
sul cus</w>
physi o
ii i-
v dr</w>
leishman iasis</w>
achiev es</w>
sau ce</w>
ser ology</w>
ne sts</w>
age -</w>
0. 39</w>
post- traumatic</w>
cou gh
combat ants</w>
ver tically</w>
k j</w>
nocic eptive</w>
remo ves</w>
in ae</w>
reg ressions</w>
interfer es</w>
her -2</w>
deline ate</w>
diff u
met ad
i od</w>
r ong
nt- probnp</w>
terri ble</w>
gradu ation</w>
cam -1</w>
temozol omide</w>
21, 22</w>
pharyn x</w>
t ze</w>
enthusi asts</w>
so aked</w>
i j
viro logical</w>
isot opic</w>
bu tan
tribu te</w>
at tr
kun ming</w>
a sion</w>
os lo</w>
18 0
qu </w>
institu t</w>
poly po
distr action</w>
27 1</w>
buil ds</w>
del aying</w>
origin ates</w>
ch ore</w>
str ain
mos cow</w>
chap ters</w>
director ate</w>
authen ticity</w>
o il
70 ,000</w>
complain ant</w>
pp d</w>
α- synuclein</w>
no x</w>
em -
us ability</w>
c ab</w>
as onic</w>
- utr</w>
eg cg</w>
lifest y
price water
sof t-
an ions</w>
twel fth</w>
form ulating</w>
mil an</w>
e ut
xi ong</w>
cholecy stitis</w>
osse ous</w>
bh utan</w>
2 95</w>
anthropo genic</w>
de mar
cal ories</w>
20 mg</w>
transpos ons</w>
bel la</w>
0. 68</w>
ar id</w>
cd 19</w>
con s</w>
ct p</w>
ri -
sk ip
panor amic</w>
broad- spectrum</w>
antagon ism</w>
r fa</w>
0. 71</w>
separ able</w>
well being</w>
l om
ro dr
in conclusive</w>
flow ing</w>
figure 5</w>
un comfortable</w>
dop a</w>
myd 88</w>
graf ted</w>
cul ture-
anophel es</w>
syri a</w>
st z</w>
recour se</w>
b anned</w>
neighbour hood</w>
subscri bed</w>
ig t</w>
bronchi ectasis</w>
p ab
201 1-
y ard</w>
lipop hil
gl m</w>
elap sed</w>
hum eral</w>
em in
pre determined</w>
tur ner</w>
wol bac
amin ation</w>
metabol omics</w>
hp i</w>
ring er</w>
mi ami</w>
methyl prednisolone</w>
don key</w>
erup tion</w>
mal di-
re ed</w>
pm n</w>
scar ring</w>
versati le</w>
affir med</w>
stock pil
op an
erythro id</w>
30 7</w>
lat ex</w>
pa a</w>
hugh es</w>
re pairs</w>
dig ree</w>
kin der
asia- pacific</w>
j av
floo ding</w>
gluco s
0. 73</w>
he el</w>
adren aline</w>
reflec tance</w>
al bert</w>
ba sil
deser ves</w>
wal ked</w>
phot o-
suppl ying</w>
countr y
l b
in consistency</w>
asbest os</w>
dil ator</w>
2 49</w>
2 41</w>
emper or</w>
hd mi</w>
sul fox
pi e</w>
far mer</w>
kn ocked</w>
v s
telecommun ication</w>
hal t</w>
lepro sy</w>
bur </w>
1. 73</w>
peri oste
agre eing</w>
disclaim s</w>
crani oc
sal es
remn ant</w>
cur ated</w>
fertili zed</w>
site- directed</w>
bir mingham</w>
5 60</w>
den ial</w>
ass ort
am yl
malon dialdehyde</w>
hol y</w>
lot us</w>
por k</w>
en ol</w>
su re-
whit ening</w>
her cul
4 9,
cul turally</w>
alg inate</w>
13 th</w>
resi des</w>
rever se-
pan asonic</w>
buff ers</w>
arbitr arily</w>
0. 58</w>
ba o
em an
inquir ies</w>
ne f</w>
ear ing</w>
c level
y ar
oth o</w>
flan ked</w>
prev ail</w>
electro -
stu ff</w>
under weight</w>
encum br
jin an</w>
breast- feeding</w>
occup ations</w>
ten sor</w>
ac i</w>
s cour
cul min
ne o-
m ock
re par
necro tizing</w>
s 1a</w>
han es</w>
b α</w>
ar ra
n ights</w>
p enc
1. 05</w>
hac ker</w>
catast roph
attac ked</w>
amp ho
comm ended</w>
be ams</w>
col oration</w>
ad ine</w>
gal ec
nel son</w>
concentration- dependent</w>
st ays</w>
16 00</w>
p 1
cyclo hex
par acetam
second- generation</w>
rel ay</w>
hc mv</w>
cd kn
iz ability</w>
un authorized</w>
9 7.
antim al
je wel
pe digree</w>
dev ised</w>
lam el
hous eco
den ver</w>
feat ured</w>
cholin esterase</w>
ren amed</w>
ar isen</w>
st amp</w>
medi atek</w>
h d-
son icated</w>
28 th</w>
rain bow</w>
hydrox ylase</w>
lou isi
t sp
guine a-
out lier</w>
kev in</w>
water proof</w>
indometh acin</w>
phosphati dyl
in us</w>
d x</w>
th am</w>
rh abdom
d 5</w>
be -
chimer as</w>
hand held</w>
n scs</w>
ensu ing</w>
pc l</w>
pro position</w>
io do
echo ic</w>
wher ever</w>
att an</w>
ud g
mic ronutri
persi st
imprin ted</w>
champ ion</w>
19 66</w>
acryl ic</w>
sw allow</w>
zheng zhou</w>
c inc
licen see</w>
2006- 2007</w>
ultrason ographic</w>
form al
zhong shan</w>
p ads</w>
cp p</w>
loc ality</w>
y r
ch at
ye e</w>
c- peptide</w>
4 2.
ultras o
stabil izes</w>
ligh tw
guaran ty</w>
att ach
ab normally</w>
c ated</w>
fi d</w>
guid es</w>
pricewater houseco
thi o
x ii</w>
anc un</w>
pal ace</w>
facsimil e</w>
deb ates</w>
amp hibi
ab duction</w>
dy l</w>
emerg es</w>
or y-
y clin
hal o</w>
co- localization</w>
pe ach</w>
omat osis</w>
t s-
signal- to-
12. 2</w>
circum fer
jin shan</w>
sl er</w>
twenty- five</w>
p eng
comp li
c pt</w>
prud ent</w>
incorrec tly</w>
jejun i</w>
3 3-
ob ses
n u</w>
3 38</w>
co met</w>
vol ution</w>
holly wood</w>
mis classification</w>
haemorrh age</w>
clean sing</w>
lo vir</w>
co ils</w>
plei otropic</w>
ub a</w>
16 0
bi e</w>
sar tan</w>
ber y</w>
k ov
hydrol ase</w>
pricewaterhouseco opers</w>
rip ening</w>
ho ech
char ity</w>
o ak</w>
transfer ee</w>
il-17 a</w>
res p</w>
gl ue</w>
mo ieties</w>
tri age</w>
ver izon</w>
cont ag
lp s-induced</w>
sor ry</w>
ure ly</w>
imp osition</w>
mcd on
over- allotment</w>
deman ded</w>
sur in
t ome</w>
dry ness</w>
st airs</w>
ric ket
dodec yl</w>
ti p
con du
δ -
tic ism</w>
chemo therap
ap parel</w>
di ph
iner tia</w>
car to
0. 41</w>
draw back</w>
g pa</w>
gam bia</w>
que bec</w>
a hi</w>
h t-
pic king</w>
m atism</w>
light ning</w>
les otho</w>
ref rain</w>
toco pher
p ns</w>
cataly ze</w>
cel ec
promo tions</w>
corr .1</w>
hot spot</w>
e ort
un usually</w>
resi s
opla sts</w>
stimul ator</w>
prevent able</w>
m app
affili ation</w>
ultra structural</w>
char itable</w>
compo si
pul l-
5- 7</w>
am ne
o 2-
obsc ure</w>
denti stry</w>
tetrazol ium</w>
bang kok</w>
coincid es</w>
anton io</w>
ul i</w>
ampho ter
entit lements</w>
w ang
intox ication</w>
membrane- bound</w>
11. 0</w>
de z</w>
trade- off</w>
hemis pheric</w>
bl ac
ser ially</w>
pat ellar</w>
policy makers</w>
je op
block age</w>
h ar</w>
obacter ial</w>
h og
β- d-
mid gut</w>
fist ul
os -
vacu ole</w>
0. 62</w>
anti serum</w>
grow th-
ab cg
my ers</w>
liqu id
air borne</w>
30 9</w>
hn scc</w>
ignor ing</w>
tob ago</w>
correl ating</w>
adi </w>
22, 23</w>
dark ness</w>
midwi ves</w>
0. 53</w>
gastroenter itis</w>
sc ul
sp as
open ness</w>
correc tive</w>
and ers</w>
tic le</w>
i tic</w>
sha ker</w>
gle ason</w>
mil it
11. 4</w>
comp etes</w>
x t</w>
cer tify</w>
mesang ial</w>
grass -
spin- off</w>
ide -
metagen omic</w>
ill iter
27 9</w>
innoc ent</w>
rad 51</w>
hun t
ac p</w>
tele ph
mos s</w>
h ans</w>
g org
ocat aly
0. 44</w>
intra thecal</w>
sil denafil</w>
kuwa iti</w>
tex tile</w>
classi fying</w>
l essor</w>
glas gow</w>
sc n</w>
ct x</w>
follow up</w>
arteri osus</w>
seropre valence</w>
f mr
long- acting</w>
cf o</w>
louisi ana</w>
res et
wor ding</w>
cobal t</w>
phon ological</w>
defen ses</w>
ad p-
100 00</w>
gp crs</w>
assi e</w>
es hif
diam onds</w>
fac tual</w>
eng ages</w>
28 2</w>
ba it</w>
cr ying</w>
ischa emic</w>
un translated</w>
x on</w>
time table</w>
insi st</w>
dr um</w>
sk ype</w>
h ev</w>
25 9</w>
fo stering</w>
iss ance</w>
al dh
dop ing</w>
12- week</w>
shen fu</w>
mil ieu</w>
trip s</w>
myco bacteria</w>
accu stom
clevel and</w>
gra zing</w>
3- 6</w>
per itoneum</w>
0. 47</w>
dis mant
he y</w>
avoid able</w>
ub un
d md</w>
mi ui</w>
lu mp</w>
t sun
1 12
neph rectomy</w>
chlor ine</w>
bi m</w>
tibe tan</w>
arach id
q a
choler ae</w>
10 b</w>
a- based</w>
accustom ed</w>
weak ening</w>
0. 64</w>
imp or
ke eps</w>
q tc</w>
n ct</w>
qualit y-
absor p
illum inated</w>
sour ced</w>
chemot actic</w>
ten o
over due</w>
n ine-
des ic
intrins ically</w>
t cf
gor don</w>
cell- based</w>
oste omyelitis</w>
bel ize</w>
under estimation</w>
r neasy</w>
sk -
de generate</w>
umb rella</w>
th p-1</w>
a. methods</w>
col pos
estim ations</w>
dis appointing</w>
ad mixture</w>
infl ated</w>
paracetam ol</w>
tur bul
insti ll
y tes</w>
down loads</w>
d nas</w>
ord inal</w>
regi on
stag ger
anc erous</w>
fron tier</w>
birth day</w>
p f-
os sification</w>
experim enter</w>
caver nous</w>
coul ter</w>
mus cle
f md</w>
liber alization</w>
tim escal
n ls</w>
he pt
propos ing</w>
0. 54</w>
m fs</w>
tetr amer</w>
dimer ic</w>
hel met</w>
h cs</w>
pun ish</w>
1 h-
inter phase</w>
hat ching</w>
et ching</w>
bo vis</w>
tim ed</w>
fra il
o ia</w>
ke epers</w>
d dr</w>
secre ts</w>
gri ds</w>
contradic tion</w>
24- h</w>
figure 3a</w>
cop ied</w>
m ip
g adol
al- like</w>
bour ne</w>
faec alis</w>
ar a
gau ze</w>
summar ies</w>
0. 46</w>
v ander
nic hes</w>
evalu able</w>
be dro
el u
oly ticus</w>
t agging</w>
won dered</w>
et an
sm es</w>
facilit ator</w>
trans vaginal</w>
hap loid</w>
desc end
k ar</w>
o o
pal pation</w>
soc ket</w>
19 60</w>
decentr alization</w>
. 15</w>
0.00 9</w>
appropri at
stand- alone</w>
min ne
anch or
ld l-
cs r</w>
tru st
leaf let</w>
retrospectivel y.</w>
pe el</w>
conf is
speci alization</w>
finger prints</w>
pre fec
vide o-
mb ps</w>
tris omy</w>
zhong gu
cu be</w>
exten sor</w>
poc kets</w>
in vertebrates</w>
uc ky</w>
ameli orate</w>
mar ia</w>
dissec ting</w>
e is
v icious</w>
decol onization</w>
r fp</w>
cell s
un listed</w>
cy r
t 5</w>
biot in-
one ur
hyper thermia</w>
nct00 00
fa ecal</w>
inter viewe
state- of-the-
flex or</w>
boo sted</w>
pp 1</w>
deb ated</w>
coup ons</w>
un realized</w>
p- gp</w>
min s</w>
emul sification</w>
acromi oclavicular</w>
un aids</w>
quad ric
30 s</w>
imag in
carr y
- shaped</w>
i re
ph y</w>
li ster
a ha</w>
a av</w>
arro whe
time- lapse</w>
ureth ra</w>
zhonggu ancun</w>
27 4</w>
stra ight-
cli ps</w>
im migrant</w>
4 5.
mi ke</w>
cataly sts</w>
29 1</w>
and or
pop s</w>
config ured</w>
prim i
p ex
sw az
6. 67</w>
cas ein</w>
11. 6</w>
ub s</w>
tr ades</w>
tri phosphate</w>
4 70</w>
exacerb ate</w>
av oids</w>
aminogly co
as hed</w>
wed ding</w>
ense mbl</w>
sub way</w>
re pairing</w>
gest ures</w>
met at
cas es.</w>
vac ation</w>
os aur
dir ty</w>
con cave</w>
n int
glu can</w>
0. 61</w>
parallel ed</w>
il- 5</w>
10 5
hon or
un satisfactory</w>
j p
r hu
in tub
secret aries</w>
answ ering</w>
sulfox ide</w>
sub species</w>
6 30</w>
polynom ial</w>
t sc
conspic uous</w>
29 6</w>
mind fulness</w>
p 38
uplo aded</w>
regi sters</w>
c tt
threat en</w>
k k</w>
v et</w>
is h-
ok la
ab eth</w>
evap orated</w>
seis mic</w>
escal ating</w>
ip c</w>
retail er</w>
k g-1</w>
12. 3</w>
studi es
c apped</w>
dic er</w>
le man</w>
heterodi mer</w>
δ δct</w>
corn ell</w>
bam hi</w>
foot note</w>
tumorig enic</w>
sl udge</w>
23, 24</w>
tour ists</w>
ven tr
kenne dy</w>
y rs</w>
ex tradition</w>
interleukin -6</w>
cc i</w>
m sct</w>
ver o</w>
pa v
a issance</w>
co di
us s</w>
rep lied</w>
m c-
7 .</w>
pow er-
fo il</w>
extr ab
chemo attrac
sch wan
3 90</w>
figure 2b</w>
e ur</w>
2 x</w>
basil ar</w>
declar ations</w>
0. 69</w>
popul ation-
ventil atory</w>
sleep iness</w>
end able</w>
. .
9 4.
hun t</w>
with stand</w>
fiduc iary</w>
thi ol</w>
st d</w>
a wa
sin o-
24, 25</w>
lipofec tamine</w>
deal ings</w>
y li
megap ixel</w>
a 1
star tup</w>
hun ter</w>
shrin k</w>
jus tification</w>
nl r</w>
degrad able</w>
ff er</w>
0. 49</w>
kent ucky</w>
gravit ational</w>
ker atitis</w>
mil lis
son i</w>
insur er</w>
g ag
sn are</w>
ol ar
d or</w>
yu en</w>
interne t-based</w>
top hy
ma e</w>
0. 51</w>
me tic
trans well</w>
sh ade</w>
dall as</w>
an tec
g se
min ds</w>
tr onic</w>
a ac</w>
deduc ted</w>
paralog s</w>
el ian</w>
papillom avirus</w>
state-of-the- art</w>
100 mg</w>
m ms</w>
o z</w>
till ation</w>
van cou
lightw eight</w>
se ab
millis ec
spati otemporal</w>
tetra hydro
os cope</w>
d é
head -
educ ators</w>
4 40</w>
step ping</w>
air line</w>
v pa</w>
foot print</w>
ket one</w>
glac ial</w>
hap log
- tb</w>
angel ica</w>
adal imumab</w>
phosphor ylate</w>
ep c</w>
om ed</w>
2 72</w>
mercapto ethanol</w>
c- kit</w>
26 4.7</w>
on ian</w>
udg etary</w>
is otropic</w>
luc ia</w>
ip d</w>
c sp</w>
prescri be</w>
extrab udgetary</w>
cd 40</w>
industri alized</w>
cre w</w>
ol itis</w>
g sp</w>
real ty</w>
hemorhe ology</w>
te d-
act one</w>
acidi fication</w>
e ucli
reco vering</w>
ad ducts</w>
kel ly</w>
swaz iland</w>
okla homa</w>
introduc tory</w>
ex ocytosis</w>
mitogen -activated</w>
r afts</w>
diver ged</w>
11. 8</w>
co de
bon a</w>
x- linked</w>
can als</w>
vil li</w>
stom atal</w>
quinol ones</w>
al e
reas oned</w>
econom ist</w>
m if</w>
d ac</w>
celec oxib</w>
insi sted</w>
angi ographic</w>
spous es</w>
10 10</w>
1. 8
viro logic</w>
epp endorf</w>
super se
deser ve</w>
en sl
un modified</w>
writ ers</w>
lu tide</w>
28 9</w>
pt x</w>
tim ber</w>
licor ice</w>
lam b
trop ic</w>
wel ding</w>
serot on
fore brain</w>
hur ric
well- characterized</w>
ip er</w>
tr ine</w>
contin gen
c sf
conver s
ps p</w>
connec ts</w>
si o2</w>
cd 45
. 11</w>
a 2a</w>
ti ffs</w>
t st</w>
g ay</w>
st am
s on-
dang dang</w>
cl p</w>
loc alisation</w>
&apos; clock</w>
ti ously</w>
amylo idosis</w>
numer ically</w>
sp un</w>
remn ants</w>
epic ardi
parkin son
comp lain</w>
pun ished</w>
p all
s srs</w>
cd 31</w>
1 14
b end</w>
d hs</w>
fdg- pet</w>
arti st</w>
obacteri aceae</w>
hercul es</w>
restr ained</w>
pc- 3</w>
ophyl line</w>
si ll
chol edo
make up</w>
rib ose</w>
ori ent</w>
am el
4 2-
me tre
oligomer ization</w>
temper ament</w>
pro tru
refres h</w>
ro chester</w>
sa me-
de uter
zoon otic</w>
ubun tu</w>
0. 59</w>
19 61</w>
ba hamas</w>
frail ty</w>
ok ie</w>
vancou ver</w>
forec asting</w>
h el</w>
act in-
md ck</w>
kinder gar
fer rous</w>
sc is
cu ret
29 4</w>
19 65</w>
sp lin
s ulation</w>
a or</w>
z inc
deleg ates</w>
pro fil
0. 57</w>
v ast
impur ities</w>
simul ating</w>
bo red</w>
mal dives</w>
tr agic</w>
8 00,000</w>
pi er
neuro surgery</w>
pc d</w>
ris on</w>
f 0</w>
ath ic</w>
extrapol ated</w>
ax in</w>
ol amine</w>
fl ank</w>
6 2.5</w>
mol e</w>
ausp ices</w>
nint endo</w>
bl 21</w>
scho ol-
ro -
complement arity</w>
cardiomy ocyte</w>
p anda</w>
broncho alveolar</w>
out lines</w>
be ac
non- compliance</w>
budg eting</w>
pg c-
10.1 186</w>
str a</w>
proper ty
sustain ed-release</w>
ig f
judg ing</w>
pur kin
50 5</w>
4 25</w>
ad am</w>
multi focal</w>
dextro se</w>
cm c</w>
ji u
gluc uron
15. 0</w>
i aa</w>
charg er</w>
iv -
de tr
hum or</w>
lat ors</w>
daw n</w>
cauc asians</w>
endang ered</w>
phosphoryl ates</w>
ç ão</w>
industri alization</w>
ly l</w>
co- infection</w>
non- responders</w>
deli vers</w>
β-lac tam
p x
anc re
pas sion</w>
multi functional</w>
ozyg ote</w>
mit tance</w>
ght ful</w>
rot ator</w>
peroxis ome</w>
architec tural</w>
k 5</w>
t ka</w>
9 20</w>
gp 120</w>
so ap</w>
at- risk</w>
e y-
plain tiffs</w>
ox -
clari thromycin</w>
brachy therapy</w>
sr -
µ mol</w>
astro cyte</w>
co-mor bidities</w>
s word</w>
cx 43</w>
pare sis</w>
l ice</w>
eb v-
intro g
hydroph ob
t age</w>
ex in</w>
dam s</w>
lncr na</w>
trim med</w>
pharmaco po
10. 9</w>
ver tices</w>
encum bered</w>
fav oring</w>
regul arities</w>
ap 2</w>
aut ocrine</w>
boo sting</w>
muc in</w>
pdg f</w>
rank ings</w>
uran ium</w>
dial ec
k ick
refl exes</w>
photos ensi
p em
sac ral</w>
alkal oids</w>
2 47</w>
signal-to- noise</w>
injec table</w>
market -
oppon ents</w>
em itting</w>
compromis ing</w>
c ach
ch c</w>
pal mit
ography .</w>
thor a</w>
ar omat
lear ners</w>
random -
load ings</w>
par ent-
n w</w>
post doctoral</w>
symb olic</w>
ur idine</w>
fas l</w>
ca tho
9 2.
am es</w>
ba um</w>
e- related</w>
pre- clinical</w>
bio sis</w>
 </w>
enc y-
ste al</w>
wi dening</w>
c va</w>
multic entre</w>
gin k
v g
c p-
group s.
el iz
i on-
deline ated</w>
imper fect</w>
sun shine</w>
mat ured</w>
n w
her ds</w>
c w
h inge</w>
imper ial</w>
transmit ter</w>
enrol ling</w>
d sm</w>
asser ted</w>
ye ung</w>
schwan n</w>
ar b</w>
disrup tive</w>
accid entally</w>
re hydration</w>
ri bb
sp rag
ail ed</w>
ri ft</w>
peri vascular</w>
sp c</w>
encap sulation</w>
thyro idectomy</w>
fav ors</w>
se al
ph oid</w>
fin s</w>
s fr
end oc
aly s</w>
bl end</w>
99mt c-
stat ure</w>
1. 6
cumber some</w>
on t</w>
transfer able</w>
in- treated</w>
28 4</w>
thromb olytic</w>
en i
motiv ate</w>
p gl
compar ability</w>
fl ights</w>
ali ke</w>
transl ating</w>
examin er</w>
un to</w>
m g-
reimbur se</w>
di ode</w>
spermat ogenesis</w>
be side</w>
cy p</w>
de mol
infrequ ent</w>
28 7</w>
gr p
post graduate</w>
tr am
ha irs</w>
tai wan
ex ams</w>
mis si
st m</w>
vasodi l
ti que</w>
cal modul
lif ted</w>
ul trac
201 2-
z on
aer ob
clin dam
sel dom</w>
car ers</w>
dys regulated</w>
f ame</w>
purkin je</w>
lo tion</w>
e ther
l on</w>
relap ses</w>
4 3.
o esophageal</w>
ct la-4</w>
bal ls</w>
inv ented</w>
17 m</w>
sahar a</w>
os ur
consecu tively</w>
13. 2</w>
cyto kinesis</w>
brac kets</w>
ur ic
β- hcg</w>
″ </w>
he idel
1- dependent</w>
ap a</w>
h l-
arrhyth mic</w>
n v</w>
secret ase</w>
xyl ene</w>
t fi
ap l</w>
inflammas ome</w>
bl es
se i</w>
8 01</w>
heur istic</w>
3 12</w>
h dr</w>
under- secretary-general</w>
p gf
ag glomer
las ers</w>
side- effects</w>
ir d</w>
acknowle dg
in human</w>
function alized</w>
vinc rist
mu d</w>
am iod
my b</w>
carboxyl ic</w>
b pm</w>
ren in</w>
ab at
osi tis</w>
glyco syl
middle- income</w>
1, 3-
oper able</w>
dom ain-
w ing
mil lil
immort alized</w>
microfluid ic</w>
brad ford</w>
metad ata</w>
2004- 2005</w>
met aph
in congruent</w>
cran io
sple ens</w>
psych opathology</w>
an thin</w>
fore ig
comp ressive</w>
con gol
s org
sprag ue-
mol yb
sr a</w>
reco veries</w>
loos ening</w>
rho dop
sto ols</w>
optim ism</w>
ch ick</w>
des per
de 3</w>
5, 6,
h end
sp rings</w>
eff er
ezh 2</w>
bul l
electro my
glomerul i</w>
sub families</w>
cyp3 a4</w>
optim ally</w>
g 201
t apping</w>
non- surgical</w>
imp etus</w>
bur dens</w>
de pot</w>
nin ety-
met amorph
2 2.5</w>
neurotransmit ters</w>
j im
aptam er</w>
intra- articular</w>
r sd</w>
ophy tes</w>
trac hom
b nb</w>
me .</w>
b k
multi tude</w>
un met</w>
pre existing</w>
toxic ology</w>
cal e</w>
opac ity</w>
8- 10</w>
trad ers</w>
di pole</w>
adop tive</w>
foc us
pk m</w>
incre di
mit ch
fe eder</w>
deliber ate</w>
1. 3
har t
gu i
non coding</w>
carbox yl</w>
in consistencies</w>
de ma</w>
paired- end</w>
bow l</w>
tolu ene</w>
mal ari
wolbac hia</w>
in land</w>
1 18
sw aps</w>
er i
under stands</w>
dis charges</w>
l k
qi an
ic lovir</w>
cirrho tic</w>
fruit ful</w>
punc tate</w>
tr pm
har d-
dis assembly</w>
flav in</w>
mar ino</w>
quadric eps</w>
cross linking</w>
w fp</w>
a- c</w>
sch ul
gan su</w>
drin kers</w>
40 3</w>
sprague- dawley</w>
dong guan</w>
am ster
con dy
pa use</w>
sym biotic</w>
option ee</w>
fram eshif
ec top
bioinform atic</w>
stere o</w>
sed ative</w>
centro some</w>
ser on
ation s.</w>
chr is</w>
l adder</w>
pre- installed</w>
uter o</w>
treatment -related</w>
le y
fl ud
co atings</w>
closed- loop</w>
morph ologies</w>
s. d.</w>
je an</w>
statis tic
en berg</w>
ly s</w>
ocyan ate</w>
pap er
bl -
renov ation</w>
un suitable</w>
extrav as
hi e</w>
pol lu
centr ality</w>
mo ody</w>
. 12</w>
diar rhe
ec o-
zur ich</w>
at rac
ri i</w>
it ong</w>
le u</w>
sc f</w>
conduc tor</w>
stri pped</w>
minne apolis</w>
def er</w>
dev ote</w>
cor ners</w>
z eng</w>
re actors</w>
ol one</w>
par s</w>
v og
tou che</w>
flo at</w>
γ δ</w>
gen ec
dan shen</w>
ent ails</w>
l ap</w>
ch ag
prur itus</w>
op ec</w>
prec ancerous</w>
car trid
amo to</w>
tac tic</w>
f ud
50 mg</w>
south western</w>
rn ap</w>
4 8.
p2 x
chim era</w>
ham ster</w>
mas ks</w>
hl h</w>
awak ening</w>
ed es</w>
ocy stis</w>
1. 02</w>
cu i</w>
bul ge</w>
si ve-
fem al
en anti
apha sia</w>
moc .
alk ali</w>
a unt</w>
understand ings</w>
a 3
d at</w>
ak in</w>
acryl ate</w>
dichlor o
carot ene</w>
lyophil ized</w>
color ful</w>
aus cul
and 2</w>
pro ves</w>
h ud
m 8</w>
whole- body</w>
viri on</w>
cd 4
cra w
hydro carbons</w>
9 3.
grass- roots</w>
aromat ase</w>
repatri ation</w>
im age-
collabor ate</w>
b 5</w>
co oper</w>
h ec
ricket t
off- target</w>
peg ylated</w>
asth enia</w>
er es</w>
it p</w>
h me</w>
biop har
s burg</w>
com memor
nec rop
quot ation</w>
insectic ides</w>
eti ologies</w>
ap gar</w>
b ble</w>
neuro developmental</w>
s gr
scinti graphy</w>
na 2
at c</w>
mon tel
blac k-
comm ens
a- specific</w>
tlr 9</w>
st acks</w>
le id
pre menopausal</w>
f ang
clu bs</w>
mobil izing</w>
to- treat</w>
specif ies</w>
ec ori</w>
pdg f-
1 gb</w>
pur ifier</w>
abrup t</w>
4 73</w>
rac ing</w>
afric an-
non- steroidal</w>
ten se</w>
forwar ded</w>
path ologically</w>
q in
g es
sp ot
extr ap
advoc ates</w>
ye asts</w>
13. 6</w>
con f</w>
e ably</w>
tic um</w>
cl oz
t1- weighted</w>
kine sia</w>
diph ther
dem o</w>
mu st
trunc ation</w>
6- fold</w>
m th
ju ana</w>
coom assie</w>
thal idomide</w>
excep tionally</w>
un safe</w>
halluc inations</w>
epti dase</w>
me p</w>
20 s</w>
is oni
with drew</w>
ab o</w>
seven teen</w>
op d</w>
n s1</w>
roc ks</w>
interpol ation</w>
5, 5</w>
amster dam</w>
sing h</w>
camp yl
bis ulf
extern ally</w>
distribu ting</w>
pip elines</w>
str ings</w>
broad ening</w>
bor g</w>
pseud op
. net</w>
kineto chore</w>
quar tiles</w>
mean time</w>
guardi ans</w>
ultr afil
propri oc
ing ham</w>
ap por
im balances</w>
self- made</w>
defe at</w>
hy dri
mm -
infer iority</w>
r fs</w>
brea th
a j</w>
retin as</w>
li de</w>
jak 2</w>
xim e</w>
4 4.
inter costal</w>
if g</w>
exemp lified</w>
superv ise</w>
ment ations</w>
replic ative</w>
c 8</w>
hyp oplasia</w>
de methylation</w>
nct0 12
p 50</w>
disrup ts</w>
dy sen
4 r</w>
f use</w>
ht ml
quar tet</w>
ell o</w>
quot ations</w>
hoech st</w>
appropriat eness</w>
temp ting</w>
l ang</w>
ri mal</w>
f ir</w>
f co</w>
fore station</w>
d- like</w>
4 1.
in activity</w>
br is
phosphat ases</w>
over time</w>
g ur
reg ain</w>
cl amation</w>
mir- 14
gam biae</w>
siz e-
z u</w>
cr 1</w>
ol ding</w>
lea ked</w>
o sides</w>
robin son</w>
day s.</w>
na i</w>
cd11 c</w>
ta k</w>
surin ame</w>
tion ality</w>
re cher
on ous</w>
attenu ates</w>
xiaob ian</w>
semi- structured</w>
ra iny</w>
leng thy</w>
or d</w>
19 49</w>
withdraw als</w>
25, 26</w>
inv aded</w>
el f</w>
artemis inin</w>
think pad</w>
lipos omal</w>
gl as</w>
comp lywith</w>
company within</w>
t se</w>
desensi tization</w>
f us</w>
favor ably</w>
e ic
pharmacopo eia</w>
su v</w>
trans genes</w>
us her
mag azines</w>
stem -
dis ney</w>
6 -</w>
ph -
o od</w>
lig o</w>
re x</w>
acet yl-
pla 2</w>
cus hi
pr of</w>
am ik
lever aging</w>
mis conduct</w>
leg ic</w>
d he
tim ulation</w>
pa in-
liter ary</w>
sof a</w>
rou ps</w>
19 64</w>
fa una</w>
in oid</w>
flat- panel</w>
3, 6
tru sted</w>
em r</w>
ct cs</w>
ambi on</w>
ext ingu
ma th
self- determination</w>
incar cer
ph p</w>
que ensl
5 01</w>
wh o
parat y
ag onal</w>
num ber
5. 00</w>
ff pe</w>
11. 7</w>
w ic
an onym
educ ate</w>
el li
pig ments</w>
repres sive</w>
porno graphy</w>
boli varian</w>
illustr ating</w>
ni aid</w>
abbrevi ations</w>
sh ocks</w>
mv d</w>
er ian</w>
vag ue</w>
synthe tase</w>
i form</w>
histopath ologic</w>
montel uk
olig omeric</w>
ti bet</w>
du m
ar o</w>
fem in
hyp no
counter stained</w>
cla uses</w>
9 8.
ang itis</w>
per m</w>
ar av
pur ine</w>
expan ds</w>
scrap ing</w>
for gotten</w>
pass -through</w>
1, 200</w>
activ ity-
bas olateral</w>
numer ic</w>
u 2
m 9</w>
d cis</w>
bom b</w>
shir t</w>
nk x
a etiology</w>
trip let</w>
mo ist</w>
epig astric</w>
4 ,0
4 6.
br and
consum mated</w>
gar lic</w>
nk t</w>
mil ls</w>
hybri doma</w>
errone ous</w>
mal arial</w>
val sartan</w>
ca re-
polyp eptides</w>
am oled</w>
br y
em bodied</w>
cc w</w>
tim ore</w>
radi ation-induced</w>
ad ams</w>
liqu ids</w>
fro st
coincid ed</w>
spi ked</w>
ess ing</w>
instill ation</w>
din ucleotide</w>
seas onality</w>
han dic
g us
cha oyang</w>
r um</w>
her self</w>
gsk -3
off enders</w>
isoni az
rostr al</w>
un used</w>
centro mere</w>
at ed-
os pasm</w>
fra ud
fac to</w>
s 1p</w>
trou t</w>
hem ic
x ine</w>
air bnb</w>
reconc ile</w>
f w</w>
poly aden
clindam ycin</w>
work station</w>
ro su
graph ite</w>
plas mic</w>
el lo
an te
top o</w>
cyp 2c
fol d-
av s</w>
bior ad</w>
politic ians</w>
terat oma</w>
st o</w>
12. 7</w>
adher ing</w>
amphoter icin</w>
fire arms</w>
ad ol</w>
trans mis
count less</w>
out performed</w>
blo om</w>
t2- weighted</w>
inform ing</w>
lim bic</w>
pharmaco dynamics</w>
step ped</w>
ifer ous</w>
bi ologists</w>
multipl ication</w>
recogn ise</w>
certif ic
cho res</w>
hydroxy apatite</w>
mcdon ald</w>
ital op
mac ao</w>
qu eti
l ite</w>
bar code</w>
commun ist</w>
deleg ate</w>
bo unds</w>
ca co-
epi phy
macro molecules</w>
huox ue</w>
aspir ations</w>
s st</w>
meth icillin
9 1.
3. 0
vincrist ine</w>
og astric</w>
ra w
impos ing</w>
mid -term</w>
i onal</w>
amiod arone</w>
etan ercept</w>
comput ations</w>
nif edi
4 7.
drop out</w>
de a</w>
end- to-
lev y</w>
the y
guinea- bissau</w>
m sec</w>
cre denti
sm ir
tuc ao</w>
mü ller</w>
view point</w>
determin ate</w>
exp ulsion</w>
pf am</w>
l ad</w>
appe aling</w>
12. 8</w>
w in-
ba si
ri dic
huvec </w>
induc ers</w>
fores een</w>
nanot ubes</w>
me 2</w>
tak ara</w>
f ide</w>
man h
la k
3 16</w>
d augh
hit achi</w>
sial ic</w>
was p</w>
ir ish</w>
mus icians</w>
l c-
ycl ic</w>
sh ocked</w>
juven iles</w>
w r</w>
install ment</w>
be am
sap on
al gesia</w>
mr -
chir al</w>
ru g
ocr yst
shig ella</w>
glutam ic</w>
26, 27</w>
flu conazole</w>
bec ton</w>
ba -
synerg istically</w>
micro structure</w>
50 3</w>
spondy litis</w>
l acti
he k</w>
tur bin
glycer in</w>
ho x</w>
hel i
y te</w>
vo ices</w>
brun ei</w>
normal ised</w>
hydro carbon</w>
are -
disease- specific</w>
bal timore</w>
under lines</w>
ban ding</w>
up -</w>
south- south</w>
quar antine</w>
w ick</w>
ar ip
conduc ts</w>
18 00</w>
pack ard</w>
electro acupuncture</w>
ins ulation</w>
ino stat</w>
oligodendro cytes</w>
vegf- a</w>
r ss</w>
special ties</w>
ha wa
mid brain</w>
bottom -up</w>
lac eration</w>
d ull</w>
oligosacchar ides</w>
15. 4</w>
y on
wave forms</w>
narrow er</w>
worth while</w>
p ond</w>
3, 7
pres sion</w>
monteluk ast</w>
den e</w>
time .</w>
re- appoint</w>
wal ks</w>
vertebr a</w>
il- 15</w>
sl ur
max illa</w>
l pa</w>
y ap</w>
real izing</w>
alop ecia</w>
ow l</w>
fat ality</w>
k han</w>
6 25</w>
hypogly ca
catast rophic</w>
maxim a</w>
ni k</w>
t ma</w>
rh am
eu x</w>
mus lim</w>
pre- tax</w>
obesi ty-
hu o</w>
curric ula</w>
d enture</w>
ind welling</w>
imag ined</w>
a eg
ab duc
denomin ator</w>
suppor ters</w>
re insurance</w>
narrow ed</w>
air- conditioning</w>
tain able</w>
furn ace</w>
set- up</w>
ple ur
pro hibi
x b</w>
pha co
somat ostatin</w>
rec a</w>
oc ort
bon e-
m -1</w>
b mi
2008- 2009</w>
implan table</w>
battle field</w>
un intended</w>
cre ek</w>
atri sts</w>
tr ay</w>
eluc idation</w>
soft bank</w>
lo h</w>
phyl um</w>
anth ra
allevi ated</w>
cranio facial</w>
ed in
key word</w>
g host</w>
table 4</w>
metabol ically</w>
butter fly</w>
fe eds</w>
es ulf
ank yl
mu t</w>
glob ular</w>
ot u</w>
fer r
cd m</w>
α v
t ner</w>
e dic
analyz ed.results</w>
thick ened</w>
ne u</w>
ner -
grass land</w>
me a</w>
dem oc
co va</w>
cancer .</w>
questi oning</w>
cp m</w>
antimic robi
exc ip
punc ta</w>
indeb ted</w>
s ga</w>
spectros copic</w>
ocy toma</w>
top s</w>
le tt</w>
italop ram</w>
go iter</w>
architec tures</w>
pu ro
ber ries</w>
pro found
franch is
p ml</w>
tm z</w>
hk fr
hem ophilia</w>
exemp ted</w>
anch oring</w>
alar ming</w>
melan ocytes</w>
14 ,000</w>
endeav our</w>
ning bo</w>
interven ing</w>
enter obacteriaceae</w>
es cap</w>
anc e-based</w>
sp asticity</w>
f z
corrobor ate</w>
cl 1</w>
t ata</w>
dis gu
m cc
radionucli de</w>
s- phase</w>
autocor relation</w>
at r</w>
s mil
aberr ation</w>
17 16</w>
metap lasia</w>
transi st
dereg ulated</w>
rou gh
simplif ication</w>
assem bling</w>
pc 12</w>
ple dges</w>
modul atory</w>
mer idi
myot ubes</w>
bot an
lipos ome</w>
l amin</w>
ti any
l ex</w>
granul ocytes</w>
dis appointed</w>
hospit alisation</w>
f na</w>
summ its</w>
tw een-
rosu vastatin</w>
heidel berg</w>
cranioc erebral</w>
pro pran
fal con</w>
super markets</w>
nom inate</w>
inc umbent</w>
dam ine</w>
twenty- one</w>
cont acting</w>
ca sts</w>
fi o2</w>
liber al</w>
don ations</w>
sacc ade</w>
val idating</w>
still birth</w>
0.0 15</w>
sit agliptin</w>
con scienti
res or
lo ved</w>
electrophore tic</w>
syn ony
rol led</w>
hawa ii</w>
ever -
h ate</w>
tour ist</w>
pl ga</w>
un supervised</w>
h ague</w>
r up</w>
g ist</w>
si li
scl eral</w>
24 th</w>
ma sters</w>
a val
in- resistant</w>
13. 1</w>
tend encies</w>
wal ter</w>
ch op
. 13</w>
land -
tryp an</w>
w alled</w>
pat ched</w>
1. 7
polymer ases</w>
non- synonymous</w>
si gh
sin o</w>
sp hen
dia sis</w>
ct gf</w>
meto prolol</w>
pl otting</w>
un is
ab ide</w>
short ages</w>
hemis pheres</w>
ru bella</w>
sal am</w>
r ight
junc tional</w>
three- month</w>
as exual</w>
ine- induced</w>
any time</w>
gon z
is se</w>
innerv ation</w>
t cd
gsk 3β</w>
chi ro
g pcr</w>
h3k27 me3</w>
ex o
eg fr-
g ou</w>
sarcom as</w>
ectom ized</w>
d -</w>
h sa</w>
ber ber
periph er
eg ta</w>
phospholip ase</w>
tro ch
am id
custom -
on- demand</w>
pd cs</w>
1 19
queti apine</w>
under line</w>
caud ate</w>
5 y</w>
profound ly</w>
set- top</w>
t c-
bru ce</w>
b s
gener ality</w>
c mp</w>
end otox
if ug
ch ia</w>
enterpr is
eort c</w>
cr af
un stimulated</w>
ass ay
adenocarcin omas</w>
non- human</w>
ap tt</w>
cm v-
chas sis</w>
50 2</w>
el o
12. 6</w>
amik acin</w>
factor- α</w>
ha y</w>
iter pen
explo iting</w>
cycl er</w>
- of-
aster is
iso metric</w>
gl n</w>
sl ugg
bi oc
termin ator</w>
dol ph
amor tisation</w>
in ject</w>
or ni
dorm ant</w>
β 1-
di morph
ing ual</w>
oblig ate</w>
b p-
ric her</w>
ind a</w>
hr p-
3 99</w>
co enzyme</w>
5- fluorouracil</w>
buff alo</w>
trachom atis</w>
capsa icin</w>
deple ting</w>
z n2</w>
me f</w>
par ker</w>
intram olecular</w>
un reliable</w>
ce ases</w>
resid ency</w>
g ly</w>
l un</w>
hpv 16</w>
lar ry</w>
sh ann
hemorrho ids</w>
oc ele</w>
ga met
reson ant</w>
asymp to
g 0
fle w</w>
conclud es</w>
d- 2</w>
solid- state</w>
is omers</w>
ag e.
swi ft</w>
menis cus</w>
gras ping</w>
8 8.
pi k3
teles cope</w>
idi </w>
sen escent</w>
en atide</w>
hydro cortisone</w>
here sis</w>
multi faceted</w>
en voy</w>
hyper emia</w>
nor theastern</w>
r yan</w>
m op
dis solve</w>
k if
he dge
f 8</w>
or opharyngeal</w>
clean er</w>
anti gua</w>
s 11</w>
e an</w>
stud y
influenz ae</w>
12. 9</w>
activ eness</w>
p tosis</w>
viri dae</w>
angiot en
ac ity</w>
weak en</w>
r ti</w>
dou glas</w>
rhabdom y
s add
hom os
los artan</w>
diag rams</w>
on ce-
two- stage</w>
infiltr ates</w>
lo res
sur round</w>
bru ker</w>
scar city</w>
o vir</w>
intrad er
bi ob
mp er
mam mo
x t
h 9
ha ze</w>
exi stent</w>
3, 5
man nose</w>
87 7-
was n</w>
travel ing</w>
squee ze</w>
call osum</w>
succ essively</w>
z ir
ophy sical</w>
pul sati
anesthe tics</w>
iso pro
toxoplas ma</w>
arip ip
dea th
multi level</w>
blind ly</w>
dis cour
oper ability</w>
pl oid</w>
gynec ologic</w>
16. 0</w>
on to
cy statin</w>
poly g
fu ji</w>
isoniaz id</w>
inter viewing</w>
asynchron ous</w>
ec ks</w>
mil lig
th ol
vaso constriction</w>
up a</w>
forty- eight</w>
ent ail</w>
u be</w>
for wards</w>
is han</w>
ro m
andor ra</w>
su rely</w>
ex qui
nifedi pine</w>
k ou
fibr il</w>
ox ic</w>
el y
ve y</w>
si ds</w>
ancest ors</w>
dea f</w>
arri ving</w>
up p
veg as</w>
7, 8,
er isa</w>
phosph odi
pd c</w>
cycl ase</w>
5 2.
pancreati co
d af
mac ros
fl are</w>
th al</w>
ht m</w>
caroten oids</w>
h7 n9</w>
13 ,000</w>
3 44</w>
ser og
ht t</w>
p mt
depend encies</w>
view er</w>
um -based</w>
rit ona
cor relative</w>
le f
ni e</w>
mot oneur
queensl and</w>
am g</w>
scrut iny</w>
charg e-
hex a
de d-
i os
27, 28</w>
tend ons</w>
1 1a</w>
d s-
ad d-
re charge</w>
lif elong</w>
f v
n ymp
modern ization</w>
fil op
ro pivacaine</w>
eluc idating</w>
candi diasis</w>
endor se</w>
mun ich</w>
con clu
k oh</w>
fec un
st uck</w>
hu bs</w>
subsi ded</w>
t yl
recomm ending</w>
anth ony</w>
ow ning</w>
or ific
propan ol</w>
analy tics</w>
tele medicine</w>
pen icillin
at ous</w>
gro unded</w>
lik es</w>
cont ours</w>
lu oro
qu ater
caco- 2</w>
10 g</w>
alph ago</w>
propran olol</w>
mi ao</w>
he i</w>
fir st
2 5.0</w>
stoichi ometry</w>
tal ents</w>
in compatibility</w>
yang tze</w>
las er-
h ments</w>
tur bidity</w>
fa i</w>
4, 5-
oph er</w>
q 10</w>
morph ologic</w>
non- redundant</w>
cor ds</w>
t1 dm</w>
notch 1</w>
cardi ogenic</w>
m x
8 .</w>
de ems</w>
verb ale</w>
pd ac</w>
sh ot
water- soluble</w>
ph e
11. 9</w>
ps 4</w>
radi ologic</w>
rum en</w>
5 8.
co ke</w>
opo ster
analy tes</w>
rec tus</w>
ns f</w>
year .</w>
u. k.</w>
∑ </w>
t ki</w>
dis mis
ec centric</w>
c m-
re sign</w>
s 2
enc e.
associ ative</w>
jo e</w>
sh 3</w>
deduc tible</w>
nit ros
pur ifying</w>
dyst onia</w>
rac es</w>
ter nary</w>
h ills</w>
gra ham</w>
por osity</w>
py raz
dis aggregated</w>
stro m</w>
spac e-
aβ 42</w>
d ms</w>
e si</w>
colleag ue</w>
g pi</w>
tn fr
mat uring</w>
def enders</w>
ri vals</w>
bar a</w>
manh attan</w>
mari juana</w>
fi res</w>
w h</w>
py thon</w>
figure 3b</w>
in e.</w>
brief ings</w>
pr 1</w>
contex t-
ak er</w>
b cc</w>
tr -
stop s</w>
cxcl 12</w>
poli o</w>
scav enger</w>
ubiquit in-
le on
c vs</w>
f ad</w>
pp a</w>
j l</w>
t estim
mid point</w>
succ in
cell- cycle</w>
forfeit ure</w>
td p-
by virtue</w>
bul ky</w>
7 8.
macro -
hu i
p s-
thrombo embolic</w>
n sc</w>
hkfr ss</w>
visco us</w>
mesothel ioma</w>
om bud
infest ation</w>
ran ib
fo etal</w>
uro logy</w>
1. 03</w>
ne es</w>
apar tments</w>
desi res</w>
nhe j</w>
ox y</w>
med tronic</w>
k ei
ν </w>
interview er</w>
some how</w>
micr on</w>
in o-
auscul tation</w>
firef ly</w>
tum oral</w>
70 ,
vacu olar</w>
un anim
m 5</w>
12. 4</w>
em e</w>
ent y</w>
ment or</w>
deci ph
imprin ting</w>
photoper iod</w>
far m
on es
unc -
pe metre
be at
co us
ad in</w>
confron tation</w>
n ap</w>
t f-
camp bell</w>
on- going</w>
astig matism</w>
un conscious</w>
g ou
ad den
senti ment</w>
ta emia</w>
fis sure</w>
kod ak</w>
strep to
fru stration</w>
bm w</w>
mp h
h pl
15 40</w>
50 8</w>
land ed</w>
ul aris</w>
iti dis</w>
frost bite</w>
non- public</w>
sha o</w>
stell ate</w>
olar yn
al b</w>
lifesty les</w>
post- test</w>
ph s</w>
je wish</w>
em base</w>
human ized</w>
us d
str ab
sis- related</w>
conc ise</w>
oc la
ic ks</w>
tri bal</w>
lute al</w>
icd- 10</w>
divor ce</w>
2- week</w>
self- timer</w>
xu e
f bi</w>
rout ines</w>
legi onella</w>
5- 10</w>
pp c</w>
manip ulating</w>
deduc tions</w>
mi dis</w>
radi ologists</w>
in- 2</w>
eliz abeth</w>
alli ances</w>
shrin king</w>
ppar -
inte ger</w>
imp edi
figure 5
institu ted</w>
2- 5</w>
3, 8
a egyp
adap tability</w>
d 7</w>
sel ects</w>
hyal uron
1. 04</w>
ur l</w>
leaf lets</w>
plas tid</w>
ann ulus</w>
immunoglobul ins</w>
h indi
bic ycle</w>
8 7.5</w>
k not</w>
uni on
aripip razole</w>
trache otomy</w>
orth otopic</w>
harmon ious</w>
g 5</w>
sch ne
chor oid</w>
3 11</w>
par kin</w>
l pr</w>
b ci</w>
abol ition</w>
attr activeness</w>
l ds</w>
a 4
it ch</w>
r é
gran tor</w>
summ ing</w>
stipul ates</w>
sub total</w>
tou ching</w>
leuk em
first- order</w>
spon sor
as ks</w>
ly sin
nine teen</w>
wai vers</w>
an abolic</w>
90 ,000</w>
audi o-
landsc apes</w>
non- smokers</w>
h frs</w>
trou bles
cd 2</w>
np y</w>
under water</w>
f aint</w>
15. 6</w>
dig esti
reflec tions</w>
bios ensor</w>
cath olic</w>
bronchi olitis</w>
sul fa
b inge</w>
sorg hum</w>
om i</w>
aqu acul
hbv- dna</w>
promp ts</w>
29 7</w>
cryp t</w>
asc o</w>
hr t</w>
mb s</w>
yel lo
smad 2</w>
ss b</w>
ge ography</w>
salic ylic</w>
ca iro</w>
cit ric</w>
energy- saving</w>
photos hop</w>
deteri orated</w>
exhal ed</w>
maca que</w>
off setting</w>
5 0.0</w>
j b</w>
intermedi aries</w>
sl ogan</w>
lipid- lowering</w>
head ings</w>
test- retest</w>
if i</w>
alk yl
edin burgh</w>
disrup tions</w>
en oic</w>
mon ey-
blastocy st</w>
turk men
sh an
f ad
5 7.
general izability</w>
6 5-
hand ful</w>
in let</w>
ro y</w>
fecun dity</w>
cru st
html 5</w>
cinc inn
ad m</w>
e du
feder ated</w>
sub standard</w>
bo oth</w>
1. 75</w>
re membered</w>
sc ro
market able</w>
ep tin</w>
ic m</w>
oper a</w>
si rs</w>
teno fovir</w>
ant arctic</w>
ll a</w>
8 3.3</w>
y c</w>
ventric les</w>
stere otyp
reduc tive</w>
imp </w>
boot str
sac ro
l bs</w>
inf lores
j ak</w>
str ate</w>
so und
lip per</w>
pac ks</w>
5 ,000,000</w>
eme sis</w>
ar k</w>
it e-
is her</w>
le tro
there with</w>
chi- squared</w>
man chester</w>
one- half</w>
3 84</w>
ap ob</w>
bund led</w>
17. 0</w>
spec tac
mode stly</w>
th ine</w>
jeop ardi
aden os
hu an
sub- commission</w>
ranib izumab</w>
vic tor</w>
trabecul ectomy</w>
tax- free</w>
gg ed</w>
c x</w>
p sd</w>
recher che</w>
4- week</w>
ax ing</w>
neuro fibro
mon ey
m z</w>
ign ers</w>
ap ob
g as-
10 7
gas oline</w>
four th-
f 12</w>
pp p</w>
cd k2</w>
liqu idated</w>
l- arginine</w>
oc tre
dis course</w>
lu mps</w>
bud a</w>
he p
sub cl
meso derm</w>
o con
scri bed</w>
abol ish</w>
bisulf ite</w>
read mission</w>
evacu ation</w>
sm i
4 3-
en e-
conve yed</w>
chol angitis</w>
ky ph
sinus oidal</w>
6 80</w>
microsat ellites</w>
break points</w>
ant ong</w>
at ra</w>
ar ic</w>
occlud ed</w>
vit rectomy</w>
depart mental</w>
hydro dynamic</w>
top ologies</w>
less ly</w>
la h</w>
arch e</w>
fluctu ating</w>
author itative</w>
attribu tion</w>
hyper algesia</w>
tr ies</w>
co- transfected</w>
cortico sterone</w>
figure 4a</w>
sol ute</w>
leiomy oma</w>
2 ,000,000</w>
ent om
. 14</w>
cd k</w>
wi zard</w>
fasc i
ag ene</w>
hypoxi a-
cross- over</w>
myelo dysplastic</w>
truc ks</w>
cincinn ati</w>
gastroenter ology</w>
al ise</w>
dar us
dr b1</w>
nor dic</w>
f eld</w>
az i</w>
g ad</w>
uv b</w>
fo v</w>
mil </w>
o y</w>
h ill
pa f</w>
interest- bearing</w>
r ant</w>
sp inning</w>
prosecut ors</w>
6 p</w>
on ates</w>
gr ating</w>
quen ched</w>
short fall</w>
group ings</w>
sle y</w>
staphylococc i</w>
divertic ulum</w>
nic u</w>
pres ti
parallel -
b- ultrasound</w>
timp -1</w>
alig ning</w>
christ opher</w>
calcul ates</w>
α- sma</w>
s mad</w>
ro und
ar n
p 9</w>
deri ves</w>
sequ oia</w>
thoracos copic</w>
turkmen istan</w>
va sive</w>
pe de
² </w>
fiel d
phylo genetically</w>
ocy st</w>
cyst ectomy</w>
hydrox y</w>
rel l</w>
uro thelial</w>
h3k4 me3</w>
p ant
pitu it
est y</w>
3, 9
en ucle
gin sen
ap b</w>
wi red</w>
catho de</w>
j ade</w>
gn rh
bruc ei</w>
peculi ar</w>
f anc
head lines</w>
sti gm
hospital .</w>
de tain
an ec
ine- rich</w>
ap ride</w>
oc ta
on- based</w>
30 min</w>
kol mo
dec el
b anner</w>
4 85</w>
1- 877-
cry o-
i 1</w>
co ty
sati ety</w>
2 100</w>
suff ers</w>
sphing olip
4 1,
strab is
40 6</w>
13. 8</w>
rever sing</w>
in convenience</w>
2 -1</w>
sm i</w>
prohib its</w>
s 3
ambigu ously</w>
sp ans</w>
oc ap
fund -raising</w>
disturb ing</w>
hum erus</w>
d- based</w>
laz y</w>
rec k
pan ss</w>
val encia</w>
mat su
assa ult</w>
concentr ic</w>
vacc inations</w>
fibrill ar</w>
epider midis</w>
ep r</w>
clea ve</w>
ji m</w>
1 mg</w>
pal mito
as par
de eds</w>
t 4
knock- out</w>
hunt ington</w>
s age</w>
3 t3-
- rich</w>
fav oured</w>
ox y-
prof iciency</w>
s 1b</w>
clos ures</w>
k am</w>
re fraction</w>
attac ker</w>
m fi</w>
de activation</w>
mil iti
ultraso und-
he ater</w>
dedic ation</w>
n sp
cross- section</w>
40 8</w>
al pine</w>
mv pa</w>
oc clusive</w>
pa e
d us
40 l</w>
flatten ed</w>
7 5-
ind ole</w>
ander sen</w>
phil ip</w>
forwar ding</w>
civil izations</w>
fibro myalgia</w>
m v-
bas ket
cucum ber</w>
il- 23</w>
zy mes</w>
d 1
ol ia</w>
h ap</w>
n un
compet ency</w>
go al-
calcin eur
nav y</w>
pl t</w>
citi group</w>
erythropo ietin</w>
in comes</w>
penc il</w>
cru ise</w>
j ona
sen ds</w>
diag no
hla- dr</w>
proteas omal</w>
vi remia</w>
hel lo</w>
deoxy chol
scut ell
consol idating</w>
glcn ac</w>
c 2c
cruc i
g anc
us eless</w>
success es</w>
eucli dean</w>
alphab et</w>
cont usion</w>
shoul ders</w>
hs v-2</w>
s d-
anc e.
forfe ited</w>
mon onucle
4- 5</w>
nh 4</w>
fer ric</w>
is ations</w>
read out</w>
bar buda</w>
k land</w>
under score</w>
li ked</w>
persist ently</w>
bu y-
cit rul
pl enty</w>
ous -
usher ed</w>
explor er</w>
t ings</w>
es d</w>
puer per
appreci able</w>
g ym
early- stage</w>
00 3</w>
ent ly-
ano de</w>
by stand
pair- wise</w>
s si</w>
con founded</w>
am h</w>
ag lutide</w>
ur ination</w>
galac tos
call us</w>
qu an
oxid es</w>
en o</w>
ri pa</w>
cp gs</w>
chol este
chee k</w>
ra mp</w>
syndro mic</w>
a me
m 0</w>
bl an
ev asion</w>
a version</w>
bc va</w>
as in</w>
un pleasant</w>
acc re
solic iting</w>
log ging</w>
os cc</w>
neighbor hoods</w>
5- point</w>
5 6.
ar ism</w>
ont ally</w>
ov -
aptam ers</w>
pre dispose</w>
stere otypes</w>
sha ken</w>
acycl ovir</w>
mac s</w>
under scored</w>
un diagnosed</w>
cloz apine</w>
t -</w>
sur </w>
in breeding</w>
ortho static</w>
tac tics</w>
at oma</w>
formal in-
a 1a</w>
wat ch
accor ded</w>
. 17</w>
po und</w>
sh s</w>
mar ath
of- life</w>
bcl 2</w>
vander bil
st up
cell a</w>
v g</w>
mo m</w>
jona than</w>
g yp
aquacul ture</w>
l anc
syncy tial</w>
n pcs</w>
margin alized</w>
it rac
f 1,
dos ed</w>
lap sed</w>
company were</w>
ni hss</w>
3. 3.</w>
bre aches</w>
kinem atic</w>
dum my</w>
ab p</w>
3 22</w>
kolmo gor
5 5,
osteopor otic</w>
figure 55</w>
sl n</w>
prud ential</w>
cryop reservation</w>
chiro prac
ch 4</w>
b on</w>
amp a</w>
real ities</w>
ch equ
co operating</w>
antimal arial</w>
- 2-
k wan</w>
pione ering</w>
cor als</w>
gir l
projec ting</w>
tsun ami</w>
re uptake</w>
ten gis</w>
and 3</w>
extre mes</w>
sp l</w>
fl ick
2. 00</w>
er .</w>
worr ying</w>
dissi pation</w>
phot ographic</w>
o ks</w>
serv ants</w>
poly styrene</w>
credenti als</w>
solubil ized</w>
impul sivity</w>
pre- ipo</w>
cef tri
interview ers</w>
in ert</w>
radi o-
centur ies</w>
64- bit</w>
inst antly</w>
molecul ar-
sub merged</w>
pemetre xed</w>
pp is</w>
k un</w>
sf 1</w>
tocopher ol</w>
waf er</w>
os p
dr illed</w>
centrifug al</w>
un altered</w>
fores kin</w>
co ins</w>
syno vi
phaco emulsification</w>
40 7</w>
re treat</w>
an ed</w>
tim eline</w>
ox ia</w>
prov oked</w>
per mutations</w>
l ur
protru sions</w>
laryn x</w>
hos tile</w>
short -</w>
l ns</w>
hall marks</w>
viol ating</w>
45 59</w>
3 8-
dro ve</w>
lev od
conjunc tiva</w>
i or-
opter a</w>
α -</w>
ens ors</w>
with hold</w>
es cc</w>
n ub
os el
dis order
mp r</w>
al u</w>
y m</w>
cent ros
darus salam</w>
p uc
ten nis</w>
14 c</w>
per vasive</w>
ec ow
dy sl
im men
1 100</w>
open ings</w>
leuk aemia</w>
ex ing</w>
ger man
s loan</w>
dis ul
topo isomerase</w>
n pv</w>
in -</w>
robu stly</w>
y at-
trans dermal</w>
3 l</w>
comp lying</w>
subver t</w>
k op
enter itis</w>
ap heresis</w>
post mortem</w>
clar a</w>
min ors</w>
biom ol
6 f</w>
2002- 2003</w>
spra ying</w>
aur icular</w>
bio compatibility</w>
el is</w>
morph ometric</w>
a as</w>
frank ly</w>
s any
defer ral</w>
maxim ally</w>
3 98</w>
40 s</w>
chi u</w>
sm uggling</w>
per im
longitud inally</w>
iκ bα</w>
t j</w>
n ile</w>
um umab</w>
r pa</w>
pb l</w>
m cao</w>
ed o</w>
sil k
puerper al</w>
co o</w>
abund antly</w>
sap ph
tili ties</w>
j eff</w>
twenty- first</w>
gink go</w>
v cam-1</w>
dialec tical</w>
s ang
mitch ell</w>
inhal er</w>
fd d</w>
p oured</w>
cholangi ocarcinoma</w>
cen tri
antibody -
pal atal</w>
n said</w>
insur ers</w>
ksh v</w>
mp 3</w>
ococc i</w>
anter oposter
mis folded</w>
letro zole</w>
bottlen ecks</w>
cor t</w>
ju mped</w>
trans located</w>
he w
sequ ester
tain er</w>
cel s</w>
k ro
crimin als</w>
annex ed</w>
ne i</w>
scler a</w>
drug- related</w>
acceler ator</w>
28, 29</w>
si eg
cross- reactivity</w>
dend ro
pre- sale</w>
one- stop</w>
confin ement</w>
pc bs</w>
acqu ain
circum vent</w>
econom ists</w>
subcl avian</w>
wi ring</w>
oscill ator</w>
sm el
os aka</w>
robo tics</w>
sl ender</w>
st oring</w>
dep t</w>
al izations</w>
connec tor</w>
antimicrobi als</w>
unve iled</w>
n hanes</w>
cor ps</w>
pro s</w>
vehicle- treated</w>
cha otic</w>
pro ving</w>
co exist</w>
high- profile</w>
mend elian</w>
st aying</w>
arachid onic</w>
gene tic
non- toxic</w>
iuc r</w>
dimension ality</w>
defaul ts</w>
ed wards</w>
3- kinase</w>
de p</w>
ab r</w>
7- inch</w>
age- dependent</w>
bro ok
lenti virus</w>
ecow as</w>
d xa</w>
gu ards</w>
d ale</w>
ari ous</w>
tom as</w>
un specified</w>
travel ers</w>
s aff
ob ium</w>
on- specific</w>
auto antibody</w>
pharmaco therapy</w>
b enzy
t ori
su s-
smooth ed</w>
ul ator</w>
imp rac
deline ation</w>
g ome</w>
trap ez
and rogens</w>
phosphatidylinosi tol</w>
5 cm</w>
5 12
a ec
ubiquit ously</w>
1. 12</w>
fra il</w>
cl 3</w>
lea ks</w>
ac on
brief ed</w>
hydrophob icity</w>
lipophil ic</w>
ceftri ax
6, 6
indemn ify</w>
splen ectomy</w>
anthro p
ov x</w>
z an
di t</w>
asc s</w>
program matic</w>
tot alling</w>
slugg ish</w>
a us</w>
tam i
r sa</w>
a waiting</w>
li ao</w>
70 5</w>
hes cs</w>
p s1</w>
gri ff
sp y</w>
8 00-
fail ure
th i</w>
pf ge</w>
al on
dur a</w>
1. 10</w>
law suits</w>
g arc
w enz
tric h
mo dy</w>
ld lr</w>
compo unded</w>
proble m-
7 80</w>
c id
gra vi
sur ia</w>
tool kit</w>
op ted</w>
stres sing</w>
10 9
am en
express way</w>
i ber
k sb</w>
hy gro
disab ling</w>
soc cer</w>
ton y</w>
car p
tit led</w>
200 1-
arth roscopy</w>
sti ff</w>
. 16</w>
5 4.
sol icit</w>
contra sted</w>
phen olate</w>
assembl ages</w>
sp ort
das atinib</w>
ens on</w>
19 63</w>
s 2a</w>
neutr on</w>
metat ar
80 ,
rot ter
kin in</w>
thor n</w>
19 50</w>
multic ellular</w>
po ag</w>
but yl</w>
5 80</w>
p is</w>
psychi atrists</w>
perme ation</w>
lamin ar</w>
hos tilities</w>
lac rimal</w>
dd t</w>
es e-
bac tam</w>
rever sibly</w>
t md</w>
j 2</w>
15. 2</w>
- 1-
satis fies</w>
l ca</w>
co iled</w>
cy 3</w>
mor bid</w>
5 3.
b ore</w>
bi bli
xi u</w>
ven ues</w>
zhu hai</w>
loc alised</w>
w ounding</w>
ct ls</w>
11 c</w>
ac tion
7- fold</w>
carb amaz
g 3
g w</w>
sil va</w>
tradi tions</w>
health ier</w>
poly propylene</w>
5 25</w>
sp am</w>
yat- sen</w>
ware housing</w>
ste in-
f 10</w>
my opathy</w>
tes co</w>
aar hus</w>
cd 44
29, 30</w>
sr p</w>
categor ised</w>
mon os
í a</w>
filari asis</w>
pre coc
es p</w>
co il
plas tics</w>
d ai
mcl -1</w>
aven ues</w>
si u</w>
splen omegaly</w>
struc k</w>
ed arav
b ms</w>
16 ,000</w>
jeff rey</w>
sp e</w>
ray mond</w>
tent ative</w>
conserv ing</w>
an ionic</w>
comm ander</w>
tool box</w>
omni bus</w>
est rogen
eleph ant</w>
blast n</w>
modi fiable</w>
an x
cat abolic</w>
inadvert ently</w>
8 d</w>
hap map</w>
ser ov
dur ability</w>
endos cope</w>
d amp</w>
con found</w>
s clc</w>
parti tioned</w>
k amp
v re</w>
sho e</w>
pet- ct</w>
un structured</w>
tre hal
cur io
na a</w>
c 5
6 60</w>
post traumatic</w>
man power</w>
s. com</w>
commens al</w>
pur pos
gab apent
f -</w>
hom ozygotes</w>
curet tage</w>
stream line</w>
schem a</w>
phil lips</w>
un protected</w>
franc is</w>
mening ococcal</w>
t 6</w>
al izes</w>
u pl
cur b</w>
5 5.
anti- cd3</w>
pr ick</w>
firm ware</w>
wil l
imp acting</w>
troph oblast</w>
st n</w>
parasi taemia</w>
720 p</w>
mar ie</w>
pul mon
nee ding</w>
ket tering</w>
re public
lap atinib</w>
be thes
rotter dam</w>
trans thoracic</w>
k hal
s j</w>
scler o
broncho dilator</w>
am c</w>
coagul opathy</w>
dis ation</w>
bmp -2</w>
respectivel y
hr a</w>
syn dic
hedge hog</w>
rober ts</w>
mal occlusion</w>
b eng
cur ious</w>
sati va</w>
oper fusion</w>
sub cloned</w>
co- cultured</w>
4 9.
jewel ry</w>
nac ional</w>
listen ers</w>
z- scores</w>
loy al</w>
pros theses</w>
p 62</w>
respectivel y.
ator ium</w>
st amp
y on</w>
p ests</w>
ta urine</w>
os h</w>
e instein</w>
h sd
u eq</w>
bac ter</w>
e hr</w>
hyper tonic</w>
ba k</w>
nan ocryst
metic ulous</w>
acin ar</w>
gsk-3 β</w>
gl arg
wat ts</w>
he m</w>
denti sts</w>
bar rels</w>
elis pot</w>
ever green</w>
fore igners</w>
rna- binding</w>
g mt</w>
c2c 12</w>
m sp</w>
radiolab eled</w>
bifid obacterium</w>
20 30</w>
deacetyl ase</w>
bal lo
cd k1</w>
re efs</w>
person- years</w>
entr icular</w>
trag edy</w>
dispen sed</w>
ultrafil tration</w>
under scores</w>
me e</w>
anaphy laxis</w>
13. 4</w>
70 00</w>
burn out</w>
a hn</w>
spher oids</w>
vi vid</w>
fant asy</w>
10- 12</w>
mar row
an aplastic</w>
embr ac
spind les</w>
nour ished</w>
sin ess</w>
f tir</w>
appear ances</w>
he pc
epi st
x e</w>
dm n</w>
ac ral</w>
z eb
op g</w>
ont ologies</w>
g s-
lin col
pl un
n fat
volt ages</w>
ul o
ke ting</w>
g k</w>
acclim ation</w>
ene di
amp ul
is othi
hydroly zed</w>
fumig atus</w>
vag al</w>
gi o</w>
ifn- β</w>
peri stal
hy aline</w>
sapph ire</w>
p 24</w>
r 2
h olog
pede stri
19 62</w>
t as</w>
crani otomy</w>
de myelination</w>
sa es</w>
an cova</w>
in vertebrate</w>
et ch</w>
mm f</w>
bethes da</w>
pl p</w>
pol is</w>
l l-
re yn
adipo genesis</w>
in activating</w>
li an
quot a</w>
vas ospasm</w>
mc p</w>
ct cf</w>
4 99</w>
b j
ses ame</w>
tri partite</w>
his ense</w>
dpp h</w>
p 1-
ritona vir</w>
termin ates</w>
ad jud
pe ts</w>
vasodi lation</w>
f 1-
s way</w>
mic hel
f og
7 10</w>
hb ss</w>
6 8.
0.0 12</w>
sumo ylation</w>
ory z
s ins</w>
j r.</w>
iti dine</w>
des orption</w>
edarav one</w>
un methylated</w>
estr us</w>
compart ment
pgc- 1α</w>
anti diabetic</w>
c ester</w>
9 .</w>
hyper uric
bi modal</w>
curio sity</w>
hom o</w>
wat ched</w>
foreig n-
50 4</w>
co expression</w>
3 14</w>
pl ague</w>
vo iding</w>
d otted</w>
intr ap
thom son</w>
ankyl osing</w>
xi ii</w>
de bil
pud ong</w>
dy -
anticoagul ants</w>
hand book</w>
de .
lati t
. 1a</w>
ceftriax one</w>
logarith m</w>
over- expressed</w>
anti trust</w>
ab t-
olaryn g
b ob</w>
psori atic</w>
80 8</w>
congrat ulations</w>
j ay</w>
c 1-
fore most</w>
lv ed
sal t-
campyl obacter</w>
administr ated</w>
indone sian</w>
bo eing</w>
loop holes</w>
aur a</w>
lam b</w>
fli x</w>
unanim ous</w>
equili bration</w>
phr ases</w>
pie zo
ac. uk</w>
5 00-
m atically</w>
straight- line</w>
post pon
eg ative</w>
dismant ling</w>
jan e</w>
y ok
ubiquit inated</w>
biot echn
5 ,0
post ulate</w>
e ability</w>
1, 2-
normal -
ms n</w>
dec ap
implic ate</w>
60 9</w>
t gg
ap hid</w>
unc i
ni v</w>
de e</w>
adden dum</w>
il- 7</w>
caspase- 8</w>
glucon e
less -
dis proportionate</w>
bm c</w>
sle eve</w>
u 1</w>
deri ving</w>
dm 1</w>
intr aspec
narco tics</w>
summ ation</w>
chlor oplasts</w>
mel bourne</w>
actu arial</w>
shar k</w>
clav icular</w>
4, 6
pat chy</w>
sla very</w>
gab aa</w>
absc esses</w>
gast roscopy</w>
h tert</w>
o h-
200 3-
muco sitis</w>
aggra vate</w>
pent obarbital</w>
var ices</w>
voltage- gated</w>
log s</w>
scot tish</w>
hus ban
ap olog
p inning</w>
fl avi
me t-
4 1-
smir nov</w>
appe aled</w>
flud arabine</w>
c dr</w>
relap sing</w>
sou theastern</w>
magnit udes</w>
9 60</w>
invari ably</w>
b oc
4, 7
dl t</w>
glo ves</w>
kn ight</w>
a ve</w>
m assi
wh ale</w>
e bs</w>
2, 3
b end
nano structures</w>
catch ment</w>
9 37</w>
glarg ine</w>
re valuation</w>
stac ked</w>
tu ps</w>
hy pers
tric k</w>
eat en</w>
stom atitis</w>
in activate</w>
ap t</w>
8 9.
wor sen</w>
than ked</w>
plan k
. 18</w>
remot ely</w>
pati ence</w>
fried man</w>
pollut ant</w>
l one</w>
tion- related</w>
or ang
sar cop
pres ump
ii ia</w>
we igh</w>
ra mp
poster iorly</w>
immunocyto chemistry</w>
ozo ite</w>
ip ss</w>
pol ished</w>
ir regularities</w>
cell- to-
cell- specific</w>
q 3</w>
transi ents</w>
il eal</w>
cr acks</w>
contain ment</w>
tb st</w>
carcin oid</w>
invo ices</w>
au g</w>
over flow</w>
extra hepatic</w>
bas eb
off ensive</w>
oh ss</w>
g nee</w>
sin o
α- syn</w>
wid ths</w>
pro tracted</w>
cyt arabine</w>
preser v
ment ality</w>
ter a</w>
pr as
incap able</w>
80 2.
high- affinity</w>
sy rup</w>
minim ise</w>
mis sis
ly n</w>
gen otoxic</w>
radi osensi
amplif ying</w>
lam ellar</w>
berber ine</w>
us p</w>
mac e</w>
chlor hex
cu ticle</w>
break point</w>
d well</w>
up set</w>
80 3</w>
18 .2</w>
op pen
precoc ious</w>
48 h</w>
1. 06</w>
hek 293t</w>
n ian</w>
14. 2</w>
ome ga</w>
two- hybrid</w>
sal ience</w>
signific ant
r ents</w>
fi b</w>
as o</w>
over estimated</w>
dis proportionately</w>
japon ica</w>
ss g</w>
cross- talk</w>
h p-
phyl a</w>
on- like</w>
pdg fr
incis ors</w>
a ag
freeze- dried</w>
9, 10,
s oring</w>
thre e
ta st
neuro physiological</w>
z ations</w>
rec an
28- day</w>
ph i
il d</w>
htt ps</w>
s ows</w>
micro titer</w>
da un
cra ig</w>
hydri de</w>
clav icle</w>
te d
d mar
spor ulation</w>
terr or</w>
net flix</w>
choleste atoma</w>
n 4</w>
li van</w>
mmp -
g im
hyper para
alk yl</w>
bcr- abl</w>
and y</w>
decentr alized</w>
spon soring</w>
flag ellar</w>
dysen tery</w>
gr ati
jo y
14. 1</w>
il ot</w>
ii ib</w>
su be
condem ned</w>
cres cent</w>
hypothe sised</w>
en ac
per k</w>
scho oling</w>
missis si
neuro transmission</w>
or p</w>
p q
sh ock
fluoresc ently</w>
is th
full ness</w>
h sa-
chori o
viti ligo</w>
her itable</w>
diphther ia</w>
meg ak
administr ations</w>
grass roots</w>
os e
p vr</w>
ot om
jo int
husban dry</w>
ven us</w>
ap re
il ia</w>
ra -
me v</w>
pu fas</w>
vort ex</w>
v smcs</w>
re gn
p ip</w>
1, 4-
form e</w>
equ ine</w>
end- diastolic</w>
ambul ance</w>
impos es</w>
14 7
penetr ance</w>
low- key</w>
ab domin
rate- limiting</w>
201 3-
ex enatide</w>
ham burg</w>
tc ga</w>
inten sively</w>
2, 3-
perpe tu
hi f</w>
real- name</w>
lir aglutide</w>
every body</w>
enti s</w>
medi ans</w>
shann on</w>
un married</w>
v ta</w>
milest ones</w>
gabapent in</w>
mal ate</w>
aegyp ti</w>
co factors</w>
found ry</w>
peroxidase- conjugated</w>
fl esh</w>
cere al</w>
l sm</w>
ol in
c gh</w>
mir- 12
out-of- pocket</w>
mil der</w>
gar bage</w>
basket ball</w>
in as</w>
dis satisfied</w>
umin escent</w>
wo ul
net com</w>
worri es</w>
au ght</w>
parad ox</w>
spar k</w>
anne aled</w>
u as-
extravas ation</w>
ad ec
alcohol s</w>
in oids</w>
lu x</w>
oly sin</w>
knowle dge
ph lo
l 1-
war ner</w>
endothel in</w>
wood en</w>
car n
le tting</w>
y t</w>
. cn</w>
spur ious</w>
3 13</w>
nc bi.
3 26</w>
observ ed.</w>
3 t3</w>
appro x</w>
14. 6</w>
ml st</w>
at elec
f ade</w>
metalloprotein ases</w>
valpro ate</w>
de ar</w>
30 ,</w>
sol idi
fum arate</w>
ma yer</w>
s ang</w>
hu at
su isse</w>
full- term</w>
5 90</w>
wav egu
ah med</w>
pyri midine</w>
acqu ir
stu mp</w>
brack et</w>
ano rectal</w>
casu alty</w>
1. 5-
p ds</w>
oper itoneum</w>
leuk openia</w>
rewar ding</w>
il- 21</w>
const ell
id f</w>
de g</w>
8 2.
4 24</w>
du o</w>
travel ling</w>
4 86</w>
elic iting</w>
un ambiguously</w>
il les</w>
c -</w>
ber kel
osel tami
8 6.
white wash</w>
pr ice-
lu mp
ali er</w>
un detected</w>
syl lab
meth y
post er</w>
jur y</w>
vaso active</w>
sex -specific</w>
centro mer
r 1
sub version</w>
sal a</w>
mes enchy
s ic</w>
chemoattrac tant</w>
gen e-specific</w>
rus hed</w>
gadol inium</w>
eo chrom
jo ke</w>
cd 20</w>
hic cup</w>
enc ycl
one- dimensional</w>
bar b</w>
pv c</w>
micro organism</w>
argu ably</w>
stern um</w>
os s</w>
mo ds</w>
12 h</w>
tit an</w>
megak ary
pe ak
k ob
par i</w>
myel inating</w>
fu si
f tc</w>
4 p</w>
py el
pre- treated</w>
13 7
taiwan ese</w>
remo vable</w>
ther mic</w>
intrat umoral</w>
dead ly</w>
psychiat rist</w>
decompens ated</w>
p and
at taining</w>
k ul
us .</w>
er ica</w>
guaran tors</w>
don ate</w>
tri ang
chimpanze e</w>
mini ature</w>
amino- acid</w>
m se</w>
induc tive</w>
t g-
recombin ase</w>
ic al
octre otide</w>
adipo genic</w>
p. o.</w>
ju mping</w>
ha idian</w>
mc mc</w>
g og
orph ine</w>
l inc
deli ver
daugh ters</w>
hyalur onic</w>
astronau ts</w>
strabis mus</w>
bu y
lac un
or in</w>
fud an</w>
scal able</w>
sy 5y</w>
ster ling</w>
1. 11</w>
hir sch
cas es.
glucos amine</w>
lin er</w>
gi e</w>
gel atin
micro tubul
c ary</w>
r k</w>
r ls</w>
clamp ing</w>
inter cep
buty ric</w>
missi les</w>
. 20</w>
exc imer</w>
penetr ated</w>
di tis</w>
si us</w>
f ats</w>
z eta</w>
hyper calc
sh am
networ k-
di ous</w>
t ung</w>
anti- angiogenic</w>
ab lative</w>
subsi stence</w>
sn acks</w>
pl aster</w>
aspar tic</w>
ag g</w>
comm ent
acknowle dging</w>
n yst
ron ate</w>
end-to- end</w>
sig mo
coch lea</w>
symptom atology</w>
90 ,
c to</w>
mortg aged</w>
objec tions</w>
osur gery</w>
dest ined</w>
ar ching</w>
v est
ss en</w>
discrimin ated</w>
ol d-
5- di
mur der</w>
〉 </w>
75 ,000</w>
hc p</w>
over estimation</w>
aspir ated</w>
r gc</w>
3 45</w>
poly unsaturated</w>
r p-
- ii</w>
higher- order</w>
fibr ate</w>
d w
smad 3</w>
mas cul
ec mo</w>
pres sure-
par asymp
week s.</w>
en closure</w>
ol actone</w>
restr aints</w>
pain ted</w>
diamin obenz
diabet es
haem ophilus</w>
por ted</w>
iso flav
coul dn</w>
pou ch</w>
pp 2a</w>
no od
sp f</w>
a ud
corrid or</w>
sk ov
ho ok
ev oke</w>
system ically</w>
te d.
puzz le</w>
ro man</w>
orig ination</w>
pu b</w>
wi kip
eto h</w>
man soni</w>
magne tization</w>
medic a</w>
sul livan</w>
ig ene</w>
p- 5</w>
st ev
star k</w>
knock- down</w>
imple ments</w>
disp arate</w>
d ba</w>
dys functions</w>
inv </w>
ali ens</w>
pen sions</w>
bro ch
a- i</w>
chemoradi ation</w>
gl ot
pe ony</w>
r ally</w>
horiz ontally</w>
hope fully</w>
be fore
flu tic
consum mate</w>
b iting</w>
tric hlor
lever aged</w>
foot wear</w>
s rna</w>
absorb able</w>
beet les</w>
short cut</w>
understand able</w>
universi ta
pec </w>
blow ing</w>
resem bled</w>
bon d
ro th</w>
jus ti
al ex</w>
was aki</w>
el sen</w>
hil ar</w>
contrac ture</w>
1. 35</w>
self- rated</w>
res e</w>
mic a</w>
nitro gen
special izing</w>
s ab</w>
si aly
maldi- tof</w>
s- 3</w>
men arche</w>
nh 4
egyp tian</w>
2 d-
manus cri
monophy letic</w>
docum entary</w>
transl ates</w>
normal izing</w>
interleukin -
din ing</w>
quater nary</w>
germin al</w>
s ants</w>
n se</w>
direc ts</w>
far ther</w>
under written</w>
methicillin -resistant</w>
heter ozygotes</w>
sand y</w>
trans locations</w>
war med</w>
d a-
mes ylate</w>
tigh tening</w>
s. 1</w>
dy nia</w>
if era</w>
15. 3</w>
- infected</w>
shiel ding</w>
h ô
ic heng</w>
toler able</w>
nct00 0
ess en</w>
8- fold</w>
patter ned</w>
geo metrical</w>
ch us</w>
hk ex</w>
im min
b umin</w>
enthusi astic</w>
deleg ated</w>
sin ai</w>
suppres sors</w>
pass aged</w>
m sd</w>
docum enting</w>
hum ane</w>
sem ide</w>
me oh</w>
expan sions</w>
lo des</w>
n ails</w>
wi dened</w>
6 2.
ascor bate</w>
bac eous</w>
s reb
cap top
thin ess</w>
5 5-
hyperpara thyroidism</w>
beac on</w>
mur ray</w>
molyb den
annex es</w>
2 l</w>
16. 1</w>
table 44</w>
anov as</w>
90 00</w>
fl our
ur acil</w>
through s</w>
notif ications</w>
mal ls</w>
bra ke</w>
transcrip tion-
techn ician</w>
rg cs</w>
3 17</w>
confron ted</w>
1. 07</w>
9 c</w>
lu bric
b j</w>
pc 2</w>
tr e</w>
ro tations</w>
ultrac entr
yl ine</w>
p z
soci alist</w>
cr ushed</w>
nct00 9
13. 7</w>
al aska</w>
fore head</w>
d af-
w p.
n ta</w>
xy lem</w>
t- 3</w>
μ s</w>
z ig
3- phosphate</w>
spaw ning</w>
tween- 20</w>
lob ectomy</w>
propri a</w>
glyca emic</w>
calcineur in</w>
epicardi al</w>
sol ids</w>
am il</w>
anti convul
aggres siveness</w>
4, 8
14. 7</w>
yl transferase</w>
varic ose</w>
h pr
win- win</w>
varic eal</w>
pen ny</w>
convers ations</w>
b illed</w>
frac tal</w>
co t
11, 12,
nh l
le d-
cy cli
cri tics</w>
sulfon yl
amplif ications</w>
per kin
glut en</w>
id b</w>
cough ing</w>
uc b</w>
inter specific</w>
pom be</w>
dis similar</w>
ic ating</w>
c grp</w>
pati al</w>
infin ity</w>
sponsor ship</w>
hol der
prob and</w>
13 25</w>
scul p
de w</w>
caly x</w>
pseud o</w>
i ud</w>
iu gr</w>
l und</w>
ob iliary</w>
b -</w>
uk i</w>
anteroposter ior</w>
parsimon y</w>
30, 31</w>
al to</w>
c sp
i ver
deduc ting</w>
attor neys</w>
flutic asone</w>
op ium</w>
t df</w>
melan omas</w>
hot line</w>
overl ay</w>
in determinate</w>
7 2.
conv ince</w>
rho damine</w>
war craft</w>
hn f
fun ny</w>
fac ets</w>
stri pe</w>
train ers</w>
d sc</w>
n ae</w>
ing -related</w>
z ole
y gium</w>
cef taz
chlorhex idine</w>
mark e
13 3
in eligible</w>
str aw
acceler ates</w>
restric ts</w>
pay er</w>
refer endum</w>
rewar ded</w>
bli sters</w>
dupl exes</w>
intensi fication</w>
ic i</w>
6 5.
pac hy
over production</w>
di p
val is</w>
qing hai</w>
un ambiguous</w>
schizophren ic</w>
con gen
levod opa</w>
ic si</w>
blood- brain</w>
h mc</w>
ev 71</w>
out- patient</w>
endocrin ology</w>
δ t</w>
liqu e
di sh
ret a</w>
restor ative</w>
mad am</w>
admis sible</w>
in- dependent</w>
fundam entals</w>
pr b</w>
snap -
lincol n</w>
wo ody</w>
l ud
nt d</w>
form is</w>
formalin- fixed</w>
y p</w>
nyst ag
is ogenic</w>
enz a</w>
venti lat
av p</w>
ton sil
k k
nic ol
dm f</w>
pap ules</w>
gn an</w>
haem olyticus</w>
over lying</w>
3 18</w>
mer op
pseudo genes</w>
str in
comm uniqu
psych ologist</w>
euro zone</w>
trou bled</w>
class ically</w>
st ut
cell-to- cell</w>
nl m.
one- to-
benef iting</w>
col loid</w>
co re-
anti proliferative</w>
19 58</w>
blo ating</w>
ti r
dl pfc</w>
k wong</w>
f ancy</w>
quin tile</w>
7 6.
v ac</w>
pur ify</w>
6 4.
calc ifications</w>
er ine</w>
13 1i</w>
attach ments</w>
interviewe es</w>
three fold</w>
cor rup
gener ators</w>
ut amide</w>
upreg ulate</w>
limit ed
du mping</w>
st- segment</w>
fentan il</w>
ob er
j ane
twenty- two</w>
bar o
h mscs</w>
percus sion</w>
disp uted</w>
persi sting</w>
cd 8
r b1</w>
hsc rp</w>
sen ate</w>
mississi ppi</w>
un am
af s</w>
ceftaz idi
self- help</w>
hab ditis</w>
under takes</w>
paste ur</w>
cle av
vac ant</w>
m atics</w>
nucle olar</w>
pre mat
leg ality</w>
ocycl ine</w>
transpor ting</w>
haemat ological</w>
s. results</w>
sant é</w>
al a
carbamaz epine</w>
si as</w>
mutag enic</w>
distr actor</w>
patient- reported</w>
ne is
circum stance</w>
ta sis</w>
ech in</w>
concentr ates</w>
bun ch</w>
bru cella</w>
in genu
neuro protection</w>
d ash</w>
nano wires</w>
pa ins</w>
22 nd</w>
6 9.
miner alized</w>
gen es
mas on</w>
fis cher</w>
polic y-
distor tions</w>
zole dr
port ability</w>
g all</w>
un balanced</w>
se y
no xi
el icits</w>
condu it</w>
anti pyre
f es</w>
5 1
14. 8</w>
intra medullary</w>
7 7.
nig ra</w>
ur v
di ving</w>
ben thic</w>
½ </w>
sub lingual</w>
subscri ptions</w>
dismis sal</w>
vascul arization</w>
. 2a</w>
lit eal</w>
em ory</w>
5 32</w>
antibio tic
myco phenolate</w>
stimul ants</w>
sp m</w>
10 8
sion .
adi um</w>
bl otted</w>
co aching</w>
4 2,
in del</w>
loc </w>
sul bactam</w>
proton ated</w>
ganc iclovir</w>
sh ell
chimpanze es</w>
ero sive</w>
mur phy</w>
e- free</w>
ox aban</w>
depend ently</w>
ten e</w>
mar c</w>
fluor oscopy</w>
psych ologists</w>
a statin</w>
d 3
tur tle</w>
in- aid</w>
disco vering</w>
al im
ex tran
s ss</w>
car p</w>
spe ech
do hme</w>
1. 08</w>
31, 32</w>
mi us</w>
argu ing</w>
toy ota</w>
4, 9
retic ular</w>
transcriptom es</w>
twit ch</w>
out going</w>
anti sera</w>
al um</w>
edr ine</w>
l ass</w>
gro ss
rich est</w>
lar va</w>
er ection</w>
concaten ated</w>
ct ni</w>
ar tistic</w>
d pp</w>
epo ch</w>
7 2
paradox ical</w>
certific ate
r ach
lamb da</w>
br ushing</w>
autop ilot</w>
aff aires</w>
dialy zed</w>
geni stein</w>
ir -
furo semide</w>
be ad
id ers</w>
z 2</w>
ccl 4</w>
collag en-
az a
prioriti ze</w>
val ine</w>
eg g
caspase- 1</w>
sw ept</w>
dispen sing</w>
high- pass</w>
tub ing</w>
em er
p2 y
glab rous</w>
ip il
sc l</w>
macro molecular</w>
so 2</w>
intramus cul
min ocycline</w>
lumin ance</w>
14-3- 3</w>
5 9.
inter related</w>
dis agreements</w>
pro of-
year- olds</w>
et ti</w>
gastro cne
nk g
puro mycin</w>
- atpase</w>
ejac ulation</w>
fore ver</w>
chron ological</w>
activ e-
cy t</w>
contingen cies</w>
aver sive</w>
captop ril</w>
1. 13</w>
adju v
cr a</w>
dom ic
d ary</w>
res amp
clock wise</w>
ca enor
negl ig
congol ese</w>
cr h</w>
ellul arly</w>
pp .</w>
ambi tion</w>
fer n
ta a</w>
dissec t</w>
re mittance</w>
in completely</w>
me tas
gro in</w>
ol or</w>
f 2-
par cels</w>
dimin ishing</w>
tlr 3</w>
tr av
pip es</w>
x ps</w>
10 4
cyto keratin</w>
bio degradable</w>
rec order</w>
6 01</w>
pl ed</w>
cra ving</w>
ac er</w>
10- ksb</w>
19 50s</w>
wu xi</w>
war ts</w>
stu b
t ine</w>
expon ent</w>
f argo</w>
gran de</w>
rmb 1,
aggres sively</w>
dorm ancy</w>
entr y-level</w>
gg e</w>
x ide</w>
ton sil</w>
as er</w>
18. 0</w>
nlm. nih.gov</w>
8 5.
oper ons</w>
thr ust</w>
figure 4b</w>
convic ted</w>
gener ational</w>
early- onset</w>
. 1b</w>
berkel ey</w>
tub erc
gra ined</w>
ation s
gender -
interleukin -2</w>
shen qi</w>
op ancre
ga a</w>
sap hen
ap ic
n 2o</w>
pax 6</w>
fil trate</w>
lim e</w>
ac re</w>
king ston</w>
car los</w>
sch iff</w>
p w</w>
16. 2</w>
d st</w>
exqui site</w>
n q
con val
m ta</w>
cach exia</w>
fe b</w>
to genesis</w>
lc 3-
disper se</w>
myel inated</w>
card inal</w>
ib ly</w>
cand y</w>
h ts</w>
gy na
implic ating</w>
at u</w>
preg ab
co w
ri der</w>
zy go
synten y</w>
collabor ating</w>
web cast</w>
nanot echnology</w>
en large</w>
bul let</w>
cy pri
f am</w>
c anti
contr aven
ultra structure</w>
pyram id</w>
1. 50</w>
exp o</w>
bu pren
post ers</w>
pr a</w>
cor tana</w>
k ir</w>
hydrogen -
tram adol</w>
fi bul
im o</w>
kum ar</w>
spectrophoto metry</w>
ar do</w>
doc ked</w>
ren illa</w>
ro p</w>
expec tor
oste ogenesis</w>
y as
wo ol</w>
pre processing</w>
pu gh</w>
64 gb</w>
re generated</w>
indi scrimin
um es</w>
cd 36</w>
ho ch
bel gian</w>
de paraff
o dium</w>
f cm</w>
pyr ro
blin k</w>
complic ating</w>
r 5</w>
n md</w>
obliter ans</w>
co incident</w>
decidu ous</w>
ine a</w>
sin uses</w>
s qui
butan ol</w>
bl er</w>
warr en</w>
cam kii</w>
thi azol
hong kong</w>
explo sives</w>
α 1-
ground -
resear ched</w>
detain ees</w>
i que</w>
snap shot</w>
qu oti
peri meter</w>
in n</w>
over represented</w>
ma ils</w>
type -specific</w>
ti sed</w>
may or</w>
lif lo
revit alization</w>
m all
mortg age-
sc p</w>
propag ate</w>
no ea</w>
cl ut
noxi ous</w>
pb st</w>
is o-
satisfac tor
tack ling</w>
c apping</w>
fo g</w>
un recognized</w>
neur ites</w>
on ec
t- to-
vegfr 2</w>
ctr l</w>
ar v</w>
cb ct</w>
bu gs</w>
201 2
- r</w>
syring es</w>
bol t</w>
modi fier</w>
sens ations</w>
inter facial</w>
run x2</w>
deteri orating</w>
custom ize</w>
tab ulated</w>
tu ous</w>
re operation</w>
atelec tasis</w>
is sa</w>
obstruc ted</w>
exer tion</w>
sh ug
no body</w>
las m</w>
8 7.
mdr -tb</w>
spl it-
low ers</w>
st en</w>
p 63</w>
centro meric</w>
di valent</w>
3 8.5</w>
pun ch</w>
b si</w>
yli dene</w>
non- target</w>
ob ron
fron t
seroton ergic</w>
o- temporal</w>
20 25</w>
gen oty
biophar maceu
prokary otes</w>
inform ational</w>
p gr
par en
xu an</w>
phenotyp ically</w>
o op</w>
weal thy</w>
kinem atics</w>
imag er</w>
disclos eable</w>
0.0 14</w>
stu res</w>
fen o
kar a</w>
impur ity</w>
cle ver</w>
ellip so
cx 3
ev o</w>
fac t-
li vely</w>
micro albuminuria</w>
mean -
spr ung</w>
maneu ver</w>
c me</w>
iz hi</w>
kle in</w>
night time</w>
h 9</w>
ster eos
ather ogenic</w>
d. c.</w>
linear ized</w>
habit uation</w>
10 6
le -</w>
wikip edia</w>
acet yl-coa</w>
claim ants</w>
repres ses</w>
l x
propor tionally</w>
palmit ate</w>
el on</w>
shot gun</w>
e wing</w>
ad duct</w>
achi an</w>
c α</w>
pay ers</w>
manuscri pts</w>
os patial</w>
merop enem</w>
conf using</w>
abor tions</w>
α- helix</w>
oun ce</w>
for age</w>
2 cm</w>
n at</w>
x o
t ases</w>
bio activity</w>
eosin ophilia</w>
color less</w>
sv z</w>
caenor habditis</w>
val e</w>
legen dary</w>
heterodi mers</w>
en ligh
rede mptions</w>
respec ting</w>
comor os</w>
inter dependence</w>
tur bine</w>
10 ,000,000</w>
3 19</w>
phen e</w>
anti- vegf</w>
phen yl-
impul sive</w>
contraindic ated</w>
sp t</w>
comm ensur
mp v</w>
19. 5</w>
program mers</w>
f 7</w>
. 19</w>
am ar
mol lus
g al-
an te</w>
hematopoie sis</w>
sett ling</w>
diversi fy</w>
n 2
se mi</w>
cu ban</w>
lig noc
su ed</w>
bisphosph onates</w>
β 4</w>
ba z
receptor -mediated</w>
cd 68</w>
circumfer ential</w>
cut ting-
1 x
cl ocked</w>
densito metry</w>
arb or</w>
17. 6</w>
tend ers</w>
inter connection</w>
periodic ity</w>
preclud ed</w>
th el</w>
sin opec</w>
o 157</w>
anis otropic</w>
pc v
enquir ies</w>
judg ements</w>
eye- catching</w>
neutr alized</w>
vent ro
capac itive</w>
inter operability</w>
gluco sidase</w>
col chic
heteros exual</w>
ic r</w>
si se</w>
vasopres sin</w>
7 3.
ou tr
m op</w>
clath rin</w>
system- wide</w>
carto on</w>
it é</w>
ann ular</w>
as leep</w>
magne to
up- to-date</w>
po 2</w>
encycl op
o ch
kerat osis</w>
compl icate</w>
pro test</w>
duoden ectomy</w>
mus car
nystag mus</w>
r er
0.0 16</w>
coil ed-
permis sible</w>
short- lived</w>
styl ish</w>
co existing</w>
multi ples</w>
tr p
un ification</w>
conform al</w>
ro okie</w>
ant ine
addi s</w>
gastrocne mius</w>
parasymp athetic</w>
a pro
aci ón</w>
meta sta
aler ts</w>
chemo embolization</w>
cr ab</w>
o res</w>
cf p</w>
un responsive</w>
intramuscul arly</w>
t les</w>
5- az
endeav ours</w>
por trait</w>
my b
phytop lankton</w>
3 7-
ure than
8 4.
vanderbil t</w>
ple thora</w>
or m</w>
enquir y</w>
ecta sia</w>
fus arium</w>
jel ly</w>
p ms</w>
keratin ocyte</w>
run -in</w>
pl c
append ectomy</w>
o -</w>
5 7,
os al</w>
trans boundary</w>
admis sibility</w>
fer i</w>
organis ational</w>
3 31</w>
m z
e ast
if loxacin</w>
no .</w>
n 0</w>
4 12</w>
hydro thermal</w>
br 1</w>
mediast inum</w>
quinol one</w>
premat urely</w>
ma stoid</w>
immun ophen
ncbi. nlm.nih.gov</w>
tri be</w>
min ded</w>
thaw ing</w>
day -
op yri
3 61</w>
biop sy
6 3.
eigen values</w>
morph ol
minim izes</w>
initi ator</w>
23 rd</w>
figure 6</w>
cy cle
parti tions</w>
6 7.
flag ella</w>
burg dor
hot -
re- suspended</w>
il 6</w>
epo chs</w>
de stabilization</w>
quanti le</w>
in ol</w>
fragr ance</w>
liflo zin</w>
β- sheet</w>
3 9-
10 0.0</w>
in hab
vo y
lister ia</w>
tu zumab</w>
lox p</w>
matthe w</w>
snap chat</w>
n gal</w>
gp x</w>
3 34</w>
ver b</w>
stand point</w>
clim b</w>
c 9</w>
i ensis</w>
am ides</w>
n z
nh 2</w>
r rt</w>
ran k-
de g
ka wasaki</w>
schne ider</w>
war nings</w>
echocardi ogram</w>
em ig
ass uring</w>
rb v</w>
kin es
cy 5</w>
rn ai
ay urv
celebr ate</w>
tro pic
modi fiers</w>
h v</w>
suff iciency</w>
mg mt</w>
dr c</w>
m able</w>
fluor ophore</w>
ful ly-
molybden um</w>
plu gs</w>
insul ts</w>
hyd rous</w>
ir id
on ically</w>
new -
a 00
am ending</w>
r arity</w>
lymp he
develop ment
sup posi
stewar t</w>
sum o</w>
ip sc</w>
studi es.
g avage</w>
p crs</w>
calc it
le ast-
cr na</w>
termin ating</w>
pac ed</w>
w 1</w>
pm 10</w>
van ke</w>
ter rain</w>
im in</w>
strength ens</w>
6 3-
break age</w>
her bic
vice- president</w>
pregab alin</w>
ck o</w>
η 2</w>
metallo proteinase</w>
bon n</w>
3 41</w>
non- hispanic</w>
ins ular</w>
break throughs</w>
artic ulation</w>
pull- down</w>
form at
myo fibroblasts</w>
qu at</w>
15. 8</w>
col lins</w>
rhu barb</w>
s ain
rever sibility</w>
bl ank
sh ame</w>
35 ,000</w>
eb p</w>
p di</w>
4 15</w>
stat 5</w>
dis similarity</w>
ultrasound- guided</w>
hospit al-
9 80
s onic</w>
din ium</w>
201 4-
extrapol ation</w>
h sd</w>
immin ent</w>
bl acks</w>
ass e</w>
pat ern
imp eded</w>
glucon ate</w>
i ap</w>
ne stin</w>
sub- paragraph</w>
si b</w>
m or</w>
toxic ological</w>
bo ehr
hyper glycemic</w>
re play</w>
cd 86</w>
denti tion</w>
aneu ploidy</w>
aff lic
ko v</w>
som ali</w>
diaminobenz idine</w>
b ls</w>
w ins</w>
13. 9</w>
sil- 2r</w>
sa k
home- based</w>
displac ements</w>
jp morgan</w>
tdp- 43</w>
pr k</w>
ro pe</w>
hepc idin</w>
2 i</w>
. after</w>
endocardi al</w>
ir bes
v ow
pris ons</w>
adv enti
refres hed</w>
explo res</w>
promin ently</w>
front- end</w>
li ve-
p esti
lin ess</w>
cal can
poly som
re trac
r ing-
second- order</w>
sen sible</w>
filop odia</w>
genit alia</w>
p iz
pyl oric</w>
cardi over
3 32</w>
al an
pat ella</w>
put atively</w>
coloc alized</w>
thro wn</w>
16. 3</w>
3 24</w>
incid entally</w>
spl its</w>
plag i
comp ass</w>
s n-
immuno stained</w>
quadru plex</w>
aca demia</w>
blastocy sts</w>
mor atorium</w>
ste ep
mac y
ic g</w>
er vation</w>
hal oper
15 g</w>
hom eless</w>
enterpris e-
observ ance</w>
rp mi-
neutr ality</w>
an p</w>
j 1</w>
sacc ades</w>
t 7
tonsil litis</w>
ug c</w>
l cs</w>
b 7</w>
j ail
co- occurrence</w>
edic s</w>
oc al
distribu tes</w>
le sion
anter iorly</w>
drow siness</w>
for bes</w>
i ors</w>
ecto derm</w>
endos ym
theat re</w>
ra o</w>
5 1.
char coal</w>
nuclear- weapon</w>
micro graphs</w>
f ts
simp son</w>
saphen ous</w>
b z
z ia</w>
peer- reviewed</w>
ig f</w>
eph edrine</w>
sh- sy5y</w>
t ga</w>
phot ograph</w>
cl ue</w>
fi a</w>
surger y.</w>
oppen he
col l</w>
3 gb</w>
gol d-
nanom aterials</w>
re placements</w>
dic hro
phosph ates</w>
tor ic</w>
y -</w>
isol ating</w>
demonstr ations</w>
br ick</w>
sub- adviser</w>
conserv atively</w>
flo x</w>
summar izing</w>
crystalli zed</w>
gr ab
phylogen ies</w>
scienti f
15. 1</w>
between- group</w>
dis ks</w>
anti- virus</w>
v ldl</w>
dr -
tr au
allo ys</w>
5 min</w>
cis plat
50 9</w>
ligam ents</w>
botan ical</w>
pp ar</w>
end anger</w>
lith o
spondy losis</w>
un characterized</w>
m ural</w>
nlr p3</w>
an dra</w>
ph eochrom
vi z</w>
per l</w>
ö </w>
fraud ulent</w>
t cc
seaf ood</w>
hn e</w>
a- related</w>
mir- 155</w>
py o
abstr action</w>
ger mp
yello wish</w>
pes si
ib o</w>
than k
g j
ke ung</w>
accompl ishment</w>
os e-
post translational</w>
oxygen ated</w>
p j</w>
environ ment
l- dopa</w>
unam sil</w>
b 3
cutting- edge</w>
bis -
amo eba</w>
man ic</w>
del ta
7- 9</w>
trans ver
disease- related</w>
u bin
y ag</w>
5, 7
eth no
re acting</w>
bl in</w>
eg ar</w>
ceftazidi me</w>
4 35</w>
enac tment</w>
hospit ality</w>
san itary</w>
supr a</w>
granul omas</w>
40 9</w>
chik v</w>
trim eric</w>
cryp tos
h w</w>
ent u
trache ostomy</w>
ip 3</w>
anaesthe tic</w>
x c</w>
vo res</w>
thol ders</w>
ie f</w>
lon ely</w>
m re
fibr illary</w>
vec tor-
am 1</w>
md x</w>
ot a
fox o1</w>
spl ic
muni tions</w>
measu red.</w>
5 6,
l at</w>
nct00 8
lep id
mat ch
presump tive</w>
l agging</w>
hyperuric emia</w>
h cm</w>
ocy sts</w>
sor bit
archi ved</w>
6. 25</w>
7 4.
substi tutes</w>
t all
32, 33</w>
meth op
q m</w>
text books</w>
pi ano</w>
e- book</w>
spac ex</w>
veter in
streptom y
ardi ac</w>
al ge
antec ed
recycl ed</w>
gly cyr
12 7
a 1-
depic t</w>
para -
enter ica</w>
i onom
c ables</w>
das 28</w>
cryp tococc
tro jan</w>
unif il</w>
plac ent
water shed</w>
he sit
peri anal</w>
sun screen</w>
mortgage- backed</w>
pream bular</w>
glyco sides</w>
accru als</w>
ombud sman</w>
su prac
streptavi din-
over estimate</w>
schw ann
stret ches</w>
3 23</w>
intermedi ate-
univer s
col our
mi u</w>
new castle</w>
cap tion</w>
bl a</w>
pen ic
nf- κ
porno graphic</w>
defin itively</w>
uph old</w>
pe ace-
uni prot</w>
x- axis</w>
th reads</w>
radi ologist</w>
cyan ide</w>
boo k-
pp b</w>
reset t
gn e</w>
asser tion</w>
p or</w>
sincer ely</w>
mon ic</w>
high- yield</w>
50 7</w>
ne dd
impro v
ch ev
al bin
m iz
id 50</w>
cor ol
log- transformed</w>
micro grams</w>
b am</w>
2 2.2</w>
mo -
ro ll
irbes artan</w>
3 28</w>
em c</w>
tap ered</w>
nhl bi</w>
3 x</w>
14. 4</w>
manifest s</w>
fox o
metac ar
ome tres</w>
re bel
new ton</w>
cruci ate</w>
lipoly sis</w>
ri pe</w>
non- pregnant</w>
pa stor
sn vs</w>
su p</w>
ma h
south- east</w>
il- 12
u iso</w>
uc sc</w>
ref seq</w>
peptid ase</w>
vou cher</w>
buff ering</w>
supple menting</w>
dissi p
bupren orphine</w>
chondro cyte</w>
ca f</w>
man nhe
complex ities</w>
deli sting</w>
th ly</w>
tax- exempt</w>
pr ad
his pan
gil bert</w>
. 25</w>
wr ky
t fa</w>
helicop ter</w>
19 51</w>
phen ol
d 4
lr r
wa ke
1 δ
prov oke</w>
l mw
comp action</w>
m l-1</w>
6 10</w>
b f
re acts</w>
vol ta
indi ans</w>
gen ome
ab uses</w>
mal e-
surviv or</w>
st 1</w>
seroposi tivity</w>
typ ed</w>
aff i
gren ada</w>
histo compatibility</w>
discrimin ative</w>
leuko tri
mp p</w>
over arching</w>
carboxyl ate</w>
gener alize</w>
over ly</w>
con ical</w>
micros copically</w>
sapon ins</w>
li ang
ps g</w>
pal e
am alg
omyc etes</w>
w ac
ob tains</w>
map ks</w>
oseltami vir</w>
urin alysis</w>
c- met</w>
mut ans</w>
oc i</w>
epig en
ur us</w>
1. 14</w>
un event
ti tres</w>
pl d</w>
and o</w>
frag ility</w>
tether ed</w>
err or-
p j
un due</w>
k 2
re statement</w>
real m</w>
p te</w>
perim en
intraspec ific</w>
nanos cale</w>
car t
pd ms</w>
4 74</w>
comm ends</w>
bure auc
electro physiology</w>
sl augh
pip 2</w>
de formed</w>
lr r</w>
eic os
non- interest</w>
attenu ating</w>
harb ors</w>
p its</w>
br en
hb o</w>
appor tion
se ma
intu itively</w>
3 21</w>
29 th</w>
g- protein</w>
af lat
t p-
n- cadherin</w>
b bs</w>
domin ant-
digo xin</w>
al tman</w>
swit ch
s- 2</w>
xu an
ab ut
pm sf</w>
ar kansas</w>
htl v-1</w>
w ax
ni x</w>
lys osome</w>
d sp</w>
indemn ified</w>
sc fv</w>
tumor- bearing</w>
galec tin-
excip ients</w>
8 gb</w>
al iz
pri t</w>
hand set</w>
y top
sh ishi</w>
ske w</w>
nor mot
mit omycin</w>
re plac
am is
hospit alier</w>
pt p
chair men</w>
camer on</w>
il is</w>
wa king</w>
bystand er</w>
daz z
ham sters</w>
19 20</w>
cdk 4</w>
cr p.
mening ioma</w>
phal lo
absor bing</w>
me ad
inv iting</w>
carb on-
stres sor</w>
hair y</w>
up per-
lic ences</w>
bou ts</w>
reyn olds</w>
ker nels</w>
so a</w>
religi ons</w>
col oured</w>
st alled</w>
dor sol
de fibrill
astrocy toma</w>
plan ets</w>
ill umin
ot ong</w>
ep end
stimul ant</w>
we ber</w>
athle te</w>
2. 25</w>
su ck
vi ve</w>
gen ius</w>
h3 n2</w>
ag og
ep ir
1 mm</w>
evap or
17 0
ater ial</w>
back light</w>
encumbr ances</w>
carcin om
val id
dwar f</w>
sp ared</w>
stoichi ometric</w>
hd l-
5 8,
re mitt
projec tor</w>
3 35</w>
90 s</w>
x un</w>
e 2-
mis m</w>
artic ulated</w>
prote us</w>
jian pi</w>
i 3</w>
defl ection</w>
6 r</w>
k shire</w>
myri ad</w>
hydro gels</w>
b out</w>
wo ven</w>
inspec t</w>
colum nar</w>
poly my
h x
qu ad</w>
ap op
indi an
laryn gitis</w>
del icious</w>
ech ino
l sd</w>
an tral</w>
b w
ati ca</w>
protr uding</w>
1. 20</w>
gran tees</w>
phot ob
rheum atism</w>
b ent
0.0 13</w>
ph os</w>
surro und
0. 99
r entals</w>
in ti
benzodiazep ines</w>
kenne th</w>
un realistic</w>
ml c</w>
ma g</w>
hepat ectomy</w>
1 a-
fl ash
. 2b</w>
marath on</w>
k om
illustr ative</w>
supr am
dis continuous</w>
ide ological</w>
im i
carc ass</w>
lon eliness</w>
fu -
s 12</w>
pro apoptotic</w>
5 h</w>
sm o</w>
oneph rosis</w>
cere als</w>
incredi ble</w>
di v</w>
ste ad</w>
plas ti
d ft</w>
targ et-
r α</w>
c- type</w>
13, 14,
marrow -derived</w>
pre emptive</w>
m ip-
clu stal
10 24</w>
and 22</w>
anch ors</w>
permeabil ization</w>
ex changing</w>
under lies</w>
op p</w>
pod ocytes</w>
sn ails</w>
cl icking</w>
industr y-
am bro
metast asi
nan or
surve y
over see</w>
tol y
arth ritic</w>
collabor ations</w>
mi an</w>
nom inations</w>
perc ei
effec tiv
ameli orated</w>
condy le</w>
par tur
he in
gingi valis</w>
bu tam
time- course</w>
dnmt 1</w>
as n
pollu ted</w>
mp er</w>
tr kb</w>
ib a</w>
p 16
preced es</w>
intram ural</w>
ur u</w>
cr ush</w>
speci es-
form amide</w>
sp astic</w>
half- lives</w>
ver a</w>
em d</w>
alog y</w>
imp ressed</w>
burgdor feri</w>
organiz ers</w>
iv c</w>
stream lined</w>
rot ate</w>
mass -
e- up</w>
assi sts</w>
anti- hcv</w>
ir t</w>
publ isher</w>
dic t</w>
yel low-
wi dow
special ised</w>
mmp 9</w>
neuro inflammation</w>
1 a2</w>
trif luoro
clean -up</w>
dis infec
ton ian</w>
su san</w>
q aly</w>
yi qi</w>
epididy mal</w>
6 32</w>
comple ments</w>
25 mg</w>
hem agglutinin</w>
ink 4a</w>
1 ml</w>
le op
osteoc la
y- axis</w>
5 2
prob es
a es
ug ly</w>
stic ks</w>
6 70</w>
institu to</w>
ser ologic</w>
l us</w>
27 th</w>
pu bli
k ak
60 5</w>
add- on</w>
non- profit</w>
rin sing</w>
r 01</w>
no tional</w>
acqui res</w>
anti -</w>
an hydrous</w>
28. 6</w>
e eding</w>
vin egar</w>
micro particles</w>
single- dose</w>
lau gh</w>
fasc ic
nitro glycerin</w>
slur ry</w>
varic ella</w>
pedi atr
mr m</w>
al tar</w>
ation- dependent</w>
devi ate</w>
universita ire</w>
fos han</w>
cal pain</w>
neuro ma</w>
gl ing</w>
dist antly</w>
b ob
oxidi zing</w>
millisec onds</w>
am ber</w>
ac idity</w>
e it</w>
war mer</w>
caroten oid</w>
me f
0.0 17</w>
f wh
sp ring
infec tion
im itate</w>
son ography</w>
bin der</w>
abbrevi ated</w>
lymphe dema</w>
ultra- thin</w>
bel ly</w>
ic f</w>
2, 4-
d j</w>
re hydrated</w>
omy cosis</w>
kl f4</w>
5 1-
den ervation</w>
prohib iting</w>
bacterioph age</w>
dat ang</w>
4 32</w>
sh at
4 22</w>
oce an
feat uring</w>
exud ate</w>
loc ks</w>
cra mps</w>
mac ul
s ow</w>
mp c</w>
ma a</w>
boehr inger</w>
prot agonist</w>
tn t</w>
sh ei
or ia</w>
contin ents</w>
meridi ans</w>
3 cm</w>
co on</w>
n f1</w>
f et</w>
acyl glycerol</w>
7 e</w>
snap dragon</w>
j w</w>
arsen ess</w>
apportion ment</w>
top ographic</w>
3 58</w>
prec ede</w>
cellul ase</w>
stag n
ver ap
mis matched</w>
mongol ian</w>
b di</w>
dend rite</w>
ma a
woul dn</w>
beet le</w>
ster ility</w>
out group</w>
zz ard</w>
g cc</w>
nicot inamide</w>
s. the</w>
evid ently</w>
3 27</w>
win 8</w>
er β</w>
enc er</w>
laryngos copy</w>
sn ack</w>
inter chang
app er</w>
thir teenth</w>
7- day</w>
k ha
5 α</w>
ass a</w>
nub ia</w>
arte facts</w>
dystroph in</w>
post- mortem</w>
dy suria</w>
glut 4</w>
se d-
introg ression</w>
graph ically</w>
staphylococc al</w>
draw ings</w>
anti apoptotic</w>
malay sian</w>
not -
mer i
2 3.5</w>
- and-
pre si
op oly
scal ability</w>
3 55</w>
win ds</w>
rel a</w>
embarr assing</w>
segreg ating</w>
ac t-
real- life</w>
gro ve</w>
silic ate</w>
r ons</w>
immuno competent</w>
bur k
inclin ation</w>
princ ess</w>
g ill
appro ves</w>
ne br
squi bb</w>
trehal ose</w>
chee tah</w>
pa z
des patched</w>
angioten sin-
jane iro</w>
oth re
ang eal</w>
1. 18</w>
aut oradi
titr e</w>
og o</w>
7 68</w>
scri p
bedro om</w>
prioriti zed</w>
spic y</w>
sub sp</w>
in separable</w>
g op
p raz
ban ana</w>
preclud es</w>
sal butam
elast ase</w>
angi osper
hong yi</w>
en shrin
g v</w>
sr .
time- points</w>
conver ter</w>
neuro toxic</w>
scor pi
4 16</w>
ig enic</w>
sr h</w>
at o
induc ement</w>
lact one</w>
om or
pec tin</w>
fos un</w>
dom ain
aggreg ating</w>
f ene
vo 2
morph ogenetic</w>
del phi</w>
gen icity</w>
immun olab
fin ely</w>
sti r</w>
r ust</w>
27 a</w>
neg ativity</w>
inter sper
os ec
14. 0</w>
kes han</w>
well ness</w>
dial og</w>
efflu ent</w>
hyper cap
c ec</w>
0.0 11</w>
g sh-
biomol ecules</w>
public -
tryp tic</w>
non- u.s.</w>
encyclop edia</w>
pw v</w>
ast in</w>
ography -
pmt ct</w>
infec tion.</w>
pcr -based</w>
fusi form</w>
sox 9</w>
fill er</w>
model -based</w>
bas oph
d ome</w>
te ens</w>
pon ds</w>
p assu
fir mic
bl os
e qs</w>
promp ting</w>
5 55</w>
1. 16</w>
5 94</w>
ti re</w>
univers ality</w>
enc e.</w>
endothel ium-
bon t</w>
min u
intrader mal</w>
k 6</w>
r rs</w>
del im
str uggl
p- selectin</w>
5, 8
asym metrical</w>
l acc
a ol</w>
conven i
nicot inic</w>
pneum operitoneum</w>
lab ile</w>
aldehy de-
cr ack
c 4
pl k1</w>
allevi ating</w>
s brt</w>
recan alization</w>
c gi-
11 b</w>
debil itating</w>
calmodul in</w>
install ations</w>
encryp ted</w>
regi stering</w>
separ ates</w>
au -
age en
mal t</w>
g ain-
guan osine</w>
a at</w>
w ri
asser t</w>
empow er</w>
rhodop sin</w>
p act</w>
chair persons</w>
g it
direc tor-
tu res
ed -up</w>
percenti les</w>
casu alties</w>
if ers</w>
de v</w>
i osis</w>
- joining</w>
piper acillin</w>
bal lot</w>
comp are
at cc
is c</w>
assembl age</w>
mannhe im</w>
tk is</w>
multi drug-resistant</w>
ba x
400 2</w>
mat a</w>
c cr</w>
contro l-
surround ings</w>
haloper idol</w>
3, 4,5</w>
s- cov</w>
motor cycle</w>
reg res
mt 1</w>
flas hes</w>
wor d-
post- transplant</w>
re invested</w>
salbutam ol</w>
girl friend</w>
streptomy ces</w>
testim ony</w>
congru ence</w>
arbit ral</w>
exc use</w>
un remarkable</w>
intr usion</w>
ter ry</w>
author isation</w>
view ers</w>
put amen</w>
ink t</w>
aza thiop
ipil imumab</w>
su tured</w>
catar acts</w>
micr one
ch k1</w>
princip als</w>
cocc i</w>
post- menopausal</w>
vi sts</w>
3 68</w>
govern ment-
i b-
cor y
ly on</w>
mis t</w>
deco y</w>
is os
co done</w>
sequenc er</w>
is omer</w>
ka iser</w>
per oxy
32 p</w>
de his
kil ometres</w>
substanti ated</w>
s bs</w>
bilir ubin
p na</w>
year book</w>
inci sions</w>
quot e</w>
strat agene</w>
paraty phoid</w>
twe ets</w>
ncr nas</w>
yl amine</w>
dp f</w>
6 47</w>
y s
lec tur
up lift</w>
ba ked</w>
ol o</w>
c pe</w>
carr ageen
13 c-
l augh
hd acs</w>
pk d</w>
b ass</w>
p 27
repres sors</w>
travel ed</w>
mis -
ophy te</w>
nmd ar</w>
n bs</w>
t ls</w>
some where</w>
,0 0
in h</w>
ig g-
dr e</w>
ff y</w>
ab aba</w>
a ção</w>
1. 33</w>
mir s</w>
sing ly</w>
t- like</w>
lip stick</w>
cat alog
primor dial</w>
comm its</w>
33, 34</w>
pc v</w>
resi stin</w>
blow n</w>
yong hao</w>
coiled- coil</w>
tax ol</w>
pre- mrna</w>
pu bic</w>
ar en</w>
ji az
v 600
b- cells</w>
k ri
coh esin</w>
l- type</w>
high -</w>
pu pae</w>
high- intensity</w>
modi fies</w>
gl ou
profes sions</w>
18. 8</w>
13 00</w>
imp regn
4 50
ordin arily</w>
conver sions</w>
cc m</w>
length ening</w>
liveli hoods</w>
amin idase</w>
viet nam
d ls</w>
60 2</w>
e oc</w>
endos cop
be ir
ti st</w>
unequivoc al</w>
i dus</w>
de hydro
ud p-
recre ation</w>
g c-ms</w>
si eve</w>
ore dox
stri pes</w>
orific e</w>
s é
100- fold</w>
gif ted</w>
ball mer</w>
exter ior</w>
is tics</w>
gr a</w>
activ in</w>
di ox
ren owned</w>
t tr</w>
cryptos por
prud ence</w>
clar ifying</w>
ser -
cycl op
at uration</w>
unic orn</w>
3 66</w>
micro surgical</w>
hu ai
mis understanding</w>
graf t-
tion ist</w>
prof icient</w>
mo h</w>
ca ul
16. 6</w>
c 9
enumer ated</w>
pollin ation</w>
seron egative</w>
k oz
el essness</w>
coty le
sign al
euthan asia</w>
b 2
strepto zot
affer ents</w>
19. 0</w>
zol id</w>
wheel chair</w>
colpos copy</w>
banc shares</w>
enem ies</w>
lamel lipo
e z-
fro gs</w>
re sts</w>
en ox
spro uting</w>
m eng
15. 7</w>
intest ines</w>
per missions</w>
con strain</w>
photo dynamic</w>
bre ed
mp i</w>
pro m</w>
st ab
cl ots</w>
th aw</w>
white- collar</w>
19 0
ol l</w>
mon tg
f to</w>
i stan
fin alize</w>
re z</w>
s 12
car pal</w>
c gg
b g
a ip</w>
fifty- ninth</w>
v n</w>
ap is</w>
pow ders</w>
ig at
s angu
jejun al</w>
calcul i</w>
8 g</w>
super position</w>
ro gers</w>
1. 09</w>
cell- derived</w>
frameshif t</w>
l son</w>
anti epileptic</w>
screen shot</w>
hospit al-based</w>
prevent ative</w>
su fentanil</w>
12 99</w>
t son</w>
g d-
j ar</w>
v et
after- tax</w>
y ip</w>
ag ent
e fa
calcit onin</w>
tri methop
. 3a</w>
high- energy</w>
prioriti zation</w>
r s-
neur itis</w>
system .</w>
han de
vi er</w>
7 9.
germp lasm</w>
adeno viral</w>
intersper sed</w>
a ac
dec ou
l ng</w>
cp d</w>
ain ment</w>
spra yed</w>
c si</w>
hex agonal</w>
ge e</w>
om andi
rat ers</w>
montg omer
op sin</w>
ic onazole</w>
x ero
m sm
vacu ol
si sters</w>
cd 38</w>
cr un
exec ut
share holdings</w>
op ic
ø </w>
cat er
fibrin olytic</w>
sub class</w>
mon ophosphate</w>
show er</w>
17. 2</w>
loc ating</w>
pg c</w>
1- deficient</w>
j j</w>
ro ller</w>
t sp</w>
ow itz</w>
tr inity</w>
damp ing</w>
tr end
lymphaden ectomy</w>
auto fluorescence</w>
multi- year</w>
gro cer
ck- mb</w>
chu an
win ners</w>
w g.
work- related</w>
dispat ched</w>
enshrin ed</w>
on- free</w>
ster ols</w>
han sen</w>
mort ar</w>
g ong
por tr
trypsin ized</w>
ca str
az ol</w>
mic ity</w>
md scs</w>
thi oredox
registr ations</w>
tis an</w>
comp ile</w>
d ob
34, 35</w>
hel ium</w>
propag ating</w>
un determined</w>
condyl ar</w>
ser ia</w>
har bored</w>
harmon ized</w>
sub tropical</w>
re use</w>
ograph ies</w>
associ ating</w>
ec c</w>
sp f
phenotyp ing</w>
legis l
kick starter</w>
re fur
v hl</w>
high- pressure</w>
ad an</w>
olymp h</w>
d z</w>
calcul us</w>
fin es</w>
sur rendered</w>
digi tized</w>
ribb on</w>
publi que</w>
aph ids</w>
vo ters</w>
chair manship</w>
snor ing</w>
mc ne
post- processing</w>
ld 50</w>
grp 78</w>
mec p2</w>
or is</w>
tgf β1</w>
chap .</w>
v angu
tur p</w>
itrac onazole</w>
coll ects</w>
europe ans</w>
cons enting</w>
g ö
enum eration</w>
concentration- time</w>
ter t-
uc tal</w>
un specific</w>
rapporte urs</w>
tur bo</w>
é s</w>
eng ag
and 4</w>
nucleoti de-
figure 1c</w>
5, 9
cooper atives</w>
p. a.</w>
200 mg</w>
eu ph
res -
main stay</w>
d 2
in definite</w>
photo volta
19 57</w>
tripl icates</w>
ement .</w>
blun ted</w>
endo derm</w>
pneum ophila</w>
mycel ium</w>
aut ocla
car ni
blast p</w>
p ell
clin ton</w>
quanti fiable</w>
distinguish es</w>
em m
upp sala</w>
m va</w>
anatom ically</w>
multip ly</w>
d ap</w>
id ed</w>
co- infected</w>
al cin</w>
biol abs</w>
implic itly</w>
ase- 1</w>
8 60</w>
neuro vascular</w>
good ness</w>
concentr ating</w>
mat osis</w>
ing -up</w>
ho arseness</w>
bor reli
bi tis</w>
non diabetic</w>
sham- operated</w>
add .2</w>
cab bage</w>
buc ks</w>
mid night</w>
mirr ors</w>
pseud ot
commission ers</w>
li fies</w>
ni ke</w>
re financing</w>
nebr aska</w>
parasit emia</w>
8 80</w>
ul s</w>
co coa</w>
ati veness</w>
p co2</w>
3. 13</w>
hu ff
remitt ances</w>
80 s</w>
3 86</w>
pre d</w>
astrocy tic</w>
hepat otoxicity</w>
row th</w>
passi vely</w>
methyl phen
perfor med
ton sill
proof- of-
fifty- eighth</w>
to es</w>
tor ate</w>
chem o-
ok ay</w>
z z</w>
oc ep
ar ize</w>
trop ism</w>
spong es</w>
centromer es</w>
ass er</w>
atrac ty
r 4</w>
open ly</w>
a 10</w>
mdr 1</w>
μ m2</w>
ophen ol</w>
bio assay</w>
s os
pr psc</w>
cb c</w>
ge or
st 2</w>
fifty- seventh</w>
sig ne
pm ma</w>
cle aves</w>
alum ina</w>
anti- tnf</w>
zz le</w>
man ure</w>
adjuv ants</w>
ac ri
moun tain
verap amil</w>
microtubul e-
0 2-
interest -free</w>
non- canonical</w>
e it
14 00</w>
osper mia</w>
3 37</w>
ser t</w>
i sis</w>
r ca</w>
tri am
helmin th</w>
elong ate</w>
e dison</w>
l agged</w>
scaff olding</w>
deep est</w>
nat o</w>
c sd</w>
prosper ous</w>
flu ent</w>
80 5</w>
sen ses</w>
bro od</w>
land er</w>
insp ire</w>
pneum atic</w>
k ay
sp line</w>
muscar inic</w>
mil ky</w>
ir vine</w>
ach illes</w>
y ak
intrad uctal</w>
sr f</w>
co me
ro th
mat ures</w>
14. 9</w>
guil t</w>
circul ate</w>
ic om</w>
stud y.
nct00 7
ti co
sa w
s re
1. 45</w>
us en</w>
anti- hiv</w>
ro e</w>
herbi vores</w>
cxcl 10</w>
instruc tor</w>
par k
bio reactor</w>
hydr onephrosis</w>
man it
4. 0
mar sh</w>
metr e</w>
composi tional</w>
discer n</w>
d me</w>
br -
restor ations</w>
hn rnp</w>
o ide
azathiop rine</w>
contradic tions</w>
symp ath
thir st</w>
c z</w>
firmic utes</w>
igg 4</w>
proof s</w>
midwi fer
3 85</w>
int us
ic hi</w>
pa hs</w>
poli tically</w>
ingenu ity</w>
dab igat
sequ ence-
maa stric
sun burn</w>
dispat ch</w>
2 40
neutr alize</w>
thermo meter</w>
knowle dg
neis seria</w>
aspir ate</w>
n ie
colon ize</w>
cef oper
on .
pheny toin</w>
figure 5a</w>
co polymer</w>
al azine</w>
at ories</w>
te g
inter ing</w>
q 4</w>
mala ise</w>
pen n</w>
º c</w>
hurric ane</w>
dec arboxyl
quick er</w>
a ag</w>
cd 56</w>
b- type</w>
19 7
de methyl
har dy-
medi ally</w>
de d.</w>
intub ated</w>
5 35</w>
ba e</w>
as l</w>
hb c</w>
promo ter-
ad ines</w>
pu st
dis miss</w>
omandi bular</w>
prov ocation</w>
cell s.</w>
clon tech</w>
specific s</w>
medul lob
counc ils</w>
scler osing</w>
plank tonic</w>
ex cur
perin uclear</w>
ep im
fac </w>
inspec tor</w>
ace i</w>
e igh</w>
5 15</w>
ess enti
control lers</w>
ham a</w>
ben th
cap tive</w>
caf es</w>
dun n</w>
00 7</w>
4 4-
h c-
spar sely</w>
ha ul</w>
az ol-
hyper sensitive</w>
leth arg
alloc ating</w>
cat alogue</w>
mox ifloxacin</w>
ch 2
day .</w>
ver ifying</w>
aut ophosphor
kineto chores</w>
stra it</w>
v ad</w>
ex otic</w>
exc essively</w>
pier re</w>
ho ff</w>
expedi te</w>
hydrochlor ic</w>
fl ush</w>
ic ola</w>
list ened</w>
bus hen</w>
β 2
00 4</w>
un avoidable</w>
mon ster</w>
k au
mang o</w>
ali ph
m ch</w>
p 10</w>
bez os</w>
sc anners</w>
20. 5</w>
intr icate</w>
ly 29
fig s
prof essors</w>
extrac tions</w>
chag as</w>
asth matics</w>
priv at
- g
hy stere
chang hong</w>
hindi ii</w>
clath r
medullob la
olig omer</w>
disposi tive</w>
dis solving</w>
common est</w>
1. 9
aden oid</w>
ju x
c. 4</w>
sc ape</w>
gren adines</w>
hyperinsulin emia</w>
fis sile</w>
ccr 7</w>
i st-
legen ds</w>
ri x</w>
ab u</w>
m glur
lacti s</w>
p ga</w>
tre x
yp d</w>
hif -1</w>
cruc ially</w>
persu ade</w>
mw c</w>
negoti able</w>
war fare</w>
t ress</w>
ti lis
p sii</w>
intus susc
he fei</w>
por a</w>
fu zhou</w>
sad ness</w>
li b</w>
embarr assment</w>
4 14</w>
me q</w>
quoti ent</w>
cd 16</w>
phospho inosi
prov o
anc e.</w>
r ds</w>
s x
f t4</w>
moderate- to-
c ic</w>
he d
lic hen</w>
vort exed</w>
5 9,
pro polis</w>
que ue</w>
ff t</w>
ass ent</w>
al- to-
di aries</w>
osa hs</w>
dorsol ateral</w>
1. 19</w>
eb na
autophag osomes</w>
xanth ine</w>
bed time</w>
passu </w>
ver ge</w>
b and-
. 3b</w>
stap led</w>
function alization</w>
sul fat
y ama</w>
ag liflozin</w>
attend ant</w>
ur t</w>
ore duc
pas sport</w>
k w</w>
bi ographical</w>
cogn i
k ie</w>
prosec ute</w>
od n</w>
dic ty
lad en</w>
nucle olus</w>
concep tually</w>
predec essors</w>
3 97</w>
y am</w>
sub classes</w>
1. 43</w>
biol uminescence</w>
un- habitat</w>
vasodil ator</w>
a ver</w>
jol la</w>
os as</w>
l ul
ke to-
stup id</w>
hyph al</w>
1. 23</w>
vag us</w>
ow ski</w>
ventilat or-
commensur ate</w>
1. 17</w>
az o
wi ves</w>
por cel
anec dot
cogn itively</w>
ev ade</w>
1- 7</w>
sep tic
harm less</w>
mo tive</w>
6 ,0
jail break</w>
7 5.
ic tal</w>
develop mentally</w>
bul </w>
am gen</w>
character izes</w>
in- binding</w>
teen agers</w>
approxim ates</w>
form ans</w>
land mines</w>
d ko</w>
unc cd</w>
substr ate-
gn a</w>
bur sting</w>
parall els</w>
substanti a</w>
bal i</w>
inv oked</w>
cur ation</w>
l f
ultracentr ifug
sa x
z ie
vangu ard</w>
v lps</w>
promis cu
18 ,000</w>
vin yl</w>
cushi on</w>
or nam
leptos pi
co- localized</w>
clu b
g cn
colchic ine</w>
plasm on</w>
fur an</w>
ser tol
cel sius</w>
- labeled</w>
iti an</w>
p si
1,2, 3</w>
high- income</w>
geo metries</w>
hand s-
notic eably</w>
ph alog
3 96</w>
lin oleic</w>
anthocyan in</w>
vaccin ia</w>
chang chun</w>
bo ar
sd k</w>
er m</w>
sex uality</w>
emul si
2 7.5</w>
em it
antr um</w>
pho x</w>
di phosphate</w>
polysom no
ah l</w>
lv h</w>
re purchases</w>
ro ot-
dar k-
dominant- negative</w>
cl omi
oxal ate</w>
w yn
glycyr rhiz
ha v
he dges</w>
shug an</w>
appro ach
ap ing</w>
mono amine</w>
1, 25</w>
brist ol-
60 6</w>
interrup tions</w>
scap ular</w>
k apo
pream ble</w>
i 9
nf- kb</w>
pop liteal</w>
prof i</w>
sing let</w>
1. 22</w>
p dr</w>
1- 6</w>
sub- item</w>
opoie tic</w>
semi- annual</w>
p 40</w>
clon idine</w>
sp rin
60 3</w>
pl ains</w>
har ry</w>
vill ous</w>
br s</w>
man dar
urethan e</w>
0. 5-
midwifer y</w>
cr pc</w>
ch 2</w>
one- step</w>
nor mox
ge force</w>
comp lies</w>
win d-
ster n</w>
lo co
pp h</w>
hs v-
ex y
lig ases</w>
sof tening</w>
if u</w>
indian apolis</w>
a a-
n cc
cd 80</w>
dun can</w>
mo tives</w>
bronch us</w>
k up
eu gen
na dir</w>
l ily</w>
parsimon ious</w>
ann y</w>
casse ttes</w>
aro used</w>
1. 21</w>
gar d
incub ations</w>
sub urban</w>
mor i</w>
famil y-
zebr a</w>
h ens</w>
duc ks</w>
contamin ating</w>
identi fications</w>
g add
rock ford</w>
lis a</w>
multipl ic
de forestation</w>
pl anc
dabigat ran</w>
2 g
hin t</w>
cn c</w>
zir con
sorbit ol</w>
silk worm</w>
hardy- weinberg</w>
inf ested</w>
sec tioning</w>
immen se</w>
cop ying</w>
vibr ations</w>
pon der
eth nic
wi shing</w>
ro om
le sional</w>
r ales</w>
en i</w>
r dr
ovi position</w>
we tting</w>
in definitely</w>
sp 2</w>
il- 22</w>
reson ances</w>
heat- inactivated</w>
isot onic</w>
troch anter
syno vitis</w>
h 2a</w>
ophy tic</w>
rig orously</w>
sal is</w>
te ster</w>
constell ation</w>
fram ingham</w>
cardi o-
6 15</w>
bar bara</w>
2- mediated</w>
c iting</w>
bru cel
profession alism</w>
wa als</w>
gig ab
str anger</w>
spectrophoto metric</w>
ab dul
elast ography</w>
u f</w>
ischa emia</w>
hystere sis</w>
s 2b</w>
protein- coupled</w>
lig and
dist ally</w>
ps v</w>
matri x-
scen ery</w>
polyaden ylation</w>
con son
ver -
nuclear- weap
hk ic
ex osome</w>
z ou</w>
caspase- 9</w>
k- ras</w>
ba thing</w>
air ports</w>
self- control</w>
safegu arding</w>
in- vitro</w>
gram mar</w>
brow sers</w>
r ab</w>
acid- base</w>
capital ised</w>
out doors</w>
h ps</w>
wom ac</w>
thyro xine</w>
skip ping</w>
hes c</w>
impair ing</w>
cor tex
param agnetic</w>
h al</w>
li zumab</w>
brut al</w>
cp i</w>
vi f</w>
har ms</w>
re generate</w>
anesthesi ologists</w>
igf- 1r</w>
g mail</w>
f viii</w>
en vision</w>
5 49</w>
chin a-
af c</w>
top ir
but yl
eif 2α</w>
re medial</w>
ste phen
spati o-temporal</w>
bil ingual</w>
crystall ography</w>
gu ys</w>
sh in</w>
th ia</w>
kil ograms</w>
enter obacter</w>
r gd</w>
mechan istically</w>
imple mentations</w>
large- screen</w>
17. 1</w>
op eptide</w>
gh s</w>
gl un
stap le</w>
thri ve</w>
p -</w>
phlo em</w>
hi ro
neur on
w t1</w>
over- represented</w>
un coupling</w>
id ong</w>
i av</w>
ali enable</w>
kin ess</w>
e. coli</w>
re tr
rein forces</w>
cover slip</w>
satur ating</w>
9 3.3</w>
aw ed</w>
or h
volcan ic</w>
succ eeding</w>
e2 f1</w>
investig ates</w>
anti angiogenic</w>
sk ep
w 2</w>
γ- secretase</w>
mp tp</w>
4 e-
prob ands</w>
res ins</w>
chel ating</w>
clomi phene</w>
free- living</w>
p raised</w>
2 1.5</w>
tra ver
extinc t</w>
op hi
tl r-
hepat oma</w>
puer peri
md c</w>
hi moto</w>
scd ma</w>
confer encing</w>
hyper plastic</w>
h b-
ac es</w>
r ented</w>
gr amin
trim er</w>
l ance
glou cester</w>
non- obese</w>
pal o</w>
pro -</w>
tri m</w>
op pression</w>
mal le
gener alised</w>
hyster oscopy</w>
t- type</w>
v v</w>
hypo echoic</w>
standar d-
dis courage</w>
atom as</w>
three- way</w>
cy ber</w>
s 3a</w>
prefec ture</w>
sun ny
at l</w>
mechan is
ic ide</w>
chic ks</w>
5, 6
k em
tin -1</w>
w end
the ophylline</w>
mat ous</w>
t bp</w>
64- slice</w>
ascer tainment</w>
den nis</w>
17. 3</w>
conc us
normox ic</w>
t ant
huang lian</w>
non- overlapping</w>
t2 wi</w>
17 12-
di o</w>
m di</w>
wor e</w>
l da</w>
pot ently</w>
serv iced</w>
sm d</w>
an ony
ure mic</w>
sap onin</w>
x hoi</w>
eas y-to-
mid west</w>
cm h2o</w>
3 64</w>
6- phosphate</w>
r yst
hard ship</w>
er s.</w>
r ns</w>
col or-
bran ch
at ch</w>
g earing</w>
te gra
squ ir
k f</w>
asympto tic</w>
i be</w>
17. 4</w>
co fil
so ared</w>
syn tactic</w>
g up
inter- individual</w>
p se</w>
ra k
dis counting</w>
psych omotor</w>
ret initis</w>
carni val</w>
h oc
distribu table</w>
1. 30</w>
8- week</w>
00 5</w>
under pin
en al
br ace</w>
ut ter
dithi othre
ov ag
d- to-
ram er</w>
lim a</w>
screen shots</w>
counter party</w>
bl essing</w>
methylphen idate</w>
col- 0</w>
pet als</w>
roman tic</w>
dec k</w>
longit ude</w>
16. 4</w>
cyste ines</w>
ph asing</w>
brist ol</w>
5 99</w>
min ur
year- over-
ent ech</w>
hyp om
re positioning</w>
ap est</w>
19 59</w>
rou x-
s ne
3 73</w>
br achi
br c</w>
transpos able</w>
15, 16,
repeat ed-
chin a.</w>
sl u
endos perm</w>
mal tose</w>
ri g</w>
vol k
her map
adv enture</w>
loos ely</w>
experim ent
electr ically</w>
1 cm</w>
athle tic</w>
fl aws</w>
eg fr
ab ies</w>
vi vi
ser y</w>
hermap hro
ul os</w>
conclu sively</w>
biog e
6 6.
mc d</w>
double- strand</w>
in alienable</w>
thor n
vice- chairman</w>
non significant</w>
gt x</w>
pik3 ca</w>
dict ated</w>
triam cin
anti-h bs</w>
p th
iz hu</w>
prog est
un fortunate</w>
hkic pa</w>
table 2.2.</w>
ud inal</w>
op pose</w>
oryz ae</w>
id g</w>
ace tam</w>
gross ly</w>
wh r</w>
cc 2</w>
18. 3</w>
o rel
e av
t- 2</w>
2- d</w>
aff ec
be ast</w>
par as
tal ented</w>
vietnam ese</w>
anti- infective</w>
az e</w>
proc ured</w>
p. c.</w>
on ion</w>
1. 26</w>
⁡ </w>
meth rin</w>
quin tiles</w>
a edes</w>
re build</w>
jun k</w>
70 6</w>
. 21</w>
18. 6</w>
dr 5</w>
fisher y</w>
hermaphro di
point- of-
engag ements</w>
re mitting</w>
spor ting</w>
body -
vor iconazole</w>
no str
miti gating</w>
paran oid</w>
min t</w>
decomp osed</w>
s our</w>
kin d
d ns</w>
stri kes</w>
bristol- myers</w>
pr inters</w>
heav en</w>
le v</w>
mam mal</w>
non synonymous</w>
oper oxidase</w>
ten g</w>
sl aughter</w>
ri var
domin ates</w>
est ro
ep stein-
smad 4</w>
ure -
ente sis</w>
dend ri
ri v
s gs</w>
interrup t</w>
gt p-
rub in</w>
uc a</w>
hol land</w>
h2 po4</w>
app raised</w>
bli zzard</w>
5 68</w>
aliph atic</w>
gon ads</w>
d ad
hh v-
self- regulation</w>
hol mes</w>
70 2</w>
pro to-
post- stroke</w>
3 o4</w>
endor ses</w>
dar ker</w>
enrol le
ph os
ha wk</w>
6, 8
stun ning</w>
parallel- group</w>
of c</w>
v p1</w>
bios ensors</w>
0.0 18</w>
qu il
ic er</w>
n z</w>
dithiothre itol</w>
er- based</w>
ra ff
shut down</w>
gastro duodenal</w>
oxid oreduc
immuno fluorescent</w>
run ners</w>
sap iens</w>
m inc
nov ice</w>
gra y
ki stan
⩾ </w>
confid ence-
ver sus-
year-over- year</w>
ectom ies</w>
osteoc alcin</w>
replen ishment</w>
rn fl</w>
trochanter ic</w>
emin ent</w>
pop -up</w>
anaphy lactic</w>
exten ded-
fluor ophores</w>
her ald</w>
c j</w>
ones elf</w>
twi sted</w>
bel ow
antipyre tic</w>
e asing</w>
f 1a</w>
sv 40</w>
cy toly
ocy te
n 1
rs 2
third- generation</w>
perimen opausal</w>
acade mic
l mp
4 97</w>
diaz epam</w>
contag ious</w>
re generating</w>
sh ang</w>
glyca emia</w>
transl ations</w>
ho mem
ro und-
mir-3 4a</w>
k 12</w>
om on
hud son</w>
self- assessment</w>
director- general</w>
im ing</w>
afric ans</w>
bio feedback</w>
n ba</w>
avi dity</w>
gran t-
way ne</w>
stat s</w>
i 7</w>
acade mics</w>
6, 7
e tr
fl utter</w>
quot es</w>
e gl
i. d.</w>
mortg ag
pa ve</w>
gob let</w>
gi p</w>
tx b2</w>
8- ox
allo dynia</w>
ple uro
revolu tion
ron ald</w>
es omeprazole</w>
intenti on-
0 9-
pe do
characteris ation</w>
deple te</w>
z nf
frequ ency-
in ization</w>
obron chial</w>
biolog ics</w>
helpl ess</w>
mother -
meth amphetamine</w>
ass y</w>
unci ation</w>
f hl
descend ants</w>
2 1.4</w>
homem ade</w>
δ g</w>
wand ering</w>
unequivoc ally</w>
cap tain</w>
af lp</w>
ta xed</w>
s sp</w>
ob s</w>
qu in</w>
let t-
gam ble</w>
softw are
no cod
arrowhe ads</w>
sub ur
lo ver</w>
exemp tions</w>
m ns</w>
arbitr ator</w>
ch es
t cc</w>
inform ation-
1 ,</w>
inter- rater</w>
work up</w>
sin king</w>
tether ing</w>
collater alized</w>
cellul arity</w>
embar ked</w>
topir amate</w>
tow ers</w>
ch x</w>
12- lead</w>
genit our
fwh m</w>
erythropo ie
c 6
retro viruses</w>
γ 2</w>
wenz hou</w>
accep tances</w>
ed ss</w>
cor rhiz
rock y</w>
end odontic</w>
shar ks</w>
or ization</w>
fifty- sixth</w>
ve .</w>
en thal
iv y</w>
rel or</w>
fd a-
c ens
35, 36</w>
vul var</w>
fre der
conve y
00 5
hirsch sprung</w>
moz illa</w>
deteri orate</w>
. 22</w>
hol o
schwar tz</w>
g ain
q 2
avi </w>
cere us</w>
genitour inary</w>
b ish
glucone ogenesis</w>
v ga</w>
retin oblastoma</w>
sertol i</w>
coo ker</w>
direc tives</w>
inf ant
dor f</w>
2- yl</w>
eu st
reg rets</w>
7 2-
tail or</w>
20 50</w>
ob tur
othi azide</w>
ble ed</w>
s ay
g ct</w>
mm t</w>
3 88</w>
s 1-
com ic</w>
medic ated</w>
suc king</w>
first- class</w>
bre tton</w>
st all</w>
g 1-
x ist</w>
en ly</w>
blu ep
mit ogenic</w>
resett lement</w>
wal tham</w>
securiti zation</w>
ell en</w>
19 56</w>
transpl ant
nct00 6
ri f</w>
k end
sh amp
6 7-
nine teenth</w>
tun nel
lo dge</w>
á n
pheochrom ocytoma</w>
19 48</w>
sixty- first</w>
fiber optic</w>
3 56</w>
benzy l</w>
swi </w>
fabric s</w>
vegf- c</w>
g6 pd</w>
h we</w>
play station</w>
b auer</w>
sr p
astig otes</w>
sp it</w>
wor d
efa vir
pin ch</w>
valu er</w>
gr asses</w>
w gs</w>
90 6</w>
encomp assed</w>
mo ul
5- 6</w>
w rap</w>
ne at</w>
pri ors</w>
cataly tically</w>
8 h</w>
exc ise</w>
am u
hr ct</w>
au gu
car ve
t 6
ql q-
cd n</w>
instruc t</w>
m hc
- out</w>
sugar cane</w>
epstein- barr</w>
d ll
pap il
fr ap</w>
kar olin
re polarization</w>
for ks</w>
it d</w>
ab lated</w>
ph obia</w>
yeth yl</w>
anti- tb</w>
polymer ized</w>
3 95</w>
travel led</w>
hypo methylation</w>
methox azole</w>
h ca</w>
country side</w>
wag ner</w>
rpmi- 1640</w>
i 5</w>
normot ensive</w>
2 a-
cann ulation</w>
sch u
7 r</w>
taz obac
cb a</w>
discer ni
chap el</w>
4 6-
stro op</w>
aut ore
hew lett-
shenz hou</w>
pre maturity</w>
j on
blast x</w>
are t</w>
hi ther
p 53
bag hd
le in</w>
x ane</w>
hamp er</w>
photograph er</w>
qi a
fos sils</w>
b il</w>
neo formans</w>
40 mg</w>
cholest asis</w>
arabin ose</w>
ak t1</w>
hyper triglycer
ag o2</w>
stan e</w>
og u
rep ell
vag in
inten sely</w>
li ons</w>
bu tter</w>
3 0.0</w>
nucle ated</w>
synchron ize</w>
chil ling</w>
hydrox ylation</w>
pt p</w>
8 0.0</w>
ad duc
is p</w>
polyvin ylidene</w>
cardio metabolic</w>
l fp</w>
fixed- income</w>
ke i</w>
pseudo aneurysm</w>
pa kistan
moham ed</w>
0. 125</w>
15 0-
troubles ome</w>
nano drop</w>
1. 24</w>
r wand
gun s</w>
x n</w>
ap illary</w>
c lif
hewlett- packard</w>
h gt</w>
epir ubicin</w>
3 29</w>
kindergar ten</w>
vag initis</w>
fif teenth</w>
ip t</w>
conf .
head phone</w>
mu th</w>
retro virus</w>
iso propanol</w>
peric ytes</w>
dis integration</w>
15. 9</w>
12 67</w>
seri ousness</w>
sleep -
miti gated</w>
micro injection</w>
syn chro
oblig atory</w>
3 43</w>
th read
av ascular</w>
19 .2</w>
immune- mediated</w>
xi ap</w>
res hap
cc n
ai ke</w>
ol ite</w>
am ends</w>
y ah</w>
check points</w>
asparag ine</w>
line zolid</w>
ml h1</w>
sub mandibular</w>
cy stitis</w>
b ap</w>
50 ,000,000</w>
benz oic</w>
time- series</w>
complex ed</w>
8 3.
late- onset</w>
cefoper azone</w>
ar yl</w>
mel phal
triamcin olone</w>
out perform</w>
0 4-
- level</w>
q r</w>
pheny le
4 28</w>
we iss</w>
ur ate</w>
on ary</w>
diarrhe al</w>
typh i</w>
stere o
nor disk</w>
un affiliated</w>
u str
index ing</w>
kim ber
d bd</w>
sa o2</w>
po e
α- tubulin</w>
ap o-
cler k</w>
ass ass
k ev</w>
nach r</w>
mar tin
td- scdma</w>
heart beat</w>
zygo tic</w>
bul lying</w>
thro wing</w>
liver -
karolin ska</w>
se a-
pr us
timo rese</w>
tel angi
vill agers</w>
ble omycin</w>
symbion ts</w>
para haemolyticus</w>
tim eliness</w>
gly cin
domes tication</w>
qa ida</w>
b 1b</w>
hos tility</w>
manag eable</w>
mang ro
ud der</w>
ro ot
un favourable</w>
well- documented</w>
fibrobl ast
arthro pods</w>
b p2</w>
motoneur ons</w>
figure 66</w>
16. 8</w>
muc 1</w>
eif 4e</w>
post age</w>
tri methyl
ventr ally</w>
world- class</w>
he si
democ rati
multin ucle
e ud
g le</w>
it .</w>
destro ying</w>
pe tic</w>
re bleeding</w>
25 6
esthe tic</w>
rest less</w>
par oxetine</w>
pr pc</w>
ac yl-
rivar oxaban</w>
slo ts</w>
av -
drain ed</w>
peri plasmic</w>
s app</w>
cl ays</w>
ke y-
oce anic</w>
figure 6
evid encing</w>
promin ence</w>
fibrin olysis</w>
isot opes</w>
imparti al</w>
sing let
sti t
ar tes
otrop ium</w>
dimin ishes</w>
18. 4</w>
pop lar</w>
denti st</w>
s lip
trim ming</w>
polypo sis</w>
hither to</w>
3 87</w>
ri p</w>
maastric ht</w>
port land</w>
mo fe
subver sive</w>
c ca
3 49</w>
tou ch-
nur sery</w>
treatment .
er ect</w>
far- reaching</w>
union pay</w>
3 46</w>
prostagland ins</w>
si v
de granulation</w>
mal absorption</w>
sion ary</w>
in- 3</w>
inv ag
d ressed</w>
i ff
c 2c</w>
tt c</w>
c imt</w>
3, 4-
te tro
navig ate</w>
im mobil
por ter</w>
al pro
sh rnas</w>
un defined</w>
η p2</w>
un itary</w>
manit oba</w>
antigen- presenting</w>
oli thic</w>
resec tions</w>
ing el
lrr k2</w>
puerperi um</w>
ran tes</w>
9 73</w>
anthra x</w>
urin ol</w>
1. 28</w>
plat form
ar om
vou chers</w>
di ol</w>
peptid oglycan</w>
mil ten
withdraw ing</w>
ab er
a 3a</w>
financ es</w>
mg so4</w>
bas ins</w>
sr t</w>
dis able</w>
than -
9 2
od ors</w>
wet lands</w>
scis sors</w>
10 d</w>
occlud er</w>
sf a</w>
perioste al</w>
depic ting</w>
n nos</w>
n ou
n ir
go od-
intrac or
universid ad</w>
er ps</w>
strang ers</w>
p st</w>
pulsati le</w>
ns 3</w>
2. 4
cogni tive-
holog raph
urg ical</w>
cd ss</w>
confidence- building</w>
bay lor</w>
17. 8</w>
mn 2</w>
gu ill
n x</w>
o coccus</w>
scour ge</w>
c se</w>
pv p</w>
eti ologic</w>
doc trine</w>
se als</w>
carve dil
con tempor
un planned</w>
us or</w>
defe ated</w>
al ice</w>
3 93</w>
de tro
el y-
ocort ex</w>
broker- dealer</w>
concep tions</w>
inter state</w>
cg m</w>
mind ful</w>
un anticipated</w>
b se</w>
chemo resistance</w>
ni elsen</w>
diffu sion-
ether net</w>
protein -1</w>
do mper
we ather
catastroph e</w>
p gs</w>
glu te
bern stein</w>
β-lactam ase</w>
propan e</w>
th f</w>
din it
self- built</w>
fr y</w>
faith ful</w>
scin tillation</w>
ti otropium</w>
litho trip
weigh s</w>
resol utely</w>
la und
dissemin ating</w>
si rt
e qtl</w>
gel -
ch yl
execu tions</w>
k atp</w>
bl ance</w>
intrav entricular</w>
t sui</w>
a ad</w>
money s</w>
liter ature
n irs</w>
3 i</w>
sl p</w>
imp ressions</w>
heart burn</w>
affi xed</w>
act ome</w>
pd z</w>
off- line</w>
domes ticated</w>
ac ylation</w>
eg g-
ph as
bo ole
tazobac tam</w>
pyre thro
tran sec
⋅ </w>
one- sided</w>
mag i
ov ate</w>
f td</w>
collec tor</w>
oligodendro cyte</w>
new ly-
phag ocytes</w>
neti zens</w>
macroph age-
postp one</w>
synthe sizing</w>
con figure</w>
ic am</w>
focus sed</w>
potenti ate</w>
al ising</w>
hr m</w>
ep ha
tro op-
form ate</w>
suv max</w>
moder ated</w>
group. conclusion</w>
tif ying</w>
mic k</w>
ming zhu</w>
omis sions</w>
de myelinating</w>
tumor- associated</w>
od ine</w>
bul bar</w>
t mem
demol ition</w>
tf h</w>
z id
neuro surgical</w>
17. 9</w>
i i.
unra vel</w>
3 48</w>
g it</w>
t mp</w>
selec tions</w>
v max</w>
w w</w>
in- plane</w>
nav al</w>
mg 132</w>
i om</w>
un explored</w>
hypercalc emia</w>
s ands</w>
n ist</w>
tr i</w>
endos ome</w>
and 33</w>
carcin ogens</w>
re deployment</w>
eg f-
col linearity</w>
right- handed</w>
gol an</w>
4 55</w>
exp ended</w>
l exic
tut orial</w>
proprioc eptive</w>
hiv- negative</w>
singlet ons</w>
w cdma</w>
de stabilizing</w>
dn tp</w>
dazz ling</w>
integr ase</w>
g e-
iv us</w>
ep ic</w>
peace- building</w>
ic loud</w>
tamp on
mon ies</w>
j ensen</w>
pec ific</w>
- t</w>
le o</w>
reb ate</w>
u 6</w>
baghd ad</w>
conventi onally</w>
con spir
v um</w>
ax ine</w>
bad ly</w>
ip ing</w>
op ti
s cl-
wo o</w>
slow s</w>
3 51</w>
entr ainment</w>
h -1</w>
3 72</w>
potenti ated</w>
epist axis</w>
sh iny</w>
mil ling</w>
it ant</w>
no st
le mon</w>
ori enting</w>
fol ia</w>
oncolog ists</w>
mt c</w>
vec </w>
ic os</w>
buck et</w>
dest inations</w>
il-1 α</w>
d pa</w>
v z
mm er</w>
assi gnee</w>
direc tionality</w>
ti tution</w>
non- randomized</w>
glyc ated</w>
ortholog ues</w>
home work</w>
fellow s</w>
f uc
contin ual</w>
mo th</w>
cur sor</w>
ic ef</w>
obses sive-
diplom acy</w>
q- pcr</w>
mmp -1</w>
time frame</w>
interfer ed</w>
lam bs</w>
stem ming</w>
des al
si o</w>
cal gary</w>
alpro sta
radi osurgery</w>
post- operatively</w>
wide- angle</w>
fibro adenoma</w>
pr st</w>
19 .1</w>
mut u
bl ur</w>
harb ouring</w>
www. ncbi.nlm.nih.gov</w>
3 89</w>
nal trex
photovolta ic</w>
as 1</w>
biom aterials</w>
ir rational</w>
3 500</w>
prop yl
min gen</w>
expor ting</w>
new sle
sh aded</w>
v smc</w>
distur b</w>
mo il</w>